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ABSTRACT 
Cyanobacteria hold significant potential as platforms for the production of a wide 
variety of high-value products and biofuel molecules such as biohydrogen, 
isoprenoids and alkanes. Currently, the genome sequences of over 120 
cyanobacterial species are publicly available, and techniques for the genetic 
manipulation of a few species are well established. However, more advanced 
metabolic engineering technologies are required for high-throughput 
production/evaluation of modified strains with improved biofuel characteristics. 
The most popular species for genetic studies is the freshwater species, 
Synechocystis sp. PCC 6803 – not least because it is naturally transformable and 
is a facultative phototroph. We demonstrated in chapter 3, that a deletion of an 
exonuclease gene in Synechocystis greatly increases transformation rates, 
probably through the promotion of non-HR events. However the mutant 
generated did not display random insertional mutagenesis but rather foreign DNA 
was being targeted to specific locations in the genome. On the other hand, 
targeted gene knock-outs and knock-ins are easily achieved in Synechocystis via 
homologous recombination (HR), but the creation of each transforming plasmid is 
rather laborious and involves several PCR and cloning steps. Chapter 4 of this 
thesis describes detailed study conducted to determine the minimum length of 
homologous DNA sequence flanking the foreign DNA that is necessary for 
efficient integration into the cyanobacterial genome. Our findings suggest that as 
little as 50 bases is sufficient for HR and open up the possibility of a quick, single 
step PCR strategy using long-tail primers to achieve any desirable knock-out or 
knock-in. However, the efficiency of the PCR needs to be optimised in order to 
make the technique more efficient. Chapter 5 describes genetic modification of 
the isoprenoid pathway for production of the novel high-value product geraniol 
(C10 monoterpene) and the fuel molecule farnesene (C15 sesquiterpene). 
Finally, chapter 6 exploits the possibility of expressing a biological plug-in for 
facilitated subtract delivery and product removal of hydrocarbons in 
Synechocystis. 
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1.1 Cyanobacteria  
Cyanobacteria (traditionally known as blue-green algae) represent an extremely 
diverse, yet highly specialised group of prokaryotic organisms that live in diverse 
environmental habitats (Hu et al., 2008). Cyanobacteria, which are considered 
ancient relatives of chloroplasts (McFadden, 1999), are the only prokaryotic 
organisms capable of carrying out both plant-like oxygenic photosynthesis 
(Ikeuchi and Tabata, 2001) and hydrogen production (Parmar et al., 2011). The 
photosynthetic apparatus involves the cooperation of two photosystems; 
photosystem I (PSI) and photosystem II (PSII) (Chauvat et al., 1989, Golden et 
al., 1987). Furthermore, they are the only prokaryotic organisms exhibiting a 
circadian clock mechanism (Kunert et al., 2000). Cyanobacteria inhabited earth 
for billions of years during the precambrian era (Mazel et al., 1990) making them 
one of the oldest organisms (Knoop et al., 2010). It has been suggested that they 
played an important role in preserving organic matter found in ancient sediments 
(Tan et al., 2011, Golden et al., 1987) and are believed to be responsible for the 
transformation of the earth’s atmosphere from anoxic to oxic state (Koksharova, 
2002, Schwartz, 1975). Cyanobacteria, being amongst the first colonizers of land, 
provided both physical and chemical substrate for the later growth of plants 
(Koksharova, 2002). Therefore, it comes as no surprise that they have played a 
key role in both evolution and shaping of the earth’s ecology (Vermaas, 2007).  
1.1.1 General overview  
Cyanobacteria are very interesting organisms as they display diversity in their 
metabolism and structure, morphology and habitats (Figure 1.1) (Deng and 
Coleman, 1999). Although classified as photosynthetic bacteria, they appear to 
be the phylogenetic link between bacteria and algae (Stanier et al., 1971). This is 
because, despite their cellular organization being prokaryotic, their photosynthetic 
physiology is very similar to that of the chloroplasts of algae and higher plants 
(Labarre et al., 1989, Koksharova, 2002). Despite the fact that cyanobacteria 
form a phylogenetically monophyletic group of Gram-negative bacteria (Porter, 
1986), they are still referred to as microalgae today (Hu et al., 2008). The distinct 
blue-green colour of cyanobacterial cultures (Figure 1.2.A) is attributed to the 
combination of the green chlorophyll pigment (chlorophyll a) and the blue pigment 
phycocyanin (Figure 1.2.B and C) (Whitton and Potts, 2000). Carotenoids are 
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also amongst other pigments found in cyanobacteria (Figure 1.2.C) (Stanier et 
al., 1971). There are over 4000 distinct species of cyanobacteria (Dismukes et 
al., 2008) and unlike most other prokaryotes (bacteria or archaea), they are 
morphologically recognisable (even at the species level) before collection 
(Castenholz, 1988) because of their conspicuous traits. Despite the fact that 
cyanobacteria lack flagella, some species seem to show a gliding type of 
movement when in contact with a solid surface, while a few are known to swim in 
liquid (Ikeuchi and Tabata, 2001, Koksharova, 2002). Moreover, various 
cyanobacteria are known to respond to light, a process known as phototaxis, 
resulting in preferential localization under certain light conditions. However, the 
exact mechanisms of how positive (towards light) and negative (away from light) 
phototaxis is controlled, and the overall motility of this cyanobacterium remain 
unclear (Ikeuchi and Tabata, 2001).  
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Figure 1.1: A picture display of variouse cyanobacterial species.  
Cyanobacterial species including: (A) Spirulina and Lyngbya, (B) Nostoc (arrows pointing at heterocyst’s), (C) Lyngbya, (D) Merismopedia, (E) Spirulina, 
(F) Synechocystis. Imagines were taken from the internet as detailed in Appendix 16. 
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Figure 1.2: The stucture of phycobilisomes and the absorption spectra of various 
pigments.  
(A) A culture of Synechocystis 6803 (B) The structure of the phycobilisome chromophore, (C) The 
adsorption spectra of various pigments present in cyanobacteria (Chlorophyl a and b, carotenoids 
and phycobilins). (Image A is from my personal collection while B and C were taken from the 
internet as detailed in Appendix 16.  
 
Cyanobacteria can be found almost everywhere on the surface of earth since 
they can grow and survive in numerous environmental conditions (Vermaas, 
2007). They are particularly common in aqueous environments including 
freshwater, brackish, marine and hypersaline (Hu et al., 2008), non-acidic hot 
springs and in soils, rocks and deserts (Ikeuchi and Tabata, 2001, Koksharova, 
2002). In temperate regions, cyanobacteria are especially common in calcareous 
and alkaline soil. They can also be found in extreme environments, such as 
acidic soils (e.g. Anabaena oscillarioides), hot springs (e.g. Synechococcus 
lividus) or moist terrestrial environments of polar regions (e.g. Nostoc 
fuscescens) (Castenholz, 1988).  
Cyanobacteria play a vital role in diverse ecological systems as they often form 
symbiotic relationships with many organisms including plants, algae, fungi, 
bryophytes, ferns, cycads, and invertebrates (corals) (Schwartz, 1975, Adams 
and Duggan, 2008, Adams, 2002).  Examples of such symbiotic associations are 
presented in Figure 1.3 and are shown to play a vital role in the recycling of 
carbon and nitrogen in the atmosphere (Ruffing, 2011). 
Cyanobacteria are generally grouped into unicellular, colonial, 
pseudoparenchymatous, unbranched filamentous, heterocystous, and 
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heterotrichous-heterocystous forms (Desikachary, 1959). Their cell walls are very 
thin, but are frequently surrounded by a broad mucilaginous sheath that may be 
coloured (Prosperi, 2000). Cyanobacterial genomes range from 1.7 Mb for 
Prochlorococcus marinus MED4 which is a marine organism believed to be the 
smallest free-living bacterial genome sequenced thus far, to 9.2 Mb for the 
largest genome that belongs to Nostoc punctiforme ATCC 29133 (Vermaas, 
2007).  
There are several properties in cyanobacteria that make them target organisms 
to study many important processes. For example, cyanobacteria being 
photosynthetic, grow and differentiate when provided with simply sunlight, air, 
and water (Koksharova, 2002). Furthermore, being prokaryotes they are in 
principle, amenable to genetic manipulation by the techniques already developed 
for the intensively studied heterotrophic bacteria such as E. coli (Porter, 1986). 
Moreover, the availability of the full annotated genomic sequence of many 
cyanobacteria makes their genetic manipulation even more attractive (Vermaas, 
2007). For the reasons mentioned above, they have been widely used to study, 
among other topics, higher plant processes like photosynthesis and its genetic 
control, nitrogen fixation, gene regulation and metabolism and heterocyst 
differentiation (Koksharova, 2002, Dzelzkalns and Bogorad, 1986, Min and 
Sherman, 2010a). 
  
23 
 
 
 
 
 
 
 
 
 
Figure removed for copyright reasons 
 
 
 
 
 
 
 
 
Figure 1.3: Examples of cyanobacterial symbiotic associations. 
(A) Symbiotic association between a dinoflagellate (green) with two morophotypes (arrows) of yellow fluorescent cyanobacteria inside the girdle of the 
dinoflagellate (Image taken by RS Foster in the subtropical Atlantic). (B) Symbiotic association between the aquatic fern Azolla and the nitrogen fixing 
cyanobacterium Anabaena, (C) Symbiotic association between the nitrogen fixing cyanobacterium Nostoc with the fungi Geosiphon pyriformis showing 
Nostoc filament (red) and the extracellular polysaccharides of Nostoc and the outer layer of the fungal cell wall labelled by the fluorescence-coupled lectin 
ConA (green).Images were taken from the internet as detailed in Appendix 16.  
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1.1.2 Commercial applications of cyanobacteria  
Microorganisms, in general, have long been exploited for their natural products, 
some of which have been used as fuels, commodity chemicals, specialty 
chemicals, polymers, and drugs (Mukhopadhyay et al., 2008). Cyanobacterial 
strains in particular, have been used for many applications as they can produce a 
range of high-value chemicals and high-energy fuels from sustainable resources 
(Tan et al., 2011) some of which will be covered in this section.  
Although the use of cyanobacteria as food supplement is currently restricted to a 
few species (Spirulina (Arthospira), Nostoc and Aphanizomenon) (Spolaore et al., 
2006), cyanobacteria have commonly been used as a food supplement since 
early history. In China for example, Nostoc flagelliforme is considered a delicacy 
(Gao, 1998) while other species are eaten in India and the Philippines (Tiwari, 
1978).  Species of Spirulina are used as a rich source of protein and vitamins 
(protein accounting for ~ 70% of the dry cell weight) and the protein is used for 
both humans and animals (Ciferri and Tiboni, 1985, Parmar et al., 2011).  
Cyanobacterial pigments are also used as a natural colourant in food (Kay and 
Barton, 1991). Recently, unicellular cyanobacteria have shown great potential for 
the production of valuable products (Knoop et al., 2010). For example, since 
cyanobacterial extracts have been shown to display antioxidant properties (Miller 
et al., 1996), they have been used in the prevention of chronic diseases (Rao and 
Agarwal, 1999) and in drug discovery (Tan, 2007, Sielaff et al., 2006). This is 
attributed to the ability of some strains to synthesise secondary metabolites with 
reported therapeutic effects (Belay et al., 1993).  
Biomolecules such as phycobiliproteins, phcoerythrin, phycocyanin and 
allophycocyanin are naturally produced by cyanobacteria and have many 
commercial applications (Parmar et al., 2011). For example, phycobiliproteins are 
commonly used in fluorescent tagging applications in research (Ruffing, 2011) in 
conjugation with monoclonal and polyclonal antibodies to make fluorescent 
antibody reagents that are used for cell sorting (Koksharova, 2002). While the 
other natural products are used as food dyes or pigments in cosmetics (Parmar 
et al., 2011). Since cyanobacteria mostly thrive in aquatic environments, they are 
excellent vectors for the delivery of mosquitocidal toxins (Ruffing, 2011) while 
some strains are commonly used as natural fertilizers since they can fix 
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atmospheric nitrogen (Parmar et al., 2011). Other environmental applications 
include the use of bioluminescent cyanobacterial reporter strains. Such strains 
have been used as biosensors for the detection of nickel, cobalt and zinc in the 
environment (Loredana et al., 2008). Furthermore, the ability of some strains to 
degrade aromatic hydrocarbons and xenobiotics (due to associated symbiotic 
bacteria) have allowed for their successful applications in bioremediation 
(Koksharova, 2002). 
Another important commercial interest is the synthesis of carotenoids, which can 
be used in industry as colouring agents for food, pharmaceuticals, cosmetics and 
in animal feed (Lagarde et al., 2000). On the other hand, genetically engineered 
cyanobacteria have been utilised to produce chemical products such as fish 
growth hormones (Ruffing, 2011), polyhydroxyalkanoates (PHA’s), a class of 
biodegradable polyesters with many industrial applications (Koksharova, 2002, 
Ducat et al., 2011b) and polyunsaturated fatty acids (PUFA) that are used as 
both human food and animal feed for their known health promoting properties 
(Radmer and Parker, 1994). The use of genetically modified cyanobacteria has 
increased the range of products that can potentially be produced. For example, 
Synechococcus has been recently genetically engineered for the heterologous 
expression of a single gene (efe) from Pseudomonas syringae that lead to the 
successful synthesis of ethylene (Sakai et al., 1997), one of the most important 
building-blocks in synthetic chemical industry (Wang et al., 2012). Furthermore, 
acetone, a solvent and also an important precursor for industrial chemicals was 
recently produced by modified Synechocystis with a reported yield of 36.0 mg/L 
(Zhou et al., 2012).  
On the other hand, many reports exist for the use of genetically modified (GM) 
cyanobacteria in the production of biofuels (Lindberg et al., 2010, Atsumi et al., 
2009). Table 1.1 contains some examples from work done by various 
researchers of such strains and the biofuels they have been engineered to 
produce while Figure 1.4 shows the central metabolic pathways in Synechoystis 
that have been engineered to produce the biofuels listed in Table 1.1 and 
variouse other products of interest. Recently, a few companies, such as Algenol 
Biofuels and Joule Unlimited, have been set up with the focus on using GM 
cyanobacteria for large-scale biofuel production. The fact that these compounds 
can be produced as finished fuels that do not require additional refining or 
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chemical modification for use in an engine (Rude and Schirmer, 2009) and that 
their composition can be tailored by genetic manipulation makes microbial-
produced fuel molecules excellent options as future fungible fuels (Golden et al., 
1987). In addition to the applications mentioned above, cyanobacteria are being 
optimised to overproduce numerous products of value (Liu and Curtiss, 2009). 
Figure 1.5 summarises the many commercial opportunities where cyanobacteria 
can be utilised. It appears that with the recent hyperbole on engineered 
cyanobacteria, it is possible that they will become the E. coli of the next industrial 
generation (Ruffing, 2011). 
Table 1.1: Biofuels produced in genetically engineered cyanobacteria. 
 
Fuel molecule 
 
Species engineered 
 
No. of 
genes 
 
ref 
Ethanol 
(C2H5OH) 
• Synechocystis sp PCC6803 
• Synechococcus elongatus sp 
PCC7942 
• Anabaena sp PCC7120 
 
2 
2 
(Dexter and Fu, 2009) 
 
(Deng and Coleman, 1999) 
 
 
Algenol Biofuels 2010 
1-Butanol 
(C4H9OH) 
• Synechococcus elongatus sp 
PCC7942 
 
5 
 
(Lan and Liao, 2011) 
Isobutanol 
(C4H9OH) 
• Synechococcus elongates sp 
PCC7942 
• Synechocystis sp PCC6803                             
 
5 
 
 
2 
 
(Atsumi et al., 2009) 
 
 
(Varman et al., 2013) 
 
Ethylene 
(C2H4) 
• Synechococcus elongatus sp 
PCC7942 
 
1 
 
(Sakai et al., 1997) 
Isobutyraldehyde 
(C4H8O) 
• Synechococcus elongatus sp 
PCC7942 
 
5 
 
(Atsumi et al., 2009) 
Isoprene 
(C5H8) • Synechocystis sp PCC6803 
1 (Lindberg et al., 2010) 
Free fatty acids 
(C10–C18) 
• Synechocystis sp PCC6803 5  (Liu et al., 2011) 
Fatty alcohols 
(C16/C18) 
• Synechocystis sp PCC6803 
 
1  (Tan et al., 2011) 
n-alkanes 
(CnH2n) 
• Synechococcus sp PCC7002 
• Thermosynechococcus 
elongatus sp BP-1 
 
2 
 
(Tan et al., 2011) 
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• Synechocystis sp PCC6803 
Hydrogen 
(H2) 
• Synechococcus elongates sp 
PCC7942 1 (Ducat et al., 2011a) 
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Figure 1.4 Central metabolic pathways and products from Synechocystis 6803.  
The functions of several pathways (marked as dot-lines) are still not verified. Key: 3PG: 3-phosphoglycerate; 
3HB: 3-hydroxybutyrate; AKG: α-ketoglutarate; CIT: citrate; F6P: fructose 6-phosphate; G6P: glucose 6-
phosphate; GAP: glyceraldehyde 3-phosphate; GLX: glyoxylate; GLY: glycine; ICT: isocitrate; MAL: malate; 
Mal-CoA: Malonyl-CoA; OAA: oxoacetate; PEP: phosphoenolpyruvate; PHB: polyhydroxybutyrate; 
PSI&PSII: photosystem I & photosystem II; PYR: pyruvate; Ru5P: ribulose-5-phosphate; RuBP: ribulose-
1,5-diphosphate; SER: serine; SUC: succinate; SucCoA: succinyl-CoA; SSA: succinic semialdehyde. 
Adopted from (Yu et al., 2013). 
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Figure 1.5: Commercial opportunities of cyanobacteria for production of biofuels and co-products. Modified from (Parmar et al., 
2011).  
Key: BTL: bipolar tetraether lipids, CH4: methane, O2: oxygen, CO2: carbon dioxide, H2O: water, H2: hydrogen, e-: electrons. 
 29 
 
1.1.3 Cyanobacterial transformation  
Several cyanobacterial strains are capable of being transformed with 
exogenously added DNA (Porter, 1986) or can accept mobilised plasmid DNA by 
conjugation from E. coli (Elhai and Wolk, 1988). Natural transformation, which is 
the transfer of free DNA into cells, was first described for Synechococcus sp. 
strain PCC7943 (Anacystis nidulans 602) by Shestakov and Khuyen (Shestakov 
and Khyen, 1970) and is still considered the primary means for gene transfer in 
unicellular cyanobacteria today (Golden et al., 1987). Synechococcus species 
along with Synechocystis species are among the few species that are known to 
be naturally transformable by exogenous DNA (Porter, 1986).   
Since the discovery of cyanobacterial transformation in the 1970’s, many 
techniques such as electroporation and ultrasonic treatment have been 
developed and applied to several cyanobacterial strains. Examples of strains 
transformed by different methods can be found in Table 1.2. It was noted that, in 
Synechocystis, almost all the exogenous DNA is integrated into the genome 
following natural transformation by means of a well-established double 
homologous recombination system (Zang et al., 2007, Kufryk et al., 2002) and 
cyanobacteria that use systems with homologous recombination mechanisms 
allow for more effective gene modifications to wild type genes (Vermaas, 1998). 
This is true since gene replacement depends on homologous recombination in 
order to replace a section of the recipient chromosome with a donor DNA that 
contains a selectable marker (Figure 1.7.A) (Williams, 1988). Williams and 
Szalay. (1983), were the first to demonstrate homologous recombination in 
cyanobacteria as a means of transformation, while Golden and Wiest. (1988), 
were the first to achieve homologous recombination in Anabaena.  
Transformation of cyanobacteria has been thoroughly reviewed (Porter, 1986, 
Shestakov and Khyen, 1970, Eaton-Rye, 2004, Koksharova, 2002) and the 
methodology has been well described (Porter, 1988, Golden and Sherman, 
1984). Nonetheless, very little is known on the mechanism by which DNA binds 
to the cell, gets processed and subsequently transported across the membrane 
during transformation (Kufryk et al., 2002, Vermaas, 1996, Barten and Lill, 1995). 
However, it is thought that type IV pili are involved in the uptake process (Ikeuchi 
and Tabata, 2001, Eaton-Rye, 2004). All of the cyanobacteria that have been 
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shown to be transformable are unicellular, non-heterocyst forming strains that 
have been classified as Synechococcus or Synechocystis (Porter, 1986). 
Furthermore, out of the approximately 300 cyanobacterial species registered in 
culture collections, less than ten have been reported to be naturally competent 
(de Tarsac and Houmard, 1987).  
There are many factors that affect the frequency and efficiency of transformation 
in cyanobacteria. These include the strain used, the length, form and 
concentration of DNA used and also on the method used for transformation 
(Kufryk et al., 2002). There is no doubt that improving transformation methods in 
cyanobacteria will help accelerate cyanobacterial research and will aid in the 
development of tools for the modification of cyanobacteria. 
Table 1.2: Cyanobacterial strains and methods used for their transformation. 
Cyanobacterial 
species 
Method of transformation Reference 
Anabaena sp.  electroporation (Thiel and Poo, 1989) 
Synechococcus 
sp.  
 electroporation 
 natural transformation  
(Matsunaga et al., 
1990)  
(Porter, 1986) 
Fremylla 
diplosiphon  
 electroporation (Chiang et al., 1992) 
Plectonema 
boryanum  
 electroporation (Vachhani et al., 
1993) 
Synechocystis sp.  electroporation 
 ultrasonic transformation  
 naturaltransformation  
(Zang et al., 2007) 
1.1.4 Genetic tools for cyanobacteria 
The past two decades have shown enormous development in the field of 
molecular biology for cyanobacteria going from almost the absence of any 
knowledge of the molecular biology of cyanobacteria in the mid-seventies to the 
development of transformation systems in the eighties (Golden and Sherman, 
1984, Golden et al., 1987) to a full-fledged unique and promising field of research 
in the nineties (Kay and Barton, 1991, Sakai et al., 1997, Vermaas, 1998) due to 
the determination of the full sequence of the cyanobacterium Synechocystis PCC 
6803 in 1996 (Vermaas, 1996). Since then, tremendous efforts have been 
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invested in the development of many genetic tools for unicellular and filamentous 
strains of cyanobacteria and they have been thoroughly reviewed (Thiel, 2004, 
Elhai, 1994, Elhai and Wolk, 1988). 
As mentioned in the previous section, cyanobacteria have a great potential in the 
production of renewable fuels, various chemicals and nutritional products. The 
development of synthetic biology tools can help un-lock cyanobacteria’s potential 
for these functions. However, the development of molecular tools and 
engineering technologies for these microorganisms is far behind those 
established for S. cerevisiae and E. coli (Berla et al., 2013). Nevertheless, the 
recent development of genetic engineering and synthetic biology tools, has seen 
significant advances in strain improvement (Alper and Stephanopoulos, 2009). 
Synthetic biology can be defined as “the use of DNA synthesis and recombinant 
DNA technologies to design and construct novel functions and genetic circuits” 
(Alper and Stephanopoulos, 2009). According to Connor and Atsumi. (2010), 
synthetic biology in its core aims to (1) use standardised and well characterised 
building blocks “bio-Bricks”, (2) hierarchical design of artificial yet nature inspired 
genetic circuits in silico, and (3) use chemical synthesis to produce novel DNA 
sequences to achieve a desired target (Huang et al., 2010). The steps therefore 
involve the creation of a “toolbox” or a “library” of biological parts that can be 
used separately or in a larger assembly for a higher function (Andrianantoandro 
et al., 2006).  
The “bio-Brick” method, involves the expression of genes in microorganisms by 
the addition of plasmids that are constructed to include standardised genetic 
“parts” such as promoters, ribosome binding sites (RBS), genes, terminators and 
other regulatory elements that can all be swapped in and out standard plasmids 
as illustrated in Figure 1.6 (Berla et al., 2013, Wang et al., 2012). This method is 
becoming routinely used for gene expression in cyanobacteria (Huang et al., 
2010, Huang and Lindblad, 2013, Landry et al., 2013).  
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Figure 1.6: A schematic representation of a typical BioBrick plasmid. 
Key: (E: EcoRI and X: XbaI): BioBrick cloning site prefix, (S: SpeI and P: PstI): BioBrick cloning 
site suffix, examples of parts include: promoters, ribosome binding sites (RBS), protein coding 
sequences (CDS) and terminators. The figure is based on an image taken from the internet as 
detailed in Appendix 16.  
 
The assembly of the biological parts/components happens in a hierarchal manner 
to create a programed cell with a desired function (Andrianantoandro et al., 
2006). This modern tool has become a valuable technology and has opened the 
doors to produce a whole new range of novel molecules in standard model 
organisms. For example, synthetic biology has been applied to build and 
introduce synthetic pathways for hydrogen production in E. coli (Yoshida et al., 
2007) while it was employed for isoprenoid-based fuel production in various other 
microorganisms including cyanobacteria (Lee et al., 2008, Withers et al., 2007, 
Keasling and Chou, 2008).  
On the other hand, metabolic engineering, which is considered as the main 
technology for designing biofuel producing organisms, emerged approximately 15 
years ago as a distinct field that is differentiated from genetic engineering by its 
focus on the properties of biosynthetic and metabolic pathways in their entirety, 
instead of single genes and enzymes (Stephanopoulos and Sinskey, 1993). 
Traditional engineering approaches therefore focus on the “fine-tuning” of core 
components to meet strict guidelines in order to achieve a specific task (Connor 
and Atsumi, 2010, Keasling, 2008). Using synthetic biology for advanced 
metabolic engineering could help in overcoming challenges such as the 
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complexity of modeling the photosynthetic metabolism and poor annotations of 
important metabolic pathways for most cyanobacteria (Berla et al., 2013).  
Model organisms: There are a number of cyanobacterial species that are 
suitable for genetic modification and these include the two model organisms, 
Synechocystis sp. PCC 6803 and Synechococcus sp. PCC 7002. Both strains 
are naturally transformable and efficiently integrate foreign DNA into their 
genome by means of homologous recombination (Williams, 1988, Vermaas, 
1998). Furthermore, Synechocystis has the ability to grow well in the absence 
photosynthesis so long as the cells are supplemented with glucose (Vermaas, 
1996). The availability of fully sequenced genomes of some strains makes 
genetic manipulations of these organisms much more attractive as information 
can be extracted through functional genomics, proteome and transcriptome 
studies (Ikeuchi and Tabata, 2001). The wealth of information on Synechocystis 
specifically allowed for biochemical pathway modifications and engineering of this 
strain (Wu and Vermaas, 1995), which allowed for the development of 
Synechocystis 6803 models that analyse growth under different conditions, 
detect bottlenecks and gene-knockout candidates for enhanced metabolic 
production of products such as hydrogen and ethanol (Knoop et al., 2010), and 
models that represent the photosynthetic apparatus in detail and can detect 
alternate flow pathways of electrons (Nogales et al., 2012). The latest strain of all 
Synechocystis 6803 models is the iSyn731 strain, which integrates all these 
recent developments and adds on to them improved metabolic capability (Berla 
et al., 2013). For example, the strain contains as many as 322 unique reactions 
including those related to the heptadecane and fatty acid biosynthesis (Saha et 
al., 2012). Nevertheless, there is an essential need to develop a more advanced 
synthetic biology toolbox for cyanobacteria similar to those developed for E. coli.  
Gene modifications: Gene modification plays a critical role in the successful 
development of engineered microorganisms (Ruffing, 2011) and can be 
performed either in cis (through chromosomal editing) or in trans (through foreign 
plasmid addition) where in cis gene modification is the most common approach in 
cyanobacterial synthetic biology (Berla et al., 2013). This is because 
chromosomal integration of a target gene allows for a more strict and 
reproducible control of the expressed gene (Ruffing, 2011). Figure 1.7 illustrates 
the difference between the two approaches for gene modifications. Furthermore, 
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advances in DNA synthesis technologies now make possible the design of 
bespoke coding sequences, and the use of codon optimised trans-genes has 
been shown to improve the expression of heterologous proteins in cyanobacterial 
hosts (Gustafsson et al., 2004). It is important to note that while the over-
expression of genes is a useful tool to increase the overall yield of a desired 
product, there are several problems associated with over-expression in an 
engineered host and these include: the depletion of precursors or resources 
necessary for the host growth and production (Glick, 1995), the stress introduced 
in the host due to heterologous protein expression (Goff and Goldberg, 1985) and 
the imbalances in the total enzyme activity in the pathway that can lead to 
restricted carbon flux and lead to accumulation of toxic intermediate or products 
(Peralta-Yahya and Keasling, 2010). Nevertheless, it has been shown that by 
over-expressing IPP and DMAPP in E. coli, using terpene synthase mutants, that 
eight different terpenes can be produced in the engineered strains (Yoshikuni et 
al., 2006).  
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Figure 1.7: An illlistration of the in cis and in trans gene modification methods. 
(A) The method for cis genetic modification employs a suicide vector that is inserted into the 
cyanobacterial genome at a neutral site (NS, black) with upstream (US) and downstream (DS) 
flanking regions in the vector (green). The insert contains an arbitrary sequence of interest 
(ATGCATG, orange) and a selectable marker (SM, purple). (B) Genetic modification in Trans via 
expression plasmids. Modified from (Berla et al., 2013). 
 
Other advances in the field include the development of gene transfer methods for 
cyanobacterial species that are not naturally transformable. Furthermore, the 
ability to mutate or manipulate endogenous genes is necessary to complement 
the introduction of novel trans-genes in any metabolic engineering strategy. Gene 
transfer methods, in addition to natural transformation, include electroporation 
and conjugation systems (Berla et al., 2013, Ruffing, 2011). Electroporation 
involves exposing the cells to an electrical field, which results in a temporary loss 
of semipermeability of cell membranes, thus leading to an increased uptake by 
cells of DNA (Tsong, 1991), while conjugation involves the transfer of plasmid 
DNA from a donor to a recipient bacterium through cell-to-cell contact (Stucken et 
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al., 2012). Although electroporation has been successfully employed for the 
transformation of filamentous cyanobacteria, conjugal transfer from Escherichia 
coli is generally the standard method of choice. On the other hand, natural 
transformation is generally the method used for the transformation of unicellular 
cyanobacteria (Ravindran et al., 2006, Thiel and Poo, 1989). 
While gene inactivation can be achieved by chemical and UV mutagenesis 
(Dzelzkalns and Bogorad, 1986), other methods are also available such as 
targeted gene interruption (Williams, 1988), site–directed mutagenesis (Chu et 
al., 1994), transposon mutagenesis (Tn5 mutagenesis) (Tandeau de Marsac et 
al., 1982, Berla et al., 2013), and random cartridge mutagenesis (Labarre et al., 
1989, Chauvat et al., 1989). All methods are equally important and the method of 
choice depends largely on the particular application. However, it should be noted 
that the use of transposons to create mutants works poorly in cyanobacteria 
(Berla et al., 2013). Figure 1.8 illustrates methods used for targeted gene 
mutagenesis.Transformation and conjugation systems combined with the ability 
to clone and inactivate genes in cyanobacteria by various methods have opened 
the door to many advanced studies (Golden et al., 1987) and can be the first step 
towards many applications such as pathway engineering, overproduction of 
specific compounds and the biochemical analysis of protein function.  
  
 
37 
 
 
 
 
 
 
 
 
 
 
 
Figure removed for copyright reasons 
 
 
  
 
 
 
 
 
Figure 1.8: Methods used for targeted gene mutagenesis. 
(A) Targeted gene interruption by means of double homologous recombination. (B) Site-directed mutagenesis employing oligonucleotides which can 
include point mutations, insertions and deletions. Figure B was modified from an image taken from the internet as detailed in Appendix 16. 
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Pathway engineering: It is well known that the metabolic networks of any 
microorganism are highly complex and nonlinear. They are also tightly 
coordinated to carry out a large number of biochemical reactions in a highly 
organised manner. While the metabolic networks of bacteria have been studied 
for over three decades, those of cyanobacteria have only relatively recently been 
investigated (Lu et al., 2011). One example is the impressive efforts done by Fu. 
(2009), who reconstructed the genome-scale metabolic network of Synechocystis 
which included 633 genes, 704 metabolites and 831 metabolic reactions. This 
was done to study optimal Synechocystis growth, network capacity and functions 
as well as in silico predictions of different growth conditions for the model 
organism. Furthermore, the model was utilised for the insertion of the ethanol 
fermentation pathway.  
It is clear from the previous example that metabolic engineering work no longer 
only focuses on re-wiring native metabolic pathways towards pathways of interest 
(Leonard et al., 2008, Zhang et al., 2008) but rather the construction of new 
pathways. Another example, is the enhanced production of farnesene and 
various long-chain alcohols (C5-C8) in E. coli by Wang et al. (2011), and Zhang et 
al. (2008), respectively via the re-construction of the yeast mevalonate pathway 
in E. coli. Nonetheless, it is still not clear whether metabolic pathway optimisation 
is more robust when it is carried out in native strains or in recombinant strains in 
which exogenous pathways are introduced (Alper and Stephanopoulos, 2009) 
and for this both methods are currently utilised.  
Finally, it is important to note that in the process of optimising microbial metabolic 
pathways, it is essential to maintain a balanced redox state in the engineered 
microbes (Mukhopadhyay et al., 2008). This is to avoid the buildup of toxic 
byproducts that will ultimately hamper the production of a desired product. 
Furthermore, production potentials are limited by the low activity of pathway 
enzymes, an important factor that needs to be addressed when developing tools 
for pathway engineering. There is no doubt that adopting recently emerging tools 
in synthetic biology will be enormously beneficial in overcoming such challenges 
(Lee et al., 2008). 
New tools for model organisms: Several new tools for the model organism 
Synechocystis have recently been developed. For example, a cell-viability 
fluorescence assay was developed that provides a quick and simple way of 
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detecting viable from none viable cells in a cyanobacterial culture. This method 
can be used to monitor the fitness of cultures grown for novel products such as 
biofuels (Schulze et al., 2011). Recently, the development of degradation tags 
used for the fine-tuning of protein levels and protein turnover times in this model 
organism has been achieved. Such advances aids in the generation of more 
complex metabolic systems that have the potential to oscillate in step with 
circadian rhythms in cyanobacteria (Landry et al., 2013). Furthermore, 
recombinant DNA technology has been employed in Synechocystis for the 
increased production of carotenoids (e.g. zeaxanthin) (Lagarde et al., 2000).  
Another important tool in genetic engineering work that has a particularly 
important industrial application is the development of gene replacements 
methods that allow for the creation of antibiotic-free genetically modified 
microorganism (Lagarde et al., 2000). Such strains can be created using the toxic 
levanusucrase gene (sacB) that is isolated from Bacillus subtilis (Eaton-Rye, 
2004, Ruffing, 2011). In this method, first the microorganism is transformed with 
the sacB gene (or any other toxic gene) linked to the selectable marker gene with 
flanking sequences to replace the target gene. This transformation will result in a 
strain that is both resistant to the selectable marker but sensitive to 5% sucrose 
since the mutant cells convert the sucrose into levans, which are toxic fructose 
polymers (Dedonder, 1966). In the second transformation, the strain is 
transformed with a construct that contains only flanking sequences upstream and 
downstream of the inserted sacB and selectable marker genes. The 
transformation results in the creation of a markerless mutant (lacking the sacB-
antibiotic resistance cassette) that can grow on 5% sucrose (Eaton-Rye, 2004, 
Liu and Curtiss, 2009, Vermaas, 2007, Ruffing, 2011). The sacB method for 
creating markerless mutants is illustrated in Figure 1.9. Such antibiotic-free 
strains are currently available for various model cyanobacterial strains.   
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Figure 1.9: The sacB method for creating markless mutants.  
(A) A DNA fragment carrying the selectable marker (SM)/sacB genes flanked on either end with 
regions homologous to the DNA sequences of the target site is integrated into the chromosome. 
(B) A DNA fragment carrying the desired deletion or insertion, again flanked by two regions 
homologous to the DNA sequences of the target sites, replaces the selectable marker /sacB 
genes through homologous recombination. Modified from (Sun et al., 2008).  
 
The potential uses of modern metabolic engineering tools and how they can play 
an important role in achieving large scale production of biofuels and other 
valuable products from microalgae were summarised by Chisti. (2007), and 
include: increase the photosynthetic efficiency of microorganisms to increase the 
biomass yield, speed up growth rates, increase the oil content in biomass, 
improve the tolerance of the biofuel producing organisms to variations in 
temperature to reduce the expense of cooling, eliminate the light saturation 
phenomena and reduce the susceptibility to photo-oxidation that leads to cell 
damage.  
To sum up, the advancement of molecular genetic tools has allowed for the 
recent progress in cyanobacterial research and with time, the methods will be 
perfected further and new methods will be developed. However, it is important to 
combine genetic tools with other disciplines such as biochemistry in order to get 
more fruitful results. Furthermore, a better understanding of the system-level of 
microbial metabolism and the effects of product toxicity is also essential 
(Mukhopadhyay et al., 2008). Part of the work presented in this thesis covers the 
potential for tools developed aimed at rapid gene modification in Synechocystis 
where a potential method for random insertional mutagenesis is covered in 
chapter 3 and a simple and quick method for targeted gene deletions is 
discussed in chapter 4. 
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1.2 Synechocystis sp. strain PCC 6803 
1.2.1 General overview 
Synechocystis sp. strain PCC 6803 (hereafter, Synechocystis) is a freshwater, 
non-filamentous, non-nitrogen fixing, unicellular, coccoid cyanobacterium lacking 
gas vesicles or a sheath (Ikeuchi and Tabata, 2001). It was isolated from a 
freshwater lake in California in 1968 and is, as mentioned earlier, easily 
transformed by exogenous DNA by means of a well-established double 
homologous recombination system (Williams, 1988, Kufryk et al., 2002). It was 
the fourth living organism to have its genome fully sequenced (Kaneko et al., 
1996) and the first photosynthetic autotrophic organism whose genome was 
completely sequenced and annotated (Dexter and Fu, 2009, Ikeuchi and Tabata, 
2001). The genome consists of a single chromosome and seven plasmids of 
different sizes [four small and three larger (>5kb)] (Kaneko et al., 1996). The 
circular genome of this cyanobacterium was originally deduced to be 3.5 Mb (3.9 
Mb including plasmids) with an average GC content of 47.7% (Koksharova, 2002, 
Kaneko et al., 1996) constituting 3317 assigned protein coding genes (3725 
including plasmids-cyanobase) (Lu et al., 2011). Many researchers reported that 
Synechocystis species carry multiple genome copies per cell with most agreeing 
that it contains approximately ten copies (Eaton-Rye, 2004, Koksharova, 2002). A 
property shared with a number of other cyanobacteria (Vermaas, 1996). In terms 
of cell division, It was reported that the cells divide by binary fission in two or 
three successive planes (Ikeuchi and Tabata, 2001). 
Although classified as a Gram negative bacterium, the DNA uptake mechanism 
during transformation is, overall, similar to that of Gram positive bacteria (Barten 
and Lill, 1995). Furthermore, Synechocystis cells, which are 1.5 to 2 μm in 
diameter (Ughy and Ajlani, 2004) (Figure 1.10), are much larger than average E. 
coli cells which are 0.5 μm in diameter.  
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Figure 1.10: Synechocystis  sp. strain PCC 6803.  
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(A) Wild type Synechocystis sp. strain PCC 6803 under the red channel showing laser excited 
chlorophyll (488 nm). Figure obtained from Joanna Sacharz (Queen Mary University of, London). 
(B) Wild type Synechocystis sp. Strain PCC 6803 under light microscope. Bar scale showing 5 
μm in both images. Figure B was taken from the internet as detailed in Appendix 16. 
 
Synechocystis is a mesophilic bacterium that grows optimally between 30°C and 
34°C and at an optimal light intensity of 40-70 µE m-2 s-1 (Vermaas, 1996). It is a 
basophilic bacterium, hence grows well between pH 8.0 and pH 10.0 (Eaton-Rye, 
2004). An interesting feature of Synechocystis is that it can utilise external fixed-
carbon sources such as glucose or organic acids and grows very well in the 
presence of these compounds even if photosynthesis has been inhibited 
(Vermaas, 2007). That is probably why Synechocystis has a large variety of 
parallel physiological pathways. It has been reported that Synechocystis can 
grow fully photo-autotrophically, mixotrophically, and chemo-heterotrophically 
(Angermayr et al., 2009), a feature that enables the organism to survive and 
thrive in a wide range of physiological conditions (Vermaas, 2007). This property 
can be exploited to isolate and study viable mutants defective in photosynthesis 
(Astier et al., 1984). For this reason, this cyanobacterium has been widely used 
as a model for photosynthesis research (Eaton-Rye, 2004, Dexter and Fu, 2009). 
Table 1.3 summarises the different growth conditions in which the 
cyanobacterium can survive in and the average doubling times under each 
condition. 
Table 1.3: Growth modes of Synechocystis. Adopted from (Vermaas, 1996).   
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Synechocystis are physiologically well characterised and relatively fast growing. 
Although Table 1.3 shows a minimum doubling time of 12 hours, some 
researchers have reported an average minimal doubling time of 6 to 12 hours 
(Heidorn et al., 2011, Angermayr et al., 2009). Furthermore, Synechocystis has 
no unusual nutritional demands, hence exhibits robust growth characteristics. In 
addition, the use of Synechocystis has the advantage of having a large body of 
methodological work associated with the genetics and genetic engineering 
strategies (Dexter and Fu, 2009). Its genome is genetically well characterised, 
and annotated, being publicly available at CyanoBase [1] and CyanoMutants [2] the 
two chief sites for information on cyanobacterial gene structure and gene 
function, respectively (Ikeuchi and Tabata, 2001). Finally, due to the development 
of genetic engineering tools for this model organism (section 1.1.4), there are a 
lot of data available on the regulation of gene expression and genetic designs 
related to promoter activities that result in controlled expression of heterologous 
metabolic pathways in this cyanobacterium (Angermayr et al., 2009). All these 
advantages make Synechocystis a well-established genetically-tractable platform 
for the production of many novel bio-products and an extremely useful and easy 
model to study cellular processes especially those of photosynthetic organisms.  
1.2.2 Cell Structure & strain origins  
Cell structure: since cyanobacteria are prokaryotic organisms, we expect their 
cellular organization to be similar to that of other bacteria. Indeed, cyanobacteria 
contain cell envelopes with combined features from both Gram positive and Gram 
negative bacteria. For instance, the overall structure resembles that of Gram 
negative bacteria but the peptidoglycan layer found in cyanobacteria is 
considerably thicker than that of most Gram negative bacteria (Hoiczyk and 
Hansel, 2000). In addition, the degree of crosslinking between the peptidoglycan 
chains within the cell wall layer of cyanobacteria (56–63%) is far higher than that 
in most Gram negative bacteria (20–33%). This may well be the reason why the 
                                            
 
1 http://www. kazusa.or.jp/cyano/  
 
2 http://www.kazuza.or.jp/cyano/mutants/ 
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DNA uptake system in Synechocystis appears to be closer related to the one in 
Gram-positives (Barten and Lill, 1995). Furthermore, there are other components 
of cyanobacterial outer membranes that are not present in Gram negative 
bacteria such as carotenoids (Omata and Murata, 1984, Resch and Gibson, 
1983), unusual fatty acids, such as β-hydroxypalmitic acid and porins (Hansel et 
al., 1998), to name a few. 
The cell envelope of Synechocystis is generally composed of four layers: the 
external surface layers (such as S-layers and carbohydrate structures), the outer 
membrane, the polypeptidoglycan layer and the cytoplasmic membrane 
(Mullineaux, 1999, Liberton et al., 2006). These layers can clearly be seen in 
Figure 1.11. The S-layer commonly found in cyanobacteria is normally composed 
of a single species of (glyco)protein that covers the entire cell. It is believed to act 
as a protective coat or molecule sieve, or is possibly involved in cell adhesion 
and recognition (Sleytr et al., 1993).  
 
 
 
                 Figure removed for copyright reasons 
 
 
 
 
Figure 1.11: The envelope layers of the Synechosystis cell.  
The S-layer (asterisk), outer membrane (white arrowhead), peptidoglycan layer (arrow), and 
cytoplasmic membrane (black arrowhead) are indicated. Scale bar, 50 nm. (Liu and Curtiss, 
2009). 
Strain origin: The Berkeley strain 6803, which was isolated from a freshwater 
lake in California in 1968 by R. Kunisawa (Stanier et al., 1971) is believed to be 
the origin of four other culture sub-strains (‘PCC’, ‘ATCC’, ‘GT’ (glucose-tolerant) 
and ‘Kazusa’). Rippka R. (1992), explained that it was originally believed that 
these subcultures were the same. For this reason, they were grouped together 
under the name of Synechocystis sp. PCC strain number 6803. The four sub-
strains were described by Ikeuchi and Tabata. (2001), where certain differences 
in their phenotypes were highlighted as are represented in Figure 1.12.  
 
 45 
 
 
 
 
  Figure removed for copyright reasons 
 
 
 
 
 
 
Figure 1.12: Strain history of Synechosystis sp. PCC 6803 (Ikeuchi and Tabata, 
2001). 
 
Some of these differences are obvious phenotypic differences, while others are 
more subtle genetic variations (Williams, 1988). For example, the Berkeley and 
PCC strains are motile, while the others are apparently non-motile. Both PCC 
and ATCC strains are sensitive to glucose, whereas the glucose-tolerant (GT) 
strain was intentionally generated under defined conditions. Furthermore, the 
Kazusa strain is non-competent for transformation with exogenous DNA, while 
the other strains are naturally transformable (Grigorieva and Shestakov, 1982). It 
is important to note that only the Kazusa strain had its genome fully sequenced 
(Kaneko et al., 1996). In addition to the previous more detailed description of the 
sub cultures, the Synechocystis genus can generally be grouped into three 
groups based on the GC content; namely, the marine group, the low GC group 
and the high GC group, where Synechocystis PCC 6803 belongs to the latter 
group (Bergey and Holt, 1994). An interesting phenomenon that has been 
observed is that cultures has been found to change upon prolonged maintenance 
in the laboratory (Ikeuchi and Tabata, 2001), an important consideration to take 
on-board when working on strains to study mutations that result in a phenotypic 
difference.  
1.2.3 Promoter systems  
Suitable promoter elements (either native or foreign) are necessary for the 
effective and strong expression of foreign genes in any microorganism. Whether 
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the integration of the foreign gene takes place in the chromosome or on a 
replicating plasmid, the expression of a foreign gene requires a promoter that can 
be recognised in the host. Many native and foreign promoters have been 
evaluated in cyanobacteria mostly using Synechocystis 6803 and 
Synechococcus 7942 (Wang et al., 2012). In Synechocystis, several strong 
promoters have been identified (Ruffing, 2011). One example is the light 
regulated psbAII promoter that has been used to overexpress a number of native 
and foreign genes in Synechocystis (Lagarde et al., 2000, Lindberg et al., 2010, 
Mohamed et al., 1993). The fact that the expression of genes under this native 
promoter can be regulated is a big advantage. (Lindblad et al., 2012) showed that 
the foreign gene expression can be up regulated when cultures are grown under 
high light intensities and down regulated when cultured under low light intensities. 
Some genes, with products that are toxic to the cell, require a controlled 
expression and for that promoters such as the native nickel-inducible promoter 
nrsB can be utilised (Liu and Curtiss, 2009). The expression of the promoter is 
tightly regulated and functions in an on-off manner and also displays a dose-
dependent response to added nickel, a very important feature for the regulated 
expression of certain genes. A list of promoters that have been used to drive 
expression in Synechocystis can be found in Table 1.4. It is clear from the table 
that the native promoters used are normally of genes that are essential to 
aspects of photosynthesis like CO2 fixation (PrbcL, Pcmp, Psbt), photosystem I (PSI) 
( PpsaA, PpsaD), photosystem II (PSII) (PpsbAI, PpsbA2), and the photosynthesis 
antenna protein phycocyanin (Pcpc) (Wang et al., 2012). Besides native 
promoters, a number of foreign promoters have also been utilised in 
cyanobacteria, although the usage of such promoters has been limited. 
Interestingly to note is that although some strong E. coli promoters (e.g. Ptac/Ptrc) 
have shown to express high levels of genes of interest in cyanobacteria, others  
(e.g. Plac, Ptet, and λ PR) show little or no detectable activity in Synechocystis 
(Wang et al., 2012). Furthermore, it has been reported that inducible promoters 
that are strictly regulated in species such as E. coli may not be controlled well in 
the cyanobacterial host (Elhai, 1994). All Synechocystis work conducted and 
presented in this thesis utilises the two native promoters psbAII and nrsB for their 
known strong and well regulated expression in this model organism. 
Table 1.4: List of promoters used to drive expression of genes in Synechocystis. 
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Promoter Source Inducer/repressor 
 and concentration 
References 
ArsB Synechocystis sp. PCC 
6803 
Inducer  AsO2- (720 Mm) (Blasi, Peca et al. 2012)   
petE Synechocystis sp. PCC 
6803 
Inducer  Cu2+ (0.5 μM) (Fernando, Verónica et 
al. 2012) 
nrsB  Synechocystis sp. PCC 
6803 
Inducer Ni2+ (0.5 μM) (Peca, Kos et al. 2007) 
nrsB  Synechocystis sp. PCC 
6803 
Inducer Ni2+ (5 μM) (Blasi, Peca et al. 2012) 
nrsB  Synechocystis sp. PCC 
6803 
Inducer Ni2+ (6.4 μM)  (Peca, Kos et al. 2008) 
nrsB  Synechocystis sp. PCC 
6803 
Inducer Ni2+ (15 μM)  
and Co2+(3μM) 
(Peca, Kos et al. 2007) 
nrsB  Synechocystis sp. PCC 
6803 
Inducer Ni2+   
(7μM and 20 μM) 
(Liu and Curtiss 2009)  
isiAB  Synechocystis sp. PCC 
6803 
Repressor Fe3+ (30μM)  (Kunert, Hagemann et 
al. 2000)  
ZiaA Synechocystis sp. PCC 
6803 
Inducer Cd2+ (2 μM) (Blasi, Peca et al. 2012) 
ZiaA Synechocystis sp. PCC 
6803 
Inducer Zn2+ (5 μM) (Peca, Kos et al. 2007) 
ZiaA Synechocystis sp. PCC 
6803 
Inducer Zn2+ (4 μM) (Blasi, Peca et al. 2012) 
ZiaAa Synechocystis sp. PCC 
6803 
Inducer Zn2+ (3.5 μM) (Berto, D'Adamo et al. 
2011) 
coat Synechocystis sp. PCC 
6803 
Inducer  Co2+ (6 μM) (Fernando, Verónica et 
al. 2012)  
coat Synechocystis sp. PCC 
6803 
Inducer Co2+ (6.4 μM) (Peca, Kos et al. 2008)  
coat Synechocystis sp. PCC 
6803 
Inducer Co2+ (3 μM) (Peca, Kos et al. 2007) 
coat Synechocystis sp. PCC 
6803 
Inducer Co2+ (1 μM) (Blasi, Peca et al. 2012) 
coat Synechocystis sp. PCC 
6803 
Inducer Zn2+ (3.2 μM) (Peca, Kos et al. 2008)  
coat Synechocystis sp. PCC 
6803 
Inducer Zn2+ (5 μM) (Peca, Kos et al. 2007) 
coat Synechocystis sp. PCC 
6803 
Inducer Zn2+ (4 μM) (Blasi, Peca et al. 2012) 
petJ Synechocystis sp. PCC 
6803 
Repressor CuSO4 (5μM)  (Tous, Vega-Palas et al. 
2001) 
psbA2  Synechocystis sp. PCC 
6803 
Inducer light (500μE/m2/s)  (Lindberg, Park et al. 
2010) 
psbA2a  Synechocystis sp. PCC 
6803 
Inducer light (50μE/m2/s) (Berto, D'Adamo et al. 
2011) 
psbA2  Synechocystis sp. PCC 
6803 
Inducer light (100μE/m2/s) (Dexter and Fu 2009) 
psaA Synechocystis sp. PCC 
6803 
Inducer light (20 μE/m2/s) (Muramatsu and Hihara 
2006) 
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psaD Synechocystis sp. PCC 
6803 
Inducer light (20μE/m2/s) (Muramatsu and Hihara 
2007) 
rnpB Synechocystis sp. PCC 
6803 
- (Huang, Camsund et al. 
2010) 
cmpA Synechocystis sp. PCC 
6803 
inducer CO2 limitation (Liu, Fallon et al. 2011) 
sbtA Synechocystis sp. PCC 
6803 
inducer CO2 limitation (Liu, Fallon et al. 2011)  
CI-PL  Synechocystis sp. PCC 
6803 
Temp inducible  (Dexter and Fu 2009) 
A1lacO-1 E. coli Inducer IPTG (1mM) (Fernando, Verónica et 
al. 2012)  
trc20 E. coli Inducer IPTG (2mM) (Huang, Camsund et al. 
2010) 
trc10 E. coli Inducer IPTG (2mM) (Huang, Camsund et al. 
2010) 
Trc E. coli Inducer IPTG (1mM) (Fernando, Verónica et 
al. 2012) 
tet E. coli - (Huang, Camsund et al. 
2010) 
nirA Synechococcus PCC 7942 Inducer/Repressor NO3-
/NH4+ 
 (17.6mM/17.6mM) 
(Qi, Hao et al. 2005)  
 
1.2.4 Plasmid vectors used for Synechocystis 
Plasmid vectors that are used in transformation of cyanobacteria can be 
classified into two main groups according to their mode of replication in the host 
(Koksharova, 2002): the first group is non-replicating plasmids or integrative 
plasmids and these cannot replicate independently and would eventually be lost 
through successive cell divisions (Wang et al., 2012). The other group is 
commonly referred to as replicative plasmids, shuttle vectors or biphasic 
plasmids and are capable of replication in both cyanobacteria and E. coli (Deng 
and Coleman, 1999, Koksharova, 2002, Wang et al., 2012) as they most often 
contain replication sequences from both E. coli and the cyanobacterial host 
(Ruffing, 2011). Both integrative and replicative plasmids have been developed 
for cyanobacteria and have their experimental uses. For example, the ideal 
plasmid vector for transporting DNA that must either transpose (e.g. a 
transposon) or integrate (e.g. by homologous recombination) in order to be stably 
maintained are the integrative vectors (Eaton-Rye, 2004, Golden et al., 1987). 
Hence, these vectors are ideal for targeted mutagenesis in which the gene in the 
chromosome is replaced by the mutated gene in the plasmid (Golden et al., 
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1987) or in which the cyanobacterial host needs to select for the recombination of 
the plasmid into the chromosome (Williams and Szalay, 1983). Interestingly, it 
has been observed that none of the common cloning vectors from E. coli seem to 
be able to replicate in cyanobacteria (Porter, 1986), presumably because the 
colE1 origin of replication carried on vectors such as pUC19, pBluescript and 
pGEM-T are not recognised by the DNA replication machinery of cyanobacteria 
(Eaton-Rye, 2004).  
Replicative plasmids can be classified into two types: those that contain replicons 
of broad-host range plasmids (Ng et al., 2000, Huang et al., 2010) and those 
derived from endogenous cryptic plasmids (Deng and Coleman, 1999, Wolk et 
al., 1984). Replicative plasmids carrying a variety of selectable markers, have 
been constructed for cyanobacteria (Golden et al., 1987). Examples include the 
pFCLV 7 (Chauvat et al., 1986) and plasmids derived from RSF1010 (for 
example, pSL1211, pPMQAK1 and pFC1) (Berla et al., 2013, Ng et al., 2000, 
Wang et al., 2012). Replicative plasmids that can replicate in multiple hosts 
(either broad or narrow host range) have the potential to express an exogenous 
gene in numerous hosts (Koksharova, 2002). Nevertheless, most shuttle vectors 
for cyanobacteria are still not well characterised for their copy number (Ruffing, 
2011), and the lack of shuttle vectors with a varied copy number puts limitations 
on the controlled expression of heterologously expressed genes by selecting their 
copy number (Dunlop et al., 2011). For example, the copy number from plasmids 
derived from RSF1010 are 10 per chromosome in E. coli cells and approximately 
10-30 per cell in Synechocystis (~1-3 per chromosome) (Huang et al., 2010, Ng 
et al., 2000). However, the copy number of other broad host-range plasmids have 
not been quantified to date (Berla et al., 2013), which adds a limitation to their 
use. A recent review is available on shuttle vectors used in various 
cyanobacterial hosts (Wang et al., 2012). An illustration of the integrative and 
replicative plasmids can be found in Figure 1.13. 
It is interesting to note that transformation of Synechocystis with plasmids 
obtained from Synechocystis cultures result in 10-20 times better transformation 
rates than transformations done using bacterial plasmids, perhaps due to a 
compatible DNA methylation pattern. Nevertheless, plasmids extracted from E. 
coli are routinely used as they are much more convenient to prepare (Labarre et 
al., 1989).   
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Figure 1.13: An illustration of the plasmids used for cyanobacterial transformation  
(A) Example of an integrative plasmid, the plasmid is eventually lost upon successive replication 
(B) An example of a replicative plasmid showing maintenance of the plasmids upon replication. 
Key: KmR: kanamycin resistance gene, AmpR: ampicilone resistance, Ori: origion of replication. 
1.2.5 Selectable markers used in Synechocystis 
It is essential to be able to select for rare transformant events amongst a large 
population of treated cyanobacterial cells (Vermaas, 2007, Porter, 1986), hence 
systematic and efficient methods whereby successful transformants can be 
identified and isolated are well established. Usually, host cells that contain the 
transferred DNA are identified by transferring a gene whose product has the 
potential to inactivate an antimetabolite, such as an antibiotic (Koksharova, 
2002). When cultured in the presence of the antimetabolite, only those cells to 
which the gene has been transferred should grow. Since cyanobacteria are 
Gram-negative bacteria, antibiotics and antibiotic-resistance genes that are 
known to be effective for that group of bacteria have been exploited extensively 
(Vermaas, 2007).  
Antibiotics used as selectable markers in cyanobacteria, in general, include 
neomycin and kanamycin and the corresponding neomycin phosphotransferase 
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(npt)-encoding genes from transposons Tn5 and Tn903, and streptomycin and 
spectinomycin and the corresponding aminoglycoside adenyltransferase (aadA)- 
encoding genes from Tn7 (Wolk et al., 1993) and the omega interposon (Prentki 
et al., 1991). Bleomycin, although expensive, is sufficiently active to be cost 
effective with Anabaena 7120. Chloramphenicol and chloramphenicol acetyl 
transferase (cat) have proven useful for unicellular cyanobacteria (Chauvat et al., 
1986) and Anabaena sp. strain 90 (Rouhiainen et al., 2000).  Antibiotics such as 
tetracycline and rifampicin, which are light-sensitive, are of much reduced 
usefulness for cyanobacteria (Koksharova, 2002, Ruffing, 2011). Other antibiotics 
with the same property include: erythromycin (Vermaas, 1996), zeocin (Howitt et 
al., 1999) and gentamicin, (He et al., 1999).  
Synechosystis shows preference to some antibiotics. For example, it has been 
reported that the transformants on the plates containing kanamycin grew 4-6 
days earlier than those on the plates containing chloromycetin (Zang et al., 
2007). Furthermore, the bacterial promoter and termination sequences of 
kanamycin is recognised by Synechosystis and hence can be used without 
further modifications (Vermaas, 2007). A summary of the selectable markers 
(antibiotics resistance markers) suitable for use in Synechocystis can be found in 
Table 1.5. 
By using a combination of antibiotic resistant cassettes identified in Table 1.5 
multiple genes can be inactivated in a single Synechosystis strain (Jansson et al., 
1987, Chu et al., 1994, Morgan et al., 1998). One thing to keep in mind when 
using multiple antibiotic resistant cassettes is that the cassette normally used for 
spectinomycin resistance also results in streptomycin-resistance. Therefore, it is 
necessary to introduce the streptomycin-resistance cassette before the 
spectinomycin resistance cassette (Vermaas, 2007).  
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Table 1.5: Selectable markers (antibiotics resistance markers) suitable for use in 
Synechocystis. 
Selectable  
marker 
              Source concentration 
(µg/ml) 
References 
chloramphenicol pBR325 5-150 (Vermaas, 1998, Eaton-Rye, 2004) 
erythromycin pRL425 5 -300 (Vermaas 1998) 
kanamycin pUC4K (Tn 903) 5-500 (Vermaas, 1998, Eaton-Rye, 2004)  
spectinomycin pHP45Ω 3-250 (Golden et al., 1987, Vermaas, 1998)  
neomycin Tn5 - (Koksharova, 2002) 
streptomycin Tn7 - (Wolk et al., 1993) 
spectinomycin pHP45Ω (Tn7) 25 (Eaton-Rye 2004)(Wolk et al. 1993)  
zeocin - 25 (Howitt, Udall et al. 1999) 
gentamicin - - (He, Schlich et al. 1999) 
SacB Bacillus subtilis 5mM sucrose (Vermaas 2007) 
 
As mentioned in section 1.1.4, the creation of markerless deletions of genetically 
modified organisms is critical for industrial applications and can be achieved in 
Synechocystis using the sacB gene since its expression has shown to be lethal  
when sucrose is present in the medium (Ermakova-Gerdes and Vermaas, 1999). 
A recently discovered system for the creation of markerless mutants in 
Synechocystis involves the use of the E. coli mazF gene, a protein synthase 
inhibitor expressed under a nickel inducible promoter, which operates in a similar 
manner as the toxic sacB gene described in Figure 1.9 (Cheah et al., 2013). 
Since both systems are based on negative selection in the second 
transformation, care must be taken to ensure that the loss of sucrose resistance 
is due to the counter-selectable marker and not due to mutation. However, either 
method allows for the re-use of a single selectable marker for making multiple 
successive modifications to the host chromosome (Berla et al., 2013). 
1.2 Biofuels  
The production of biomass-derived fuels is gaining increasing interest worldwide. 
Climate change, rising fuel prices, concerns about greenhouse gas emissions 
and political instability in the producing countries are some of the recent concerns 
that sparked interest into alternatives for fossil fuels (Al-Haj, 2012). Currently, 
fuels make up approximately 70% of the global final energy market (Parmar et 
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al., 2011) while the remaining 30% is accounted from global electricity 
(Hankamer et al., 2007). The US enacted the Independence and Security Act of 
2007 where it set a goal of producing 36 billion gallons of renewable fuel by 2022 
with 16 billion to be obtained from cellulosic ethanol (EISA, 2007). According to 
the Renewable Fuels Association, 80 billion litres of biofuels were produced 
worldwide in 2009 most of which were crop-based fuels (bioethanol from corn 
and biodiesel from soybeans) (Zhou and Li, 2010).There are on-going debates 
over the most suitable host for biofuel production, the best type of biofuel, and the 
best biological platform to use for biofuel production. These topics along with 
challenges facing biofuel production will be discussed in the following sections.  
1.3.1 Choosing a biofuel-producing host  
There are basically three alternative routes to convert renewable resources into 
energy-rich, fuel-like molecules or fuel precursors (Rude and Schirmer, 2009): 
first, fermentative or non-fermentative production by heterotrophic 
microorganisms, such as bacteria, yeast or fungi; second, direct production by 
photosynthetic organisms, such as plants and algae; and third, chemical 
conversion of biomass to fuels (not covered here). It is therefore essential to 
identify the pros and cons of producing biofuels from heterotrophic and 
phototrophic microorganisms in order to decide which host to use for a novel 
microbial biofuel production.  
It is evident that the two heterotrophic model organisms Saccharomyces 
cerevisiae and Escherichia coli are being used to develop most of the new 
microbial fuels (Lee et al., 2008). Needless to mention, these model organisms 
have been used in industrial processes for centuries for the production of fuels, 
chemicals, and pharmaceuticals (Alper and Stephanopoulos, 2009). 
Nevertheless, the main drawback of using these heterotrophic microbes is the 
cost of their organic feedstock (carbohydrates), which remains the major cost 
driver for fuels production (Rude and Schirmer, 2009, Ducat et al., 2011b). 
Another drawback is the recovery cost associated with the fuel extraction from 
the fermentation broth and the cost for any additional chemical modifications 
necessary to convert a precursor fuel into an engine-ready fuel. It would be ideal 
to generate microorganisms that can produce biofuels similar to current 
petroleum-based transportation fuels as it would allow the use of existing engines 
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and infrastructure and would save a vast amount of capital necessary for 
replacing the current infrastructure to accommodate biofuels that have properties 
significantly different from petroleum-based fuels (Lee et al., 2008). 
Plants, on the first view, look more attractive as they produce fuels directly from 
CO2 using photosynthetic metabolism; hence the process is carbon-neutral and 
does not rely on expensive feedstocks. However, this approach also faces 
several major hurdles, most importantly the use of a food source for fuel, 
scalability, the need for freshwater resources, and land use issues (Al-Haj, 2012). 
Unicellular microalgae and cyanobacteria on the other hand, seem to have an 
advantage for biofuels relative to terrestrial plants, some of which are 
summarised by Dismukes et al. (2008), in the following points:- 
Microalgae require a smaller land footprint and less irrigation for cultivation, many 
species of algae thrive in salt water and are able to grow all year round in diverse 
conditions. Furthermore, they do not accumulate recalcitrant lignocellulosic 
biomass and more importantly, genetic manipulation techniques have been 
developed for some species, and are increasingly being applied to optimise 
biofuel production in several algal systems. Furthermore, photosynthetic 
microorganisms, such as cyanobacteria and unicellular algae, are more efficient 
than crop plants in converting solar energy to biofuels (Melis, 2009, Beer et al., 
2009). For example, microalgae has shown to convert up to 3% of solar energy 
into chemicals while higher plants a mere 0.5% (Li et al., 2008). Another 
advantage of photosynthetic organisms is that they can grow to high densities 
within a fully enclosed photo-bioreactor (Chisti, 2007, Beer et al., 2009, 
Angermayr et al., 2009) and can tolerate higher CO2 content in gas streams, an 
attractive advantage for the conversion of CO2 from flue gases into organic 
substances (Zhou and Li, 2010). Cyanobacteria offer yet another advantage over 
algae and that is faster growth rates and easier genetic manipulation (Berla et al., 
2013).  
Oleaginous microbes (those that accumulate >20% of their cellular dry weight in 
lipids) whether phototrophic or heterotrophic, can be used as another option to 
achieve high yields of microbial fuels (Rude and Schirmer, 2009). For example, 
yeast, fungi and algae are being utilised as they accumulate high amounts of 
lipids in the form of triacylglycerol (TAG) (Hu et al., 2008, Li et al., 2008). In some 
reports, the amount of TAGs accumulated as lipid storage during microbial stress 
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can reach 20-50% of the cell dry weight. However, naturally occurring 
cyanobacteria have not been shown to accumulate significant amounts of TAGs 
(Hu et al., 2008). Nevertheless, this problem can probably be mitigated by 
utilising advances in metabolic engineering and synthetic biology to convert 
model cyanobacterial strains such as Synechocystis or even heterotrophic 
organisms such as Saccharomyces cerevisiae and Escherichia coli into 
oleaginous organisms (Rude and Schirmer, 2009). At the moment, it is not clear 
whether using a single organism or a consortium is best for biofuel production. 
The question whether a single organism can be engineered that out-competes a 
collection of specialised organisms has yet to be answered (Dismukes et al., 
2008).  
The development of a “chassis” organism for synthetic biology is a difficult task 
(Lee et al., 2008). Ideally, the microorganism of choice for biofuel production 
should be able to utilise high amounts of substrate, accumulate high amounts of 
lipid, able to process it quickly, should have high metabolic fluxes, produce a 
single product and have good tolerance to inhibitors and product (Alper and 
Stephanopoulos, 2009). The organism should also be able to grow relatively fast 
and be amendable to genetic manipulation. Using cyanobacteria as the host of 
choice for biofuel production is an attractive option for the many advantages they 
offer. Nevertheless, direct biofuel production from cyanobacteria still faces some 
bottlenecks and until today no ideal chassis organism that ticks all the boxes has 
been found or created. Whether such an organism will be engineered using an 
isolated strain or an established model organism as the starting point is unclear. 
The choice between engineering natural function and importing biosynthetic 
capacity depends on the current progress in metabolic engineering and synthetic 
biology (Alper and Stephanopoulos, 2009).  
In summary, after analysing the different parameters involved in selecting a host 
organism for biofuel production it seems clear that employing engineered 
photosynthetic microbes, specifically cyanobacteria strains, is the most efficient 
strategy to produce novel biofuels. Recent advances in molecular, systems, and 
synthetic biology now allow for the rapid engineering of microbial biosynthetic 
pathways to produce a variety of advanced biofuel candidates such as alcohols, 
esters, alkanes, and alkenes from the isoprenoid and fatty acid pathways 
(Peralta-Yahya and Keasling, 2010). The ideal microorganism that consolidates 
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all desirable biofuel processing characteristics does not exist so far (Alper and 
Stephanopoulos, 2009). Some of the desired individual characteristics mentioned 
above can be found in certain species but never combined in one “super strain”. 
Finally, one must be aware that in the pursuit of renewable biofuels, we need not 
only look at the best “organism” for biofuel production but also the “process” and 
“product” (Lindberg et al., 2010). 
1.3.2 Types of biofuels  
In order to replace current liquid transport fuels with biofuels, alternatives to 
gasoline, diesel and jet fuel need to be found (Peralta-Yahya and Keasling, 
2010). There are certain physical and chemical characteristics that a biofuel 
needs to meet in order to replace such fuels. Therefore, it is critical to assess the 
produced biofuels and determine their suitability as fuel molecules (Fortman et 
al., 2008). A recent publication investigated the potential of producing isoprenoid-
derived fuels in cyanobacteria alongside terpene combustion characterisation 
and emissions produced in both gasoline and diesel engines (Hellier et al., 2013). 
Such studies are critical for the development of biofuels that are sustainable in 
both production and utilisation. For example, replacement fuels need to be stable 
in the engine and show predictable combustion at high pressures as well safe to 
store and transport, and of course contain high energy density (Antoni et al., 
2007). They also need to show similar chemical composition to fossil fuels in 
order to be compatible in the existing engines and transportations systems 
(Hellier et al., 2013). Fatty acid esters, long chain fatty alcohols and fatty alkanes 
are a few examples of such fuels (Lu, 2010). More examples of fuels that meet 
some/all of these requirements and the fossil fuel types they can replace either 
as full replacement fuels or fuel blends are found in Table 1.6. Researchers 
engaged in finding fossil fuel replacements such as those listed in Table 1.6 have 
recently produced fermentative alcohols (Atsumi et al., 2008a, Hanai et al., 2007, 
Inui et al., 2008, Nielsen et al., 2009, Steen et al., 2008, Jojima et al., 2008), non-
fermentative higher alcohols (Atsumi et al., 2008b), isoprenoid-derived fuels 
(Carter et al., 2003, Withers et al., 2007) and lipid fuels (Steen et al., 2010, Lu et 
al., 2008, Liu et al., 2010, Kalscheuer et al., 2006). Representative structures of 
the different fuel types can be found in Figure 1.14. Alternative biofuels can be of 
a gaseous or liquid nature and each exhibits its pros and cons. Fuels that are 
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liquid at atmospheric pressure and ambient temperature (e.g. alcohols) are easier 
to store, distribute and use while gases from microbial origin (e.g. hydrogen, 
methane, and isoprene), although easer to capture from the gas space of culture 
vessels, need to first be liquefied by cooling and compression for transport (Lu et 
al., 2011). Furthermore, they are more difficult to store and transport and would 
probably need a new distribution infrastructure. Liquid biofuels however, need to 
remain in the liquid form and be pumpable at all temperatures encountered and 
remain stable during storage (Antoni et al., 2007).   
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Table 1.6: Biofuel alternatives to the conventional transport fuels.  
conventional 
fuel 
advanced biofuel alternative  carbon 
length  
Gasoline short -chain alcohols and alkanes C4-C12  
 
Diesel 
 
FAMEs, fatty alcohols, alkanes and linear or cyclic 
isoprenoids 
 
C9-C23 
 
 
Jet fuel fatty acid and isoprenoid based fuels C8-C16 
 
 
Figure 1.14: Representative structures of the different fuel types 
(A) Examples of alcohol-derived fuels including short-chain alcohols and higher alcohols, (B) 
Examples of Isoprenoid-derived fuels and (C) Examples of lipid-based fuels.   
 
Out of the variety of biofuel options available, only biodiesel and bioethanol are 
produced in industrial scale today, biomethane is produced in a large scale but 
still not utilised for transport, and biobutanol is gaining increasing interest and 
seems that it will soon be used as a supplement for gasoline, diesel and 
kerosene while both biohydrogen and biomethanol need further development 
(Antoni et al., 2007). Despite the recent hyperbole on biofuels, the actual concept 
of biofuel is surprisingly old and was used throughout man’s long history. Rudolf 
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Diesel, who is the inventor of the diesel engine, used vegetable oil as a fuel 
source for his engine in the 1900’s [3]. Before that, in the 1860’s, Nikolaus August 
Otto used ethanol in his prototype of the spark ignition engine (gasoline 
replacement). His work was sponsored by a sugar factory interested in mass 
production of ethanol (Antoni et al., 2007). The use of vegetable oil (e.g. peanut 
oil) along with corn based fuel were used for a long time until petroleum entered 
the picture and proved to be a superior fuel. This was determined from factors 
such as the fuel supply, fuel price and efficiency. Nevertheless, both vegetable 
oils and ethanol continued to be used as diesel and gasoline replacement fuels 
during the 1930s and 1940s although at a much smaller scale (Antoni et al., 
2007). The concept of using algae for biofuels was introduced in 1955 by Meier 
(1955), who used the carbohydrate fraction of the cell for methane production. 
The idea was further improved in 1960 when growing algae in large raceway 
ponds and digesting the algal biomass for methane production was introduced 
(Oswald and Golueke, 1960). In the 1970’s, although the concept of ethanol 
revived due to the “crude oil crisis” (Antoni et al., 2007), the potential use of algae 
as biofuels gained more attention as concerns for raising conventional fuel prices 
increased (Hu et al., 2008). Since then microbial systems specifically have been 
extensively explored and successfully used for the biosynthesis of some biofuels, 
most notably ethanol. However, with increased knowledge of the properties 
required for ideal biofuel molecules, scientists agree that ethanol might not be the 
best option as it is corrosive and cannot be used in the current distribution 
infrastructure (Connor and Atsumi, 2010). 
 Furthermore, higher-chain alcohols such as isobutanol offer several advantages 
compared with ethanol, such as higher energy density, lower water solubility 
(Atsumi et al., 2008b) and less corrosion (Ducat et al., 2011a). Algal-derived 
biofuels currently being investigated include alcohols from starches, biodiesel 
from lipids and H2 for fuel cells (Beer et al., 2009). However, thus far, crop-
derived biodiesel and bioethanol (Ragauskas et al., 2006, Lee et al., 2008) and 
algal biodiesels (Chisti, 2007) are the main biofuels being produced at an 
industrial scale with algal biodiesels considered the most efficient (Chisti, 2007). 
                                            
 
3 http:// www.biodiesel.com/index.php/biodiesel/history_of_biodiesel_fuel. 
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Nevertheless, the many intermediate steps involved in the production of both 
types of fuels contribute significantly to the high cost of production (Atsumi et al., 
2009) and it is therefore essential to find means to achieve a more cost effective 
industrial scale production.  
Biofuels can be classified into first, second, third and fourth generation according 
to the feedstock. Biofuels that are made from crop plants such as corn and sugar 
cane, discussed above, are called first generation biofuels. While second 
generation refers to the utilisation of all forms of (ligno)cellulosic biomass for 
biofuels production and includes non-crop plants such as willow and Miscanthus. 
Both third and fourth generation biofuels apply to the utilisation of microalgae 
(algae and cyanobacteria) for the “ algae-to-fuel” technology; where the former 
uses the actual algae biomass for biofuel production and the latter employs 
metabolic engineering for the modification of microalgae in order to convert them 
into microbial fuel factories (Lu et al., 2011). The four generations of biofuels will 
be discussed in more detail in section 1.3.3.  
1.3.3 The four generations of biofuels  
Many platforms have been explored as a source for biofuel production ranging 
from plants, to waste organic material, to microorganisms and microalgae (Al-Haj, 
2012). As introduced in the previous section, the four generations of biofuel differ 
mainly in the biomass resource platform.  
First generation biofuels: utilises plant-derived biomass such as corn grain, 
sugarcane, soybean and rapeseed for biofuel production (Dismukes et al., 2008). 
Examples of biofuels produced from plant-derived biomass include bioethanol, 
biomethane and biodiesel. Besides the obvious food for fuel issue associated 
with first generation biofuels [e.g. the US currently uses 25% of its total corn 
production for biofuels (Zhou and Li, 2010)], first generation biofuels suffer many 
other drawbacks.  
Traditionally bioethanol was produced via yeast fermentation using relatively 
expensive feedstocks, such as corn starch and cane sugar (Deng and Coleman, 
1999). Bioethanol production from sugarcane was pioneered in Brazil 
(Goldemberg, 2007) and currently bioethanol from starch is the main type of first 
generation biofuels (Lu, 2010) and the major biofuel being used in the 
transportation sector (Peralta-Yahya and Keasling, 2010). Bioethanol has many 
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disadvantages such as incompatibility with the distribution and storage 
infrastructure, corrosiveness, low energy content (Fortman et al., 2008), is based 
on the limited agricultural/food resources and needs large agriculture land 
(Sheehan, 2009, Hellingwerf and Teixeira de Mattos, 2009, Dexter and Fu, 
2009), furthermore due to its high volatility, it is difficult to transport and finally it is 
toxic to the producing host (Lu, 2010). The production of biomethane is not a new 
concept and has been achieved decades ago (Hellingwerf and Teixeira de 
Mattos, 2009). Although the large-scale production of biomethane as a biofuel 
has been largely overlooked in the past 20 years (Åhman, 2010), it remains of 
interest today (González-Fernández et al., 2012, Murphy and Power, 2009, 
Tilche and Galatola, 2008, Åhman, 2010). However, being a gaseous fuel, it has 
disadvantages. Moreover, the conventional production of biomethane from woody 
biomass via gasification needs to be further developed (Åhman, 2010). Biodiesel 
on the other hand, is produced mainly from soybeans (Chisti, 2007) while other 
sources for commercial biodiesel include canola oil, animal fat, palm oil, corn oil, 
waste cooking oil (Felizardo et al., 2006, Kulkarni and Dalai, 2006) and jatropha 
oil (Barnwal and Sharma, 2005). Biodiesel offers several advantages over 
bioethanol and biomethane, most notability nontoxicity and ease of storage and 
transport (Schenk et al., 2008). Furthermore, biodiesel production is cheaper than 
bioethanol production in some cases (e.g. the energy yield from soy oil per 
hectare is far lower than the ethanol yield from corn) (Pimentel and Patzek, 
2005). Nonetheless, scientists researching into biofuels are turning away from 
ethanol derived from sugarcane and starch and away from biodiesel derived from 
animal fats and vegetable oil, and are finding alternatives to these crop based 
biofuels (Sheehan, 2009).   
Second generation biofuels: These include plant-derived lignocellulose from 
agriculture and agro-industrial residues. Examples of which are wood chip, corn 
stover, sugarcane, rice and wheat straw (Machado and Atsumi, 2012) and in 
some cases, plant seeds as many seeds accumulate high amounts of tri-
glycerides, which upon transestrification produce biodiesel (long-chain fatty acid 
methyl esters) (Hellingwerf and Teixeira de Mattos, 2009). Second generation 
biofuels are therefore not tied to food crops or in limited supply. However, the use 
of lignocellulosic biomass can be expensive since this biomass is tough due to 
the presence of cellulose, hemicellulose and lignin that needs to be enzymatically 
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processed (Lu et al., 2011). The discovery of enzymes that can degrade plant 
polysaccharides and lignins into simple sugars available for microorganisms to 
ferment into fuel would open the door for a more efficient conversion of 
lignocelluloses to biofuels. There is much research focused on solving this issue, 
however the solution is a long term goal (Sanderson, 2011).  
Third generation biofuels: Until recently, biodiesel was only produced from 
plant and animal oils and not from microalgae (Chisti, 2007). However, this is 
changing rapidly as companies are attempting to commercialise microalgal 
biodiesel (Solazyme, Synthetic Genomics and Joule to name a few). Third 
generation biofuels includes the production of natural oils (lipids), from algae, for 
the conversion into some form of renewable biodiesel (Sheehan, 2009). A 
process that requires growth, harvesting and extraction (Chisti, 2007). For some 
species the natural content of lipids is ~30% by weight and for selected species 
this content can go up to 80% (e.g. Schizochytrium sp and Botryococus braunii) 
(Hellingwerf and Teixeira de Mattos, 2009). The lipid content in microalgae can 
be increased by subjecting them to stressful environmental conditions. This has 
been demonstrated by several researchers. For example Liu et al. (2008), 
showed that using high initial concentrations of iron in the culture media elevated 
lipid accumulation in the microalga Chlorella vulgaris, while Illman et al. (2000), 
showed that nitrogen depravation led to the accumulation of total lipids in five 
different Chlorella strains. Third generation biofuels represented in algal-derived 
fuels offer many competitive advantages over first and second generation 
biofuels. For example, algae can grow extremely rapidly [doubling times of <24 
hours and in some cases as fast as 3.5 hours per day (Chisti, 2007), they are not 
based on food and do not require arable land (Parmar et al., 2011) and can utilise 
a wide variety of water sources (Hu et al., 2008). Some microalgae accumulate 
large quantities of neutral lipids and can thrive in adverse ecological conditions 
(Hu et al., 2008). Furthermore, algae are not only utilised for their oils but also the 
remaining biomass can be converted to biogas through anaerobic fermentation 
(Wijffels and Barbosa, 2010). It is for all these reasons that algal biodiesel has 
been a hot topic in biofuel production recently. Nevertheless, producing 
microalgae biomass is generally more expensive than growing crops since they 
need light, CO2, water, inorganic salts such as nitrogen, phosphorus, iron and 
some cases silicon, and need to be maintained at temperatures around 20-30oC 
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(Chisti, 2007). Furthermore, the production of microbial fuels requires high energy 
inputs due to the many steps involved in microalgal harvesting (including 
flocculation, sedimentation, flotation, centrifugation or filtration). There are also 
other costs associated with the actual lipid extraction where harsh conditions 
(e.g. mechanical, chemical and physical stress) need to be used to break the 
thick cell walls that algae normally possess (Wijffels and Barbosa, 2010, 
Sheehan, 2009). Some of these issues are currently being addressed by 
developing what is called “Fourth generation biofuels”.  
Fourth generation biofuels: In the development of fourth generation biofuels, 
also referred to as advanced biofuels, advances in the field of science and 
engineering need to be employed to ensure the produced fuels are sustainable in 
both production and utilisation (Hellier et al., 2013). Fourth generation biofuels 
involves the employment of synthetic biology and genetic engineering to modify 
photosynthetic microorganisms in order to turn them into factories for biofuel 
production (Dexter and Fu, 2009, Lu et al., 2011). The main difference between 
4th and 3rd generation biofuels is that the former applies the “cell factory” concept 
for the production of gaseous and liquid biofuels by utilising advances in synthetic 
biology and genetic engineering approaches to both produce and excrete the 
biofuel out of the cell, thereby reducing the cost of downstream processing (Lu et 
al., 2011). As mentioned in section (1.1.2), engineering cyanobacterial strains by 
means of either single gene modification (deletions/insertions) or pathway 
engineering (native or heterologous) could lead to production of novel fuel 
molecules (Table 1.1). Fourth generation biofuels that are currently being 
produced include long chain alcohols, isoprenoid derived fuels and fatty-acid 
derived fuels (Peralta-Yahya and Keasling, 2010). Examples of advanced 
biofuels that have recently been produced in engineered cyanobacteria are listed 
in Table 1.1. Although several potential advanced biofuels have been produced in 
microbes, metabolic engineering tools need to be employed to increase the titre 
for the cost effective industrial production of these fuels (Peralta-Yahya and 
Keasling, 2010). Furthermore, there are many factors that need to be considered 
when designing novel fuels and these include: the energy content, combustion 
quality, volatility, freezing and boiling points, odour and toxicity (Lee et al., 2008). 
The aim is to produce advanced biofuels with high energy content that are 
compatible with the exciting storage and distribution infrastructures, and that are 
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also economically feasible (Peralta-Yahya and Keasling, 2010) while keeping in 
mind that metabolically engineered strains are forced to produce a compound 
that my lead to its autoinhibition (Angermayr et al., 2009). 
A main advantage of 4th generation biofuels is the reduced number of steps 
needed to go from sunlight capture to formation of fungible biofuels. It is clear in 
Figure 1.15 that the steps needed are much less compared to the previous 
methods thereby reducing the large capital costs associated with production. 
However, the development of 4th generation biofuels is still in its infancy and the 
technology lags far behind that established for the other methods (Lu et al., 
2011). 
At this point no advanced biofuel production technology has come out on top. 
However, with the wide range of molecules in petroleum-based fuels and the 
large amount of renewable fuels urgently needed to power the large 
transportation sectors, there is enough room to accommodate all technologies. 
The development of advanced fuels that will work with the existing transportation 
infrastructure is certainly a step in the right direction toward usability and 
economic viability (Peralta-Yahya and Keasling, 2010).   
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Figure 1.15: Comparison fo the typical bioprocess steps needed for 4 generations of biofuels production  
It is clear how 4th generation processes shorten the steps towards biofuel production significantly. Microalgae refer to both algae and cyanobacteria. 
Figure modified from (Lu et al., 2011).
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1.3.4 Challenges facing biofuel production 
Besides challenges associated with the selection of the best type of biofuel or the 
most suitable host for biofuel production discussed in the previous sections, there 
are a lot of other challenges that need to be overcome for successful, commercial 
level, biofuel production. For example, biofuel production yields need to be 
enhanced in a cost effective manner in order to become competitive to fossil 
fuels. Issues related to fuel toxicity need to be addressed (Zhou and Li, 2010) 
and the availability of metabolic cofactors required in engineered microbial 
pathways need to be enhanced. Furthermore, product scale–up and biorefineries 
need to be set up (Wijffels and Barbosa, 2010) and robust strains need to be 
used for genetic engineering purposes for novel biofuel production (Koffas, 
2009). Importantly to note is that large scale cultivation of genetically modified 
strains can pose a risk of escape and contamination of the surrounding 
environment and crossing with native strains. Thus cultivation of engineered 
strains can have unintended consequences to public health and the environment 
(Parmar et al., 2011). There is no doubt that the solution to these challenges will 
need a multidisciplinary approach. For example, in order to cover all these 
challenges in an integrative manner, people from the fields of fundamental 
biology, systems biology, metabolic modeling, strain development, bioprocess 
engineers, scale-up and biorefinery need to work hand in hand to realize the full 
potential of microalgal biofuel production (Wijffels and Barbosa, 2010, Wijffels et 
al., 2010).  
Although a wide variety of biofuels are produced routinely on the lab scale, one of 
the major hurdles in biofuel production is associated with the cost of its 
commercial production (Wijffels and Barbosa, 2010, Peralta-Yahya et al., 2012, 
Steen et al., 2010). Key is to find processes that will aid in reducing the overall 
fuel production costs. Product-recovery efficiency is an important determinant of 
the total production cost and a major limitation of biochemical production from 
photosynthetic organisms (Atsumi et al., 2009). It is estimated that 70-80% of the 
total cost of biofuel production comes from the biomass extraction processes as 
these are very energy intensive (Molina Grima et al., 2003, Robertson et al., 
2011). Therefore finding means of extracting the produced fuels in a more 
effective manner would aid in the reduction of the overall cost of biofuel 
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production. It is apparent that in order to achieve such goals both the fuel-
producing hosts and pathways must be engineered and optimised (Lee et al., 
2008, Peralta-Yahya and Keasling, 2010). Modifying microbial pathways will 
require the employment of advanced technologies such as synthetic biology and 
metabolic engineering tools such as those described in section 1.1.4. An 
important challenge facing biofuel production through microbial metabolic 
engineering is satisfying cellular energetic concerns (thermodynamic constraints) 
(Fortman et al., 2008). Novel biofuel production requires re-wiring of the native 
pathway or the introduction of a heterologous pathway in the engineered strains, 
which ultimately leads to carbon flux imbalance. Therefore, it is essential to 
redirect the carbon flux and finely control the fixed carbon partitioning in central 
metabolic pathways, something that is still challenging in the field of metabolic 
engineering (Melis, 2013). One way of approaching this challenge is by targeting 
the non-growth phase of the engineered photosynthetic organisms. Since it has 
been demonstrated that biofuels can be produced by metabolically active cells 
even when they have ceased growing (Atsumi et al., 2009, Wang et al., 2013, Liu 
et al., 2011). However, in order for gain full advantage of this opportunity, 
complete genetic circuits need to be designed that remains highly active during 
the stationary phase (Berla et al., 2013).  
Many researchers have investigated the challenges associated with biofuel 
production (Dismukes et al., 2008, Lu et al., 2011, Robertson et al., 2011, Chisti, 
2007, Parmar et al., 2011), the following section aims at highlighting some of the 
main concerns.   
Photobioreactor design: whether shallow big ponds, open or closed ponds, flat 
panels, closed columns or tubular bioreactors are used for culturing organisms 
for biofuels production, the reactor design should include factors that aim to 
optimise solar insulation and distribution (Chisti, 2007), maintain a good culture 
density and manage properly the gas mass transfer, mixing and temperature 
(Robertson et al., 2011). There is no bioreactor design that has been developed 
that meets all these criteria thus far. Nevertheless, a lot of efforts are currently 
been exerted in the development of photobioreactors that incorporate the 
discussed features (Parmar et al., 2011, Hankamer et al., 2007, Molina Grima et 
al., 2003, Cogne et al., 2005, Chisti, 2007). Figure 1.16 shows examples of 
different photobioreactor designs used for algal/cyanobacterial cultivation. 
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Downstream processing of cultures: typically microalgal cultures are very 
dilute and require several techniques for their harvesting. The problems lie in the 
high energy requirements associated with the multiple steps involved in 
harvesting the cells (including flocculation, sedimentation, flotation, and finally 
centrifugation or filtration) (Parmar et al., 2011). In addition, the cost associated 
with the actual lipid extraction needs to be addressed. This is due to the harsh 
conditions required to break the sturdy cell walls of the microalgae (Wijffels and 
Barbosa, 2010, Parmar et al., 2011), the cost of transesterification of the TAGs, 
and the significant amount of glycerol produced as a byproduct (Liu and Curtiss, 
2009, Chisti, 2007). All these processes add significantly to the cost of the 
produced biofuel (Lu, 2010). On the other hand, the cultures are normally 
dewatered post harvesting in order to obtain the actual fuel from the culture. High 
water content and high nitrogen and phosphate contents are major limitations in 
downstream processing of microalgae. Furthermore, issues such as energy cost 
associated with downstream processing, the plant site, transportation, water 
quality and recycling have to also be considered for efficient biofuel production 
(Parmar et al., 2011). The idea of creating microalgae that can self-destruct (Liu 
and Curtiss, 2009) would aid in both reducing the cost and achieving quicker 
recovery of the product.   
Photosynthetic efficiency: Although algae and cyanobacteria have better 
photosynthetic efficiency than terrestrial plants, culturing strategies that promote 
high photosynthetic conversion efficiencies are still needed for microalgae in 
order to maximise the photosynthetic efficiency. Employing genetic engineered 
cyanobacterial strains is one way of increasing the photosynthetic efficiency. The 
theoretical maximum photosynthetic efficiency of engineered cyanobacteria can 
reach a striking 10-12% (Robertson et al., 2011, Parmar et al., 2011, Ducat et al., 
2011b) compared to un-engineered strains (7.2%) and algae growing in open 
ponds (1.5%) [Parmar et al. (2011), reports 5%]. While conventional crops such 
as corn or sugar cane have a photosynthetic efficiency of just 1% (Parmar et al., 
2011).  
Accumulated by-products & product toxicity: Product toxicity is a major 
concern in the production of advanced biofuels and needs to be addressed (Lu et 
al., 2011). For example, Atsumi et al. (2008a), mentioned that it is necessary to 
improve the tolerance of microorganisms for advanced biofuel production in order 
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to overcome the current limitations of the yield of the product. E. coli for example, 
can only tolerate up to 10 g/L of butanol if the tolerance is not increased 
genetically. Issues related to biofuel product toxicity are covered in more detail in 
Chapter 5. 
 
 
  Figure removed for copyright reasons 
 
 
Figure 1.16: Examples of different photobioreactor designs  
(A)Flat panels bioreactor, (B) Tubular low cost bioreactor, (C) Open pond bioreactors, (D) Closed 
tubular bioreactors,(E) An architectural design of bioreactors of the future. Images were obtained 
from the internet as detailed in Appendix 16.  
 
1.4 Isoprenoids  
Isoprenoids are naturally occurring branched or cyclic hydrocarbons (Lee et al., 
2008) made from a branched five-carbon precursor that are synthesised in all 
living organisms (Ershov et al., 2002). They are considered the most ancient and 
diverse class of natural products (Lange et al., 2000) encompassing over 30,000 
known compounds (Sacchettini and Poulter, 1997, Ershov et al., 2002) and were 
reported in the sediments as long as 2.5 billion years ago (Summons et al., 1999, 
Brocks et al., 1999).The isoprenoid pathway in plants, bacteria, microalgae and 
cyanobacteria has been of interest to many researchers for its essential cellular 
compounds (Lange et al., 2000, Lichtenthaler, 2000, Martin et al., 2003, Ro, 
2006, Yoon et al., 2007, Lee and Schmidt-Dannert, 2002, Chang et al., 2007). 
The isoprenoid biosynthetic pathway can be exploited for the production of 
several branched-chain alcohols, alkanes, alkenes and cyclic hydrocarbons 
(Fortman et al., 2008).  
1.4.1 Isoprenoid biosynthesis  
There are essentially two distinct and independent biosynthetic pathways for 
isoprenoid biosynthesis (Figure 1.17); the mevalonate (MV) or mevalonic acid 
pathway (MVA), and the methyl-erythritol-4-phosphate (MEP) or also called the 
DXP pathway (Martin et al., 2003, Daum et al., 2009). The former is most 
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common in eukaryotes while the latter operates in prokaryotes (Daum et al., 
2009, Lindberg et al., 2010, Dewick, 2002) including cyanobacteria (Ershov et al., 
2002) and in higher plants, within the plastids (Cordoba et al., 2009, 
Lichtenthaler, 2000). In both pathways, Isopentenyl diphosphate (IPP) is 
considered the central intermediate (Lange et al., 2000) and is converted to 
dimethylallyl (DMAPP) via the IPP isomerase (Cordoba et al., 2009, Lindberg et 
al., 2010). In mammals and yeast and other eukaryotes other than plants, the 
pathway towards IPP synthesis starts from acetyl-CoA proceeding through the 
intermediate mevalonic acid (MVA) (Cordoba et al., 2009) while in the MEP 
pathway the synthesis starts by the condensation of pyruvate and 
glyceraldehyde-3-phosphate (G3P) via 1-deoxyxylulose-5-phosphate (DXP) as 
the first intermediate as seen in Figure 1.17 (Lange et al., 2000, Cordoba et al., 
2009). This step is catalyzed by 1-deoxy-D-xylulose-5-phosphate synthase (DXS) 
while DXR catalyses the second step pf the pathway. Both enzymes (indicated in 
red) are considered rate limiting steps in the MEP pathway, as has been shown 
in several plants (Cordoba et al., 2009). However, examining Figure 1.17, which 
includes the direct link between the primary products from photosynthesis and 
the isoprenoid biosynthetic pathway, indicates that the G3P and pyruvate are not 
strictly the only substrates for the MEP pathway (sugar phosphates from the 
pentose phosphate cycle can also feed as substrates). Whatever the starter 
substrates are, the product of the two pathways leads to the production of the 
five-C compound Isopentenyl diphosphate (IPP) (Lange et al., 2000). For the 
isoprenoid synthesis, the Isopentenyl diphosphate (IPP) and dimethylallyl 
pyrophosphate (DMAPP) are linked together in a head to tail condensation 
manner, to form the precursors geranyl pyrophosphate (GPP, C10) which is 
considered the universal precursor of all monoterpenes (Iijima et al., 2004, 
Oswald et al., 2007), farnesyl pyrophosphate (FPP, C15) and geranylgeranyl 
pyrophosphate (GGPP, C20), respectively. Finally, fuel ready molecules such as 
geraniol, farnesol and geranylgeraniol can then be synthesised from GPP, FPP 
or GGPP respectively by introducing a single additional enzyme (a terpene 
synthase) (Rude and Schirmer, 2009, Peralta-Yahya and Keasling, 2010) as 
seen in the same figure. The classification of the terpenoids are generally based 
on the number of IPP units from which they derive (Daum et al., 2009). 
 
 71 
 
Figure removed for copyright reasons 
 
 
Figure 1.17: Isoprenoid biosynthesis from the MEV and MEP pathways. 
Abbreviations used: G3P= glyceraldehyde 3-phosphate; DXP=1-Deoxylulose-5-phosphate, MEP= 2-C-
methyl-D-erythritol, 4-phosphate, CDP-ME= diphosphocytidylyl methylerythritol; CDP-MEP= CDP-ME 2-
phosphate; ME-cPP=methylerythritol 2,4-cyclodiphosphate; HMBPP=hydroxymethylbutenyl diphosphate; 
IPP=isopentenyl diphosphate; DMAPP= dimethylallyl diphosphate; HMG-CoA:= Hydroxymethylglutaryl-CoA 
. Enzymes: DXS= DXP synthase; DXR= DXP reductoisomerase; IspD= CDP-ME synthase; IspE=CDP-ME 
kinase; IspF=ME-cPP synthase; GcpE (IspG)=HMBPP synthase; IspH=HMBPP reductase;Ipi/Iidi= IPP 
isomerase; atoB=acetoacetyl-CoA thiolase; HMGS=hydroxymethylglutaryl-CoA synthase; tHMGR=truncated 
hrdroxymethyl-glutaryl-CoA reductase; Erg1= MEV kinase; Erg8=phosphomevalonate kinase; MVD1=MEV 
pyrophosphate decarbonylase; gpps= geranyl pyrophophate synthase; fpps=farnesyl pyrrophosphate 
synthase; ggpps= geranyl-geranyl pyrophosphate synthase; ts= terpene synthase. Modified from (Peralta-
Yahya and Keasling, 2010, Lindberg et al., 2010). 
1.4.2 Isoprenoid biosynthesis in Synechocystis 
The MEP pathway in cyanobacteria is vital for the synthesis of terpenoid-based 
molecules that are needed for essential cell functions such as photosynthesis, 
membrane stability and carotenoid production (Poliquin et al., 2004). 
Synechocystis appears to have genes that are homologous to the genes of the 
MEP pathway present in E. coli that leads to the synthesis of IPP and DMAPP 
(Figure 1.17). However, work done by Ershov et al. (2002), showed that the initial 
substrate of the MEP pathway in Synechocystis is not the same as that of E. coli 
(not pyruvate or deoxyxylulose-5-phosphate). Furthermore, he was unable to 
demonstrate the activity of the IPP isomerase in the cyanobacterium and 
therefore suggested that the interconversion of DMAPP and IPP is unlikely, which 
is expected due to the absence of the ipi gene in its genome (Kaneko et al., 
1996). These results suggest that the MEP pathway as presented in E. coli is not 
the primary pathway by which isoprenoids are synthesised in Synechocystis 
under photosynthetic conditions and suggest that the products of photosynthesis 
(i.e. metabolites of the pentose phosphate pathway cycle) lead to the production 
of DMAPP (Figure 1.17). In this context, it is interesting to note that during 
photosynthesis, the majority of the carbon flux (80-85%) is directed towards 
sugar biosynthesis, approximately ~10% is for fatty acid biosynthesis while 
terpenoid biosynthesis accounts for only 3-5% (Lindberg et al., 2010). It is clear 
that in order to increase the titre of novel isoprenoids, metabolic engineering 
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strategies would need to be employed to shift the carbon flux away from sugar 
biosynthesis and more towards isoprenoid biosynthesis.  
1.4.2 Application of isoprenoids  
Because of their diversity, isoprenoids exhibit many variable biological functions, 
for example isoprenoids have been exploited for their pharmaceutical value 
(antibiotic, anticancer drugs and hormones) (Daum et al., 2009) and their 
nutritional value for many years (Rude and Schirmer, 2009). However, 
isoprenoids also serve many other functions including; quinones in electron 
transport chains, components in membranes, involved in subcellular targeting 
and regulation, as photosynthetic pigments, fragrance compounds, and as plant 
defense compounds (Lange et al., 2000, Martin et al., 2003). They are also 
important components of vitamins, essential oils, rubber, carotenoids and plant 
hormones (Ershov et al., 2002). Moreover, there are different structures 
accessible via the isoprenoid biosynthetic pathway that can be exploited for the 
production of biofuels as alternatives to gasoline, diesel and jet fuel (Peralta-
Yahya and Keasling, 2010). It has been reported that pure hydrocarbons are 
generally considered better biofuels than sugars and alcohols as they store more 
energy in the hydrocarbon molecules (Schakel et al., 1997). It is for these 
reasons that isoprenoids have recently been exploited for novel biofuel 
production. E. coli platforms (Carter et al., 2003, Peralta-Yahya and Keasling, 
2010) and S. cerevisiae platforms (Chambon et al., 1990, Chambon et al., 1991, 
Oswald et al., 2007) are already in place for the production of a wide range of 
isoprenoids. For example, the productions of the sesquiterpenes farnesol and 
farnesene, which are both derived from FPP, have already been achieved in both 
species using truncated yeast phosphatase (Song, 2006) and a plant terpene 
synthase (Martin et al., 2004), respectively. The C5 terpene, isoprene, has also 
recently been produced in cyanobacteria (Lindberg et al., 2010). However, one of 
the main obstacles for efficient microbial biosynthesis remains the production of 
the universal precursors IPP and DMAPP (Peralta-Yahya and Keasling, 2010) 
and the establishment of a photosynthetic platform for isoprenoid biosynthesis, 
something that was attempted in work presented in chapter 5.   
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1.5 Objectives of the presented work  
This thesis describes genetic tools developed for the creation of Synechocystis 
transformants that will ultimately aid in the advancement of cyanobacterial biofuel 
research.  
The aims of the work undertaken are: 
 To develop a quick method to generate random Synechocystis mutants 
using a gene tagging approach based on the random insertion into the 
genome of a marker gene. This is covered in chapter 3. 
 To develop a rapid one-step PCR based method for creating transforming 
DNA for targeted gene deletions in Synechocystis that will result in 
eliminating the need to construct plasmids for transformation. This is the 
topic of chapter 4. 
 To create a photosynthetic “cell factory” for the synthesis of selected 
isoprenoid-derived fuels, namely geraniol and farnesene, and assess their 
toxicity on the cyanobacterial host. Strain creation, biofuel production and 
toxicity tests are covered in chapter 5.  
  To test the function of the AlkL membrane protein as a hydrocarbon pump 
in Synechocystis and compare it to its recently established role in E. coli. 
Chapter 6 covers work related to AlkL, which was carried out in 
collaboration with Dr Christopher Grant from the Department of 
Biochemical Engineering at University College London.  
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Chapter 2: Materials and Methods
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2.1 Chemicals  
The chemicals used in this work were of the highest chemical grade available. 
Unless otherwise specified, the chemicals were purchased from Sigma Aldrich 
and all solutions were prepared using double distilled water (ddH2O) from a 
Maxima water filtration unit (Elga, High Wycombe). Solutions that required 
sterilisation were autoclaved (Priorclave Midas 56, UK) at 1210C and 1 atm for 15 
min and handled using aseptic techniques. All restriction enzymes used in this 
work were purchased from New England Biolabs (NEB).   
2.2 Strains employed, their growth and storage conditions  
2.2.1 Escherichia coli bacterial strains 
The bacterial strain used was Escherichia coli DH5α, {genotype: F-, 
(φ80lacZΔM15), Δ(lacZYA-argF)U169, deoR, recA1, endA1, hsdR17(rk-, mk+), 
supE44, thi-1, gyrA96, relA, λ} supplied by CLONTECH Laboratories, Inc. This 
stain will be referred to as E. coli hereafter.  
2.2.2 Growth and storage of Escherichia coli 
E. coli was grown in LB (lysogeny broth) medium containing 10 g/L tryptone 
(Difco), 5 g/L bacto yeast extract (Difco), and 10 g/L NaCl. For LB plates, 15 g/L 
Agar was added to the LB medium (Bertani, 1951). Cultures were grown at 37oC 
in shacking incubators [Stuart Scientific Incubator S.I.60, UK with built-in shaker 
IKA-VIBRAX-VXR, IKA® Labortechnik, Germany] at 170 rpm. The LB plates 
were incubated overnight in a static incubator [LAB. Companion, Fisher 
Scientific].  
For short-term storage the bacteria grown in liquid or solid media were stored at 
4oC. Where appropriate, the autoclaved and cooled medium (< 50oC) was 
supplemented with ampicillin, kanamycin or zeocine at concentrations of 75 
µg/ml, 50 µg/ml and 25 µg/ml, respectively.  
For long-term storage, E. coli strains were stored as 20% (v/v) glycerol stocks. 
This was achieved by mixing equal volumes (~0.5 ml) of grown bacterial cultures 
with 80% (v/v) autoclaved glycerol, vortexed briefly, snap frozen in liquid nitrogen 
and stored at -70oC or below (Williams, 1988). 
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2.2.3 Synechocystis strains and mutants created 
The wild type (WT) (large, glucose tolerant) Synechocystis strain was obtained 
from Prof Conrad Mullineaux, Queen Mary University of London. 
The recJ deleted mutants of Synechocystis were created by deleting the recJ 
gene (gene code: sll1354) in the wild type Synechocystis strain. This was done 
by inserting either the ble cassette or kanamycin resistance (kmR) gene in the 
recJ gene and transforming the corresponding plasmids carrying the deleted 
genes into WT Synechocystis creating the ΔrecJ.ble and the ΔrecJ.kmR 
Synechocystis mutants, respectively. Details of the plasmids created to make the 
mutants can be found in Appendix 1.  
2.2.4 Growth and storage of Synechocystis strains 
Synechocystis strains were grown photoautotrophically on solid BG11 medium 
prepared by mixing equal volumes of 2X BG11 medium with 3% (w/v) agar after 
autoclaving (Table 2.1). Cultures on agar plates were stored in a lit incubator at 
30oC with a light intensity of 30-50 µmol/m2/s for two to three weeks (Castenholz, 
1988). Single colonies were re-streaked every 3-4 weeks on fresh BG11 plates 
and stored under the same conditions to confirm the growth and isolation of 
axenic Synechocystis strains. Cells were grown in liquid culture at 30oC at 150 
rpm under a light intensity of 20-50 µmol/m2/s. All microbiological manipulations 
were done in a laminar flow hood. 
All mutants of Synechocystis were grown under the same culture conditions. 
Where appropriate, BG11 plates were supplemented with either kanamycin or 
zeocin at concentrations of 200 µg/ml and 25 µg/ml, respectively.  
For long-term storage, cells were stored in 15% glycerol. Cells from 100 ml of 
liquid culture (OD750: 1-2) were harvested by centrifugation (MISTRAL1000, MES 
Scientific Instruments, Loughborough) at 4,500 x g for 6 min at room 
temperature. Cell pellets were re-suspended in residual growth medium present 
in the pellet; the volume of the dense suspension was measured, then mixed with 
0.24 volumes of autoclaved 80% glycerol before being stored at -80oC (Bishop, 
2002). For recovery, the cells were thawed and either spread onto plates or 
inoculated into liquid medium. 
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Table 2.1: Recipe of BG11 medium for Synechocystis 
 
1 L 1X BG11 liquid medium Amount  
100X BG11 (a) 10 ml 
Trace elements (b)  1 ml 
Iron stock (c)  1 ml 
ddH2O  to 1 L 
 
Autoclave and allow to cool then add 
 
Phosphate stock (1) 1 ml 
Na2CO3 stock (2) 1 ml 
NaHCO3 stock (3)  10 ml 
TES buffer (4) 10ml 
(Castenholz, 1988) 
 
For BG11 plates, 2X concentrated BG11 was prepared including 3 g of sodium 
thiosulphate and mixed with Difco Bacto-agar (3% w/v in distilled water) to give 1 
L of BG11 plates (1X BG11 and 1.5% agar). Details for the preparation of 
solutions a, b, c and 1,2,3 and 4 can be found in Appendix 2.   
2.2.5 Quantification of Synechocystis cultures 
The optical density (OD750) of the liquid culture was measured at 750 nm using a 
Unicam UV-Vis spectrometer (Thermo Electron Corporation, Cambridge). The 
concentration of cells (cells/ml) was calculated by multiplying the figure obtained 
by 1.15 x 108 (Bishop, 2002).  
2.2.6 Growth tests on solid media “spot tests”  
Spot tests of strains of interest were performed where small aliquots of the 
cultures (~6 µl) at the mid-log phase were applied on BG11 plates supplemented 
with the appropriate antibiotic when necessary. The spots were allowed to dry 
completely before incubating them at 30oC with a light intensity of 30-40 
µmol/m2/s for 5-7 days depending on the tested strain. Wild type strains were 
always included as controls.  
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2.3 DNA techniques  
2.3.1 Expression vectors 
The list of expression vectors used in this study can be found in Table 2.2 
Table 2.2: Plasmids, their source and usage. 
Expression 
vector Source Usage 
pUC.psbN.kmR.A Saul Purton’s collection 
 
pUC9-based vector for targeted incorporation of a km-
resistance cassette into a neutral locus in Synechocystis 
(psbN) 
pUC4K (Taylor and Rose, 1988) 
 
source of a km-resistance gene 
pzΔES Saul Purton’s collection 
 
source of a ble cassette 
pUC18 (Yanisch-Perron et al., 1985) 
 
base for creating the two expression vectors pLAH.A2 
and pLAH.nrsB (section 2.3.11) 
pskΔE Saul Purton’s collection 
 
a pBluescript.sk based plasmid  used in the creation of 
the ΔrecJ.ble and subsequently the ΔrecJ.km plasmids 
pCRT7/CT-
TOPO 
Eran Pichersky  
(Iijima, Gang et al. 
2004) 
 
source of the geraniol synthase gene (GES) (sequence 
of the CDS of GES can be found in Appendix 4) 
 
Classical molecular techniques were carried out for DNA manipulation as 
described in (Sambrook and Russell, 2001). 
Appendix 1 details the plasmids utilised and created in this work. 
2.3.2 Plasmid DNA isolation 
Small scale plasmid DNA isolations were obtained using 1.5-3 ml of a 10 ml 
bacterial culture using a QIAprep Spin Miniprep Kit (QIAGEN, Crawley, UK) 
according to the manufacturer’s instructions. This was used mainly to isolate 
plasmids for transformation and sequencing purposes where clean preparations 
were essential.  
For crude plasmid extracts, a simple alkaline lysis method was used (Birnboim 
and Doly, 1979). In this method cells from 3-5 ml of an overnight grown E. coli 
culture were spun down, the supernatant discarded and 250 µl of re-suspension 
buffer (50 mM Tris pH 8.0 with HCl, 10mM EDTA, 100 µg/ml RNase A) was 
added to the pellet. The cells were lysed by adding 250 µl of lysis buffer (200 mM 
NaOH, 1% SDS, freshly prepared) followed by the addition of 350 µl of 
neutralising solution (3.0 M potassium acetate, pH5.5) and mixing the solution by 
inverting it several times. The mixture was centrifuged for 10 min at 16,200 x g 
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(Biofuge Pico, Heraeus) and the lysate transferred to a fresh 1.5 ml eppendorf 
tube. Absolute ethanol was added to precipitate the plasmid DNA followed by a 
15 min spin that resulted in the precipitation of a glossy pellet. The pellet was 
washed with 70% ethanol and allowed to air dry before the plasmid DNA was re-
suspended in 50 µl of ddH2O. 
2.3.3 Synechocystis genomic DNA isolation   
2.3.3.1 Genomic DNA isolation for PCR 
The Chelex-based method adapted from Werner and Mergenhagen. (1998), was 
used for the extraction of genomic Synechocystis DNA. In this method, a loopful 
of cells from a BG11 plate was re-suspended in 20 µl of sterile ddH2O. 20 µl of 
absolute ethanol was added and the mixture was incubated at room temperature 
for 1 min. 200 µl of a 5% v/v suspension of Chelex 100 resin (Bio-Rad) was 
added and the samples were mixed briefly using a vortex and placed in a boiling 
water bath for 5 min. The samples were then centrifuged at 16,200 x g for 2 min 
(Biofuge Pico, Heraeus) after which the supernatant was transferred to a fresh 
tube. 2 µl of this extracted DNA was used in 50 µl PCR reactions (section 2.3.5). 
2.3.3.2 Total genomic DNA for southern blot analysis 
Genomic DNA was isolated from 20 ml of stationary phase Synechocystis cells 
(OD750 of ≥1.0). The cells were harvested by centrifugation in a bench top 
centrifuge (MISTRAL1000, MES Scientific Instruments, Loughborough) at 3000 x 
g for 15 min. The supernatant was discarded and the pellet re-suspended in 400 
µl TES buffer (composed of 5 mM Tris.Cl pH 8.5, 50 mM NaCl and 5 mM EDTA). 
It was then transferred to a 2 ml Eppendorf tube where the cells were lysed by 
the addition of lysozyme (10 mg/ml) followed by incubation for 45 min at 37oC. 
Next, 50 µl sarkosyl and 600 µl saturated phenol pH 8.0 (BDH, Germany) were 
added to the tube. The tubes were mixing using a vortexer for 10 min after which, 
100 µl of 5 M NaCl, 100 µl CTAB-NaCl (700 mM NaCl, 10% (w/v) CTAB) and 600 
µl chloroform:isoamylalcohol (24:1 v/v) were added. The tubes were mixed again 
in the same manner (once a minute for 10 min). Centrifugation on a bench top 
micro-centrifuge (HERAEUS PICO21, Thermo Scientific, Germany) at 1500 x g 
for 2 min produced a nucleic acid-containing top phase which was transferred to 
a fresh 2 ml Eppendorf tube where a second phenol-chloroform extraction was 
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performed using equal volumes of saturated phenol pH8.0 and 
chloroform:isoamylalcohol (24:1 v/v).  
Precipitation of the genomic DNA was achieved by the addition of 1 ml of cold 
ethanol, followed by 20 min incubation at -20oC and micro-centrifugation in a 
bench-top centrifuge (HERAEUS PICO21, Thermo Scientific, Germany) at 3000 x 
g for 10 min. The pellet was washed with 70% (v/v) ethanol for 5 min at room 
temperature then dried at 37oC for 5 min. The DNA was finally dissolved in 50 µl 
of ddH2O/RNaseA (10 µg/ml) (Bishop, 2002). 
This procedure produces enough DNA of sufficient purity for two to four 
restriction digests for Southern analysis. 
2.3.4 Preparation of competent E. coli 
To create competent E. coli cells, the DH5α strain (2.2.1) was re-streaked from 
frozen glycerol stocks on a fresh LB plate and incubated overnight at 37oC.  A 
single colony was used for inoculation of 5 ml LB medium and incubated under 
the same conditions. 1 ml of the grown culture was used to inoculate a 100 ml of 
fresh LB medium and allowed to grow for 2.5 hours at 37oC and shaking at 200 
rpm. The 100 ml culture was then placed on ice for 15 min, pelleted in pre-cooled 
20 ml tubes [Sterilin Ltd, Thermo Scientific, UK] at 3000 x g for 5 min. The cell 
pellet was re-suspended in 40 ml of ice-cold 50 mM CaCl2 and kept on ice for 30 
min. The cell suspension was pelleted another time under the same conditions 
and re-suspended once more with fresh ice-cold 50 mM CaCl2 to up to 8 ml. The 
solution was mixed with 3.5 ml of 50% (v/v) glycerol, aliquots of 200 µl were 
prepared and frozen in liquid nitrogen and stored at -80oC. 
2.3.5 Polymerase chain reaction  
For the amplification of either plasmid or genomic DNA a programmed 
thermocycler was used (Eppendorf mastercycler® personal, Hamburg) or 
(Techne TC-3000X Thermal Cycler, California, USA). Reactions were performed 
in a total volume of 50 µl and the reaction mixture comprised: 10 µl 5X Phusion 
HF buffer (New England Biolabs), 1 µl of 20 mM mixed dNTPs (Fermentas, York, 
UK), 0.5 µl of forward and reverse Eurofins MWG Operon primers (Ebersberg, 
Germany) with a final concentration of 100 pmol/µl, 0.5 µl (1U) of Phusion® High-
Fidelity DNA Polymerase (New England Biolabs), 1 µl template DNA 
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(aproximately 1 µg genomic or 10 ng plasmid DNA). Finally, ddH2O was added to 
the reaction mixture to make a final volume of 50 µl.  
For PCR reactions using Taq polymerase (NEB), reactions were performed in 25 
μl reaction mix where 0.75 μl of 25 mM MgCl2 was added to 2.5 μl of the 10X 
PCR buffer supplied with the enzyme. Then, 0.5 μl of 10mM dNTPs, 1 μl of 
template DNA and 0.25 μl of each primer and 1 μl of Taq polymerase (NEB) were 
used and the final volume was reached by adding ~19 μl of ddH2O.  
For GC rich DNA, 1.5 µl 100% DMSO was added to the reaction mixture and 5X 
Phusion GC rich reaction buffer was used.  
The steps were carried out according to the manufacturer’s instructions and 
where necessary; the programme included a ‘hot start’ where the DNA template 
was incubated at 98oC for 1 min before adding the Phusion® High-Fidelity DNA 
Polymerase to the reaction.  
2.3.6 PCR purification and sequencing  
PCR products were purified using the QIAquick PCR purification Kit (QIAGEN) 
according to the manufacturer’s instructions. DNA samples that required 
sequencing were sent to the scientific support services at the Wolfson Institute for 
Biomedical Research at University College London. The samples were 
sequenced using BigDye3.1 chemistry (Applied Biosystems) and analysed using 
an Applied Biosystems AB3730XL genetic analyser. The returned data was 
checked manually for base-calling errors using Emboss align [4] and NCBI thermo 
Align [5].  
2.3.7 Oligonucleotide primers  
Appendix 3 details the primers used in this work and the experiments in which 
they were used. All primers were synthesised by Eurofins MWG (Ebersberg, 
Germany).  
                                            
 
4 http://www.ebi.ac.uk/Tools/psa/ 
5 http://blast.ncbi.nlm.nih.gov/Blast.cgi 
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2.3.8 Codon optimisation  
For the genes in this study that required synthetic production, GeneArt 
(www.geneart.com) was consulted where they carried out both gene codon 
optimisation and gene synthesis.  
2.3.9 Agarose gel electrophoresis  
DNA fragments were separated according to size on 1% (w/v) agarose gels 
made in 1X TAE buffer (40 mM Tris, 1 mM sodium EDTA, 17.5 mM glacial acetic 
acid). To run the gel, 6X DNA Loading Dye & SDS solution (Fermentas) was 
added to the DNA sample and the gel was pre-stained with ethidium bromide (1 
µg/ml). The gels were submerged in 1 x TAE buffer in an electrophoresis tank 
(Sigma) and allowed to run for 90 min at 85 V (Gibco power supply). Finally, the 
gels were illuminated on a UV transilluminator (UVP Gel Documentation System) 
to visualise the bands. O'GeneRuler™ 1 kb Plus DNA Ladder, ready-to-use 
(Fermentas) was used to estimate the size of the DNA fragments.  
2.3.10 Recovery of DNA from agarose gels  
To recover the DNA from the gel, the gel was placed on a UV plate (UVP, 
California) and the area that contained the DNA of interest was excised using a 
razor blade. The DNA was recovered using the QIAquick Gel Purification Kit 
(GIAGEN, Crawley) according to the manufacturer’s instructions.  
2.3.11 Construction of Synechocystis expression vectors 
2.3.11.1 Expression vectors 
For heterologous expression of foreign genes in Synechocystis, plasmid 
constructs were created to allow the replacement of the dispensable psbA2 
coding sequence (gene code = slr1311) with the CDS of the gene of interest via 
double homologous recombination. This is covered in detail in chapter 5 section 
(5.3.1). 
2.3.11.2 Restriction digests and cloning 
1 µg of DNA was cut with at least 1 unit of restriction enzyme in the 
recommended buffer (New England Biolabs, Hitchin). Dilutions of the digestion 
were done using ddH2O, and supplemented with 1X BSA when necessary. All 
steps were carried out according to the manufacturers’ instructions. The pJET 
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vector (Clone JET PCR Cloning Kit, Fermentas, Germany) was used for routine 
cloning according to the manufacturer’s instructions. 
2.3.11.3 DNA Ligation 
Linearised vector, insert DNA, T4 DNA ligase buffer and T4 DNA ligase were 
added according to the manufacturer’s instructions to give a total volume of either 
10 µl or 20 µl. The ratio of insert: vector DNA was ~ 6:1. Ligation reactions were 
typically incubated for ≥ 2 hours at room temperature. The ligation mix was used 
directly for transformation of the competent DH5α strain of E. coli.  
2.4 Transformation technique 
2.4.1 Transformation of competent E. coli 
Competent DH5α cells (section 2.3.4) were thawed and placed on ice. 1 µl of a 
plasmid mini preparations (diluted 1/10) or 10-20 µl of the ligation mix (section 
2.3.11.3) were added to the 100 µl thawed competent cells and the mixture was 
incubated on ice for at least 30 min before subjecting it to a heat shock at 42oC 
for 60 seconds. It was then placed briefly on ice followed by the addition of 1 ml 
of fresh sterile LB medium. The cell suspension was incubated at 37oC for 1 hour 
in a shaking incubator (Stuart Scientific Incubator S.I.60, UK with a built-in shaker 
IKA-VIBRAX-VXR, IKA® Labortechnik, Germany) at 170 rpm. The cells were 
pelleted by centrifugation in a bench top centrifuge (HERAEUS PICO21, Thermo 
Scientific, Germany) at 16,200 x g for 2 min. The supernatant was discarded and 
the pellet re-suspended in 300 µl of fresh LB medium. Aliquots of 100 µl of the 
culture was plated on selective LB plates and incubated overnight at 37oC. The 
selective LB plates contained ampicillin, kanamycin or zeocin at concentrations of 
75 µg/ml, 50 µg/ml and 25 µg/ml, respectively depending on the antibiotic 
resistance marker present in the introduced plasmid. Single colonies were picked 
for inoculation in 5 ml of LB medium containing the suitable antibiotic for selection 
and incubated overnight with shaking at 170 rpm.  
2.4.2 Transformation of Synechocystis 
For the transformation of Synechocystis, a loopful of cells from freshly re-
streaked plates was inoculated in 100 ml of liquid BG11 medium and allowed to 
grow in a light shaking incubator at 25oC and a light intensity of 15 µmol/m2/s for 
four days. The cultures were quantified by measuring the OD of the liquid culture 
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at 750 nm using a UNICAM UV/Vis Spectrometer. The concentration (cells/ml) 
was calculated using the method described in (2.2.5). 
The transformation method employed was adapted from (Williams, 1988). Wild 
type or mutant Synechocystis with an OD750 between ~0.4-0.8 was harvested by 
centrifugation using a bench top centrifuge at 3000 x g for 10 min. The cells were 
washed in 2 ml of fresh BG11 medium and spun down a second time. The 
washed cell pellets were re-suspended in BG11 medium to a final concentration 
of 4 X 108 cells/µl. In duplicates, 1-5 µg of the DNA to be transformed was added 
to 200 µl of the re-suspended cells. These were then incubated at 30oC for 4-6 
hours. The cells were spread onto BG11 plates, allowed to dry, and then 
incubated for 2-3 days to allow expression of the introduced resistance marker. 
The plates were then overlain with 3 ml of 0.6% (w/v) agar with added kanamycin 
or zeocin giving a final concentration of 200 µg/ml and 25 µg/ml, respectively. 
The plates were incubated for approximately two weeks in a light intensity of ~40 
µmol/m2/s at 30oC and were then examined for the presence of putative 
transformant colonies. 
2.4.2.1 Isolation and analysis of homoplasmic Synechocystis strains   
Colonies were picked using sterile cocktail sticks and streaked to form single 
colonies on BG11 plates supplemented with the appropriate antibiotic. Single 
colonies were taken through three rounds of selection and homoplasmicity 
confirmed by PCR (2.3.5) using wild type or the untransformed strain as controls. 
2.5 DNA analysis  
2.5.1 Southern blotting  
The methodology employed was adapted from that established by Southern 
(1975) and described in Sambrook and Russell. (2001). In this method, the DNA 
of interest was digested with the appropriate enzyme, run on a 1% agarose gel 
and soaked, with agitation, in denaturing solution (1.5 M NaCl, 0.5 M NaOH) for ≥ 
30 min. The gel was then briefly rinsed with distilled water and soaked in 
neutralising solution (1 M TrisHCl pH 8.0, 1.5 M NaCl) for 20 min followed by 
further 20 min soak in fresh solution. The DNA was irreversibly transferred to an 
uncharged nylon membrane (Hybond-N, GE Healthcare) by capillary action 
following an overnight transfer at room temperature according to the protocol 
described in (Sambrook and Russell, 2001). The DNA was fixed to the 
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membrane by baking it for 1 hour at 80oC between 3MM Whatman paper 
(Whatman, Maidstone).  
2.5.2 Probe labelling and detection 
The probe was produced using ~1 µg of template DNA produced from either a 
PCR product or gel purified DNA from a restriction digest. DNA labelling and 
detection was done using the DIG High Prime DNA Labelling and Detection 
Starter Kit II (Roche Diagnostics GmbH, Mannheim, Germany) following the 
manufacturer’s instructions.  
2.6 Protein analysis  
2.6.1 Isolation of crude whole cell protein extracts of Synechocystis  
Synechocystis strains of interest were re-streaked several times on BG11 plates 
before inoculating them in 50 ml flasks containing 25 ml of BG11 medium and 
allowed to grow to mid-log phase. The optical density of the cells was measured 
using the UV-Visible spectrometer (Thermo Electron Corporation, USA) at 750 
nm. 20 ml of the culture was harvested in a bench top centrifuge at 3000 x g for 
10 min and re-suspended in X ml of solution A (0.8 M TrisHCl pH 8.3, 0.2 M 
sorbitol, 1% β-mercatoethanol) where X is the reading at 750 nm. This was done 
to obtain samples with approximately the same cell concentration. The samples 
were stored at -80oC. 
2.6.2 Protein gel electrophoresis  
Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) was 
carried out using the mini-PROTEAN* System (BioRad). Laemmli’s recipe 
(Laemmli, 1970) was used to prepare the gels as detailed in Table 2.3 and mixed 
in the order listed with TEMED added last. The gel comprised a 15% resolving 
gel that was allowed enough time to fully polymerise (≥ 30 min). Prior to 
polymerisation a thin layer of ethanol was overlain on the resolving gel to ensure 
a flat interface between the resolving and stacking gels. This thin layer was 
removed by filter paper before pouring the 3.75% stacking gel and a 10-well 
comb was added to the gel before it started to polymerise. 
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Table 2.3: Laemmli gel recipe for SDS-PAGE (Laemmli, 1970).  
 
Reagents 
 
Volume for 2 gels 
 
15% resolving gel: (~10 ml) 
• Acrylamide/bisacrylamide 
             40% stock, 37:1 [Sigma, Dorset, UK] 
• Resolving gel buffer (8 x stock) 
 3 M Tris-HCl, pH 8.8 
• 10% SDS  
• ddH2O 
• 10% ammonium persulfate (AMPS) [Sigma, Dorset, UK]  
• N,N,N′,N′-Tetramethylethylenediamine (TEMED) [Sigma, Dorset, 
UK] 
 
 
3.75 ml 
 
1.25 ml 
 
0.1 ml 
4.5 ml 
0.375 ml 
3.75 µl 
 
3.75% stacking gel: (~5 ml) 
• Acrylamide/bisacrylamide 
                 40% stock, 37:1 [Sigma, Dorset, UK] 
• Stacking gel buffer (4 x stock) 
                  0.5 M Tris-HCl, pH 6.8 
• 10% SDS  
• ddH2O 
• 10% ammonium persulphate (AMPS) [Sigma, Dorset, UK]  
• N,N,N′,N′-Tetramethylethylenediamine (TEMED) [Sigma, Dorset, UK] 
 
 
0.47 ml 
 
1.25 ml 
 
0.05 ml 
3 ml 
0.25 ml 
3.75 µl 
 
The polymerised gel was assembled into the Mini-PROTEIN* System (BioRad) 
and the tank filled with Tris-glycine-SDS electrophoresis buffer (0.025 M Tris, 
0.192 M glycine and 0.1% (w/v) SDS, pH 8.3).  
The crude protein samples were prepared by adding 11 µl of 10% SDS to 100 µl 
of the protein sample and boiled at 99oC for 1 min in a heat block (Thermomixer 
Comfort, Eppendorf). The samples were spun down to remove cell debris and 30 
µl of each sample were loaded on the gel. 5µl of PageRulerTM prestained protein 
markers (Fermentas, York, UK) was used to estimate protein sizes. For good 
protein separation, gels were typically run for 2 hours at 120 V using a PowerPac 
300 (Biorad, Hemel Hempstead, UK). 
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2.6.3 Western blot analysis  
Following SDS-PAGE to fractionate the proteins according to size, the gel was 
soaked in Towbin buffer (25mM Tris, 192 mM glycine and 20% (v/v) methanol) 
for 30 min together with a piece of HybondTM ECL nitrocellulose membrane 
(Amersham GE Healthcare) and eight pieces of 3 MM Whatman paper that were 
all pre-cut to the gel size.  
Protein transfer to the membrane was carried out using a Semi-Dry Transfer Cell 
TRANS-BLOT*SD (BioRad). The setup was as follows, starting at the base of the 
electroblotter: four pieces of 3 MM Whatman paper, the HybondTM ECL 
nitrocellulose membrane, the gel, and the other four pieces of 3 MM Whatman 
paper. A voltage of 20V was applied for 1 hour using a Fisons FEC 570 
Powerpac.  
2.6.4 Immuno-detection  
Once the transfer was complete, the membrane was incubated overnight at 4ºC 
with gentle agitation in blocking solution comprised of 0.5 % (w/v) of low fat 
powdered skimmed milk prepared in TBS (20 mM Tris base, 137 mM NaCl, 1 M 
HCl pH 7.4).  
Subsequently, the membrane was washed vigorously (80 rev/min) with 1X TBS-T 
(20 mM Tris base, 137 mM NaCl, 1 M HCl pH 7.4, 0.1% Tween-20) once for 15 
min then twice for 5 min each. The membrane was then incubated at room 
temperature for a minimum of 1 hour on a Stuart Scientific (Stone, UK) 3D 
rocking platform with the primary antibody diluted in blocking solution. The 
membrane was then washed with 1X TBS-T for at least 45 min (a 15 min wash, 
then 3 X 10 min washes) followed by incubation with the secondary antibody also 
diluted in blocking solution. When necessary, in case of a light sensitive 
secondary antibody, the membrane was covered with a black cloth. Finally the 
membrane was rinsed with TBS-T (1 wash of 15 min followed by 3 X 5 min 
washes). A final wash with TBS was done if the Odyssey system was used for 
detection. Dilutions used for primary and secondary antibodies are listed in Table 
2.4. 
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Table 2.4: Details of primary and secondary antibodies. 
 Table includes the name, source, type and the dilutions of the antibodies used in this application. 
Protein  Antibody Source Type 
Dilution 
factor 
 Primary antibody 
  
      
HA Anti-HA Sigma Aldrich Rabbit monoclonal 1:2000 
 
Ble 
 
Anti-Ble CAYLA Rabbit polyclonal 1: 2000 
 
 
Secondary antibody 
    
Rabbit 
IgG 
ECL anti-rabbit IgG Sigma (A3687) 
 
horseradish peroxidase 
conjugated (from donkey) 
 
1:10,000 
Anti-rabbit IgG (H+L) 
Thermo Scientific 
DylightTM 800 conjugated  
(from goat) 
1: 20,000 
Rabbit 
IgG 
ECL anti-rabbit IgG Sigma (A3687) 
horseradish peroxidase 
conjugated (from donkey) 
 
1: 5000 
Anti-rabbit IgG (H+L) 
ThermoScientific 
DylightTM 800 conjugated  
(from goat) 
1: 15,000 
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To detect the antibody complex, an enhanced chemiluminescence (ECL) 
detection kit was used (SuperSignal (R) West Pico Chemiluminescent Substrate, 
supplied by Thermo SCIENTIFIC, Rockford, USA). After removing excess wash 
buffer, equal amounts of detection solution one and two were applied to the 
membrane ensuring full membrane coverage. The membrane was incubated for 
1 min at room temperature and excess solution wiped off. The membrane was 
sealed between polythene sheets using a heat sealer and placed in a developing 
cassette. In the dark room, the membrane was exposed to a sheet of Hyperfilm 
ECL (GE Healthcare) and developed using an automatic film processor (Xograph 
Compact X4 film developer). The signal strength was adjusted by exposing the 
membrane for various times (5 sec to up to 45 min) to achieve the desired signal 
strength.  
When protein intensity were to be compared, the Odyssey®infrared imagining 
system (Licor-Bioscience, Lincoln, Nebraska, USA) was used according to the 
manufacturer’s instructions.  
2.7 Synechocystis toxicity tests 
Geraniol, geranial, linalool, farnesene and citronellene were used to assess the 
level of toxicity of selected terpenes to Synechocystis.  
2.7.1 Testing for growth of Synechocystis in the presence of terpenes  
Synechocystis was grown in a liquid culture to an OD750 of ~1.7. Inocula of 0.5 ml 
of the culture were added to each of 6 flasks containing 25 ml of growth medium 
(BG11). Aliquots of each terpene were added to individual flasks to a final 
concentration of 0.02%, 0.1%, 0.2%, 0.4% or 1% (v/v). Cultures with no added 
test compound were monitored to check viability during the course of the 
experiment. Photographs were taken every 24 hours for four days to produce a 
color series of culture viability. 
2.7.2 Tolerance of established cultures of Synechocystis to terpenes 
Synechocystis was cultured in shaker ﬂasks in 25 ml of BG11 medium (Section 
2.2.4). Aliquots of each of the test compounds were added to individual ﬂasks 
containing established cultures of Synechocystis to a ﬁnal concentration of 
0.02%, 0.1%, 0.2%, 0.4% or 1% (v/v). The additions were done when cell growth 
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was in the exponential phase and the population was approximately 7 x 107 
cells/ml. Cultures with no added test compound were monitored to check viability 
during the course of the experiment. Photographs were taken every 24 hours for 
four days to produce a visual series of culture viability. 
2.7.3 Effect of a two-phase culture system on tolerance levels 
Cultures (25 ml) were grown to a cell population of approximately 7 x 107 cells/ml 
before adding 0%, 0.02%, 0.04%, 0.08%, 0.1%, 0.2% and 1% v/v of the terpene 
followed by 5 ml of n-dodecane (Alfa Aesar) to create an organic phase above 
the aqueous medium. Cultures with 0–1% v/v test compound were also grown in 
the absence of n-dodecane for comparison. Photographs of the cultures were 
taken every 24 hours for four days. 
2.8 Biofuel and hydrocarbon analysis  
2.8.1 Supernatant extracts from cyanobacteria cells 
Cyanobacteria strains expressing α-farnesene synthase under the control of the 
nrsB inducible promoter were used for this extraction method. 450 ml of un-
induced culture grown to mid-log phase was centrifuged for 15 min at 10,722 x g 
using a Sorval Evolution RC (Kendro Lab Products, USA). The supernatant was 
discarded and the pellet re-suspended in 60 ml of fresh BG11. Of the 60 ml of re-
suspended cells, 15 ml were harvested in falcon tubes by centrifugation in a 
bench top centrifuge at 3000 x g for 2 min. The supernatant was transferred into 
a new falcon tube following the addition of 3 ml of hexane while the pellet was 
later used for cell extraction (Section 2.8.2). The supernatant/hexane mix was 
vigorously mixed using a vortex and the phases allowed to separate before 
transferring the top phase into gas chromatography (GC) vials for GC analysis. 
This was used as a negative control. The remaining 45 ml culture was induced 
with NiCl2.6H2O4 added to a final concentration of 6.4 µM.  The culture was 
incubated at 30oC under a light intensity of 30 µmol/m2/s for 4 hours then later 
split into three 15 ml cultures. One of the 15 ml induced cultures was harvested 
with hexane and the pellet saved as described above while the remaining two 
cultures were spun down, their supernatant discarded and the pellets used for 
cell extraction (Section 2.8.2). All flasks used were acid washed with 5 M HNO3 
overnight. 
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2.8.2 Cell extracts  
Cell extracts for biofuel analysis: In this method, three high-performance liquid 
chromatography (HPLC) grade solvents (hexane, methanol and ethyl acetate) 
were used for farnesene extraction from the pellets. The pellet in one falcon tube 
(section 2.8.1) was re-suspended in 1 ml of hexane and transferred to a 2 ml 
Eppendorf tube containing ~500 µl of acid washed 212-300 µM glass beads 
(Sigma). The same process was carried out using 1 ml of ethyl acetate and 1 ml 
of methanol. The tubes were mixed vigorously using a vortexer for 2 min followed 
by 2 min incubations on ice. The vortex/ice incubation steps were performed 5 
times before spinning the cells for 5 min at 16,200 x g (Biofuge Pico, Heraeus) 
after which, the top solvent phase was transferred into GC vials for GC analysis. 
An un-induced culture of the farnesene synthase expressing strain was used as a 
negative control. The samples were run in parallel with standards of commercial 
β-farnesene prepared in hexane at concentrations of 1 ppm, 50 ppm and 100 
ppm that also served as positive controls. 
 
Cell extracts for hydrocarbon analysis: In order to determine the hydrocarbons 
in the microwells, the contents of the cell were removed 21 hours post dodecane 
addition and transferred to pre-weighed 15 ml polypropylene falcon tubes for 
extraction in ethyl acetate directly. They were then centrifuged in a bench top 
centrifuge (HERAEUS PICO21, Thermo Scientific, Germany) at 16,200 x g for 15 
min after which the supernatant was tipped into another 15 ml falcon tube and 
pellets were spun down once more for 4 mins. The remaining supernatant was 
carefully transferred to the falcon containing the supernatant where 2 ml ethyl 
acetate was added to them. They were vortexed and left in the heated cabinet for 
30 mins after which they were re-vortex and spun down for 4 mins at 16,200 x g. 
1 ml of the top phase was transferred into the GC vials for analysis. The 
extraction method using ethyl acetate was done according to (Grant et al., 2012).  
For pellet extractions, 1 ml ethyl acetate was added to the pellet, and it was 
vigorously shaken and placed in a heated cabinet for 30 mins. Two pre-weighed 
control tubes were included that only contained 1 ml ethyl acetate. This was done 
to determine the effect of adding ethyl acetate on the mass of tube (effect on dry 
cell weight measurements). The tubes were vortex, centrifuged for 4 mins at 
16,200 x g and finally the liquid was transferred to vials for GC analysis.  
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2.8.3 Two-phase extraction method 
In this method, Synechocystis strains expressing α-farnesene synthase under the 
psbA2 and nrsB promoters (strain one and strain two respectively) and a 
negative control (Wild type -WT- Synechocystis strain transformed with an empty 
pLAH.A2 vector) were analysed.  300 ml of each strain were grown in acid 
washed flasks to an OD750 of ~0.5, at which, strain two was induced with 6.4 µM 
of NiCl2.6H2O4 for 4.5 hours. Two non-toxic solvents namely, n-dodecane and 
decane were used for terpene extraction. The cultures were overlaid with 5 ml of 
the solvent tested and placed in a shaking incubator set at 120 rpm. They were 
allowed to shake for 17 hours to allow enough time for the terpene to partition 
into the solvent layer. The solvent phase of the two-phase culture system was 
collected and centrifuged for 10 min at 4000 x g to remove cell debris, and 
subsequently subjected to GC-MS. Samples spiked with 0.02% and 0.2% (v/v) 
terpene standard were used to check the extraction method using each solvent. 
The sample set up and the extraction method is illustrated in Figure 2.1. 
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Figure 2.1: Schematic representation of extraction methods 
(A) Two-phase extraction method from the cell culture (B) Glass bead extraction of the pellet. N-
dodecane and decane were used in both extractions. Key: Negative control (-c): WT 
Synechocystis strain transformed with an empty pLAH.A2 vector. Strain 1: Synechocystis 
expressing farnesene synthase (FS) under psbA2 promoter, Strain 2: Synechocystis expressing 
FS under nrsB promoter. 
 
Cells in the remaining culture were pelleted by spinning for 10 min at 16,200 x g 
(Biofuge Pico, Heraeus) and the supernatant discarded. The pellets were re-
suspended in 500 µl of solvent (n-dodecane or decane) and transferred to a 2 ml 
Eppendorf tube containing ~250 µl of acid washed 212-300 µM glass beads 
(Sigma) Figure 2.1 B. The tubes were vigorously mixed using a vortex for 2 min 
followed by 2 min incubations on ice. The vortex/ice incubation steps were 
performed 5 times before spinning the cells for 5 min at 16,200 x g and 
transferring the top solvent phase into GC vials for GC analysis. The samples 
were run in parallel with standards of 1 ppm, 50 ppm and 100 ppm of commercial 
β-farnesene synthase prepared in decane and n-dodecane respectively.  
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2.8.4 Gas Chromatography analysis  
For GC analysis for biofuels:  Gas Chromatography (GC) analysis on the 
samples from sections 2.8.1, 2.8.2 and 2.8.3 was carried out using a Clarus 500 
GC system equipped with a Clarus 500 mass spectrum (MS) detection system 
(both from Perkin-Elmer, life sciences, UK). The samples were separated on a 
Restek Rxi-5ms column, 30 m length, 0.25 mm ID, 1.0 µm film thickness. Helium 
was used as a carrier gas flowing at a rate of 1 ml/min. 1 µl of each sample was 
injected using an autosampler (Perkin Elmer), splitless. The oven temperature 
was initially held at 80oC for 1 min and was increased at a rate of 10oC/min to 
250oC where it was held for 1 min. The temperature of the injector and detector 
were maintained at 260oC and 220oC respectively. A selected ion recording (SIR) 
mode was used where the following eight masses were selected for: 41, 53, 67, 
69, 79, 93, 120, 133. The retention times of product peaks were compared to the 
trans-β-farnesene standard purchased from Sigma-Aldrich. 
For GC analysis of hydrocarbons: quantification of cell extracts from section 
2.8.2 was performed by Gas-chromatography using an FID detector (Flame 
ionization detector). The column used was a Restek 5MS column (30m x 0.25mm 
x 1µm) with helium carrier gas under a constant pressure of 17Psi. The samples 
were eluted in an initial temperature of 100 oC for 1 minute followed by a linear 
increase of 10 oC per minute to reach a final temperature after ramping of 280oC 
which was held for 2 minutes.  
2.9 Growth analysis 
The growth curve of WT Synechocystis was established using an Algem 1.0 
photobioreactor (Algenuity, UK) with WT Synechocystis grown under a constant 
temperature of 30oC, a light intensity of 200 µmol/m2/s and constant mixing at 
120 rpm. Growth comparisons between different mutants of Synechocystis were 
achieved by growing the strains under the same conditions and monitoring their 
growth simultaneously using an automated programme. The Algem was set 
according to the manufacturer’s instructions. The OD525 was measured and 
saved automatically every 10 min and a plot constructed using the instrument’s 
built in software when necessary.  
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2.10 Cell density determination 
Cell density measurements were taken by sacrificing the well contents and 
centrifuging the samples at 4000 g for 5 minutes. The supernatant was treated 
separately and used for GC analysis (6.3.3) while the dry cell weight of the pellets 
was determined by subtracting the weight of pre-weighted empty 15 ml 
polypropylene falcon tubes that were used for harvesting the culture from the 
same tubes containing the pellet after drying the pellets in the oven at 100oC for 
24 hours. 
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Chapter 3: Attempts for the development of a simple 
system for random insertion mutagenesis in 
Synechocystis 6803
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3.0 Introduction  
Transformation of the cyanobacterium Synechocystis with exogenous DNA 
(whether homologous or heterologous) is easily achieved with a high level of 
efficiency (Barten and Lill, 1995). The natural competency of this cyanobacterium 
is one reason for it being adopted as a model for molecular genetic studies. With 
the sequencing of its genome (Kaneko et al., 1996) and the development of 
molecular tools for gene knockouts and gene mutagenesis (Kufryk et al., 2002, 
Dzelzkalns and Bogorad, 1986, Williams, 1988, Labarre et al., 1989) the identity 
and function of many gene products have been identified. Nevertheless, out of a 
total of 3167 potential protein-coding genes in Synechocystis, 679 are still with an 
unknown function (CyanoBase [6]).  
Gene modifications represents one approach that truly revolutionised the ways in 
which protein function is analysed, whether these modifications are introduced at 
specific loci or randomly in the genome (Vermaas, 1998). Furthermore, the 
creation of cyanobacterial mutants which are altered in particular functions is one 
of the most powerful approaches to the study of cellular phenomena such as 
photosynthesis (Golden, 1988). Proposed techniques for the creation of 
cyanobacterial mutants using both random mutagenesis and site-directed 
(targeted) mutagenesis are described in the current and following chapters 
(chapter 3 and 4 respectively).  
Transformation via double homologous recombination, which involves 
recombination between the chromosome and added heterologous DNA linked to 
host DNA, is very successful in creating targeted gene knockouts in 
Synechocystis (Kufryk et al., 2002, Vermaas, 1998). This method is illustrated in 
Figure 4.1 and discussed in detail in chapter 4. It would, however, be 
advantageous to have a system for introducing heterologous DNA into 
Synechocystis cells directly without the need of creating a plasmid construct in 
which this DNA is flanked by the chromosomal DNA elements required to 
mediate homologous recombination. Work presented in this chapter aims to 
develop a transformation system for the cyanobacterium Synechocystis that does 
                                            
 
6 http://www. kazusa.or.jp/cyano/  
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not require the construction of cloning vectors, digestions or ligation steps and 
which does not rely on homologous recombination to achieve transformation.  
According to Kufryk and colleagues, transformation efficiency of the host strain of 
Synechocystis can be increased by two orders of magnitude if a mutant strain is 
used in which the sll1354 gene encoding the exonuclease RecJ is deleted 
(Kufryk et al., 2002). In the work presented here, recJ– strains were created and 
employed as a recipient strain for the transformation of a kmR cassette that is 
‘naked’ in the sense that it is not flanked by any DNA homologous to the 
cyanobacterial genome. The goal of this study is to achieve random insertion of 
the cassette into the Synechocystis genome, and thus develop this as a method 
for random mutagenesis in which mutated genes are ‘tagged’ by the kmR 
cassette. Thus, unlike conventional UV or chemical mutagenesis, the mutated 
gene can be rapidly identified using inverse PCR that amplified genomic DNA 
flanking the cassette, or cloning approaches that rescue the cassette plus 
flanking sequence back to E. coli.  Figure 3.1 shows an illustration of the 
proposed random insertion mutagenesis method. 
 
Figure 3.1: Illustration of the proposed method of random kmR cassette integration 
into a recJ- strain. 
A) Isolation of naked kmR cassette from pUC4K plasmid as SalI and HincII fragments with no 
flanks. (B) Transformation of the naked kmR cassette into ΔrecJ.ble strain achieving random 
integration within the genome. Key: ble; bleomycin selectable marker.  
 99 
 
3.1 Background  
3.1.1 Current random methods of mutagenesis  
In contrast to targeted gene disruptions (so-called ‘reverse genetics’) in 
Synechocystis which are based on double homologous recombination, random 
methods of disruption of the host DNA includes chemical and UV mutagenesis 
and transposon mutagenesis (also referred to as classical mutagenesis or 
‘forward genetics’) (Golden, 1988). Both chemical and UV mutagenesis have 
been of limited value in Synechocystis possibly due to the availability of multiple 
genome copies which makes the detection of recessive mutations induced by 
these methods more complicated (Labarre et al., 1989).  
In heterotrophic bacteria, using transposons for mutagenesis is the most common 
approach for identifying genes that have not been described before. However, 
the use of transposons for mutagenesis in cyanobacteria is not well characterised 
(Labarre et al., 1989, Golden, 1988). Transposon-based methods that have been 
developed for use in other strains can work poorly in cyanobacterial hosts (Berla 
et al., 2013, Golden, 1988). Although the reasons behind this have not been fully 
elucidated, it is reported that the method results in only few mutants (Tandeau de 
Marsac et al., 1982). Hence, the ability to find conditions that will induce 
transposition at a higher frequency or the identification of elements that readily 
transpose in cyanobacteria strains would enhance the usefulness of this method 
(Golden, 1988). As a result, other methods were recently developed that do not 
depend on classical mutagenesis methods. One example is the insertional 
mutagenesis method developed by (Labarre et al., 1989). In this method, the 
disruption of the host genome is done by the insertion of an antibiotic cassette. 
The advantage here is that recessive mutants can be recovered since positive 
selection for the antibiotic allows recovery of homoplasmic mutants in which all 
copies of the genome carry the recessive mutation. Random integration of the 
marker DNA was achieved by randomly ligating it to a pool of restriction 
fragments of the host genome. The ligation mix (selectable marker physically 
linked to cyanobacterial DNA) is then used directly for transformation into 
Synechocystis. The authors highlight that this does not suggest that the 
integration of the antibiotic marker necessarily results from homologous DNA 
pairing and recombination between the donor DNA molecule and the host 
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genome. Rather, the linear marker DNA might need to be extended by adding 
additional DNA to either end merely to protect against exonucleolytic 
degradation, whereas integration itself may need little or no homology to the host 
DNA. It has been suggested that short exposure of Synechocystis to low-level UV 
irradiation reduces the effect of endogenous nucleases and allows for integration 
of heterologous DNA into the cyanobacterial host independent of either 
autonomously replication or homologous recombination (Dzelzkalns and 
Bogorad, 1986). Nevertheless, the process still involves the use of UV irradiation, 
which as mentioned earlier, has a number of disadvantages. 
From the previous discussion, it appears reasonable to speculate that if the 
native host nuclease degradation process can be mitigated, it might be possible 
to transform the host cell with heterologous DNA without the need for the marker 
DNA to be physically linked to Synechocystis chromosomal DNA. In 
Synechocystis, this could possibly be done by deleting the recJ gene. The 
importance of eliminating the exonuclease RecJ for better transformation 
efficiency was identified by Porter (Porter, 1986) who also suggested that the 
most pressing need in cyanobacterial genetic engineering in general is the 
development of rec- strains of the appropriate organisms. 
The presence of the exonuclease RecJ in Synechocystis is well documented. 
This 759 amino acid protein is a single-strand DNA-specific exonuclease that 
degrades foreign DNA from the 5’-3' end. It was Kufryk and colleagues who were 
the first to develop a recJ- strain in Synechocystis 6803 (Kufryk et al., 2002). In 
their work, it was demonstrated that deleting the sll1354 gene that encodes RecJ 
significantly improved the transformability of the host strain of Synechocystis by 
two orders of magnitude. It would appear that loss of the exonuclease extends 
the half-life of the transforming DNA allowing inefficient illegitimate (i.e. non-
homologous) recombination events to occur.   
3.2 Chapter aims 
• To develop a rapid and simple method for random foreign gene insertion 
into the genome of Synechocystis based on an antibiotic resistance 
marker and a RecJ- deficient host as illustrated in Figure 3.1. 
• To use the newly established method to identify novel mutants for 
identification of novel mutants using forward-genetic screens and also as a 
 101 
 
promoter-trap when employing a promoter-less version of the marker to 
identify novel strong or inducible/repressible promoters. 
3.3 Results and discussion  
3.3.1 Creation of the ∆recJ Synechocystis mutant  
For the creation of the Synechocystis mutant strain with a deleted recJ gene, an 
existing pRecJ::ble plasmid construct (kindly provided by Saul Purton) was 
utilised. In this construct recJ is interrupted with the ble marker gene conferring 
resistance to zeocin. Details of the plasmid can be found in Appendix 1. The 
transformation method for wild type Synechocystis with the pRecJ::ble plasmid is 
described in section 2.4.2.  
Putative colonies appeared within ten days post antibiotic selection and eight 
isolated colonies were taken through three rounds of re-streaking on selective 
medium to ensure that the transformants reached the homoplasmic stage. 
Genomic DNA from eight lines was isolated as described in section 2.3.3.1 and 
used in a PCR reaction with primers annealing at the 5’ and 3’ ends of recJ 
(Appendix 3) to confirm the insertion of the ble gene. Various controls were also 
included: namely the pRecJ::ble plasmid which was used a positive control, the 
plasmid pRecJ that contains an intact version of recJ, and genomic DNA from 
wild-type Synechocystis 6803 which both served as negative controls. This was 
done to compare the band sizes of the wild type vs. disrupted versions of recJ to 
confirm the isolation of successful transformants. The expected size for the WT 
PCR product is 2002 bp and that of the recJ::ble allele is 1695 bp as illustrated in 
Figure 3.2.A.  
As shown in Figure 3.2.B, the results of the PCR confirm that transformant lines 
T1 – T4 contain a disrupted version of recJ. Furthermore, the lack of a 2 kb wild 
type (WT) band indicates that all 12 or so copies of the polyploid genome present 
in each cell have the mutant allele (i.e. the transformant lines are homoplasmic 
for the knockout). Since all the transformant lines are presumed to be genetically 
identical, only one was chosen as a representative line and its phenotype 
confirmed by growth tests on different solid media as shown in Figure 3.3. Such 
‘spot tests’ were undertaken as described in 2.2.6 and confirmed that the line is 
resistant to zeocin while remaining sensitive to kanamycin and can thus be used 
as a recipient strain when using the kmR marker. 
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Figure 3.2: PCR confirmation for the isolation of a ΔrecJ Synechocystis mutant 
(A) Schematic representation of WT size of the recJ gene (2.0 kb) versus the recJ::ble knockout 
(1.7 kb) (B) PCR confirming the isolation of ΔrecJ Synechocystis transformants (T1 – T4).  Key: 
pRecJ; plasmid containing uninterrupted version of the recJ gene (-C), pRecJ:ble; plasmid 
containing recJ gene deleted with a ble marker (+C), T1-T4; transformants.  
 
 
Figure 3.3: Spot tests of WT, a kanamycin-resistant transformant line (psbN.km) 
and a representative recJ::ble transformant line. 
3.3.2 Transformation of the ∆recJ Synechocystis mutant 
To test for random integration of foreign DNA into the ΔrecJ mutant strain, a 
kanamycin resistance cassette was isolated by digesting the pUC4K plasmid 
(Appendix 1) with SalI according to methods described in section 2.3.11.2. The 
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1.2 kb band corresponding to kmR cassette was excised from the gel and 
purified. The same method was performed to isolate the kmR cassette as a HincII 
fragment.  
The cassettes, isolated with blunt ends (HincII) or a four-base 5’ overhang (SalI), 
were both used for two independent transformation experiments using either the 
wild type strain or the ∆recJ strain. After ten days, many colonies were visible for 
the ∆recJ strain while only very few small colonies were obtained in the wild type 
recipient strain for both isolated kmR cassettes as shown in Figure 3.4. The tiny 
colonies that appeared from the transformation of WT strain were too small to be 
picked and appear to be pseudo-transformant colonies arising through depletion 
of antibiotic in the media. These colonies were not analysed further. Similar early 
work (Labarre et al., 1989) showed that the transformation of selectable markers 
that were not physically linked to Synechocystis DNA (i.e. carrying no homology 
to the genome of the cyanobacterial host) produced no transformants in wild type 
Synechocystis strains.  
Colonies were readily obtained using the recJ mutant strain indicating that in this 
mutant background the marker DNA is sufficiently stable to become incorporated 
into the genome, and that DNA integration does not require tracts of homology 
between the DNA and the genome. Sixteen isolated colonies were taken through 
three rounds of re-streaking on selective media to ensure they reached the 
homoplasmic state before being tested by PCR analysis. Representative 
transformants for both the HincII and SalI forms of the cassette were included to 
test whether using blunt or sticky ends would have an effect on the integration 
pattern of the selectable marker within the genome.  
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Figure 3.4: Transformation of WT and ΔrecJ strains with the kanamycin-resistance cassette 
Colonies obtained from the transformation of ΔrecJ and WT Synechocystis strains with the kmR cassette as a HincII fragment (A) and as a SalI fragment 
(B).
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3.3.3 Analysis of ∆recJ Synechocystis transformed with the kmR cassettes 
3.3.3.1 PCR analysis  
DNA preparations of the isolated transformants obtained in section 3.3.2 were 
used in a PCR reaction to test for the integration of the kmR cassettes into the 
transformants genome.  Primers used for the amplification of the kmR cassette in 
this PCR reaction are listed in Appendix 3. A positive control for the cassette 
(plasmid pUC.psbN.kmR) and negative controls with DNA lacking the cassette 
(genomic DNA from the WT Synechocystis and the recJ::ble recipient line) were 
also included in the PCR reactions to test the specificity of the primers. The 
results are presented in Figure 3.5 and show a band of 1.2 kb band in all eight of 
the ‘HincII’ transformant lines confirming the presence of the kmR cassette. The 
same results were obtained when analyzing the eight transformants generated 
with the kmR cassette as a SalI.  
It is worth noting here that it is not advisable to use Phusion® High-Fidelity DNA 
polymerase, for the screening of transformants for the presence of kmR cassette. 
It was observed that a band corresponding to the kmR cassette was routinely 
detected in the negative control samples. After prolonged investigations to 
identify the source of contamination, it appeared that traces of the kmR marker 
were present in the polymerase itself. This is probably due to the fact that the 
recombinant Phusion is expressed in E. coli from a plasmid carrying the 
kanamycin-resistance gene and the isolated polymerase is contaminated with 
trace amounts of such plasmid. For this reason Taq polymerase was used for 
screening tests instead. 
 
Figure 3.5: PCR confirmation of kmR integration in the ΔrecJ strain. 
All transformants show an amplified band for the kmR cassette at ~1.2 kb indicating the presence 
of kmR cassette as both HincII and SalI fragments in all isolated transformants. Key: ΔpsbN.km: 
plasid containing a psbN gene interrupted with a kmR gene (+C), ΔRecJ.ble: plasid containing a 
recJ gene interrupted with a ble selectable marker (-C).  
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3.3.3.2 Southern blot analysis 
Whilst the PCR result confirms the presence of the kmR cassette in the 
transformant genomes, it does not provide any information about the copy 
number of the cassette or the site of integration in the genome. In order to 
determine whether the cassette integrates at random loci, as predicted, genomic 
DNA was prepared for the 16 isolated transformants as detailed in section 2.3.3.2 
in order to carry out a Southern blot. In order to simplify the expected pattern and 
to test for random integration, two restriction enzymes (XmnI and BsaAI) that do 
not cut the kmR cassette were chosen for digestion. Accordingly, the size of any 
genomic fragment containing the cassette will be dependent on the particular 
insertion site and the location of XmnI or BsaAI sites around the site. If a single 
copy of the cassette has integrated randomly in each transformant then we would 
predict a Southern blot result in which a single band hybridizing to the probe is 
seen for each transformant line, but with each band of a different size.  
The Southern blots were set up and the probe was prepared according to 
methods detailed in section 2.5.1 and 2.5.2, respectively. Figure 3.6 shows the 
results with DNA isolated and digested from 15 transformants (one sample was 
lost during genomic DNA preparation) and probed with a labelled KmR cassette 
isolated from pUC4K. Both the XmnI and BsaAI digestions show the same 
pattern for all transformants – namely, a band of the same size in each 
transformant, suggesting that the marker is either integrating a single copy into a 
preferred location within the genome, or that the DNA has not integrated but is 
being freely replicated, either as a linear molecule or in a circular form. This 
observation was contradictory to what was expected. Therefore further 
investigations were made in order to determine if the DNA is freely replicating 
within the cell or integrated into the genome, and if it was the latter, the site of 
integration.  
To investigate whether the marker is present as a freely replicating form, a further 
Southern blot was set up where enzymes XmnI and BsaAI were used to digest 
the genomic DNA of two independent transformants ΔrecJ.ble.km(HincII) and 
ΔrecJ.ble.km(SalI), while one genomic sample was left undigested (control). A 
ΔpsbN.km transformant in which the psbN gene was interrupted by the insertion 
of the kmR cassette (Chapter 4) was used as a positive control to check the 
functionality of the probe.  Figure 3.7.A shows the possible scenarios of the 
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digested genomic products containing the kmR cassette. Since the cassette lacks 
both restriction sites then ‘digestion’ of a freely replicating form (either linear or 
circular) should have no effect and the distance migrated on the blot will be the 
same for all three cases (uncut, XmnI-cut and BsaAI-cut). However if the 
genomic DNA digested with XmnI or BsaAI in the two independent transformants 
resulted in different band sizes to each other and to the uncut control, this would 
indicate that the cassette had integrated into the host genome – either into the 
main chromosome or into one of the host plasmids. 
As seen in Figure 3.7.B two different band sizes are seen for the digestion of 
XmnI and BsaAI confirming that the kmR cassette was integrated into the genome 
of the recipient strain. Importantly, the fact that the same size bands are seen for 
independent transformant lines following digestion with a particular restriction 
enzyme (Figures 3.6 and 3.7) suggests that integration is occurring at a specific 
genome locus rather than at random sites. The next stage was therefore to 
identify the exact location at which the cassette was integrating in the host 
genome.  
 
Figure 3.6: Southern blot analysis of ΔRecJ.ble transformants. 
Southern blot analysis shows presence of the kmR cassette in the genome of all transformants. (A) Blot from 
DNA digested with XmnI.  (B) Stained gel of XmnI digests. Note: the absence of some bands in the Southern 
blot can be explained by the low yield of the genomic DNA extracts. (C) Southern blot analysis of 
transformants following digestion with BsaAI. Key: ΔpsbN.km transformant (+C), genomic DNA of recJ.ble 
strain (-C1, -C2), genomic DNA of WT6803 strain (-C3). T1-T8 transformants containing the kmR cassett.  
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Figure 3.7: Southern blot to test for genomic integration of kmR in the ∆recJ strain. 
(A) Schematic representation of the possible ways the naked kmR cassettes are being inserted 
into the ∆recJ recipient strains. (B) Southern blot analysis confirms that the cassette has 
integrated into the genome of the recipient strain. 
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3.3.3.3 Identifying the site of integration  
In order to identify the exact location at which the kmR cassette had integrated, it 
was necessary to isolate the cassette together with flanking genomic DNA from 
the transformants, and clone it into a plasmid vector (e.g. pJET). This would allow 
the sequencing of the flanking DNA and identification of the insertion site. For 
this, firstly a set of eight enzymes (AgeI, BamHI, BspEI, BssHII, EaeI, SphI, XbaI 
and EcoRV) that do not cut the kmR cassette were selected to be used for the 
digestion of the genomic preparations of a representative ΔrecJ.ble.km(SalI) 
transformant. This was done to see which of the enzymes would result in the 
smallest band size containing the kmR cassette that could be used for cloning 
purposes into pJET. The eight samples of digested genomic DNA were then used 
in a Southern blot that was probed using the kmR probe. Results from the blot 
showed that the enzymes XbaI and EcoRV yielded the smallest bands containing 
the kmR cassette (~1.4 and ~4.5 kb, respectively) as seen in Figure 3.8. This 
information was used to prepare larger scale genomic digests of the same 
transformant using these two enzymes as per section 2.3.11.2.  
The digests were run on a 1% agarose gel and the area around each band size 
was excised and purified as shown in Figure 3.9.A. The purified gel extracts were 
then cloned into pJET and transformed into competent E. coli cells (section 2.4.1) 
that were selected on LB plates supplemented with both ampicillin at 75 μg/ml (to 
select for uptake of the pJET DNA) and kanamycin at 50 μg/ml (to select for the 
KmR cassette ligated into pJET). No colonies were obtained for the EcoRV 
cloning, but eight colonies were recovered for the XbaI cloning (this difference is 
possibly due to the fact that cloning of smaller fragments into plasmids is more 
efficient).  
To confirm the presence of the kmR cassette in the plasmids isolated from the 
eight colonies, test digests were done using XbaI. This was because XbaI cuts 
pJET once and does not cut the kmR cassette (the sites were lost during cloning 
into the vector due to the use of a blunt cutting enzyme as part of the protocol), 
therefore a successful cloning would show a single band of ~4.4 kb comprising 
the 3.0 kb vector plus the 1.4 kb insert.  
Figure 3.9.B shows that a 4.4 kb band is obtained for all six of the plasmids 
analysed. Plasmids 4 and 6 were sent for sequencing using pJET-specific 
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primers flanking the cloning site in order to determine the genomic sequence at 
either end of the cloned kmR cassette and thus identify the site of integration.  
 
Figure 3.8: Southern blot of genomic DNA digested with eight enzymes and 
probed with a kmR probe.  
Results showed that the enzymes XbaI and EcoRV yielded the smallest bands containing the kmR 
cassette (~1.4 and ~4.5 kb, respectively). 
 
Figure 3.9: kmR cassette extracted as XbaI and EcoRV fragments and cloned in 
p.JET. 
(A) Gel extraction of the kmR cassette isolated by genomic digestion with XbaI and EcoRV 
enzymes. (B) Test digests using XbaI confirm the presence of the kmR cassette in the six 
plasmids analysed. +C represents the empty pJET vector (3.0 kb). 
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3.3.3.4 Sequence analysis  
Analysis of the DNA sequence from the ΔrecJ.ble.km(SalI)#4 transformant 
confirmed that the plasmid insert contained the kmR cassette together with 
flanking regions of 152 bp and 47 bp.  These two sequences were used in a 
BLASTN search of the published Synechocystis genome sequence [7]. The 152 
bp sequence showed a match to part of the speA gene (gene code = slr1312) 
that encodes for an arginine decarboxylase (Figure 3.10.A and B). However, the 
downstream element (47 bp) showed no significant match to the genome of 
Synechocystis possibly due to the short length of the query sequence (Figure 
3.10.C). Nonetheless, the genome around the speA gene was examined and 
predictions were made as to whether the kmR cassette has been inserted in 
between speA and the upstream gene psbAII or had in fact replaced part of the 
psbAII gene as depicted in Figure 3.10.C. The sequence analysis of the cassette 
region from the other transformant (ΔrecJ.ble.km(SalI)#6) confirmed the same 
integration pattern for the kmR cassette – i.e. upstream of the speA gene, but 
again no additional information was obtained on the location of the other end of 
the cassette. 
In order to further study the integration of the cassette in the different 
transformant lines primers were designed (Appendix 3) in order to amplify the 
area of the Synechocystis genome containing the speA and psbAII genes. The 
location of the primers (named P1 and P2 for simplicity) is indicated on Figure 
3.10.C. The expected wild type band size using these primers would be ~1.5 kb 
while transformants containing the kmR cassette at the locus were expected to 
show a band size of ~2.7 kb if the 1.2 kb cassette has inserted without replacing 
part of the locus. 
All 16 transformants together with an untransformed control strain were analysed 
by PCR with the results shown in Figure 3.11. The results show a band shift from 
the wild-type in all transformants tested. However, the band shift reveals a size 
increase of only ~100 bp as opposed to the expected 1.2 kb. This suggests that 
the kmR inserted in this area was actually replacing approximately 1.1 kb of the 
genome including part of psbAII as shown in Figure 3.10.C. The psbAII gene, 
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along with two other genes psbAI and psbAIII, encode the highly expressed D1 
protein of photosystem II. The psbAII gene is dispensable and its deletion is not 
lethal to the cell (as seen in these experiments). What makes the psbAII gene 
dispensable is the fact that the psbAIII gene express enough D1 protein in the 
absence of psbAII (Mohamed et al., 1993). 
 
Figure 3.10: Sequance alignment and schematic representation of the 
ΔrecJ.ble.km(SalI) transformant. 
(A) Figure showing the alignment between the forward flank sequence (152 bp) and part of the 
speA gene and their orientations. (B) Sequence alignment between the 152 bp sequence 
(highlighted in yellow) and part of the speA gene. (C) Schematic representation of the 
ΔrecJ.ble.km(SalI) transformant. P1 and P2 represent primers used for amplification of target 
area (speA and psbAII genes). 
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Figure 3.11: PCR results confirming the presence of kmR cassette in the 
speA/psbAII locus.  
PCR results show an increase of ~100 bp of DNA into the speA.psbAII locus in all the 16 
transformants. -C: WT genome (1.5 kb), transformants (~1.6). 
 
In order to confirm that the kmR cassette was replacing part of the genome at the 
psbAII locus, a new PCR analysis was carried out using a primer designed 
further upstream of psbAII within the adjacent gene sll1212, and another primer 
within the cassette itself, named P3 and P4 for simplicity, as shown on Figure 
3.12 (primers listed in Appendix 3). This was also done to try to gain a better 
understanding as to why the kmR cassette had not inserted at random sites in the 
genome of the transformants. One transformant was selected for analysis and 
the PCR product obtained was purified and sent for sequencing using primers 
listed in Appendix 3.  
Sequence results revealed that a recombination event took place in which the 
kmR cassette replaced the majority of the psbAII gene. Figure 3.12 shows a 
physical map of the DNA surrounding the insertion site of the kmR marker gene in 
both the wild type (ΔrecJ.ble strain in this case) and the ΔrecJ.ble.km mutant. 
The observation that genomic DNA had been deleted in the transformants is 
similar to earlier findings by two groups (Chauvat et al., 1989, Labarre et al., 
1989) who showed that transformants obtained using kmR and cmR cassettes that 
had been randomly ligated to fragmented Synechocystis DNA, were usually 
accompanied by a gene deletion. The annotated sequence of the 
ΔrecJ.ble.km.HincII transformant can be found in Figure 3.13.  
It is unclear whether there is related sequence to the speA/psbA2 sequence 
within the kmR cassette that favours its integration in this locus, thus preventing 
its random integration into other sites in the genome, although a BLASTn search 
of the genome using the cassette sequence failed to identify any homology. On 
the other hand, it may be possible that there is something related to the 
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sequence of that area of the genome, such as the presence of a strong promoter 
or a specific DNA element that makes it act as a “hot spot” for integration. It has 
been reported by (Zang et al., 2007) that a mechanism exists in Synechocystis, 
based on a palindromic element of the genome, that allows for site specific 
recombination to take place, a property that leads to DNA integration taking place 
easily at some “ hot spots” of the genome. Two of these elements, namely, the 
HIPI (highly iterated palindrome) and IS (insertion sequences) have already been 
identified (Ikeuchi and Tabata, 2001). There are 3160 copies of the 8 bp HIPI 
palindromic sequences, GCGATCGC that is found in a frequency of once every 
1131 bp while there are 77 IS-like elements (grouped into nine groups based on 
sequence similarities) also present throughout the genome. These elements may 
play a role in the local dynamics alteration of the genome or mediate homologous 
recombination between IS-like sequences at different positions in the genome. 
Examining the genome around the integration site shows the presence of the 8 
bp HIPI palindromic sequences both upstream and downstream the psbAII site 
(Appendix 6). This may be the reasoning behind the integration of the kmR 
cassette at this location.  
However, in order to test the two possibilities, a further experiment was designed 
in which a recipient line is created where the recJ gene was interrupted with the 
kmR cassette (rather than with the ble cassette), and then a ‘naked’ ble cassette 
(with no flanking sequence) is used as the foreign DNA to transform the new 
host. The integration pattern of the ble marker gene in the new strain would 
provide more information in order to come to more conclusive results. Such work 
is presented in the following sections.  
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Figure 3.12: Illustration of the insertion of the kmR marker in the psbAII locus.  
Comparison of the map of the DNA surrounding the insertion site of the kmR marker gene in wild type (top) and in the ΔrecJ.ble.km mutant (bottom). The 
kmR marker replaced most the psbAII locus. Gene codes are given above each gene. P3 and P4 stand for primers 3 and 4 used for PCR analysis.  
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KEY: GDP-mannose (sll1212) (blue), GDP-mannose start codon (pink), GDP-mannose/psbAII 
intergenic sequence (green), psbAII promoter (maroon), part of psbAII CDS including start codon 
(orange). Blue highlighted sequence is the site after which the kmR cassette was integrated.  
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Figure 3.13: The annotated sequence of the ΔrecJ.ble.km.HincII transformant.  
(A) Sequence alignment between WT (ΔrecJ.ble) and ΔrecJ.ble.km.HincII transformant show the 
absence of the psbAII sequence in the mutant strain. (B) Sequence alignment between the kmR 
cassette and the ΔrecJ.ble.km.HincII transformant shows integration of the kmR cassette just 
upstream of the psbAII locus. The recombination resulted in the replacement of the psbAII 
sequence and a DNA rearrangement indicated by the presence of 31 bp of unidentified DNA at 
the site of integration (red). KEY: GDP-mannose (sll1212) (blue), GDP-mannose start codon 
(pink), GDP-mannose/psbAII intergenic sequence (green), psbAII promoter (maroon), part of 
psbAII CDS including start codon (orange), recombination site (red), kmR gene (purple). Blue 
highlighted sequence is the site after which the kmR cassette was integrated. 
3.3.4 Creation of the ∆recJ.km Synechocystis mutant. 
For the creation of a new recJ- strain of Synechocystis, the pRecJ::ble plasmid 
was modified such that the recJ gene was disrupted with the kmR cassette (as 
opposed the ble cassette). The cloning strategy for the construction of the 
pRecJ::Km plasmid is shown in Figure 3.14.  
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Figuer 3.14: The construction of the pRecJ::Km plasmid.  
(A) The ΔRecJ.ble plasmid was digested with HincII to drop out 914 bp of the recJ gene 
containing the ble cassette. (B) The purified digested plasmid was ligated to a kmR cassette 
isolated from pUC4K as a HincII fragment (1.2 kb) resulting in the construction of the ΔRecJ.km 
plasmid (5.3 kb).  
The pRecJ::Km plasmid was used for transformation wild type Synechocystis as 
described in section 2.4.2. The transformants were selected by supplementing 
the BG11 plates with kanamycin at a concentration of 200 µg/ml. Putative 
colonies appeared within five days post antibiotic selection and four isolated 
colonies were taken through three rounds of re-streaking on selective medium to 
ensure that the transformants were homoplasmic. Genomic DNA was isolated 
from the putative transformants as described in section 2.3.3.1 and PCR 
reactions were performed as described in section 2.3.5 using primers to the recJ 
gene as described in section 3.3.1. Controls using DNA from the recJ::ble mutant 
strain and the wild-type were included in the PCR reactions. The expected size 
for the WT recJ product is 2.0 kb and that for the recJ::ble product is ~1.7 kb, 
while a recJ::km Synechocystis mutant was expected to give a ~2.3 kb product. 
As shown in Figure 3.15.A, the PCR product sizes obtained confirm that the 
transformants are recJ::km mutants. 
Having made this new recipient line, the next stage was to isolate the ‘naked’ ble 
cassette (i.e. with its own promoter that is functional in Synechocystis but no 
flanking DNA) to be used for transformation. The cassette was isolated by 
amplification from the pZΔES plasmid that contains the ble gene under the 
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control of the bacterial bla promoter, using primers listed in Appendix 3. The 0.6 
kb ble cassette was successfully amplified as seen in Figure 3.15.B.  
 
Figure 3.15: PCR confirmation for the isolation of ΔrecJ.km strain. 
(A) PCR results confirm that transformants T1, T2, T3 and T4 are ΔrecJ.km strains (predicted 
band size ~2.3 kb).  +C: ΔrecJ.ble strain (~1.7 kb). –C: wild-type strain (2 kb). (B) Amplification of 
the ble cassette (~0.6 kb) from plasmid pZΔES. 
3.3.5 Transformation of the ΔrecJ.km strain with the ble cassette 
The ble PCR product was purified and used for transformation into both the WT 
and ΔrecJ.km strains as per methods described in section 2.4.2. Three 
independent transformations were performed using the ΔrecJ.km recipient strain 
to ensure the isolation of independent transformants. Both positive (i.e. 
transformation with plasmid pPsb28-2::ble which contains the cassette flanked by 
sequence from the non-essential Synechocystis gene psb28-2) and negative (no 
DNA) controls were included for each of the WT and the ΔrecJ.km strain 
transformations. The transformants were selected with 25 μg/ml of zeocin with 
putative transformants appearing after ~10 days. Whilst many colonies were 
obtained from the ΔrecJ.km recipient, very few colonies were obtained from the 
wild type recipient strain (Figure 3.16 and Figure 3.17, respectively). The two 
figures also show a few colonies on the negative control plates (no DNA) from 
both the wild type and the ΔrecJ.km recipient strains. This is probably due to 
spontaneous resistance to the antibiotic or the depletion of the antibiotics on the 
plates. 
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Figure 3.16: Transformants obtained from transformation of ble cassette in ΔrecJ.km strain. 
The figure shows transformants obtained from three independent transformations of ble into the ΔrecJ.km recipient strain. Negative and positive controls 
are ΔrecJ.km strain with no added DNA and ΔrecJ.km strain transformed with a Δpsb28.2.ble plasmid (psb28.2 gene interrupted with a ble cassette), 
respectively.     
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Figure 3.17: Zeocin-resistant colonies obtained from transformation of the ble 
cassette in the WT 6803 strain. 
Very few colonies were obtained in the WT 6803 recipient strain. Negative and positive controls 
are the WT strain with no added DNA and the WT strain transformed with the ΔRecJ.ble plasmid, 
respectively.     
3.3.6 Analysis of ∆recJ.km Synechocystis transformed with the ble 
cassette.  
Five transformants from each of the three independent ΔrecJ.km strain 
transformations (total of 15 transformants) and five colonies from the WT 
transformation were re-streaked three times on selective medium to achieve 
homoplasmy. The colonies obtained from the transformation of the WT strain 
died off after the first round of re-streaking, suggesting that they were false 
transformants that arose due to local depletion of antibiotic on the plate. Total 
genomic preparations of the 14 isolated transformants from the ΔrecJ.km strain 
were made according to the method described in section 2.3.3.2 and used 
directly for Southern blot analysis (one sample lost during preparation).  
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3.3.6.1 Southern blot analysis 
In order to determine whether the ble marker gene was randomly integrated into 
the genome of the isolated transformants, a Southern blot was set up with all 14 
lines that were derived from three independent transformation events. For this, 
genomic DNA prepared in section 3.3.6 was digested with XmnI, an enzyme that 
does not cut the ble cassette according to methods described in section 2.3.11.2. 
The Southern blot was set up and a labeled probe for the ble DNA was prepared 
according to methods detailed in section 2.5.1 and 2.5.2, respectively. Figure 
3.18 shows the results of the Southern blot and reveals that the ble cassette 
appears to be inserted in two distinct locations in the host genome indicated by 
the presence of two distinct bands in each of the transformants analysed. As with 
the results from the kmR cassette transformations, this result indicates that 
integration of foreign DNA into the Synechocystis genome is not random, but 
results in integration into specific sites even in the absence of any flanking 
sequences to mediate homologous recombination. The next question is whether 
the ble cassette has integrated into the ‘same’ site as the kmR cassette – i.e. the 
speA/psbAII locus. This is investigated in the next section. 
 
Figure 3.18: Southern blot analysis of three sets of transformants (T1-T3) from the 
ΔrecJ.km strain transformed with the ble cassette. 
All 14 transformants analysed show the same integration pattern for the ble selectable marker. -C: ΔrecJ.km 
strain, +C; ΔrecJ.ble strain. T1-T3 represents the three independent transformations while 1-5 represent the 
number of transformants from each independent transformation. 
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3.3.6.2 Determining whether the ble marker has integrated at the 
speA/psbAII locus. 
As revealed in section 3.3.3.4, the kmR cassette appeared to be landing in the 
speA/psbAII region of the genome and the integration was accompanied with a 
deletion of the psbAII locus. The same region in the new ΔrecJ.km strain 
transformed with the ble cassette was therefore examined by PCR analysis to 
check for the integration of the cassette. For this PCR, three independent 
transformant lines were selected for analysis (since all 14 transformants showed 
the same integration pattern, as seen in Figure 3.18) and primers that amplify the 
speA/psbA2 area of the genome (Appendix 3) were used. Controls included in 
the PCR reaction were WT DNA and DNA extracted from the ΔrecJ.km recipient 
strain. The PCR results are presented in Figure 3.19 and show that psbAII region 
is unaffected in the transformant lines, indicating that the ble cassette integrates 
elsewhere in the genome. Further analysis needs to be done in order to identify 
the location at which the ble marker was integrated and to understand why the 
kmR and ble cassettes favoured the integration at these specific locations within 
the genome.  
 
Figure 3.19: PCR analysis to investigate the itegration pattern of ΔrecJ.km 
transformed with ble cassette.  
Analysis of three independent transformants (T1.1, T2.1 and T3.1) show that the ble selectable 
marker had not integrated in the speA.psbA2 region.  –C: WT genomic DNA, -C*: ΔrecJ.km 
recipient strain.  
3.4 Conclusion and future work 
The results obtained in this work provide the following picture of foreign DNA 
integration into the genome of Synechocystis 6803. When using a WT (i.e. recJ+) 
strain, successful integration requires the foreign DNA to be flanked by regions of 
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genomic DNA homologous to the site of integration, thereby allowing a double 
homologous recombination to take place. This is confirmed by the failure to 
obtain any true transformants for the wild type recipient strains of Synechocystis 
when either ‘naked’ (i.e. lacking any flanking sequences) kmR or ble selectable 
markers were used in the transformation.  
In contrast, when the recJ deletion strains of Synechocystis are used as 
recipients, then transformants can be recovered (albeit at a lower efficiency) with 
both the naked kmR and ble selectable markers. We can therefore conclude that 
large tracts of flanking sequence [typically > 500 bp (Vermaas, 1998)] serve to 
protect the cassette from degradation by the RecJ exonuclease, and also provide 
sequences for efficient homologous recombination, but that in the absence of 
RecJ the cassette is not rapidly degraded, and even in the absence of extensive 
homology, integration of the cassette can still occur. However, both Southern blot 
analysis (Figures 3.6 and 3.7) and sequence analysis (Figure 3.10 and 3.13) 
confirmed that the integration of the kmR cassette into the genome of the 
ΔrecJ.ble recipient strain was not at random locations but rather directed to a 
specific locus within the genome (speA/psbAII). On the other hand, although 
sequence analysis was not performed on the ΔrecJ.km.ble transformants due to 
lack of time, both Southern blot analysis (Figure 3.18) along with PCR results 
(Figure 3.19) confirm that the ble marker was also not integrated randomly in the 
genome, but neither was it landing in the speA/psbAII locus. Intriguingly, the 
Southern blot analysis seemed to indicate integration at two specific loci. There 
are three possibilities as to why two bands appear on the blot; the ble marker has 
either (i) been inserted in two distinct locations “hot spots” in the genome or (ii) 
the DNA remains free in the cell and migrating to two locations on the gel or (iii) 
an experimental error was made and the ble marker was accidently digested with 
XmaI (that cuts in the middle of ble) rather than XmnI (which does not cut ble). 
Future sequence analysis of the transformants would reveal the answer to that 
question. However, whatever the case, the fact that the two selectable markers 
do not integrate at the same locus raises a question as to whether integration is 
related to the sequence of the actual selectable marker used in the 
transformation rather than the site of integration. For example, it has been 
reported that the promoter and termination sequences of kanamycin are 
recognised by Synechocystis (Vermaas, 2007). However, BLAST results of both 
 125 
 
the kmR cassette and the ble selectable marker did not show any significant 
similarities between the sequence of the selectable markers and that of the 
genome of Synechocystis. 
An interesting phenomenon reported by Ukita and Ikeda. (1996), is that the recJ 
gene product in E. coli is preferentially involved in the illegitimate recombination 
at hotspots of the genome. However, it was also reported that the illegitimate 
recombination at non-hotspots still took place in recJ mutants as direct repeat 
sequences were also found in the non-hotspot sites. From the previous 
discussion, it is also possible that the integration of both the kmR and ble markers 
is affected by the presence of repeat sequences around the site of integration. 
Further investigations need to be made in order to understand the integration 
patterns of foreign DNA into recJ- strains by conducting experiments aimed at 
testing the integration of a range of selectable markers. Nevertheless, we can 
conclude that using the recJ- strains in order to insert heterologous DNA 
randomly across the Synechocystis strain does not look feasible. Further genetic 
studies on illegitimate recombination will be required to clarify these points.  
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Chapter 4: Development of a ‘one-step’ PCR-based 
technique for insertion of foreign DNA into 
Synechocystis 6803
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4.0 Introduction  
DNA-mediated transformation in the cyanobacterium Synechococcus sp. strain 
PCC7943 signaled the beginning of genetic exchange systems in cyanobacteria 
(Golden et al., 1987). Today the method remains the primary means for gene 
transfer in unicellular cyanobacteria. There are a few species that belong to two 
families of unicellular cyanobacteria (Synechococcus spp. and Synechocystis 
spp.) that are known to be naturally transformable by exogenous DNA and 
therefore amenable to genetic studies (Labarre et al., 1989). Because of the ease 
and efficiency of the transformation procedure and the metabolic flexibility of 
Synechocystis (Kufryk et al., 2002) it has been widely used to study diverse 
biological processes (Koksharova, 2002). Modifications to wild type genes can be 
done by various means, including interruption or deletion of the whole gene, 
introduction of site-directed mutations, deletion of domains within a gene, and 
gene replacement by genes from other organisms. Such modifications of wild-
type genes can be introduced effectively only in systems with homologous 
recombination mechanisms such as that found in Synechocystis (Vermaas, 
1998). In all cyanobacteria for which gene transfer is feasible, the popular method 
of choice for targeted gene inactivation is the interruption of the cloned gene with 
a selectable marker (Golden et al., 1987, Vermaas, 2007).  
To do this, a plasmid is constructed that can replicate in Escherichia coli but not 
in Synechocystis (e.g. pUC or pBR derivatives). This plasmid should contain 
Synechocystis sequences upstream and downstream of the gene to be deleted, 
with the gene itself being replaced by a selectable marker of choice. Two 
crossover events take place, followed by a selective pressure that selects for the 
acquisition of the foreign DNA (e.g. selection for antibiotic resistance) resulting in 
the recovery of transformants carrying the modified genotype (Vermaas, 1998). 
An illustration of this method is found in Figure 4.1.  
 
 
  Figure removed for copyright reasons 
 
 
Figure 4.1: A schematic representation of double homologous recombination in 
Synechocystis.  
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Double homologous recombination between the cyanobacterial genome and an introduced 
plasmid carrying Synechocystis sequences identical to those upstream and downstream of a 
cyanobacterial target gene (upstream and downstream elements are indicated by open and 
closed ovals). The homologous recombination results in the replacement of the chromosomal 
segment with a selectable marker. 
4.1 Literature review 
4.1.1 Current methods for gene replacement in Synechocystis  
In Synechocystis, transformation by exogenous DNA is done using either shuttle 
plasmids that can replicate independently of the cyanobacterial genome or by 
integration of the transforming DNA into specific loci in the genome via 
homologous recombination (Chauvat et al., 1986, Grigorieva and Shestakov, 
1982). The latter method is particularly valuable as a reverse-genetics tool for 
modifying endogenous genes – either by creating null (or ‘knockout’) mutants by 
gene disruption or by introducing site-directed changes into the gene 
(Koksharova, 2002). Whilst site-directed variants can also be introduced in 
shuttle vectors, this approach suffers from the problem of gene dosage effects if 
the plasmid is present in multiple copies, and the necessity of analysing the site-
directed change against a background of endogenous gene activity from the wild-
type gene present in the genome (Zorin et al., 2005). The traditional construction 
of knockout mutants in Synechocystis is a time consuming process (Lesic and 
Rahme, 2008) as it required several cloning steps. As shown in Figure 4.2, these 
steps are: i) isolation of genomic DNA and amplification of the target gene by 
PCR amplification; ii) cloning the PCR product into a restriction enzyme (RE)-cut 
plasmid vector; iii) isolation of a DNA fragment carrying an antibiotic-resistance 
marker; iv) cloning of the marker into the plasmid at a restriction site such that it 
disrupts the target gene; v) preparation of the final plasmid and checking by 
restriction digest for the correct insertion and orientation of the marker. Faster 
methods of creating plasmid vectors that avoid RE-based cloning have been 
developed recently. These methods include sequence- and ligation-independent 
cloning (SLIC) (Li and Elledge, 2007), Gibson assembly  (Gibson et al., 2009), 
circular polymerase extension cloning  (CPEC) (Quan and Tian, 2011), fusion 
PCR (Schwarz et al., 2013), Uracil-Specific Excision Reagent (USER) (Geu-
Flores et al., 2007) and the Golden Gate method (Engler and Marillonnet, 2011). 
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The common feature between these methods is the use of multiple PCR products 
with overhangs that undergo special treatment to fuse the fragments to form the 
plasmid used for transformation. Although these methods are considered faster 
than traditional cloning methods, they still suffer some limitations as they require 
the amplification and assembly of multiple PCR products to create the gene 
knockout plasmid. Scientists were therefore encouraged to develop a more time-
efficient mutagenesis method that does not require cloning or the need of multiple 
PCR products. As shown in Figure 4.2, a simple strategy is to generate a PCR 
product directly from the selectable marker using 5’-extended primers that 
introduce short flanking regions with homology to the gene to be deleted. This 
“one-step PCR-based method” for gene deletion thus requires only a single PCR 
reaction, with no genomic isolation or plasmid cloning steps, and would therefore 
be considerably faster than the traditional method. Furthermore, the site of 
insertion and orientation of the marker is not constrained by the availability of 
suitable RE sites, and therefore the marker can be targeted to any location in the 
gene. The one-step PCR-based method described above has already been 
described in E. coli (Datsenko and Wanner, 2000), Aspergillus nidulans 
(Chaveroche et al., 2000), Yersinia (Derbise et al., 2003, Lesic et al., 2004), 
Salmonella (Husseiny and Hensel, 2005, Beloin et al., 2003), Shigella (Beloin et 
al., 2003), P. aeruginosa (Lesic and Rahme, 2008) and Serratia (Rossi et al., 
2003). However, to the best of my knowledge, no such reports exist for 
Synechocystis, or other cyanobacteria. The closest work developed for quick 
gene knockouts in Synechocystis that is independent of cloning, is the technique 
described by Taroncher-Oldenburg and Stephanopoulos. (2000), who used a 
PCR-based method for the construction of targeted gene disruptions and gene 
fusions in Synechocystis using regions of homology with the target gene. The 
proposed method, called long flanking homology polymerase chain reaction 
(LFH-PCR), involves creating a conversion cassette of the deleted gene using 
two separate PCR reactions to generate products with overlapping sequences 
that can be used in another PCR to generate a product containing the gene 
interrupted with the selectable marker. Although this method is faster than 
creating plasmid constructs, it still involves multiple PCR steps.   
This chapter describes the development of the one-step PCR method for 
generating gene knockouts in Synechocystis that should greatly accelerate the 
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reverse-genetic analysis of any gene in this model cyanobacterium. However, a 
key aspect of developing such a method is identifying the minimum length of the 
flanking sequences required for homologous recombination. 
 
 
 
  Figure removed for copyright reasons 
 
 
 
Figure 4.2: Comparison between the traditional and one-step PCR methods in 
creating gene knockouts in Synechocystis.  
A comparison between the “traditional method” (left) and the proposed quicker “one-step PCR” 
(right) for creating gene knockouts in Synechocystis. Modified from (Vermaas, 2007). 
4.1.2 The minimum length for homologous recombination 
Transformation of Synechocystis with either circular or linear DNA (e.g. PCR 
products) requires large tracts of DNA sequence flanking the transgenic DNA to 
be introduced, such that the two homologous recombination events can occur 
efficiently. Typically, the advice is to ensure that each flanking DNA region is 
>500 bp. This is considered particularly important when using a linear construct, 
possibly as a consequence of exonuclease activity inside or outside the cell 
degrading the ends of the DNA (Vermaas, 1998).  
The minimum length of flanking sequences required for efficient insertion of the 
DNA in Synechocystis has not been systematically studied, with most 
researchers simply ensuring that each of the flanking sequences are typically 
>500 bp in length. However, Zang et al. (2007), reported that transformation was 
possible with only 200 bp of flanking sequence on one side (1300 bp on the other 
– a “1300/200” arrangement). Furthermore, the same group showed that a 
“400/400” arrangement also yielded transformants. Similarly, Ikeuchi and Tabata. 
(2001), showed that 400 bp, but not less, was enough for a double homologous 
recombination in Synechocystis. Labarre and collegues. (1989), earlier reported 
success with “900/800” but very few transformants with “900/300” and no 
transformants with “900/0” while Vermaas. (1998), concluded that efficient double 
homologous recombination between the genomic DNA of the organism and 
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introduced DNA requires at least 100 to 400 bp sequence identity in both 
recombination domains. Initial studies in Saul Purton’s lab by Edward Burton (an 
undergraduate project student) showed that a “186/171” was sufficient for 
insertion of a kanamycin resistance marker at the psbN locus. It is reported that 
the psbN gene that encodes a photosystem II associated protein PSII-N (Kaneko 
et al., 1996) is not essential for photosynthetic growth and is fully dispensable 
(Vermaas, 1998). Consequently, in the work described in this chapter, attempts 
have been made to use a series of different PCR products derived from the same 
psbN::kmR knockout construct to determine the minimum size of homologous 
flanking regions of linear dsDNA that is required for successful transformation in 
Synechocystis via double homologous recombination (Figure 4.3). This 
information is used to determine if we can ultimately target foreign DNA into a 
specific locus of the Synechocystis genome by simply transforming with a PCR 
product in which only the necessary flanking sequences are added to the foreign 
DNA using “long tail” primers that are homologous to the kanamycin resistance 
cassette at their 3' ends and homologous to the target gene at their 5' ends as 
illustrated in Figure 4.2. 
Furthermore, since the transformation efficiency drops markedly for DNA with 
shorter homologous segments (Ikeuchi and Tabata, 2001), it was therefore 
essential to identify the shortest homologous recombination fragment necessary 
for  efficient transformation to occur in Synechocystis.  
 
4.2 Chapter aims 
The aim of the work undertaken in this chapter was to develop a rapid method for 
creating gene knockouts in Synechocystis by: 
• Identification of the shortest size of flanking regions necessary for efficient 
double homologous recombination transformation to occur in 
Synechocystis.  
• To use this information to generate gene knockouts in Synechocystis 
using a quick one-step PCR-based method that is independent of a 
transforming plasmid or the fusion of multiple PCR products. 
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4.3 Results and Discussion  
4.3.1 Identification of the minimum flanking length necessary for 
transformation 
4.3.1.1 Generation of test PCR products with different flanking lengths 
For this work, plasmid pUC.psbN::kmR (Appendix 1) was used as a template for 
the generation of a series of PCR products containing a psbN::kmR knockout with 
flanking regions ranging from 1000 bp down to 30 bp as illustrated in Figure 4.3. 
The primers used in this work are found in (Appendix 3). 
The PCR was carried out as described in section (2.3.5) and an aliquot of the 
products was analysed by agarose gel electrophoresis. The expected sizes of the 
PCR products (~3.1 kb - 1.3 kb) were confirmed by comparison to a 1 kb ladder 
(Figure 4.4). PCR products were purified using the QIAquick PCR purification Kit 
(QIAGEN), according to the manufacturer’s instructions and treated with the 
restriction enzyme DpnI, which cuts only methylated DNA (at the sequence: 
GmeATC). Since the PCR products are unmethylated, but the pUC.psbN::kmR 
plasmid used as the PCR template is methylated since it was produced in E. coli 
(which contains the dam enzyme that methylates GATC), then this treatment 
avoids the possibility of trace amounts of the plasmid contaminating the PCR 
product and giving rise to transformant colonies.  
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Figure 4.3: A schematic representation of the PCR products with different flank 
sizes. 
Utilizing pUC.psbN::kmR for the generation of Synechocystis psbN knockouts with different 
flanking sizes. The psbN gene is interrupted by the insertion of a kanamycin resistance cassette. 
(1000flk -30flk) represents primers used to generate PCR producted with variouse flank sizes.  
 
Figure 4.4: PCR amplification of psbN::kmR knockouts with different flanking 
sizes.  
The amplification of PCR products derived from the same psbN::KmR knockout construct with 
different flanking regions ranging from 30 bp to 1000 bp. M represents the 1 kb marker.  
4.3.1.2 Obtaining Synechocystis transformants using the PCR products 
The PCR products (1–5 µg) obtained in the previous section were used for 
transformation into Synechocystis as described in section 2.4.2. According to 
(Zang et al., 2007), seven times more transformants survive when transformed 
cells are grown in medium containing no antibiotics for at least one day prior to 
being transferred to a medium containing the selective antibiotic. Therefore, the 
transformed cells were allowed to recover for ~48 hours before being overlaid 
with soft agar (0.6 %) supplemented with 50 µg/ml kanamycin. 
The transformation was successful and putative colonies appeared on the plates 
within seven to ten days post antibiotic selection. The efficiency of the 
transformation was found to be directly proportional to the length of the flanking 
regions in the PCR products, with higher transformation rates obtained with PCR 
products with longer flanking elements (Figure 4.5.A). Figure 4.5.B shows the 
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average colony counts of Synechocystis transformed with the different PCR 
products. The average represents counts from three independent 
transformations, although error bars are not included in the plot as the three 
transformations were not carried out under identical conditions (variable DNA 
concentrations and growth stage at time of transformation). However, the same 
trend of a decrease in colony counts with decreased flank size down to a 
minimum of 200 bp was observed in all three transformations. Conversely, the 
colony counts for products with <200 bp varied and did not follow any trend, such 
that in some cases, slightly more transformants were obtained with PCR products 
with shorter flanks (Figure 4.5). It can be concluded that although it is possible to 
obtain transformants using PCR products with short flanks (<200 bp), the 
efficiency of transformation is very low. 
4.3.1.3 Analysis of the transformants 
Individual colonies were picked and re-streaked onto fresh medium 
supplemented with kanamycin. This was repeated three times to ensure that the 
cells achieve homoplasmy before isolating genomic DNA as described in section 
(2.3.3.1). The extracted DNA was used as a template in a PCR reaction using the 
primers named “1000 flanks” (Appendix 3) – i.e. outside of the region of the 
transforming DNAs to check for the correct integration into the psbN locus. PCR 
conditions were carried out as described in section (4.3.1.1) and results 
presented in Figure 4.6.A show the successful isolation of transfromants carrying 
a psbN::kmR knockout. Controls were included for band size comparisons. Both a 
plasmid carrying a WT psbN gene and genomic WT DNA were used as negative 
controls while pUC.psbN::kmR was used as a positive control. A band shift from 
1.9 kb (representing the WT psbN gene) to a band size of 3.1 kb (psbN gene 
including the kmR cassette) confirms the isolation of psbN::kmR knockouts (Figure 
4.6.B). 
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Figure 4.5: Transformants generated using the traditional method.  
(A) Synechocystis transformants obtained upon transformation with psbN::kmR PCR products with 
1000 bp to 30 bp flanks on either side. (B) Transformation efficiency represented by the number 
of transformants decreases with reduced flank size. 
 
B 
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Figure 4.6: PCR results confirming isolation of psbN::kmR knockouts using the 
different PCR products. 
(A) PCR results confirming the isolation of psbN::kmR knockouts in Synechocystis even with the 
shortest flank (30 bp). (B) WT size = 1.9 kb (represented within the blue rectangle), transformants 
size = 3.1 kb (represented within the red rectangle). Controls in order: (-C): plasmid carrying WT 
psbN gene (plasmid A without kmR), (+C): pUC.psbN::kmR, (-C): WT genomic DNA. 
 
Despite several published reports on the failure to produce successful gene 
knockouts in Synechocystis by means of double homologous recombination 
using flanking sequence less than 200 bp (section 4.1.2), this current study 
establishes the possibility of creating targeted gene knockouts using PCR 
products containing as little as 30 bp flanking regions. Nevertheless, the 
efficiency of the transformation did drop markedly with decreased flanking size. 
However, findings presented in this section opened the door to investigate the 
possibility of creating gene knockouts using a quick one-step PCR-based method 
as described in the following section. 
4.3.2 Testing the one-step PCR-based method for generating gene 
knockouts in Synechocystis  
Work done in this section was aimed at investigating the feasibility of targeting 
foreign DNA into a specific locus of the Synechocystis genome by simply 
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transforming Synechocystis with a PCR product in which the necessary flanking 
sequences are added to the foreign DNA using “long tail” primers that are 
homologous to a resistance cassette at their 3' ends and homologous to the 
target gene at their 5' ends. However, since the maximum length of primer that 
can be realistically synthesised with reasonable cost is ~100 bases in length, and 
if ~20 bases is typically needed for priming, then this means that the maximum 
flanking sequences that can be created using this one-step PCR-based approach 
is “80/80”. According to the results from section 4.3.1 this should be feasible.  
4.3.2.1 Generation of PCR products using the one-step PCR method 
PCR was employed to amplify the kanamycin resistance cassette directly from 
the plasmid pUC4K (Appendix 1) and recreate a psbN::kmR product using long-
tail primers. The primers were designed such that 22 bp were homologous to the 
resistance cassette at their 3' end and short flanks (30 bp, 50 bp and 80 bp, 
respectively) were homologous to the target gene (psbN) at their 5' ends as 
illustrated in Figure 4.7.A.  
PCR results presented in Figure 4.7.B show the successful amplification of 
psbN::kmR products in a single PCR step using the long-tail primers. Once the 
correct PCR product size (~1.3 kb) was confirmed, the PCR product was purified 
and used in transformation of WT Synechocystis recipient cells. DpnI treatment 
was not necessary in this case; since the pUC4K used as a template to generate 
psbN::kmR PCR products does not contain genomic Synechocystis DNA and 
therefore there is no risk of generating false positive transformants. Sequences of 
the long-tail primers used are listed in Appendix 3. 
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Figure 4.7: PCR amplification of psbN::kmR knockouts using one-step PCR 
method.  
(A) Schematic representation illustrating the amplification of the psbN::kmR knockout with short 
flanks (less than 100 bp) using one-step PCR. (B) The successful amplification of psbN::kmR 
knockouts in a single PCR step.  PCR product shown in the figure is with 30 bp flanks homology.   
4.3.2.2 Transformation of one-step PCR products in Synechocystis 
Approximately 1-5 µg of the PCR products obtained in section 4.3.2.1 were used 
for transformation into wild type Synechocystis as per methods described in 
section 2.4.2. Many colonies were recovered upon transformation of the PCR 
products within seven to ten days post antibiotic selection using 50 µg/ml of km. 
Surprisingly, thousands of colonies were obtained using this method for PCR 
products of psbN::kmR knockouts with 30 bp homology to the target gene 
(hereafter LT30) while those obtained from both psbN::kmR PCR products with 50 
bp and 80 bp homology to the target gene (hereafter LT50 and LT80, 
respectively) showed a few hundred colonies, and four colonies, respectively as 
seen in Figure 4.8. This is contrary to what was expected and observed earlier 
where fewer transformants were obtained when shorter regions of homology to 
the target gene were utilised in the transformation. Furthermore, the number of 
transformants obtained with PCR products with 30 bp and 50 bp homology 
obtained from the one-step PCR method presented here was much higher 
compared to the number of colonies obtained with the same size flanks using 
derived by PCR from the original pUC.psbN::KmR plasmid (Figure 4.5.A). This 
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observation raised doubts as to whether the transformants were actually obtained 
as a result of double homologous recombination or via other means. The 
transformants were probably not due to spontaneous resistance to kanamycin 
since no colonies were observed on the negative control (‘no DNA’) plate. 
4.3.2.3 Analysis of psbN::kmR knockouts generated using the one-step PCR 
method 
Thirty independent transformants obtained using either the LT30 and LT50 PCR 
products, and the four transformants obtained using the LT80 PCR product were 
re-streaked on BG11 plates supplemented with kanamycin added to a final 
concentration of 50 μg/ml. From these plates, colonies were further restreaked 
twice, to ensure that all copies of the polyploid chromosome contained the 
introduced DNA. Genomic DNA of the transformants was prepared as described 
in section 2.3.3.1. The extracted DNA was used as a template in a PCR reaction 
as before (section 4.3.1.1) using primers of 1000 flanks to check for the correct 
integration into the psbN locus. PCR results presented in Figure 4.9 show that 
none of the tested transformants gave a positive result for a psbN::kmR knockout. 
The same positive and negative controls were included in the PCR reactions as 
those used in section 4.3.1.3 including an extra positive control (a positive 
psbN::kmR knockout obtained in the previous section).  To confirm this result, the 
transformation was repeated using the same methods described above for the 
LT30, LT50 and LT80 transformants and out of hundreds of colonies obtained 
from the transformations using LT30 or LT50 PCR products (no colonies 
appeared using the LT80 PCR product) five colonies of each transformation were 
screened for targeted gene replacement but again, all ten transformants 
screened showed a wild type band size of 1.9 kb. Figure 4.9 shows PCR results 
of three representatives of each transformation type. 
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Figure 4.8: Transformants obtained by one-step PCR using short flank PCR products. 
The number of transformants obtained decreased with increased flank size contrary to what was expected. Selection was on BG11 plates supplemented 
with 50 μg/ml of km. The 30-80 bp flanks represents transformants obtained with PCR products with 30 bp, 50 bp and 80 bp flanks on either end of the 
kmR cassette.  
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Figure 4.9: PCR results of transformants obtained using products from a one-step PCR. 
Top figure shows Synechocystis transformants generated from PCR products with 30 bp, 50 bp and 80 bp flanks using the one-step PCR method (A, B 
and C respectively). Bottom figure shows PCR results confirming the absence of psbN::kmR knockouts in any of the transformants. Wild type bands are 
enclosed in a blue rectangle (1.9 kb) whereas positive controls are enclosed in a red rectangle (3.1 kb). Controls are indicated within the figure. 
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In an attempt to understand the reason behind the high numbers of antibiotic-
resistant transformants that are not psbN gene disruptions obtained from the one-
step PCR-based method, predictions were made on the possible events that 
might have taken place during transformation. There are three possible ways in 
which km resistant transformants can be obtained: firstly, the one-step PCR 
product integrated via double homologous recombination (HR) resulting in psbN 
knockout. Secondly, the PCR product inserted into the genome by means of non-
homologous recombination (NHR) and finally only the kmR cassette was 
integrated into the genome without the short flanks possibly through pUC4K 
contamination.  
In order to identify which of the three events took place; a PCR was carried out 
on the genomic extract of a representative LT30 transformant using psbN locus-
specific primers (1000 flank primers), PCR product-specific primers (30 flank 
primers) and kanamycin-specific primers (km primers). The primer positions and 
predicted PCR outcomes are illustrated in Figure 4.10.A.  The PCR was carried 
out under the same conditions described in section 4.3.1.1. The results of the 
PCR represented in figure 4.10.B show a positive result for both the PCR 
product-specific primers and the kmR primers (same bands as the positive 
control). This result confirms the integration of the entire PCR product (i.e. the 
kmR cassette along with the 30 bp psbN flanks on either side of the cassette) and 
rules out the possibility of contamination with traces of the pUC4K plasmid. 
However, as seen earlier, the results show a negative result for the psbN locus-
specific primers (1000 flank primers) suggesting that the PCR products were 
integrated elsewhere into the Synechocystis genome via non-homologous 
recombination.  
In order to understand the reason behind the different integration patterns (HR 
versus NHR) between the PCR products of psbN gene knockouts obtained from 
the PCR products generated from the pUC.psbN.KmR plasmid and the one-step 
PCR products (respectively), attempts were made, to identify the factors that may 
have led to the different integration patterns.  
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Figure 4.10: Analysis of transformants obtained by one-step PCR with short 
flanks. 
(A) Illustration showing PCR set up to investigate scenarios of possible integration of the PCR 
product with 30 bp flanks obtained from one-step PCR method (B) PCR results confirm the non-
homologous integration. Primers 30, 1000 and km were used to test integration of the entire PCR 
product (LT30), integration of PCR product in psbN locus and insertion of the kmR cassette 
respectively. The plasmid control used was pUC.psbN::kmR. 
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4.3.2.4 Variability in growth and transformation conditions 
It may be possible that the integration patterns of the PCR products of psbN::kmR 
knockout obtained from the two methods showed variability due to factors related 
to the conditions in which the transformation was carried out. Therefore, PCR 
products with flanking regions ranging from 1000 bp to 30 bp (made by the 
traditional method – Figure 4.4) and an LT30 PCR product of the psbN::kmR 
knockout (from the one-step PCR method) were transformed into Synechocystis 
under the same conditions. Transformation was carried out as described in 
section 2.4.2 and using 2 μg of DNA and a recipient cell concentration of 4x108 
cells/ml. The transformants were allowed to recover for 48 hours before 
overlaying them with kanamycin added to a final concentration of 50 μg/ml on the 
plates.  
Putative colonies appeared on the plates from all transformations and showed 
the expected trend where fewer colonies were obtained with PCR products with 
shorter flanks. Interestingly, even the transformation with the PCR product 
produced via the one-step PCR method gave only a single colony, which is 
contrary to previous results where hundreds of colonies appeared from the PCR 
product with 30 bp of homology (Figure 4.9). This result in itself was a good 
indication that the one-step PCR product had in fact been integrated via double 
homologous recombination. To confirm this, PCR analysis was carried out 
including the same positive and negative controls used in section 4.3.2.3. Results 
presented in Figure 4.11 confirm the isolation of psbN::kmR knockouts with PCR 
products obtained from both methods.  
To compare the kanamycin resistance of the transformant obtained using the 
one-step PCR method (LT30) obtained in this experiment (psbN knockout) to 
those (non-psbN knockouts) isolated using the same method obtained in section 
4.3.2.3, ‘spot tests’ were carried out as described in section 2.2.6. Despite the 
fact that the LT30, LT50 and LT80 (NHR) transformants had previously survived 
three rounds of re-streaking on BG11 plates supplemented with 50 μg/ml of 
kanamycin, spot tests of the same isolated transformants (two months later) 
failed to grow under the same concentration of kanamycin, indicating loss of 
resistance, probably due to loss of the inserted kmR cassette (Figure 4.12.A). This 
also suggests the possibility of the one-step PCR products being linked to each 
other in circular structures (concatamers), independent of the host genome, that 
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are ultimately lost upon successive replication. On the other hand, the true 
psbN::kmR knockout obtained in Figure 4.11 (LT30) showed resistance to even 
higher concentrations of km (200 μg/ml) for several generations (Figure 4.12.B), 
further confirming proper integration of the kmR cassette. 
 
 
Figure 4.11: Transformants obtained with the traditional and one-step PCR 
methods. 
PCR results confirm the isolation of psbN::kmR knockouts (~3 kb) even with PCR products with 
the shortest flanks (enclosed in green rectangle) using both the traditional and one-step PCR 
methods. +C: plasmid A and a psbN::kmR knockout, respectively. – C‘s: Plasmid A lacking the 
kmR cassette and genomic DNA respectively. 
 
 
Figure 4.12: Spot  test showing tolerance of Synechocystis psbN knockouts to 
kanamycin. 
(A) LT30, LT50 and LT80 transformants lose resistance to kanamycin after many generations. (B) 
Synechocystis psbN knockouts obtained from one-step PCR showing resistance to high 
concentrations of kanamycin (200 μg/ml). -C: WT cells, +C: ΔrecJ::kmR Synechocystis strains. 
 
To summarise, the transformants of PCR products with short flanks obtained 
from the traditional method normally resulted in the isolation of targeted gene 
knockouts (with very few exceptions) while on the other hand, transformants of 
PCR products with short flanks obtained from the one-step PCR method rarely 
resulted in the isolation of targeted gene knockouts (an exception was the single 
transformant shown in Figure 4.11).  
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From these findings, it was hypothesised that non-homologous recombination 
was significantly more likely than homologous recombination with PCR products 
obtained from the one-step PCR method. It is also possible that Synechocystis 
likely has a recombination system that could insert such a cassette in “hot spots” 
in the genome (as seen in chapter 3), probably when the homologous sequences 
flanking the sides of the cassette were not identified. This hypothesis might 
explain the trend obtained in Figure 4.8 where PCR products with shorter flanks 
resulted in higher number of transformants possibly as a consequence of the 
PCR product with very short flanks (30 bp) being identified as a “naked” 
kanamycin cassette thus leading to its integration at these “hot spots”. 
Homologous recombination, on the other hand, was significantly more likely than 
non-homologous recombination with PCR products from the traditional method 
for reasons that are identified later in this chapter. This hypothesis is depicted in 
Figure 4.13. 
The following sections describe attempts to improve the ratio of homologous to 
non-homologous recombination events taking place in Synechocystis in order to 
create a more efficient and reproducible one-step PCR method.  
           
Figure 4.13: Possible integration patterns of PCR products with short flanks 
obtained from the traditional and one-step PCR methods.  
HR represents homologouse recombination. 
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4.3.3 Improving HR:NHR ratio of transformants obtained by one-step PCR 
method. 
The successful application of targeted gene disruption and replacement is 
dependent on the ratio of homologous to illegitimate recombination (NHR) events 
during integrative transformation (Zorin et al., 2005). This section describes 
experiments aimed at improving the ratio of homologous to non-homologous 
recombination using PCR products from a one-step PCR method.  
4.3.3.1 Using ssDNA for transformation 
Several reports in literature have demonstrated the improvement of the HR/NHR 
ratio by using single stranded DNA for transformation. Such improvements have 
been shown in the single celled eukaryote microorganisms; Chlamydomonas 
(Zorin et al., 2005) and Saccharomyces cerevisiae (Simon and Moore, 1987) and 
in the single celled cyanobacterium Cyanothece sp. strain PCC 7822 (Min and 
Sherman, 2010a). Work done in these organisms provided some evidence that 
single stranded DNA (ssDNA) is more efficient than double stranded DNA 
(dsDNA) for targeted recombination. 
It is hypothesised that the use of ssDNA might prevent illegitimate integration 
processes (Min and Sherman, 2010b). For example, when using ssDNA to 
transform C. reinhardtii, non-homologous DNA integration appeared to be more 
than 100-fold reduced compared with the use of dsDNA, thus allowing the 
isolation of homologous recombinants in this organism (Zorin et al., 2005).  
During transformation in Synechocystis, a Ca2+ dependent nuclease located in or 
on the cytoplasmic membrane degrades one of the two strands of DNA during 
uptake resulting in the incorporation of ssDNA (Barten and Lill, 1995). Although 
Synechocystis can be transformed with either single- or double-stranded DNA 
(Vermaas, 1998),  DNA taken up by the cell is always in the form of ssDNA 
(Kufryk et al., 2002). In the following section, ssDNA was transformed into 
Synechocystis to determine whether HR/NHR ratios could be improved. The 
psbN knockout PCR product with 1000 flanks, generated in section 4.3.1.1 was 
used as a template to generate either ssDNA or dsDNA. Template PCR product 
(300 ng) was used for the amplification of ssDNA using only one primer - either 
the 1000 flanks forward primer or the 1000 flanks reverse primer, while 3 ng of 
the PCR product was used for the amplification of the dsDNA using both and 
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primers. The same positive and negative controls were included in the PCR 
reactions as those used in section 4.3.2.3 for band size comparison.  
The PCR products were purified and the ssDNA were treated with HindIII to get 
rid of possible trace contamination of the template dsDNA. Transformation was 
done according to the standard protocol and transformants were selected on 50 
µg/ml kanamycin-containing medium. The transformation resulted in many 
colonies, from which four of each transformation type were selected for PCR 
analysis to check for targeted psbN::kmR knockout as described in section 
4.3.1.3. PCR results presented in Figure 4.14 show that all transformants 
analysed were targeted psbN gene knockout (3.1 kb). This confirms the feasibility 
of generating targeted gene knockouts in Synechocystis using ssDNA. 
 
 
Figure 4.14: PCR results of Synechosystis transformed with single stranded DNA. 
Transformants generated using ssDNA of the sense primer (F), none sense primer (R) and 
dsDNA all with 1000 flanks homology to psbN. All transformants are psbN::kmR knockouts (3.1 
kb).This result indicates the possibility of using ssDNA for targeted gene knockouts in 
Synechosystis. The controls in order are: plasmid A without a km cassette (-c), plasmid A (+c) 
and genomic 6803 DNA (-c). 
 
The next step involved using ssDNA and dsDNA with shorter flanks (100 bp or 
less). The same protocols were conducted for the generation, purification and 
transformation of the ssDNA and dsDNA PCR products with short flanks. 
Transformants were obtained for both ssDNA and dsDNA with 100 flanks. 
Interestingly, a single transformant was obtained with ssDNA with 50 bp flanks 
using forward and the reverse primers, while no transformants were obtained with 
the dsDNA of the same size flanking regions. Finally, using ssDNA with 30 bp 
homology resulted in no transformants, while four colonies were obtained with 
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dsDNA of the same size. The variability in obtaining transformants using both the 
ssDNA and dsDNA when using flanking regions less than 100 bp is similar to the 
results obtained previously in Figure 4.5 that showed inconsistency of the colony 
counts with PCR products with regions less than 100 bp.  
PCR analysis of the transformants for psbN knockout was done as described in 
section 4.3.1.3 and revealed that the majority of the transformants were not psbN 
knockouts. One exception was of the ssDNA with 50 bp flanks obtained using the 
forward primer (Figure 4.15). This experiment showed that using ssDNA with 
short flanks (<100 bp) did not show any improvement to the HR:NHR. 
Furthermore, the fact that even the dsDNA obtained in this traditional method did 
not result in targeted psbN knockout further supports the hypothesis put forward 
in Figure 4.13.  
 
 
Figure 4.15: PCR results of Synechocystis transformed with single stranded DNA 
with short flanking sequences. 
Only one of the ssDNA transformations resulted in a psbN::kmR knockout (ssDNA with 50 bp 
flanks T1). In this case even dsDNA did not result in a positive knockout. The controls in order 
are: plasmid A (+c), plasmid A without a kmR cassette (-c), psbN::kmR knockout (+c) and genomic 
6803 DNA (-c). 
4.3.3.2 Varying DNA and cell concentration used in transformation  
Typically for Synechocystis transformation, 1-5 μg of DNA is added to recipient 
strains at a concentration of 4 x 108 cells/ml (Zang et al., 2007, Kufryk et al., 
2002, Lindberg et al., 2010). In this section, the effect of varying DNA 
concentration and recipient cell concentration on the ratio of HR:NHR was 
investigated. 
For this experiment, LT30 PCR products were generated using standard PCR 
conditions described in section 4.3.2.1. It took many PCR attempts in order to 
amplify 9 μg of the LT30.psbN::kmR knockouts using the one-step PCR method. 
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This amount was split in the transformation to be used as 0.5 μg, 1 μg, 1.5 μg 
and 2 μg of PCR product added to 1 ml of WT recipient cells containing 4 x 108 
cells. On the other hand, 1 μg of the same DNA was added to 1 ml of WT 
recipient cells containing 100%, 50%, 25% and 12.5% of WT recipient cells (with 
100% equal to a cell count of 4X108 cells). This experimental set up is illustrated 
in Figure 4.16.A. Furthermore, 1 ml of a negative control (WT recipient strain) 
was included in the experiment that contained 4X108 cells with no added DNA. 
This was used to test whether colonies appear due to spontaneous resistance to 
the antibiotic.  
Transformation was carried out according to methods described in section 2.4.2. 
The transformants were allowed to recover for 48 hours before overlaying them 
with BG11 containing 50 μg/ml kanamycin. Of the hundreds of colonies visible on 
the plate, seven to ten days post antibiotic selection, 37 were re-streaked on 
kanamycin selective medium out of which only ten survived (Figure 4.16.A). PCR 
analysis done on the surviving colonies, using the same PCR conditions and 
primers described in section 4.3.1.3, showed that only one of the ten colonies 
screened was a psbN knockout (Figure 4.16.B). The results show that varying the 
concentration of DNA and recipient cell concentration does not seem to have an 
observable effect on the HR:NHR, at least at the DNA and cell concentrations 
used. Nevertheless, a wider range of DNA concentrations should be used and 
more colonies screened in order to gain a more conclusive result.  
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Figure 4.16: Transformants & PCR results of transformants obtained by varying 
DNA and cell concentration.  
(A) Schematic of Synechocystis transformation using varying DNA and cell concentrations, as 
described in section 4.3.3.2. (B) PCR results show that a single psbN::kmR knockout was 
obtained, indicating that changing DNA concentration or concentration of cells used in the 
transformation had no observed effect on improving HR:NHR. The controls in order are: genomic 
6803 DNA (-c), plasmid A (+c), plasmid A without a km cassette (-c), T1-T9 represents the 
transformants. [Note: T10 which was not a psbN knockout is not included in this figure]. 
4.3.3.3 Using ΔrecJ.ble as recipient strain for transformation.   
As discussed in chapter 3, the RecJ-deficient strain displayed higher 
transformation efficiency due to the deletion of the recJ gene that encodes an 
exonuclease responsible for foreign DNA degradation. In this work, this “super 
strain” was used as a recipient strain as opposed to WT cells to determine 
whether this would improve the HR:NHR ratio. Furthermore, since Synechocystis 
can resist high concentrations of kanamycin (up to 200 μg/ml) as seen in earlier 
spot tests (Figure 4.12.B); selection of transformants was carried out using 200 
μg/ml of the antibiotic. This was done to reduce background colonies that may 
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arise due to spontaneous resistance. Finally, PCR products of psbN::kmR 
knockout with 50 bp flanks were used as opposed to 30 bp in previous work to 
improve the integration process. 
PCR was carried out to amplify the psbN::kmR PCR products with 50 bp flanks 
(LT50) from the pUC4K plasmid as in section 4.3.2.1 using a ‘hot start’ in an 
attempt to generate the PCR product more easily. The PCR product was purified 
and treated with DpnI and 7 μg used in the transformation of both WT and 
∆recJ.ble recipient strains. WT and ΔrecJ.ble strains were also transformed with 
a PCR product generated from the pUC.psbN.kmR plasmid with 1000 bp of 
flanking sequence (as a positive control), and with no DNA (negative control). A 
large number of putative transformants (116 kanamycin resistant colonies) 
appeared within seven days of antibiotic selection using the RecJ- recipient 
strain, while no transformants were obtained from the WT recipient strain, 
confirming the higher transformation efficiency of the RecJ- strain.   
Sixty isolated colonies were selected for analysis after undergoing three rounds 
of selection on medium supplemented with 200 μg/ml of km. DNA extraction from 
the colonies was done in such a way that every ten colonies were pooled in a 
single preparation and used for PCR analysis. PCR analysis on the pooled DNA 
extracts was carried out to check for targeted psbN gene knockout as described 
in section 4.3.1.3. The PCR results confirmed the presence of psbN knockouts in 
each of the pooled DNA preparations (Figure 4.17.A). To investigate the 
proportion of psbN knockouts in the pooled samples, twelve representative 
colonies (two from each pool) were randomly selected and individual genomic 
preparations were made for PCR analysis. Results in Figure 4.17.B show that all 
twelve individual colonies screened were positive for the psbN::kmR knockout.  
After confirming the ability to generate a large number of psbN gene knockouts 
by means of homologous recombination using the one-step PCR method with an 
LT50 product and using the ΔrecJ.ble as the recipient strain, it was necessary to 
check for reproducibility of these results. Therefore, the same experiment was 
repeated three times; however, results obtained were not consistent with our 
initial findings as very few colonies were isolated and most were not psbN::kmR 
knockouts (Table 4.1).  
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Figure 4.17: PCR analysis of transformants in ΔrecJ.km recipient strains.  
(A) The transformation of ΔrecJ.km strain with PCR products of psbN::kmR with 50 flanks resulted 
in psbN::kmR knockouts within pooled DNA of 60 tested transformants. Each lane (numbered 1-6) 
is a PCR result on DNA pooled from 10 transformants. The controls in order are: genomic 6803 
DNA (-c), plasmid (+c), plasmid without a kmR cassette (-c). (B) 12 random transformants (T1-
T12) from those analysed in (A) were selected to test for gene knockouts in the ΔrecJ.km strain 
and all showed a positive result for the psbN::kmR knockout.  
 
Table 4.1: Transformation results of LT50.psbN::kmR PCR products in ΔrecJ.ble 
and WT recipient cells.  
TRANSFORMATION 
# 
RECIPIENT 
STRAIN 
# OF 
TRANSFORMANTS 
PSBN 
KNOCKOUT 
1 ΔrecJ.ble 
116 60 pooled 
DNA 
 WT 0 - 
2 ΔrecJ.ble 1 YES 
 WT 0 - 
3 ΔrecJ.ble 2 NO 
 WT 0 - 
4 
ΔrecJ.ble 3 NO 
 WT 0 - 
 
The failure to reproduce successful psbN::kmR knockouts raised a question as to 
whether there is something about the psbN locus itself that might be playing a 
role in preventing consistent HR. Therefore, two other genes, psbA2 (gene 
code=slr1311) and psb28.2 (gene code=slr1739) were selected for targeted gene 
knockouts in the ΔrecJ.kmR strain. The two genes were selected on the basis 
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that, like psbN, they are both benign and deleting them should not result in any 
phenotypic change or effect on the physiology and growth of the deleted strain. 
Again for this PCR, primers were designed such that 22 bp were homologous to 
the kanamycin resistance cassette at their 3' end and ~50 bp were homologous 
to psbA2 and psb28.2 genes at their 5' ends. Primers used for this PCR can be 
found in Appendix 3.  
The PCR was performed as before (section 4.3.2.1) using pUC4K as the 
template for the PCR reaction. For both sets of primers the kmR gene was 
successfully amplified with ~50 bp flanks on either end, generating the expected 
~1.3 kb gene product. A psbN::kmR product with 50 bp flanks was also produced, 
together with the psbA2::kmR and psb28-2::kmR products. The products were 
purified and treated with DpnI, after which 3-8 μg of DNA was used for 
transformation into both WT and ΔrecJ.ble recipient strains. Negative and 
positive controls for both strains were included in the transformation for band size 
comparisons. The details of the controls used are in the legend of Figures 4.18 
and 4.19. 
Putative colonies appeared seven to ten days post antibiotic selection (200 μg/ml 
of km) from all three gene transformations using the ΔrecJ.ble recipient strain, 
whereas no colonies were observed for the WT recipient strain. Approximately 
150 colonies were obtained from the LT50.psbA2.kmR PCR product, five colonies 
from LT50.psbN::kmR and ~60 colonies from LT50.psb28.2.kmR. For PCR 
analysis of the putative transformants for targeted gene knockouts, sixty isolated 
colonies were selected from both LT50.psbA2.kmR and LT50.psb28.2.kmR where 
every ten colonies were pooled in single genomic preparations. Genomic DNAs 
from the five colonies from LT50.psbN::kmR transformants were prepared 
individually. Primers were designed upstream and downstream of each tested 
gene to check for integration of the PCR products in the psbA2 and psb28.2 loci. 
The expected band size of psbA2 knockouts was ~1.4 kb (722 bp for WT) and 
~1.5 kb for psb28.2 knockouts (755 bp for WT), and as before 3.1 kb for psbN 
knockouts (1.9 kb for WT). Primers used in this PCR analysis are listed in 
Appendix 3.  
PCR analysis of the transformants was carried out according to methods 
described in section 4.3.2.1. Results presented in Figure 4.18 showed that none 
of the 60 colonies screened for targeted gene knockouts for the two genes psbA2 
 155 
 
or psb28.2 were positive, while only one of the five transformants screened for 
psbN gene knockout was positive.  
Next, four random colonies were selected from each of the LT50.psbA2.kmR and 
LT50.psb28.2.kmR transformants for individual PCR analysis to confirm the 
absence of genes knockouts. Again, none of the individually screened 
transformants showed targeted gene knockouts. From these results we can 
conclude that, at least for the three genes selected in this study, the gene locus 
did not appear to affect the integration pattern of the PCR products with short 
flanks. Further analysis was carried out to find out where the PCR products were 
being inserted when not integrated via double homologous recombination. It was 
hypothesised that the PCR products may be integrating in the same “hot spot” 
identified in chapter 3 (speA/psbA2 locus). It is possible that the short flanks of 
the PCR products sometimes fail to locate their homologues in the genome, 
therefore acting like the naked kmR cassette landing in these "hot spots". To test 
this theory, a PCR was carried out where DNA from pooled genomic preparations 
of the LT50.psbA2.kmR and LT50.psb28.2.kmR transformants and the five 
individual DNA preparations from the LT50.psbN::kmR transformants were used 
as templates. Primers were designed where one primer was located upstream of 
the hot spot area (speA/psbA2 area) and another located within the kmR 
cassette. Obtaining a PCR product using this set of primers would confirm the 
integration of the PCR product in the speA/psbA2 locus. 
The PCR was carried out using primers listed in Appendix 3. Wild-type genomic 
DNA was used a negative control, while genomic preparations of the 
ΔrecJ.km.HincII strain (obtained from work carried out in chapter 3) was used as 
a positive control since the kmR cassette in this transformant was found to be 
located in the speA/psbA2 area. Results presented in Figure 4.19 show that 
some of the PCR products did indeed integrate in the speA/psbA2 area. Three of 
the five LT50.psbN::kmR PCR products and one of the sixty LT50.psb28.2.kmR 
PCR products were located in the speA/psbA2 region, while none of the 
LT50.psbA2.kmR PCR products were found in that area and have probably 
integrated elsewhere in the genome. We can conclude from the previous results 
that when non-homologous recombination events take place in Synechocystis 
using PCR products of gene knockouts with short flanks, some PCR products act 
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as naked kmR cassettes and integrate into hot spots in the genome, while others 
integrate randomly in other locations.  
After testing several parameters for the improvement of the HR:NHR ratio (e.g. 
using ssDNA, varying DNA and recipient cell concentrations and using a modified 
recipient strain of Synechocystis) and combining the results with those obtained 
in chapter 3 (similar integration patterns between PCR products of kmR gene 
knockouts with short flanks to those of a naked kmR cassette), it was concluded 
that the sequence of the kmR cassette itself may favored integration into random 
or hot spots in the genome, similar to results obtained in Chapter 3. However, 
before exploring this hypothesis, it was necessary to compare the two kinds of 
PCR products that are, at least in principle, identical but give different 
transformant outcomes in terms of HR;NHR ratios. PCR products obtained from a 
knockout plasmid (pUC.psbN.KmR) and from the one-step method (with 5’ 
extensions homologous to psbN), both with 50 bp flanking regions, were 
transformed into Synechocystis for direct comparison of different types of PCR 
products (as illustrated in Figure 4.20). 
 
Figure 4.18: Applying the one-step PCR to knock out three genes using ΔrecJ.km 
as recipient strain. 
(A) psbN::kmR knockout (3.1 kb). The controls in order are: (-C): plasmid carrying WT psbN gene 
(plasmid A without kmR), (+C): pUC.psbN::kmR,  (-C): genomic 6803 DNA. (B) PCR results show 
no positive psbA2.kmR knockouts (WT band size ~ 0.72 kb) (-C): genomic 6803 DNA. (C) PCR 
results show no positive psb28.2.km knockouts (WT band size ~ 0.75kb). (-C): genomic 6803 
DNA. Each lane (numbered 1-6) is a PCR result on DNA pooled from 10 transformants (for both B 
and C). 
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Figure 4.19: Testing the integration of PCR products of three genes with short 
flanks in the speA/psbA2 area.  
(A) None of the LT50.psbA2.kmR transformants are in the speA.psbA2 area. (B) Only one of the 
LT50.psb28.2.km transformants was integrated in the speA.psbA2 area. Individual analysis of the 
pooled DNA in preparation # 2 showed only 1/10 pooled DNA integrated in speA.psbA2 area. (C) 
Three transformants of LT50.psbN::kmR (1, 2 & 4) integrated in speA.psbA2 area. Each 
preparation (numbered 1-6) is a PCR result on DNA pooled from 10 transformants. +C: 
ΔrecJ.km.HincII strain that contains a kmR cassette in the speA.psbA2 area, (-C): genomic 6803 
DNA. 
4.3.4 Comparison of PCR products from the traditional and one-step PCR 
methods: 
In order to understand the reason behind the different modes of integration of 
what ought to be the same final PCR product derived from both the traditional 
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method (section 4.3.1.1) and one-step PCR method (section 4.3.2.1), it was 
necessary to compare the steps undertaken in generating the PCR products from 
each method. Figure 4.20 illustrates the PCR product of a psbN::kmR knockout 
produced via the traditional method and the one-step PCR method. From the 
figure, we can conclude that there are two apparent differences in obtaining the 
final product that may play a part in the difference in integration patterns between 
the two PCR products; namely, the template used for amplifying the gene 
knockout and the primers used for the amplification.  
With regard to the template used in the traditional method, one may argue that 
there is a possibility of trace amounts of the original pUC.psbN::kmR plasmid 
construct that may be contaminating the PCR product and giving rise to the 
transformant colonies via double homologous recombination. However PCR 
products generated from the plasmid were treated with DpnI that recognises the 
sequence GATC and digests it when methylated [=plasmid DNA], but doesn’t 
digest the un-methylated sequence [=PCR products], as illustrated in Figure 4.12. 
Furthermore, the possibility that transformants were obtained from trace amounts 
of plasmid that might have escaped the DpnI digestion can be ruled out since the 
number of colonies obtained from transformation with each PCR product (with 
varying flank sizes) was proportional to the length of regions of homology to the 
target gene carried on the PCR product suggesting that transformation arose 
from the PCR products and not from traces of the plasmid construct (Figure 4.5).  
Next, the primers used in the one-step PCR method were examined. It is known 
that PCR involving long-tail primers are prone to be more complex since longer 
primers are expected to be contaminated with incomplete primers that are not 
full-length (Datsenko and Wanner, 2000). Therefore, to investigate the effect of 
employing long-tail primers in amplifying gene knockouts and to check for the 
addition of proper flanks to the kmR cassette in the generated PCR products, the 
product of psbN::kmR with 50 bp flanks obtained from the one-step PCR and that 
obtained by amplification from pUC.psbN.KmR were sequenced and compared. 
Interestingly, sequence results revealed that the junction between the kmR 
cassette and the flanking sequences (homologous to psbN) are not the same in 
the two PCR products and nucleotide deletions and additions are found at the 
junction in PCR products obtained from the one-step PCR method as shown in 
Figure 4.22.A.  
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Interestingly, a search of the BLAST database with a sequence of 30 bp present 
in the junction between the part of the long-tail primer that primes to the kmR 
cassette (highlighted in grey in Figure 4.22.B) and the part of the long-tail primer 
representing the psbN flank (highlighted in yellow in the same figure) is part of 
the kmR cassette itself. It is unclear why this recombination/shuffling took place at 
the junction but it seems to be due to issues related to the sequence of the kmR 
cassette. From the sequence results obtained, it seems reasonable to conclude 
that the PCR products generated using long-tail primers (one-step PCR method) 
combine less efficiently due to the deletions and mutations that take place during 
the amplification of the PCR product.  
To further investigate the effect of using long tail primers, the PCR product of 
LT50.psbA2.kmR was also sequenced to examine the integration of the correct 
flanks in this PCR product. As seen with the LT50.psbN.kmR PCR product, the 
sequence results confirmed the presence of nucleotide deletions and mutations 
in the PCR products within the long-tail primers (Appendix 7). A study done by 
Datsenko and Wanner. (2000), showed that a single nucleotide deletion that 
occurred in long-tail primers (≥60 bp) happened very near the junction of the 
priming site and homology extension which resulted in less efficient 
recombination of the PCR products.  
In our case, four nucleotide deletions took place at the junction and therefore it is 
arguable that the recombination of the PCR product is even less efficient. These 
kinds of errors are difficult to avoid since oligonucleotides with internal deletions 
arise from chemical synthesis and are difficult to remove by conventional 
purification methods (Temsamani et al., 1995). Alternatively, the problem might 
arise from secondary structure formation in the primers during PCR amplification. 
The mis-matches/deletions in the PCR product could explain why targeted gene 
knockouts were not obtained using the one-step PCR method while targeted 
psbN::kmR knockouts were obtained with PCR products amplified from the 
plasmid construct. On the other hand, it could also be possible that the inefficient 
recombination (NHR) of the one-step PCR product was due to the DNA shuffling 
that took place between the kmR cassette and the long-tail primer (Figure 4.22.B) 
and that there were high chances of generating errors in the long-tail primers 
when the kmR is used. The following section explores the possibility of using 
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another marker instead of the kmR cassette to circumvent these apparent 
problems.   
 
Figure 4.20: Illustrations of PCR products obtained from traditional and one-step 
PCR methods. 
(A) PCR products amplified from plasmid construct containing psbN::kmR knockout using the 
traditional method (B) PCR product of psbN::kmR knockout amplified directly from plasmid 
carrying the kanamycin resistance cassette using the one-step PCR method. 
 
Figure 4.21: Illustration of DpnI digestion of kmR cassette in pUC.psbN::kmR 
plasmid. 
(A) KmR cassette showing DpnI sites. (B) Plasmid digested with DpnI at methylated sites. (C) 
PCR product protected from DpnI digestion (Nonmethylated). 
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Figure 4.22: Sequence results of PCR products obtained by one-step PCR and 
traditional methods. 
Sequence analysis shows that the junction area between the long-tail primer segment 
homologous to the target gene (highlighted in yellow) and that homologous to the selectable 
marker (grey) are not the same in PCR products obtained from the knockout plasmid and the one-
step PCR method. (A) The junction shown in red font contains four nucleotide deletions and an 
extra nucleotide. (B) Blast results of the 30 bp extra nucleotides highlighted in red were found to 
be part of the kmR cassette that has been inserted in the junction between the part of the long-tail 
primer that primes with the kmR cassette (light grey) and the psbN flank (yellow).   
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4.3.5  Utilisation of ΔrecJ.kmR strain and new gene knockouts for one-step 
PCR  
In order to test whether the choice of the selectable marker (kmR cassette) was 
responsible for the NHR events taking place in Synechocystis, the ble selectable 
marker (encoding zeocin resistance) was chosen to replace the kmR cassette in 
creating targeted psbA2, psb28.2 and psbN gene knockouts using the one-step 
PCR method. The following section describes the utilisation of the ΔrecJ.kmR 
mutant strain (developed in chapter 3, section 3.3.4) and the ble marker in 
creating the three gene knockouts. 
4.3.5.1 One-step PCR gene deletion using ble as the selectable marker.  
Long-tail primers were designed to amplify the ble resistance cassette directly 
from plasmid pZΔES (Appendix 1) as psbN.ble, psbA2.ble and psb28.2.ble gene 
knockouts. The long-tail primers were designed such that ~22 bp were 
homologous to the ble cassette at their 3' end and ~50 bp flanks were 
homologous to the target gene (psbN, psbA2 and psb28.2) at their 5' ends. PCR 
was performed as described in section 2.3.5 and results presented in Figure 4.23 
show the successful amplification of all three LT50 products in a single PCR step. 
The purified PCR product (0.6-0.7 kb) was DpnI-digested and used for the 
transformation into the ΔrecJ.kmR strain of Synechocystis as described in section 
4.3.4.1. Sequences of the long-tail primers used can be found in Appendix 3. 
4.3.5.2 Transformation of ΔrecJ.kmR strain with the one-step PCR products 
The PCR products obtained in section 4.3.5.1 were used for transformation into 
both WT Synechocystis and the ΔrecJ.kmR mutant as in section 2.4.2. 
Transformants were allowed to recover for 48 hours before selection with zeocin 
at a final concentration of 7.5 µg/ml. Approximately 60 colonies were recovered 
(7-10 days post antibiotic selection) upon transformation of the ΔrecJ.kmR strain 
with the PCR products, while no colonies appeared on the negative control, 
indicating that the obtained colonies are most likely true transformants. 
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Figure 4.23: PCR products of psbN, psb28.2 and psbA2 gene knock using ble marker 
gene. 
PCR products of psbN, psb28.2 and psbA2 gene knockouts using long tail primers and ble as the 
selectable marker (one-step PCR products). Expected product sizes = ~0.7 kb. 
 
Interestingly, the number of transformants varied between the three 
transformations with more transformants obtained with PCR products of 
LT50.psbN.ble PCR product (48 colonies) followed by LT50.psbA2.ble PCR 
product (six colonies) while only two colonies were obtained using 
LT50.psb28.2.ble PCR product (Figure 4.24). The variability in the colony count is 
probably due to differences in the sequences of each gene that may affect 
integration. On the other hand, transformation of the WT strain yielded only a few 
transformants for LT50.psbN.ble, LT50.psbA2.ble and LT50.psb28.2.ble PCR 
products (10, 15 and a single colony, respectively). Additionally, many colonies 
appeared on the negative control plate, indicating that the colonies generated 
from the WT strains are probably false transformants that appeared due to 
spontaneous resistance or local depletion of the antibiotic on the plate.  
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Figure 4.24: Transformants of psbN, psb28.2 and psbA2 gene knock-outs in ΔrecJ.kmR recipent strain. 
(A) Negative and positive controls (strain with no added DNA, strain transformed with Δpsb28.2.ble respectively) of the ΔrecJ.km strain showed expected 
results. (B) Six colonies obtained from transformation of ΔrecJ.kmR strain with psbA2.ble PCR product. (C) 48 colonies obtained from transformation of 
ΔrecJ.kmR strain with psbN.ble PCR product. (D) Two colonies obtained from transformation of ΔrecJ.kmR strain with psb28.2.ble PCR product.   
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4.3.5.3 Analysis of transformants for the three gene knockouts in 
ΔrecJ.kmR strain.  
Genomic DNA of selected transformants obtained in section 4.3.5.2 was 
prepared and used as a template in a PCR reaction using primers designed to 
check for the correct integration of the PCR products into the targeted gene loci 
(one primer upstream of the gene of interest and other designed within the ble 
marker gene). Results presented in Figure 4.25 shows the successful isolation of 
gene knockouts for all three genes tested. As seen in the figure, 5 out of 6 tested 
transformants were psbA2.ble knockouts, 6 out of 10 tested transformants were 
psbN.ble knockouts and the single colony obtained with LT50.psbA2.ble PCR 
product was also a knockout. On the other hand, none of the transformants 
obtained using the WT recipient strain were positive gene knockouts for any of 
the three genes tested, confirming that they were false transformants. Positive 
(for psb28.2) and negative controls (WT genomic DNA) were included in some of 
the PCR reactions. Primers used to test for the transformants can be found in 
Appendix 3.   
From the results obtained above, we can conclude that the one-step PCR 
method can be efficiently used to create targeted gene knockouts in 
Synechocystis when the kmR selectable marker is replaced with the ble 
selectable marker, possibly due to matters related to the sequence of the kmR 
cassette that favour its recombination into other areas in the genome, as seen in 
chapter 3. It would be beneficial to be able to use shorter flanks for homology to 
the target gene, thereby shortening the overall length of the primer and reducing 
the cost of primer synthesis.  
Primers were designed that contained at their 5’ ends 30 bases of homology to 
the flanking regions of psbN, psbA2 and psb28.2 genes and at their 3’ end 22 
bases of homology to the ble resistance cassette. As before, the ble cassette was 
amplified from pZΔES as a template using the different primer pairs as listed in 
Appendix 3. The PCR products were used for transformation into both WT and 
ΔrecJ.kmR recipient strains. However, no transformants were obtained using 7 μg 
of the each of the PCR products as shown in Figure 4.26. The transformation 
was repeated to confirm the findings and the same result was obtained. Our 
inability to obtain transformants indicated that 50 bases is likely close to the 
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minimum length of homology needed for this method using ble as the selectable 
marker. 
 
 
Figure 4.25: PCR analysis of transformants of three gene knockouts in ΔrecJ.km 
strain. 
(A) 5 out of 6 colonies screened for psbA2 gene knockout in ΔrecJ.kmR recipient strains were 
knockouts while none of the five colonies screened for psbA2 gene knockout were positive in the 
WT recipient strain. (B) 6 out of 10 colonies screened for psbN gene knockout were positive; (C) 
The single colony screened for psb28.2 gene knockout was a knockout while the single colony 
screened for psb28.2 gene knockout was negative in WT recipient strain.  Key: -C; WT genomic 
DNA, +C; Synechocystis with psb28.2 gene knockouted out with a ble marker.   
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Figure 4.26: Transformation of WT and ΔrecJ.kmR recipents strains with three gene knockouts with 30 bp flanks from one-step 
PCR. 
(A) No transformants obtained in WT recipient strains from any of the three gene knockouts with 30 bases homology to the target gene. (B) No transformants obtained in 
ΔrecJ.kmR recipient strains from any of the three gene knockouts with 30 bases of homology to the target gene. Positive controls show a successful transformation 
procedure. +C for WT; WT recipient strain transformed with RecJ.ble plasmid, +C for RecJ; RecJ.km recipient strain transformed with plasmid containing a psb28.2 gene 
knockout out with a ble marker. 
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4.3.5.4 Large chromosomal deletions using one-step PCR 
After the successful isolation of psbN.ble, psbA2.ble and psb28.2.ble gene 
knockout mutants using the one-step PCR method, the method was tested for the 
ability to create large chromosomal deletions (for example, removal of an entire 
operon). The ability to delete large segments of DNA would benefit from saving 
immense time in creating knockouts for each gene of an operon. Furthermore, 
the method can be used to study the effect of operon deletions as well as 
individual gene deletions.  
In this investigation, a four-gene operon consisting of cpcC1 (gene code: 
sll1580), cpcC2 (gene code: sll1579), cpcA (gene code: sll1578) and cpcB (gene 
code: sll1577) was selected. The genes of this operon encode components of the 
phycobilisome complex which is the peripheral light-harvesting complex of 
cyanobacteria (Vermaas, 1998) and are therefore for required for efficient 
photosynthesis. It has been reported that the deletion of these four genes would 
result in a phenotypic change where the colony and culture colour of successful 
knockouts would be olive green as opposed to the distinct blue-green colour 
normally observed in Synechocystis transformants with benign gene deletions 
(Lea-Smith et al., 2013). Creating a deletion (whether gene or operon) that would 
result in such a phenotypic change makes identification of successful 
transformants a much easier task.  
The genome sequence of Synechocystis was consulted through Cyanobase to 
design primers to amplify the target operon. Each primer was designed so that 24 
bases were homologous to the ble marker at the 3’ end and ~50 bases were 
homologous to the target operon at the 5’ end as seen in the schematic 
representation shown in Figure 4.27. Sequences of these LT50 primers can be 
found in Appendix 3. PCR was performed as described in section 4.3.4.2 and 
resulted in the amplification of the correct size of PCR product (~0.7 kb). If 
successful, the knockout would result in the replacement of the 2 kb 
chromosomal segment with the ~0.6 kb ble selectable marker. The purified PCR 
product (∼4.5 µg) was used for transformation into the ΔrecJ.kmR strain. 
Transformants were allowed to recover for 48 hours before being selected on 
media containing 25 µg/ml zeocin. Only a single colony was obtained 14 days 
post antibiotic selection. The delay in the appearance of the transformant was 
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expected since the deletion targeted essential photosynthesis components. The 
colony was taken through three rounds of antibiotic selection before being 
analysed by PCR. For PCR analysis, primers were designed upstream and 
downstream of the targeted deletion (indicated in solid black arrows in Figure 
4.27.B) to check for the correct insertion of the one-step PCR product. Primers 
used to check for the knockouts are listed in Appendix 3. Results of the PCR 
analysis shown in Figure 4.28 revealed that the tested colony was not a 
successful knockout indicated by the WT band size of ~2.5 kb (a positive 
chromosomal knockout would be ~1.2 kb). A second attempt to generate the 
large chromosomal deletion described earlier was made using the same methods 
described above. However, no transformants were obtained, indicating that 
employing the one-step PCR method for large chromosomal deletions may not 
be feasible.  
 
Figure 4.27: Schematic representation of the large chromosomal section proposed 
for one-step PCR deletion. 
(A) pZΔES plasmid was used as template to amplify a deleted operon using ble as the selectable 
marker and using long-tail primers (indicated with blue curves) that represent the part of the 
primer homologous to the selectable marker while parts homologous to the target genes are 
highlighted in orange and red arrows.  (B) 2 kb of a chromosome segment including the full or 
partial sequence of four genes (cpcC1, cpcC2, cpcA and cpcB), to be replaced with the ble 
selectable marker (~0.6 kb) in a single PCR step. Figure modified from (Lea-Smith et al., 2013). 
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Figure 4.28: PCR result of large chromosomal deletion 
using one-step PCR. 
The one-step PCR method was not successful in deleting the operon 
consisting of the four genes as shown by the WT band size of 2.5 kb 
obtained from PCR analysis.  
 
4.4 Conclusion and future work  
Work done by several researchers suggests that the minimum length of flanking 
regions necessary for a successful double homologous recombination in 
Synechocystis is in the region of 200-500 bp. However, results from the first part 
of this study showed that the minimum length necessary to create targeted gene 
knockouts using PCR products was as little as 30 bp on either side of the foreign 
DNA. Nevertheless, there was an obvious difference in transformation efficiency 
between Synechocystis transformed with PCR products with long and short 
flanks with higher transformants obtained with increased flank lengths (Figure 
4.5.A). The information obtained was used to test the possibility of creating 
targeted gene knockouts in Synechocystis using the proposed one-step PCR 
method. After several unsuccessful attempts to generate targeted gene 
knockouts of Synechocystis using the one-step PCR method using the kmR 
selectable marker (with a few exceptions), it was found that the kmR cassette 
tended to insert randomly or in “hot spots” of the Synechocystis genome. 
Sequence results show that nucleotide mutations/deletions and insertions of 
parts of the kmR cassette in the PCR product obtained using long-tail primers in 
the one-step PCR may have led to less efficient homologous integration, since 
the flanks were probably not recognised by the host as homologous to the gene 
hence identifying the kmR cassette as a naked kmR cassette (no flanks) and 
inserting it randomly or in hot spots in the genome. This was confirmed when the 
results were compared to transformants obtained from the transformation of the 
“naked” kmR cassette (no flanking regions) in chapter 3 that were also integrating 
in identified “hot spots” in the genome. PCR results presented in Figure 4.10.B 
indicated random integration of the kmR cassette in the genome.  From such 
results we concluded that non-homologous recombination events were 
significantly more likely than homologous recombination using PCR products 
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obtained from the one-step PCR method and that Synechocystis 6803 likely 
contained a recombination system that could insert such a cassette randomly or 
in “hot spots”. 
Studies done by other researchers showed that DNA concentration (Porter, 1986; 
Kufryk et al., 2002), length of homologous recombination fragments (Williams, 
1988; Labarre et al., 1989), and details in the transformation procedure (Kufryk et 
al., 2002) can affect transformation efficiency in Synechocystis (Zang et al, 2007).  
In this study, we investigated whether similar factors would also play a role in 
improving the HR:NHR ratio. Results showed that using ssDNA and various DNA 
and recipient cell concentrations did not improve the ratio. However, we found 
that using an improved strain of Synechocystis (recJ- strain) did result, for the 
first time, in the isolation of large numbers of targeted psbN::kmR (Figure 4.17). 
However, the results were not reproducible and further studies showed that the 
choice of the selectable marker played a more significant role in obtaining 
targeted gene knockouts. This was confirmed when three targeted gene deletions 
of the genes psbN, psb28.2 and psbA2 were obtained using the one-step PCR 
method only after the kmR marker gene was replaced with the ble selectable 
marker (Figure 4.25). Attempts to create gene knockouts using 30 bases of 
homology linked to the ble marker did not work, nor did the attempts to generate 
large chromosomal deletions (Figure 4.26).  
Finally, we can conclude that a one-step PCR-based method for creating 
targeted gene knockouts in Synechocystis has been developed. However, it 
appears that the following conditions need to be met for the successful 
application of this method (i) a recJ- strain of Synechocystis as opposed to the 
WT Synechocystis strain needs to be used as the recipient for transformation (ii) 
the ble marker should be used as the selectable marker of choice (use of the kmR 
cassette should be avoided) and finally (iii) at least 50 bases of homology to the 
target gene needs to be used. 
Recommended future work would include creating more targeted gene knockouts 
using the ble marker. This will confirm the efficiency and reproducibility of the 
developed method. Furthermore, checking the use of the developed method 
using a range of selectable markers (e.g. streptomycin, gentamicin and 
chloramphenicol resistance markers) would allow for the development of a list of 
“recommended markers” to be used with this method.   
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Chapter 5: The potential of engineering Synechocystis 
6803 for photosynthetic terpene production
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5.0 Introduction 
Terpenes, also referred to as terpenoids and isoprenoids, are typically derived 
from plant sources and have many industrial applications. Section 1.4.2 in the 
Introduction chapter describes the industrial applications of these classes of 
biological compounds, most notably in the perfume industry, pharmaceuticals and 
as insect repellants (Sikkema et al., 1995, Dunlop et al., 2011, Ro et al., 2006). 
Monoterpenes, such as geraniol, are commonly used as a fragrance component 
in consumer products and as an anticancer and antimicrobial agent (Gilpin et al., 
2010, Sato et al., 2007, Andoğan et al., 2002) and its commercial production is 
highly desirable. On the other hand, there has been a recent hyperbole on 
terpene-derived fuels due to the many advantages they offer. For example, 
terpenes contain high energy densities and low freezing points and since they 
generally have methyl branches, double bonds and ring structures, their fluidity is 
improved at lower temperatures (Lee et al., 2008). Furthermore, they are 
considered ‘drop-in’ or ‘fungible’ fuels as they are compatible with existing engine 
infrastructure (Lu, 2010). Most of these terpene-derived fuels however have been 
produced in genetically engineered heterotrophic hosts such as E. coli and 
yeasts (Peralta-Yahya and Keasling, 2010, Peralta-Yahya et al., 2012, Lee et al., 
2008, Atsumi et al., 2009). If similar metabolic engineering approaches were 
successfully applied to photosynthetic micro-organisms, such as eukaryotic 
microalgae or cyanobacteria, it would result in an efficient biological system for 
direct light-driven conversion of CO2 into high value products and advanced 
biofuels. To date, there are only two reports of isoprenoid pathway engineering in 
Synechocystis with the products being isoprene (Lindberg et al., 2010), and the 
sesquiterpene, β-caryophyllene (Reinsvold et al., 2011).  
In this chapter, research is described that aims at creating transgenic 
Synechocystis strains that have the potential to produce (i) the medium chain 
(C10) monoterpene geraniol that can serve as both a high value product and a 
potential biofuel and (ii) the C15 sesquiterpene farnesene, a potential diesel 
replacement fuel. This was to be achieved by means of genetic engineering 
techniques to introduce novel terpene biosynthesis enzymes that convert 
metabolic intermediates to these high value products and engine ready fuels. The 
chapter also describes toxicity tests of selected terpenes on Synechocystis and 
methods used to mitigate the toxic effects of these terpenes on the 
cyanobacterium.  
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5.1 Literature review 
5.1.1 Terpene production as high value products and biofuels  
Historically, the use of prokaryotes as a source of terpenes was not considered 
feasible (Daum et al., 2009), possibly as terpenes are naturally produced in such 
small quantities (Martin et al., 2003). However, this situation has changed 
dramatically over the past decade with the advancement of metabolic 
engineering. Due to the many applications of terpenes in industry, engineering 
metabolic pathways for the production of large quantities of terpenes from 
amenable biological hosts seems more attractive than chemically synthesizing 
the terpenes or extracting them from the natural source where their amounts are 
limited (Martin et al., 2003).  
In recent years for example, there has been considerable progress in the use of 
synthetic biology tools to re-engineer metabolic pathways in the heterotrophic 
model organism E. coli to produce a range of novel hydrocarbons (Peralta-Yahya 
et al., 2012). Such hydrocarbons including long chain alcohols, fatty acid-derived 
and terpene-derived fuels, have the potential to be used as fungible fuel 
molecules and currently, are being developed to serve as either supplements or 
drop-in replacements for existing petroleum fuels (Dunlop, 2011). One example 
of a potential terpene-derived fuel is the monoterpene alcohol geraniol which is 
considered a superior gasoline replacement compared to ethanol (Peralta-Yahya 
and Keasling, 2010) and a high value product. The production of geraniol has 
been reported in modified yeast (Oswald et al., 2007) and tomato (Davidovich-
Rikanati et al., 2007). Farnesene on the other hand makes a good biodiesel 
replacement fuel (Rude and Schirmer, 2009) and has been produced in both 
genetically engineered E. coli  (Wang et al., 2011) and  S. cerevisiae (Peralta-
Yahya et al., 2012, Brennan et al., 2012). 
To date, out of the terpene-based biofuels being produced, farnesane is the 
closest to commercialization. This is because farnesane contains a higher cetane 
number (58) relative to farnesene, which translates to higher energy density, and 
is therefore a preferred diesel fuel replacement. Nevertheless, since farnesane is 
produced by means of chemical hydrogenation of farnesene, it is vital to be able 
to synthesise this fuel precursor (Rude and Schirmer, 2009).  
Indeed, promising initial work has been reported in which the model species, 
Synechocystis, or other genetically tractable cyanobacterial species have been 
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engineered to produce a range of industrial compounds including biofuels (Ducat 
et al., 2011b). Table 1.1 in the introduction chapter shows several examples of 
high value chemicals (fatty alcohols) and potential high-energy fuels 
(hydrocarbons) that have been produced in various cyanobacteria. 
As discussed in chapter one sections 1.4.1 and 1.4.2, the terpenoid (or 
isoprenoid) pathway in Synechocystis is a particularly attractive target for next 
generation biofuel engineering. The isoprenoid pathway is responsible for the 
biosynthesis of a wide range of compounds using five-carbon isoprene units as 
building blocks (Vranova et al., 2012). Figure 5.1 gives an overview of the basic 
pathway and highlights how the introduction of additional enzymes could create 
novel C5, C10 or C15 products that are potential biosynthetic alternatives to 
gasoline, diesel, and jet fuel. In many cases, only a single enzyme such as 
isoprene synthase or geraniol synthase is required, although additional enzymes 
could be employed to further modify the product. For example, adding geraniol 
dehydrogenase will convert geraniol to geranial, which is another potential 
biofuel.  A desirable objective will be to extend the isoprenoid pathway of 
Synechocystis for synthesis of monoterpenes and sesquiterpenes that can be 
used as potential advanced biofuels.  
 
 
Figure 5.1: The isoprenoid pathway in Synechosystis  
The isoprenoid pathway in Synechocystis is highlighted in grey. The pathway gives examples of possible 
pathways (red) that could be introduced to produce novel hydrocarbons (blue). IPP=isopentenyl 
diphosphate; DMAPP= dimethylallyl diphosphate; IPS: isoprene synthase; LS: limonene synthase; LLS: 
linalool synthase; GES: geraniol synthase; GDH: geraniol dehydrogenase; CJFS: (E)-β-farnesene synthase.  
 176 
 
5.1.2 Toxicity of terpenes on micro-organisms  
Despite the fact that advanced biofuels such as terpene-derived fuels may offer 
many advantages as mentioned earlier, they are often toxic to the microbial host 
(Andoğan et al., 2002, Azevedo et al., 2012, Dunlop, 2011, Somolinos et al., 
2010). Product toxicity introduces an undesirable trade off in engineered strains 
since the producing strain must balance production against survival. This is a 
common problem in strain engineering for biotechnology applications (Dunlop et 
al., 2011). The level of tolerance of microorganisms to advanced biofuels varies 
amongst different species and strains and also depends on the type of biofuel 
being produced. Studies on the mechanisms of toxicity of terpenes on 
microorganisms indicate that the key factor that contributes to the toxic effect 
correlates to the hydrophobicity (also known as lipophilicity) of the produced 
terpene (Dunlop, 2011). Hydrophobicity determines the extent by which the 
terpene accumulates on the cytoplasmic membrane and therefore how well it 
partitions in the cell membrane. This is often measured by the octanol-water 
partition coefficient (log Pow). Compounds with log Pow values between 1 and 5 
are highly toxic for microorganisms (Dunlop et al., 2011, Isken and de Bont, 
1998, Sikkema et al., 1995). 
It is essential to understand the mode of toxicity of a synthesised terpene in order 
to be able to mitigate its effect. The mechanisms of membrane toxicity have been 
extensively reviewed (Dunlop, 2011, Sikkema et al., 1995) and can be 
summarised as follows: The accumulation of hydrophobic compounds in the 
cytoplasmic membrane results in an increased membrane permeability and 
fluidity which ultimately leads to the release of ATP, ions, RNA, phospholipids 
and protein. This in turn will lead to diminished energy status of the cell, loss of 
membrane protein function and affect the overall stability and structure of the cell 
membrane and its overall role as a barrier. It is therefore crucial to improve 
tolerance in parallel with the development of genetically engineered strains for 
the production of advanced biofuels.  
The development of methods that improve tolerance of microorganisms to such 
products has gained a lot of interest. In recent years, a range of approaches has 
been described (Brennan et al., 2012, Dunlop, 2011, Dunlop et al., 2011, Isken 
and de Bont, 1998, Sikkema et al., 1995). These include expressing efflux 
pumps, heat shock proteins, membrane modifying proteins and activations of 
general stress response genes. The detailed description of these methods is 
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beyond the scope of this chapter and can be found in Dunlop, 2011. Another 
method that can help mitigate the toxic effect of advanced biofuels is controlled 
production by means of a tightly regulated promoter. In this method, the 
production of biofuels would be switched on only after the initial growth phase 
has been established. A method that has been reported to be successful in 
alleviating biofuel toxicity (Brennan et al., 2012). 
An alternative to employing molecular engineering of cyanobacteria for improved 
tolerance is to use a biphasic extraction system whereby an inert solvent phase is 
added to the medium to create an isolation layer that helps separate the biofuel 
from the producing host. This has been shown to alleviate terpene toxicity in 
Saccharomyces cervisiae (Brennan et al., 2012). This chapter will focus on 
attempts made to use both an inducible promoter system to achieve controlled 
terpene production and a two-phase extraction method for improved biofuel 
tolerance. 
5.1.3 Physical properties and engine performance of advanced biofuels 
Identified metabolic pathways offer several possible avenues for the biosynthesis 
of novel fuel molecules (Fortman, 2008) but before producing such fuels in an 
industrial setting, the physical and chemical properties of the potential biofuel 
should be considered. These properties impact on almost everything from 
suitability as a fuel for extraction, purification, processing, to their behavior in 
combustion engines. There are various reviews that emphasise the importance of 
considering factors such as engine type (spark or compression ignition), energy 
content, combustion quality or ignition delay, cloud point, volatility, lubricity, 
viscosity, stability, odour, toxicity, water miscibility and cost when developing 
advanced biofuels from micro-organisms (Antoni et al., 2007, Lee et al., 2008, 
Peralta-Yahya and Keasling, 2010). The compatibility of the biofuel with the 
engine type is a very important factor. It is often that engines have to either be 
adapted to the biofuel or the biofuel has to be designed to mimic, as closely as 
possible, all important features of traditional fossil fuels (Antoni et al., 2007). 
Alternatively, biofuels could be blended with traditional fuels.  
It is essential, when developing future fuels, to make use of advances in many 
fields of science and engineering to ensure that such fuels are sustainable in both 
production and utilization (Hellier et al., 2013). To date, and to the best of my 
knowledge, there has not been a study combining the microbial production of 
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advanced biofuels together with experimental studies on an engine. Attached to 
this thesis is a joint publication that was an outcome of the collaborative work with 
Dr Paul Hellier from the Department of Mechanical Engineering at University 
College London where some of the engine parameters listed above was 
discussed alongside the possible biological production of selected terpenes in 
Synechocystis. The initial idea was to test the diesel engine performance of the 
C10 compound, geraniol, to explore its potential as a possible diesel engine 
replacement. However, 11 other terpenes that represent a change to the 
molecular structure of geraniol were also selected for the investigation. This was 
for the personal interest of Dr Paul Hellier whom conducted the engine tests.   
In summary, conclusions as to the suitability of the terpenes as potential single 
component fuels in diesel engines were, in general based on the ignition delay 
time of the tested fuel and a ranking was produced to show best to worse diesel 
replacement fuel as seen in Table 5.1. By virtue, what is a poor diesel fuel would 
potentially prove better suited to be a gasoline fuel and vice versa (Hellier et al., 
2013).  
Table 5.1: Ranking of 12 selected terpenes from best to worst performance in 
diesel engine. 
Ranking was done according to the ignition delay and emissions produced.  
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5.2 Chapter background and aims 
In the work presented here, the aim was to genetically engineer Synechocystis to 
generate transgenic strains capable of geraniol production mainly as a potential 
high value product and secondarily, as a possible fungible fuel in conventional 
diesel or gasoline engines. The toxicity of geraniol on Synechocystis, and the 
effect of a two-phase culture system on Synechocystis tolerance towards geraniol 
were investigated. Furthermore, the performance of geraniol along with other 
selected terpenes as fuels for diesel engines were assessed in collaboration with 
Dr Paul Hellier from the Department of Mechanical Engineering at UCL. Results 
from engine tests suggested other terpenes (e.g. farnesene) as superior fuels, 
and these were further explored through toxicity testing and additional transgenic 
lines were created.  
5.3 Results and discussion  
5.3.1 Constructing and testing the pLAH.A2 and pLAH.nrsB expression 
vectors 
In order to transform Synechocystis it was essential to build and test vectors that 
would allow for the successful integration and expression of foreign genes in 
Synechocystis. For this, the pLAH.A2 and the pLAH.nrsB plasmid vectors were 
constructed and tested. In both constructs the psbA2 gene (gene code = slr1311) 
was selected as the site of insertion of the foreign genes. The psbA2 gene is one 
of three genes (psbA1, psbA2 and psbA3) that codes for the D1 protein of 
photosystem II (Vermaas, 1998) that is believed to be responsible for protection 
against photodamage or stress (Ikeuchi and Tabata, 2001). The reason behind 
selecting the psbA2 locus is that it has been shown that psbA2 knockouts can 
grow photoautotrophically given that the other genes are still active (Mohamed et 
al., 1993) and its deletion does not lead to a reported phenotype (Vermaas, 
2007). The following sections details the construction of the two expression 
vectors and experiments conducted to test their functionality.  
5.3.1.1 Constructing the pLAH.A2 expression vector:  
The pLAH.A2 vector was constructed to allow expression of foreign genes under 
the control of the native constitutive (but up-regulated by light) psbA2 promoter. 
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The genome sequence of Synechocystis was consulted through Cyanobase [8] to 
design primers to amplify a 2530 bp sequence around psbA2 from genomic DNA. 
This amplified DNA was then used as a template to amplify both the upstream 
and downstream elements of the coding region used to construct the integration 
platform. Two regions of the Synechocystis genomic DNA containing 574 bp and 
723 bp of sequence located immediately upstream and downstream, 
respectively, of the psbA2 coding region were amplified to give elements with 
suitable restriction enzyme sites at either end and then assembled into a cloning 
vector using classical molecular techniques. The primers used are listed in 
Appendix 3. Finally, a Tn903 kanamycin resistance cassette from pUC4K was 
digested with HincII before cloning it in the Smal site of the expression vector 
resulting in the complete assembly of the 4450 bp pLAH.A2 expression vector as 
showed in Figure 5.2. 
An NdeI site was introduced at the translation start to allow for a simple in-frame 
introduction of any gene into the integration platform under the control of the 
psbA2 promoter. Similar psbA2-based vectors have been described (Lagarde et 
al., 2000).  
 
                                            
 
8 http://www.kazusa.or.jp/cyano/cyano.html 
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Figure 5.2: pLAH.A2 expression vector including the psbA2 light regulated promoter.  
Key: Green rectangles represent the upstream (including the psbAII promoter sequence) and downstream psbAII elements, MCS; multiple cloning site, AmpR; 
ampicillin resistance caseett, Ori; origion of replication, kmR: kanamycin resistcane cassett, G.O.I; gene of interest.  
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5.3.1.2 Constructing the pLAH.nrsB expression vector: 
The pLAH.nrsB vector was constructed to allow expression of foreign genes 
under the control of the native tightly controlled, nickel inducible promoter (nrsB). 
The nrsB promoter is part of the nrsBACD operon that encodes four proteins 
involved in Ni2+ resistance and upstream of this operon are the nrsR and nrsS 
genes which make the two-component signal transduction system involved in 
Ni2+ sensing and induction of the operon (López-Maury et al., 2002). In this 
expression vector the nrsB promoter along with its regulatory element were used 
to drive the expression of foreign genes. 
Once more, the genome sequence of Synechocystis was consulted through 
Cyanobase to design primers needed to amplify a 634 bp region of the 
Synechocystis genomic DNA located immediately upstream of the psbA2 coding 
region (avoiding the psbA2 promoter) to give an element with HindIII enzyme 
sites at both ends. The upstream element was then cloned in the HindIII site of 
the pUC18 already containing the same downstream element as that in the 
pLAH.A2 expression vector.  A kmR resistance cassette was isolated from pUC4K 
plasmid by digesting it with HincII and subsequently cloned in the SmaI site of the 
expression vector. The 875 bp nrsB promoter sequence along with its regulatory 
element (nrsRS) was amplified using primers that added SphI and XhoI 
restriction sites at either end and an NdeI site used for the start of transcription on 
the gene of interest. Primers used are listed in Appendix 3. The nrsB sequence 
was digested with SphI and XhoI and subsequently cloned into the SphI and SalI 
sites of expression vector (XhoI and SalI generate the same overhangs). This 
resulted in the complete assembly of the 5389 bp pLAH.nrsB expression vector 
as showed in Figure 5.3.  
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Figure 5.3: pLAH.nrsB expression vector including the nrsB inducible promoter. 
Key: Green rectangles represent the upstream (excluding the psbAII promoter sequence) and downstream psbAII elements, MCS; multiple cloning site, AmpR; 
ampicillin resistance cassette, Ori; origin of replication, kmR: kanamycin resistance cassette, G.O.I; gene of interest, nrsB; inducible promoter including its regulatory 
element.
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5.3.1.3 Testing the functionality of pLAH.A2 and pLAH.nrsB expression 
vectors 
The two expression vectors described in previous sections were constructed to 
allow the expression of selected terpenes in Synechocystis. In case of the 
expression of non-toxic or less toxic terpenes, the pLAH.A2 expression vector 
allows expression of genes constitutively under the control of the psbA2 
promoter. The pLAH.nrsB expression vector allows for the expression of more 
toxic genes under tightly controlled inducible conditions. This section describes 
results from experiments conducted to test the functionality of the two expression 
vectors.  
The ble selectable marker conferring resistance to zeocin was used to test the 
two expression systems. Details of primers used to amplify the 381 bp ble 
sequence from the pRecJ:ble plasmid (Appendix 1) with engineered NdeI and 
BamHI sites can be found in Appendix 3. This product was cloned into NdeI and 
BamHI sites of the two expression vectors using standard molecular techniques 
creating the pLAH.A2.ble and pLAH.nrsB.ble plasmids. The latter was sent for 
sequencing and results confirm the correct cloning of the ble marker under the 
control of the nrsB promoter (Appendix 9). 
Synechocystis was then transformed with the two plasmids as described in 
section 2.4.2. Putative transformants appeared within seven days post selection 
on medium supplemented with zeocin at 25 µg/ml and in addition to 6.4 μM of 
NiSO4.6H2O for transformants expressing the gene under the nrsB promoter. 
There were then taken through three rounds of selection on zeocin-containing 
medium to ensure they reached homoplasmy before genomic DNA was isolated 
(section 2.3.3.1) for PCR analysis (section 2.3.5). The correct integration of the 
ble marker into the genome of Synechocystis at the psbA2 site under the control 
of the two promoters was confirmed by PCR, with results for the nrsB plasmid 
shown in Figure 5.4, using primers located within the upstream element of the 
psbA2 gene and the other within the kmR cassette. Details of primers can be 
found in Appendix 3.  
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Figure 5.4: PCR results confirming the integration of the ble marker gene in the 
psbA2 locus.  
Three isolated transformants show the presence of ble marker gene under the nrsB promoter 
(expected band size of 1.4 kb). Positive control (+C): pLAH.nrsB.ble plasmid, M: 1 kb molecular 
marker, T1-T3; transformants.  
 
The positive transformants were then tested for active and controlled ble 
expression in Synechocystis using western blot analysis and spot tests. In both 
methods, the following were tested: WT Synechocystis, a single transformant 
containing the ble selectable marker under the control of the psbA2 promoter and 
three independent transformants with ble under the nrsB promoter (Figure 5.4). 
Cultures were grown to an OD750 of ~0.4.  Each culture was then split in two 
flasks, where one culture was induced with NiCl2.6H2O added to a final 
concentration of 6.4 µM and the other kept un-induced. The cultures were 
incubated for three hours under standard growth conditions (section 2.2.4) and 
later used for western blot analysis and spot tests. 
Western blot analysis: the western blot was set up according to methods 
described in section 2.6. The controlled expression of the ble protein, in the three 
strains expressing ble under the inducible promoter, was confirmed by the 
presence of the protein (~13.6 kDa) in cultures that have been pre-induced with 
nickel ions added to a final concentration of 6.4 µM (Figure 5.5 lanes 3, 5 & 7).  
Un-induced cultures showed no ble protein (lanes 4, 6 & 8) confirming the tightly 
controlled expression of ble under the nrsB promoter. The constitutive expression 
of ble protein under the psbA2 promoter was confirmed by the appearance of a 
band at ~13.6 kDa in lanes one and two where the expression was independent 
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of nickel induction. The non-specific bands served as loading controls and 
showed equal loading of samples. It is worth noting that the level of the ble 
protein is significantly higher when expressed constitutively under the control of 
the psbA2 promoter when compared to its induced expression under the nrsB 
promoter. 
 
 
Figure 5.5: Testing the functunality of pLAH.A2 and pLAH.nrsB expression 
vectrors. 
Western blot confirming expression of the ble protein (~13.6 kDa) under constitutive (lane 1 and 2 
from the left) and inducible promoter conditions (lane 3, 5 and 7 from the left). (+) indicate cultures 
induced with NiSO
4.
6H
2
O while (-) represent un-induced cultures, T1 psbAII and T1-T3 nrsB 
represent ble expressed under the psbAII promoter and three independent transformants of ble 
expressed under the nrsB promoter respectively.   
 
 
The spot test: Growth tests on solid medium (“spot tests”) were prepared 
according to section 2.2.6. The results presented in Figure 5.6 shows the WT and 
each of the transformants spotted on four plates (done in duplicates) where plate 
one contained only BG11 medium, plate two contained BG11 supplemented with 
NiCl2.6H2O to a final concentration of 6.4 µM. Plate three contained BG11 
supplied with zeocin added to a final concentration of 25 µg/µl and NiCl2.6H2O to 
a final concentration of 6.4 µM. Finally, plate four was supplied with only zeocin 
to a final concentration of 25 µg/ml.  
Plate one, which served as a positive control, showed the healthy growth of the 
ten cultures of Synechocystis. Plate two was used to demonstrate that 
NiCl2.6H2O at concentrations used for induction (6.4 µM) had no detrimental 
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effect on the cultures and this was confirmed by the healthy growth of the ten 
cultures. The expression of ble protein under the control of the psbA2 constitutive 
promoter was confirmed by the survival of the transformants strain of 
Synechocystis on both plates three and four containing zeocin irrespective of 
induction. The expression of ble protein under the nrsB inducible promoter was 
confirmed by the growth of the three pre-induced cultures on plate three and the 
failure of the three un-induced cultures to grow on the same plate demonstrating 
the expression of ble only under induced culture conditions. However, it is worth 
noting that when the previously un-induced cultures were plated on BG11 plates 
containing the inducer (NiCl2.6H2O) a few colonies appeared on the plates 
showing the sensitivity of the nrsB promoter towards the inducer. The controlled 
expression of ble under the nrsB promoter was demonstrated on plate four where 
pre-induced cultures that have previously shown to express ble (plate three) 
failed to grow on plate four containing zeocin in the absence of the inducer. The 
spot test results confirmed that the inducible system is tightly controlled. 
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Figure 5.6: Spot tests showing the expression of active ble protein. 
Spot tests showing the constitutive and inducible expression of an active ble protein under the psbA2 and nrsB promoters in Synechocystis.  (+) indicate cultures pre-
induced with NiSO
4.
6H
2
O while (-) represent un-induced cultures. 
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5.3.2 Potential for geraniol production in Synechocystis   
Geraniol could potentially be produced in Synechocystis by introducing a well 
characterised Geraniol Synthase (GES) enzyme from sweet basil (Ocimum 
basilicum) into the isoprenoid pathway (Figure 5.1). Geraniol, being a volatile 
alcohol would diffuse out of the cell upon production thus reducing the economic 
cost and energy intensity of downstream processing. Furthermore, and as 
mentioned earlier, the production of geraniol has been achieved in yeast (Oswald 
et al. (2007), and tomato (Davidovich-Rikanati et al. (2007). All these factors 
make geraniol an attractive candidate for expression in Synechocystis. In this 
section, the toxicity of geraniol on Synechocystis was examined, methods to 
mitigate its toxic effect were investigated, and attempts to create a transgenic line 
of Synechocystis expressing the GES gene are detailed.   
5.3.2.1 Geraniol toxicity studies 
Toxicity tests were conducted to examine the ability of Synechocystis to grow in 
the presence of increasing amounts of geraniol as described in chapter two 
(section 2.7.1). The toxic effect of geraniol can be observed visually as seen in 
Figure 5.7. It is clear that Synechocystis cells failed to grow in the presence of 
even the lowest concentration of geraniol (0.02% v/v) proving that geraniol was 
extremely toxic when co-inoculated with Synechocystis. This result suggested 
that the constitutive production of geraniol in Synechocystis would be difficult to 
achieve.  
On the other hand, an experiment was set up to investigate the levels of 
tolerance of already established cultures of Synechocystis to exogenously added 
geraniol (section 2.7.2). In this experiment, the tolerance was investigated in 
liquid cultures by monitoring whether the post addition of geraniol inhibited further 
growth and led to bleaching of the culture.  
As seen in Figure 5.8, adding geraniol to established cultures also displayed a 
toxic effect indicated by the gradual loss of pigmentation of the cultures over a 
time period of 72 hours. Cultures inoculated with the lowest concentration of 
geraniol 0.02% (v/v) survived only 24 hours post addition then gradually lost 
pigmentation and by 72 hours, were completely bleached (Figure 5.8 A, B and C 
respectively). Cultures inoculated with 0.1%, 0.2% and 0.4% (v/v) geraniol turned 
yellow after just 24 hours post inoculation (Figure 5.8 B).  
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Figure 5.7: Co-inoculation of Synechocystis with increasing amounts of geraniol. 
Synechocystis failed to grow in the presence of geraniol even at the lowest concentration of 
0.02% v/v showing the highly toxic effect of geraniol. Control flask (0% geraniol) showed healthy 
growth of Synechocystis in the culture medium.  
 
 
Figure 5.8: Tolerance of established cultures of Synechocystis to geraniol. 
The tolerance of established cultures of Synechocystis to increasing amounts of geraniol 24h and 
72h post addition. (A) Cultures of Synechocystis grown to mid-log phase in the absence of 
geraniol.  (B) 24 hours post geraniol addition into established culture of Synechocystis. (C) 72 
hours post geraniol addition into established cultures. Control flask; culture contains 0% geraniol. 
 
To confirm that the loss of pigmentation of Synechocystis cultures reflected death 
of the cells, 200 μl of medium from the cultures shown in Figure 5.8.B were 
plated on solid medium and tested for cell growth. Only a few colonies (~10) were 
recovered from cultures inoculated with 0.02% (v/v) geraniol 24 hours post 
addition and no colonies were recovered from flasks inoculated with 0.1%, 0.2% 
and 0.4% confirming cell death.  In contrast, a lawn of cells was recovered from 
the positive control (no geraniol) (Figure 5.9). This suggests that even the 
induced biosynthesis of geraniol in genetically engineered Synechocystis would 
rapidly prove toxic, and thus expression even under these conditions would be 
challenging. Additional methods would therefore need to be employed to 
overcome the toxicity issue.  
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Figure 5.9: Cofirming cell death in treated cultures of Synechosystis.  
Confirming that death of Synechocystis can be represented by the loss of its pigmentation (A) cultures of Synechocystis inoculated with increasing amounts of 
geraniol (%v/v) (B) 200µl of each culture plated on BG11 plates to check cell viability. Full growth appears on the control plate, few colonies from the cultures with 
0.02% geraniol while no cells recovered from cultures with higher concentrations of geraniol. Control flask; culture contains 0% geraniol. 
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5.3.2.2 Effect of a two-phase culture system on tolerance levels  
In order to be able to produce geraniol in Synechocystis, it was essential to find 
ways to mitigate the toxic effects of this terpene on the cells. The effectiveness of 
using a two-phase extraction system to reduce monoterpenes toxicity in S. 
cerevisiae has already been demonstrated (Brennan et al., 2012). The possibility 
of using a two-phase culture system to potentially “milk” the toxic product from 
the cultures of Synechocystis was therefore investigated. Figure 5.10 shows a 
simple experiment employing a two-phase culture system, using the hydrophobic 
solvent n-dodecane, for extraction of geraniol from the culture. The use of n-
dodecane as an extracting solvent has already been established (Jang et al., 
2011). In this experiment four flasks were inoculated with 25 ml of Synechocystis 
cells grown to an OD750 of ~ 0.7. Flask one was used as controls to show normal 
growth in absence of geraniol and n-dodecane while flask two was used to 
examine whether n-dodecane itself would have a detrimental effect on the 
culture. Flasks three and four were used to compare growth of cultures 
inoculated with 0.02% (v/v) geraniol in the presence or absence of ~17% n-
dodecane, respectively. The growth of the cultures was observed over ten days 
and results are shown in Figure 5.10. Cultures in flask three, containing n-
dodecane, showed a marked improvement in the survival of Synechocystis even 
after ten days as compared to cultures in flask four that lacks n-dodecane, 
(highlighted in yellow rectangle). N-dodecane itself had no detrimental effect on 
the growth of the Synechocystis cultures even after ten days as seen in flask two 
(similar appearance to cultures in the control flask one). From these results, it can 
be said, that adding this non-toxic organic solvent to the culture medium helps 
improve the survival of cells by forming a two phase system in which the toxic 
product accumulates in the organic phase (indicated by a red arrow in Figure 
5.10). This result shows that the controlled biosynthesis of at least small amounts 
geraniol in Synechocystis could potentially be improved significantly in the 
presence of a media additive such as n-dodecane.  
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Figure 5.10: Two-phase culture system used to improve tolerance towards 
geraniol. 
Cultures in flask three show a marked improvement in survival of Synechocystis in the presence 
of n-dodecane as compared to cultures grown in the absence of the media additive (flask four). 
 
5.3.2.3 The expression of geraniol synthase in Synechocystis  
This section describes the isolation and cloning of the cDNA of sweet basil GES 
into the pLAH.A2 and pLAH.nrsB expression vectors. It also highlights the 
challenges that were encountered in order to obtain both E. coli and 
Synechocystis transformants expressing the GES gene under the psbA2 and 
nrsB promoters.  
5.3.2.3.i Isolation and cloning of GES in the pLAH.A2 and pLAH.nrsB expression 
vectors.  
The pCRT7/CT-TOPO plasmid was used as the source of the sweet basil GES 
cDNA in these experiments. The cDNA [(encoding a ~ 65 kDa protein (Iijima et 
al., 2004)] was amplified by PCR without the predicted plastid targeting 
sequence. The primers used for amplification provided NdeI and BamHI 
restriction sites necessary for cloning of the GES coding sequence (CDS) into the 
corresponding sites of both pLAH.A2 and pLAH.nrsB expression vectors. 
Furthermore, an HA-tag sequence was attached to the GES CDS at its 3’ end to 
enable detection using commercial α-HA antibodies. Primers used and 
sequences of the GES CDS and the pCRT7/CT-TOPO plasmid can be found in 
Appendices 3, 4 and 5, respectively.  
The PCR product of ~1.6 kb was excised from an agarose gel, purified (section 
2.3.10) and cloned into the pJET vector. It was then excised using NdeI and 
BamHI enzymes (Figure 5.11) and subsequently ligated into the corresponding 
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sites of both the pLAH.A2 and pLAH.nrsB expression vectors (section 2.3.11.3). 
This is depicted in Figure 5.12.  
 
 
Figure 5.11: GES gene isolated from  pJET as a NdeI and BamHI fragment.  
(A) GES CDS (1.6 kb) isolated by double digesting pJET with NdeI and BamHI. Lanes 1-6 
represent six representative samples of pJET containing the gene. (B) GES gene gel extracted 
and purified for cloning into the pLAH.A2 and pLAH.nrsB expression vectors. 
 
Figure 5.12: A schematic representation showing cloning of GES gene under the 
psbA2 and nrsB promoters. 
(A) Cloning steps for the construction of pLAH.A2.GES plasmid. (B) Cloning steps for the 
construction of pLAH.A2.GES plasmid.  
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5.3.2.3.ii Transformation of E. coli  
Transformation of the pLAH.A2.GES and pLAH.nrsB.GES plasmids obtained in 
section 4.3.2.3.i into competent E. coli cells was done according to methods 
described in section 2.4.1.  
The transformation of E. coli using pLAH.A2.GES resulted in tens of colonies 
when selected on LB plates supplemented with 50 µg/ml of kanamycin. However, 
test digests (using NdeI) were performed on plasmids from a total of 20 colonies 
and revealed the absence of the GES gene in the isolated transformants since 
they showed the same band size as the negative control (Figure 5.13). On the 
other hand, E. coli transformation with pLAH.nrsB.GES resulted in tens of 
colonies and test digests on six plasmids confirmed the successful isolation of 
positive transformants indicated by a band shift of 1.6 kb (representing the GES 
gene) from the negative control (result not shown). A single representative 
plasmid was sent for sequencing and results confirmed the correct insertion of 
the HA-tagged GES CDS under the nrsB promoter (Appendix 13). This plasmid 
was later used for transformation into WT Synechocystis (section 4.3.2.3.iii). 
 
 
Figure 5.13: Test digests on the pLAH.A2.GES plasmid.  
Test digests showed the absence of the GES gene in any of the pLAH.A2 clones. T1-T4; 
transformant lines, negative control: pLAH.A2 expression vector (4.5 kb), M; 1 kb molecular 
marker. 
 
The failure to recover any pLAH.A2.GES clones was intriguing. According to 
Eaton- Rye. (2004), Synechosytsis PCC 6803 promoters may be recognised by 
E. coli and there are reports of the Synechocystis psbA2 promoter being 
functional in E. coli. One example is the work done by Utah State University 
iGEM team in 2010. The team demonstrated a reasonably strong expression of 
the green fluorescent protein (GFP) gene using the Synechocystis psbA2 
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promoter in an E. coli host [9]. Moreover, as mentioned in the introduction chapter, 
there are many studies that describe the antimicrobial activity of geraniol to 
different microorganisms including E. coli. Therefore, it is not unreasonable to 
conclude that the absence of E. coli transformants containing the GES gene upon 
the transformation of E. coli with the pLAH.A2.GES was due to the expression of 
the toxic GES gene under the strong psbA2 promoter that led to cell death due to 
product toxicity. Furthermore, the fact that positive E. coli transformants were 
obtained upon transforming E. coli with the GES gene under the nrsB promoter 
further supports this hypothesis. The nrsB promoter has not been reported to be 
functional in E. coli and thus there is probably no issue of product toxicity with this 
promoter. A control experiment was carried out to test whether the expression of 
GES in E. coli under the Synechocystis psbA2 promoter was the reason behind 
the absence of E. coli positive transformants.  
The control experiment: A partially deleted version of the GES gene under the 
control of the psbA2 promoter was used for transformation into E. coli along with 
the full-length version under the control of the same promoter. Obtaining positive 
E. coli transformants using the deleted version of the GES gene and the absence 
of positive E. coli transformants from transformation with the full sequence of the 
GES gene will confirm our hypothesis.  
In order to create a non-functional GES gene, a “cut and shut” method was used 
where an enzyme was selected (BglII) that cuts the GES CDS at two locations 
without cutting the pCRT7/CT-TOPO plasmid backbone, thereby releasing a 708 
bp fragment. The plasmid was re-ligated and PCR was performed on the re-
ligated mix using the GES primers as above to give a 0.9 kb product. The 
pCRT7/CT-TOPO plasmid carrying the full GES CDS (PCR product of ~1.6 kb) 
was used as a positive control. The PCR products obtained were purified, cloned 
into pJET before being digested with NdeI and BamHI restriction enzymes and 
ligated into the corresponding sites of the pLAH.A2 expression vector to create 
the pLAH.A2.GES(F) and pLAH.A2.GES(D) plasmids as described in section 
2.3.11.3. These ligations were used to transform competent E. coli cells and 
colonies appeared on LB plates supplemented with kanamycin at 50 µg/ml for 
both transformations. Plasmids prepared from randomly picked colonies were 
                                            
 
9 http://2010.igem.org/Team:Utah_State 
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digested using NdeI and BamHI restriction enzymes to check for the presence of 
the deleted and full-length GES sequences. As predicted, only the transformation 
of pLAH.A2 carrying the deleted GES gene yielded the correct recombinant 
plasmid as confirmed by a restriction digest in which a 0.9 kb fragment 
representing the deleted GES gene was observed. On the other hand, none of 
the ten screened plasmids from the transformation with using the full-length GES 
gave the expected band size of 1.6 kb, with most remaining undigested 
suggesting the absence of the GES DNA. Figure 5.14 shows the results for a 
representative of each transformant. For confirmation, one of the putative 
pLAH.A2.GES.F plasmids was sent for sequencing. BLAST results revealed no 
significant match to GES and that a random piece of DNA was inserted 
downstream of the psbA2 promoter (Appendix 10). 
 
 
Figure 5.14: Test digests on putative pLAH.A2.GES.F and pLAH.A2.GES.D 
plasmids. 
Test digests confirm the isolation of pLAH.A2.GES.D plasmid by dropping out a 0.9 kb fragment 
representing the deleted GES. The results indicate the absence of the full-length GES in 
pLAH.A2.GES.F. M1; Fermentase 1 kb molecular marker, M; NEB 1 kb molecular marker. 
 
5.3.2.3.iii Transformation of Synechocystis  
The pLAH.nrsB.GES and the pLAH.A2.GES.D plasmids obtained in the previous 
section were used for transformation of WT Synechocystis as per methods 
described in section 2.4.2. For both transformations, colonies appeared within 
one week of selection on medium supplemented with kanamycin added to a final 
concentration of 200 µg/ml. Genomic DNA was isolated from several colonies 
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from each transformation experiment and analysed by PCR using primers 
designed to check for correct integration of the GES gene in the psbA2 locus. 
Unfortunately, PCR results confirm that none of the five representative 
transformants containing the GES gene under the control of the nrsB promoter 
were positive for GES (Figure 5.15.A). To confirm the results obtained in Figure 
5.15.A, an additional PCR was carried out that would result in a product size of 
1.4 kb using the same forward primer used in 5.15.A and an internal GES primer. 
The results presented in Figure 5.15.B confirm the absence of the GES gene in 
the five transformants. One possible explanation to the lack of positive 
Synechocystis transformants might be attributed to leaky expression of the toxic 
GES gene under the nrsB promoter that caused cell death. Since geraniol has 
already shown to be highly toxic to the cell, even minute amounts of the 
expressed gene may lead to cell death.   
On the other hand, PCR results presented in Figure 5.15.C confirm the isolation 
of Synechocystis strains with the deleted GES gene under the psbA2 promoter 
that has been integrated at the psbA2 locus. Traces of the wild type bands also 
appear in the PCR results demonstrating that the cells have not yet reached the 
homoplasmic stage. Nevertheless, these results confirm that once the gene 
product has been inactivated by partial deletion of the gene, integration and 
detection of GES at the psbA2 site was possible (Figure 5.16), thus further 
confirming that the lack of positive transformants obtained from both the 
pLAH.A2.GES and pLAH.nrsB.GES was due to either strong or leaky expression 
of GES, respectively. 
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Figure 5.15: PCR results of Synechocystis transformed with full and deleted GES. 
(A) Results show the absence of positive Synechocystis transformants for GES under the nrsB 
promoter. -C: pLAH.nrsB without the GES gene (~ 1 kb). +C: pLAH.nrsB.GES plasmid (~ 2.6 kb). 
Many non-specific bands appear on the gel. (B) PCR analysis of the same five transformants and 
controls shown in (A) using an internal GES primer, (C) PCR results showing the isolation of 
Synechocystis strains with the deleted GES gene incorporated in the psbA2 locus. Expected 
band size ~ 1.2 kb. 
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Figure 5.16: Synechocystis transformed with a partially-deleted version of GES. 
BG11 plates supplemented with km (200µg/ml) show the successful isolation of 1000’s of 
transformants recovered from transforming wild type Synechocystis with pLAH.A2.GES.D. 
5.3.3 Toxicity tests of five selected terpenes on Synechocystis   
Based on the engine tests conducted by Paul Hellier, geraniol, although an 
attractive high-value product to produce, was considered not suitable as either a 
diesel or gasoline replacement fuel. On the other hand, the best candidates as 
diesel fuels were identified to be geranial and farnesene and the best candidates 
as gasoline fuels were shown to be citronellene and linalool (Hellier et al., 2013). 
After exploring the feasibility of metabolically engineering Synechocystis for 
production of these selected terpenes (Figure 5.1) they were selected for further 
investigation.  
This section describes the toxicity tests that were performed on Synechocystis 
using the five selected terpenes. 
5.3.3.1 Testing for growth of Synechocystis in the presence of five selected 
terpenes 
The toxicity test of the five selected terpenes was set up according to methods 
described in section 2.7.1. The toxic effect of the tested terpenes can be 
estimated visually as shown in Figure 5.17. Geraniol and geranial were both 
extremely toxic and no growth was observed even at the lowest concentration 
(0.02% v/v). Linalool was less toxic at lower concentrations with the concentration 
of cells in the flask containing 0.02% linalool close to that of the control (2 x107 
cell/ml and 3 x107 cell/ml, respectively). Cultures containing farnesene showed an 
interesting behaviour where the growing cells started to clump together after 16 
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hours with more clumping observed at higher concentrations (Figure 5.17.C), and 
by the fourth day the cultures were dead. Citronellene was the only test 
compound that did not seem to inhibit the growth of Synechocystis. Cultures grew 
well even in the presence of the highest concentration of citronellene (1% v/v). 
The absence of growth of Synechocystis in the flasks was confirmed by an 
absence of colonies after plating 200 µl of the cultures on solid medium. The 
viability of the starter culture was confirmed by observed growth in the control 
flasks.  
It can be concluded from the toxicity test that none of the five tested terpenes 
have the potential to be expressed constitutively (except for small amounts of 
linalool) in Synechocystis due to their inhibitory effect. Citronellene, although 
showing no observed inhibitory effect on Synechocystis, cannot be produced 
naturally (Figure 5.1) leaving the idea of constitutive expression of the selected 
terpenes very challenging. 
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Figure 5.17: Testing for Synechocystis growth in the presence of five selected terpenes. 
(a) Flasks containing inoculums of Synechocystis spiked with increasing amounts of selected terpenes. (b) Growth of Synechocystis in the presence of 
increasing amounts of five selected terpenes four days post co-inoculation. (c) Clumping of Synechocystis cells 16 hours post co-inoculation with higher 
concentrations of farnesene. 
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5.3.3.2 Testing levels of tolerance of established cultures of Synechocystis 
to added terpenes 
The tolerance of pre-established liquid cultures of Synechocystis to geraniol, 
geranial, linalool, farnesene and citronellene was investigated by monitoring 
whether addition of the test compound inhibited further growth and led to 
bleaching of the culture.  
As shown in Figure 5.18, geraniol and geranial had the most toxic effects on 
Synechocystis even after 24 hours of addition as shown by the almost complete 
loss of pigmentation even at a concentration of the 0.02 % (v/v). Linalool was less 
toxic than geraniol and geranial at lower concentrations while the cyanobacterium 
was able to tolerate the highest concentration (1 %) of both farnesene and 
citronellene, suggesting that controlled biosynthesis of these two compounds in 
genetically engineered strains should not prove toxic, at least at this 
concentration. 
 
 
Figure 5.18: The tolerance of Synechocystis to increasing amounts of terpenes (24 
hours). 
 
Figure 5.19 shows the same experiment after four days. It is clear that the 
cultures are unable to recover from the addition of geraniol or geranial, even at 
the lowest concentration. The death of the cells was confirmed by plating aliquots 
from the 0.02 % geraniol flask onto solid medium, and observing that no colonies 
appeared following incubation. Whilst reduced growth is observed for 0.02 % 
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linolool and farnesene, higher concentrations appear toxic despite the promising 
observation for farnesene at 24 hours (Figure 5.18). The least toxic compound is 
citronellene and healthy growth of Synechocystis is seen even after four days 
exposure to the highest concentration (1%). 
 
 
Figure 5.19: The tolerance of Synechocystis to increasing amounts of teperens 
(four days post addition).  
 
5.3.3.3 Effect of a two-phase culture system on tolerance levels 
In this experiment the effect of using a two-phase culture system on tolerance 
levels of Synechocystis to terpenes was examined. Figure 5.20 demonstrates the 
effect of adding n-dodecane to the culture medium, and compares cultures of 
Synechocystis inoculated with 0 %, 0.02 %, 0.04 %, 0.08 %, 0.1 %, 0.2 % and 1 
% v/v farnesene (i.e. the most promising terpene) grown in the presence and 
absence of n-dodecane. The flasks containing n-dodecane showed a marked 
improvement in survival after four days of co-inoculation as seen in Figure 
5.20.A, even at farnesene concentrations of 1 %. Figure 5.20.B shows viable 
cells from cultures grown in the presence of 1% farnesene supplemented with 5 
ml of n-dodecane. It can be concluded that adding this non-toxic organic solvent 
to the culture medium helps improve the survival of cells by forming a two phase 
system. Consequently, it might be possible to “milk” the toxic farnesene from 
engineered cells even at concentration up to 1% v/v farnesene.  
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Figure 5.20: Effect of adding n-dodecane on survival of Synechocystis in the 
presence of increasing amounts of farnesene. 
(A) Growth of Synechocystis in the presence of increasing amounts of farnesene, and in the 
presence or absence of n-dodecane overlaying the culture medium. (B) 200 µl from the culture 
inoculated with 1.0% farnesene in the presence of n-dodecane plated to check viability of cells on 
the fourth day. 
 
The effect of n-dodecane on improved survival rates of Synechocystis was 
previously examined for low concentration of geraniol (Figure 5.10). However, the 
effect of n-dodecane with higher concentration of geraniol was not tested. 
Therefore, another experiment was set up to investigate the more toxic terpenes 
namely geraniol, geranial and linalool. In this set up the lowest tested 
concentration (0.02% v/v test compound) and the highest tested concentration 
(1.0% v/v test compound) were used in the investigation. The cultures were 
grown in the presence and absence of n-dodecane for four days. Figure 5.21 
shows that n-dodecane helped improve the survival of cultures at the lower 
concentration of each test compound (Similar results obtained in Figure 5.10) 
while it did not show any marked improvement in cultures inoculated with the 
higher concentration of the test compound. Using n-dodecane as a two-phase 
system to improve tolerance of Synechocystis to extremely toxic terpenes to 
Synechocystis (geraniol, geranial and linalool) might not be practical and 
alternative strategies may need to be adopted to overcome the toxicity issue for 
higher concentrations of these highly toxic compounds.  
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Figure 5.21: Effect of n-dodecane on Synechocystis survival in the presence of 
highly toxic terpenes. 
(a) Low (0.02% v/v) and high (1.0% v/v) concentrations of geraniol, (b) low (0.02% v/v) and high 
(1.0% v/v) concentrations of geranial and (c) low (0.02% v/v) and high (1.0% v/v) concentrations 
of linalool. In each case, cultures were grown in the presence and absence of n-dodecane where 
the presence of n-dodecane helped improve tolerance of only low levels of each tested 
compound.  
5.3.4 Expression of a α-farnesene synthase gene in Synechocystis 
This section describes the synthesis of a synthetic α–farnesene synthase gene 
and its heterologous expression in Synechocystis. It also details attempts to 
improve expression of the synthase under both the psbA2 and nrsB promoters. It 
describes GC-MS methods used for detection of farnesene and finally, discusses 
interesting phenotypic observations of the α-farnesene synthase expressing 
strains.  
5.3.4.1 Synthesis of codon-optimised gene for α–farnesene synthase 
In order to obtain high and stable expression rates of α–farnesene synthase in 
Synechocystis, a synthetic, codon optimised, version of the gene was 
commercially synthesised by GeneArt [10].  The synthesis was based on the 
mature protein of α–farnesene synthase from Pyrus communis (GenBank: 
AY566286.1) and the codon usage was adapted to the codon bias of 
Synechocystis sp. PCC 6803 genes. The codon optimised gene sequence and its 
corresponding protein sequence can be found in Appendix 11.  
                                            
 
10 www.geneart.com 
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5.3.4.2 Construction of plasmids for transformation of Synechocystis with 
the α-farnesene synthase gene   
For western blot detection purposes an HA-tag sequence was added to the 3’ 
end of the codon optimised α–farnesene synthase (FS) gene. The addition was 
done by PCR amplifying the α–farnesene synthase gene from the construct 
provided from GeneArt using a reverse primer with an attached HA-tag 
sequence. The primers also included a unique NdeI restriction site at the 5’ end 
of the gene that served as the start codon for translation and a unique BamHI 
restriction site designed immediately downstream of the HA-tag sequence and 
stop codon. These engineered sites were used for cloning in the corresponding 
restriction sites of the pLAH.A2 and pLAH.nrsB expression vectors. Details of the 
primers can be found in Appendix 3.  
The PCR product was digested with NdeI and BamHI restriction enzymes and 
cloned into the vectors to create pLAH.A2.FS and pLAH.nrsB.FS. The correct 
insertion of the α–farnesene synthase gene in the two plasmids was confirmed by 
digestion using NdeI. Empty pLAH.A2 and pLAH.nrsB (lacking the FS gene) were 
used as negative controls. A band shift of ~1.7 kb from the negative controls 
confirmed the insertion of the FS gene in both vectors as seen in Figure 5.22. To 
check for mutations, a representative of each recombinant plasmid was sent for 
sequencing and results showed that the pLAH.A2.FS carried a synthase that was 
a 100% match to the codon optimised sequence of the α–farnesene synthase 
gene (42 bases were not sequenced due to bad signal) while the pLAH.nrsB.FS 
showed a 99.9% similarity due to the presence of two nucleotide mismatches. 
However the two mutations were silent and did not result in changes in the amino 
acid sequence of the synthase (Appendix 17). 
 
 
Figure 5.22: Test digest confirming insertion of FS into pLAH.A2 and pLAH.nrsB 
expression vectors. 
Negative controls -C and –C* represent the empty pLAH.A2 (~ 4.4 kb) and the empty pLAH.nrsB (~ 5.3 kb) 
expression vectors respectively. Correct recombinant plasmids indicated in red rectangles.   
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5.3.4.3 Transformation of Synechocystis  
The resulting FS plasmids from section 5.3.4.2 were used for transformation into 
WT Synechocystis, as detailed in section 2.4.2. Transformants were selected on 
medium supplemented with kanamycin (200 µg/ml). Individual colonies were 
picked and re-streaked on fresh selective medium and taken through three 
rounds of selection. 
As before, genomic DNA was isolated from eight colonies and analysed by PCR 
using primers designed to check for correct integration of the FS gene constructs 
into the psbA2. Results from the PCR analysis are shown in Figure 5.23 and 
confirm the isolation of strains with the α–farnesene synthase gene under the 
control of the psbA2 and nrsB promoters (hereafter, Synechocystis strains 
6803.pLAH.A2.FS and 6803.pLAH.nrsB.FS, respectively). Primers used in this 
PCR gave a product size of ~2.7 kb for positive transformants containing the 
gene under the nrsB promoter and a PCR product size of ~1.9 kb for those 
containing the gene under the psbA2 promoter. Primers used can be found in 
Appendix 3.  
 
 
Figure 5.23: Synechocystis transformants obtained using FS in pLAH.A2.FS and 
pLAH.nrsB.FS plasmids.  
PCR results confirm the isolation of transformants expressing the α-farnesene synthase gene 
under the psbA2 and the nrsB promoters. The negative controls -C and –C* represent the empty 
pLAH.nrsB (~1.0 kb) and the empty pLAH.A2 (~0.25 kb) vectors, respectively. All screened 
transformants were positive for the FS gene. 
5.3.4.4 Western blot analysis of Synechocystis transformants  
Western blot analysis was used to confirm the constitutive and induced 
expression of the α–farnesene synthase gene from the transformants obtained in 
section 5.3.4.3. 
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Cultures of the 6803.pLAH.A2.FS strain and the 6803.pLAH.nrsB.FS strain were 
grown to mid log phase. Strains transformed with empty pLAH.A2 and pLAH.nrsB 
expression vectors were used as negative controls to rule out any non-specific 
bands that may appear at the expected protein size of 66 kDa. The 
6803.pLAH.nrsB.FS and 6803.pLAH.nrsB control strain were then induced with 
6.4 µM of NiCl2.6H2O for 4.5 hours, after which both cultures were harvested for 
protein analysis as described in section 2.6. The western blot was set up and the 
protein detected by ECL using anti-HA antibodies as detailed in section 2.6.3 and 
2.6.4 respectively.  
Results shown in Figure 5.24 clearly show the presence of the recombinant α-
farnesene synthase protein in the Synechocystis transformants. The protein was 
produced under both constitutive and inducible promoter systems where the 
constitutive expression is evident in Figure 5.24.A indicated by the presence of 
band at ~66 kDa, and induced synthesis of α-farnesene synthase observed in 
Figure 5.24.B. In this figure, bands corresponding to α-farnesene synthase were 
only seen under induced culture conditions and no expression was observed in 
any of the negative controls confirming the tightly controlled expression of the 
gene under the nrsB promoter.  
 
 
Figure 5.24: Western blot analysis confirms expression of the α-farnesene 
synthase gene in Synechocystis transgenic lines.  
(A) Constitutive expression of the gene for α-farnesene synthase (FS) (~ 66 kDa) under the 
psbA2 promoter (5 min exposure to X-ray film). (B) Expression under Ni+ induced conditions (15 
min exposure). * WT transformed with an empty pLAH.A2, **WT transformed with an empty 
pLAH.nrsB. The + and – signs correspond to induced and un-induced cultures, respectively. 
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5.3.5 Optimising α-farnesene synthase expression  
5.3.5.1 α-Farnesene synthase expression under the psbA2 promoter 
To test the efficiency of the psbA2 promoter on the expression of the FS gene, 
experiments were conducted where cultures of Synechocystis transformants 
were subjected to growth under different light conditions since the psbA2 
promoter is known to be light induced and regulated (Lindberg et al., 2010). To 
test expression under low and high light, two independent transformants 
expressing the FS gene under the psbA2 promoter were selected for analysis. 
Each of the transformants was grown under two light conditions, a low light 
intensity of 20 µmol/m2/s and a high light intensity of 200 µmol/m2/s. The cultures 
were grown at 25oC to an OD750 = 0.8-1.0 before being harvested for western blot 
analysis using anti-HA primary antibodies. Details of antibody concentrations and 
ECL detection methods can be found in Table 2.3. 
Figure 5.25 appears to show that accumulation of α-farnesene synthase (~66 
kDa) in cultures grown under high light intensities is higher as compared to the 
same cultures grown under lower light intensities, indicated by a more intense 
band. Although these results requires further study to confirm the observation, 
the finding is in agreement with work done by (Mohamed and Jansson, 1989, 
Lindberg et al., 2010) who showed that high light intensities enhance expression 
of the psbA2 gene.  
 
 Figure 5.25: Light regulated expression of α-farnesene synthase.  
Western blot results showing accumulation of α-farnesene synthase (~ 66 kDa) in Synechocystis 
cultures grown under low light (20 µmol/m2/s) and high light (200 µmol/m2/s). No protein is 
detected with the negative controls. FS: α-farnesene synthase, +C: FS expressing strain, -C: WT 
6803 transformed with an empty pLAH.A2 vector. 
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Work done on optimising the expression of a isoprene synthase (IPS) gene in 
Synechosystis under the psbA2 promoter showed that the levels of IPS was 
induced as a function of time under high light, with levels of protein increasing 
steadily between 0 and 6 hours of post high light incubation (Lindberg, Park et al. 
2010). Therefore, the same experiment was performed to investigation the levels 
of α-farnesene synthase in cultures grown firstly under low light followed by a 
shift to high light conditions. 
For this study, T1 from Figure 5.25 was selected for the analysis with a culture 
grown under low light intensities (20 µmol/m2/s) to an OD750 of ~0.7 before 
shifting it to high light conditions (200 µmol/m2/s).  Samples were harvested 
between t= 0 to t= 6 h after the shift. Figure 5.26 shows that α-farnesene 
synthase accumulated to a higher levels at t= 0.5h and t= 2h after shifting to high 
light. Longer incubations of the culture under high light condition appear to result 
in a reduced signal. Although these results are not consistent with that shown by 
Lindberg and colleague’s. (2010), they still demonstrate the ability of the psbA2 
promoter to regulate the expression of the heterologous expressed FS gene in 
response to shifting irradiance conditions.  
 
Figure 5.26: Effect of high light treatment on FS expression levels.  
Western blot showing higher levels of α-farnesene synthase with cultures initially grown in low 
light (20 µmol/m2/s) to the mid log phase then shifted to high light (200 µmol/m2/s) for 0.5 or 2 
hours. 
5.3.5.2 α-Farnesene synthase expression under the nrsB promoter 
Figure 5.24.B showed the induced expression of the α-farnesene synthase gene 
in cultures exposed to 6.4µM of Ni2+ for 4.5 hours. The inducer was added in the 
cultures at OD750 ~ 0.7. The concentration of the inducer and the duration of 
induction were selected based on published work (García-Domínguez et al., 
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2000, López-Maury et al., 2002, Liu and Curtiss, 2009) and were used as 
reference points for work in this section. However, in order to achieve higher 
levels of induced FS in Synechocystis, it was essential to study different 
parameters that may affect the expression level. This section describes 
experiments where the effect of Ni2+ concentration; induction duration and stage 
of growth at time of induction are evaluated.  
Effect of Ni2+ concentration: To study the effect of Ni2+ a transformant 
expressing α-farnesene synthase gene under the nrsB promoter was grown to an 
OD750 of ~0.7. The culture was split into six flasks and NiCl2.6H2O added to a 
final concentration of 0 µM (control), 0.8 µM, 1.6 µM, 3.2 µM, 6.4 µM and 12.8 
µM, respectively. The cultures were induced for 4.5 hours before being harvested 
for western blot analysis as before. 
Work done to evaluate the effect of Ni2+ concentration on the accumulation of the 
nrs mRNA in Synechocystis showed that the level of expression increased with 
increased Ni2+ concentration (García-Domínguez et al., 2000). The study showed 
that the operon responsible for nrs expression was induced at Ni2+ concentration 
above 0.45 µM and showed a steady increase in expression with higher 
concentrations of Ni2+ up to a maximum of 17 µM. It was therefore expected that 
higher concentration of the α-farnesene synthase protein would be obtained with 
increased Ni2+ concentration. However, Figure 5.27 shows no obvious trend in 
FS levels when induced with 0.8, 1.6, 3.2, and 6.4 µM, while cultures induced 
with 12.8 µM appear to show reduced levels possibility as a consequence of less 
loading indicated by a weaker loading control. As before, no FS was observed in 
the negative control (un-induced culture) confirming the tightly controlled 
expression of the synthase under the nrsB promoter. 
It is well established that essential transition metals such as Ni2+ are toxic to cells 
at above critical concentrations. However, concentrations of 17 µM of NiSO4 have 
not been shown to be toxic to Synechocystis cultures (García-Domínguez et al., 
2000) and therefore in this case, it cannot be concluded that the reduced 
expression was due to a Ni2+ toxicity effect. The loading control suggests that the 
faint band may have been due to unequal loading of the sample or unequal 
distribution of the antibody in the membrane. However, the same samples were 
re-loaded on a new gel and similar results were obtained. Further studies with 
additional controls are required to establish whether >12.8 µM Ni2+ does indeed 
impact on FS levels. 
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Figure 5.27: Levels of α-farnesene synthase at different concentrations of the 
inducer. 
Similar levels are seen with concentrations of 0.8 µM, 1.6 µM, 3.2 µM and 6.4 µM of the inducer. 
No FS is seen in the negative control and a very faint band in cultures induced with 12.8 µM of 
NiCl2.6H2O. Negative control (-C); WT 6803 transformed with the pLAH.nrsB expression vector. 
 
Effect of induction duration: In order to study the effect of induction duration on 
the levels of α-farnesene synthase, the same strain used for the Ni2+ 
concentration dependent experiment was grown to an OD750 ~ 0.8. The culture 
was split into eight flasks and 6.4 µM of the inducer was added to each flask with 
the exception of the negative control that was left un-induced.  The cultures were 
induced for 0, 1.5, 3, 4.5, 6, 7.5, 9 and 24 hours respectively before being 
harvested for western blot analysis using the anti-HA antibodies. 
Figure 5.28 shows that cultures induced for 7.5 hours resulted in maximum levels 
of α-farnesene synthase followed by the culture induced for 9 hours while no 
band was observed in cultures induced for 24 hours. The absence of a band in 
the 24 hour induced culture may suggest that prolonged exposure to the inducer 
may show detrimental effects on the expression of α-farnesene synthase in 
Synechocystis. The level of α-farnesene synthase for 4.5 hours appears lower 
than previous results (Figure 5.24.B) where higher expression levels were 
observed with the same strain induced under the same conditions. This may be 
due to the physiological state of the strain at the time of the experiment. 
Nevertheless, it is evident in this study that cultures induced for ~7.5 hours 
resulted in the highest levels of α-farnesene synthase under the described 
conditions. 
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Figure 5.28: Effect of induction duration on the levels of α-farnesene synthase. 
Levels of α-farnesene synthase after induction with 6.4 µM NiSO
4.
6H
2
O for different durations 
(time expressed in hours). Cultures induced for 7.5 hours showed highest expression while the 
signal disappeared after 24 hours of induction. -C: un-induced culture harboring the FS gene. 
 
Effect of growth stage: Finally, the effect of growth stage at the time of induction 
on FS levels was investigated. In this experiment, a 150 ml culture was grown to 
an early log phase of OD750 0.3 after which, 25 ml of the culture was harvested 
and treated as the negative control (un-induced). The remaining 125 ml culture 
was split into five flaks and inducer (NiCl2.6H2O) added to a final concentration of 
6.4 µM when cultures reached OD750 0.3, 0.5, 0.7, 0.9 and 1.2, respectively. 
Each culture was induced for 4.5 hours before being harvested for western blot 
analysis. 
For this particular experiment, FS was detected using the Odyssey®infrared 
imagining system using Anti HA primary antibodies and Odyssey anti rabbit IgG 
Dylight800 conjugated secondary antibodies, each incubated with the membrane 
for two hours. 
Figure 5.29.A shows the successful synthesis of FS at different growth stages 
including the early log phase (OD750 ~0.3 – ~0.5), mid log phase (OD750 ~0.7), 
late log phase (OD750 ~0.9) and stationary phase (OD750 ~1.2). In this 
experiment, the Odyssey system was used to measure band intensity in order to 
compare FS levels at different growth stages. (Figure 5.29.B) shows that the 
highest level was obtained with cultures induced at an OD750 ~ 0.5 (band intensity 
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0.11) while a similar value were obtained when cultures were induced at OD750 ~ 
0.9 and OD750 ~ 1.2 with band intensities of 0.08 and 0.07 respectively. The 
lowest levels were obtained when cultures were induced at OD750 ~ 0.3 and 
OD750 ~ 0.7 (both with a band intensity of 0.03). The low level at OD750 ~ 0.7 
when detected by Odyssey is contrary to what was obtained in previous 
experiments where ECL was used to detect FS from the same strain, induced 
under the same conditions of inducer concentration, inducer duration and growth 
stage at time of induction (Figure 5.29.C). This might be due to using the ECL for 
detection as the time of exposure can be adjusted to achieve desirable band 
intensities. It is worth mentioning that in nrsB characterization studies (Garcia-
Dominguez, Lopez-Maury et al. 2000, López-Maury, García-Domínguez et al. 
2002) the inducer was always added when Synechosystis cells reached the mid 
log phase. To the best of my knowledge, no studies on the effect of growth stage 
at time of induction on expression levels of the protein has been reported.  
 
Figure 5.29: Levels of α-farnesene synthase in cultures induced at different OD750.  
(A) Induction of cultures at different growth stages. The level of α-farnesene synthase is highest in 
the culture induced at an OD750 of ~0.5. (B) Band intensity measurements of the α-farnesene 
synthase. (C) Previous western showing higher levels at OD750 = 0.7.  
5.3.6 Farnesene production assays  
The next step after the successful expression of the FS gene in Synechocystis, 
under the control of both the psbA2 and nrsB promoters, and optimization of 
protein levels, was to test cell extracts for active farnesene production. 
Supernatant and cell extracts obtained from FS expressing strains under both the 
psbA2 and nrsB promoters were prepared according to methods detailed in 
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sections 2.8.1 and section 2.8.2, while samples from the two-phase culture 
system were harvested according to methods described in section 2.8.3. All the 
above samples were analysed on a gas chromatography-mass spectrometry 
(GC-MS) machine according to methods described in section 2.8.4.   
5.3.6.1 GC-MS analysis of samples extracted with different solvents  
In this section, cell lysates from FS strains that had been extracted using hexane, 
methanol and ethyl acetate were analysed by GC-MS along with standards 
represented by hexane spiked with commercially-available farnesene at different 
concentrations.  
The successful detection of the farnesene standard in the three standards (1 
ppm, 50 ppm and 100 ppm, respectively) can be seen in Figure 5.30, where a 
clear peak corresponding to farnesene was obtained at a retention time of 13.95 
minutes. Using the selected ion recording (SIR) scanning mode for detection 
increased the sensitivity of the results through the determination of particular 
masses present only in farnesene (see section 2.8.4). The standards were used 
to produce a calibration curve for the quantification of farnesene in the samples 
extracted from Synechocystis. Positive and negative controls, represented by a 
standard with 1 ppm farnesene in hexane and a methanol extract from un-
induced cultures respectively, were included in the analysis. The negative control 
was included to test the possibility of a false positive (samples contaminated with 
farnesene) while the positive control was added as a reference for the 
identification of retention time. Results obtained in Figure 5.31 show that no 
farnesene could be detected in any of the cell extracts, whether extracted using 
hexane, methanol or ethyl acetate, while the positive control showed a clear peak 
at the expected retention time. The absence of farnesene in the samples can be 
attributed to many possible reasons. Firstly, farnesene might have been 
produced in very small amounts that were below the detection limit of the GC-
MS. Secondly, the biomass used might have not been sufficient to extract 
detectable amounts of farnesene. Thirdly, the extraction method used (glass 
beads and solvent extraction) might have not been sufficient to extract small 
amounts of the product. Furthermore, the amount of the precursors (IPP) and 
(DMAPP) or the amount of the direct precursor for α-farnesene (FPP) (Figure 
5.1) might not have been adequate for the sesquiterpene production. Finally, it is 
 217 
 
possible that the recombinant α-farnesene synthase was not active. The following 
sections investigate the first three possibilities.  
GC-MS detection limit: In order to determine the GC-MS detection limit for 
farnesene, standards of 0.5 ppm 0.25 ppm and 0.125 ppm farnesene in methanol 
were prepared and run on the GC-MS using the same methods described in 
section 2.8.4. Figure 5.32 shows the detection of farnesene even in the lowest 
standard of ~0.1 ppm (100 ppb) confirming that the GC-MS method used was 
capable of detecting trace amounts of farnesene.  
Effect of amount of biomass used: an attempt was made to evaluate the effect 
of increasing the biomass and concentrating the cultures used for farnesene 
detection. In this method, the culture size of α-farnesene synthase expressing 
strain and a negative control (WT Synechocystis transformed with empty 
pLAH.nrsB vector) were increased to 500 ml (20 folds). The cultures were grown 
to an OD750 ~ 1.0 before being induced with 6.4 µM of NiCl2.6H2O for 4.5 hours. 
Pelleted cells from both cultures were analysed for farnesene production. For 
extraction, in order to concentrate the samples, only 2 ml methanol was added to 
the pellets along with 500 μl of acid washed glass beads and extraction was 
carried out as described in section 2.8.2 before being transferred to GC vials for 
analysis. Unfortunately, no farnesene was detected using this method suggesting 
that biomass was not a limiting factor in terms of farnesene detection at the 
conditions tested (Figure 5.33). 
Effect of the extraction method: to examine the efficiency of the extraction, 
which in this case involved vortexing with glass beads in the presence of a 
solvent, experiments were undertaken using different extraction methods. 
Sonication for 2 x 15 min in a sonication bath was used as an alternative to glass 
beads to extract the product using the same three solvents. However, no 
farnesene was detected in samples prepared with this method (data not shown) 
suggesting that the absence of farnesene in the samples tested was probably not 
due to the breakage method. 
A further investigation involved the use of different solvents in a “two-phase 
extraction method” to test extraction of farnesene from the supernatant. For this 
the non-toxic solvents (decane and n-dodecane) were used. The use of decane, 
as an extraction solvent has been previously reported (Yoon et al., 2008). This 
experiment is described in detail in the following section. 
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Figure 5.30: Standards of farnesene in hexane at concentrations of 1 ppm, 50 ppm, and 100 ppm.   
Peaks corresponding to farnesene obtained at a retention time of ~ 13.95 min. 
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Figure 5.31: GC-MS results for samples containing FS extracted in three different solvents. 
GC-MS results showed no detection of farnesene (RT=13.95 min) in pellet extraction with any of the three solvents. The negative control was a methanol pellet 
extraction from un-induced cultures. The positive control was a standard of farnesene in hexane (1 ppm). 
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Figure 5.32: GC-MS results for standards of farnesene in methanol 
Farnesene detected in methanol cell extracts of 1 ppm (A), 0.5 ppm (B), 0.25 ppm (C) and 0.1 ppm (D).GC-MS can detect farnesene in the lowest prepared standard 
of ~ 0.1 ppm.  
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Figure 5.33: Testing the presene of farnesene in samples with increased biomass.  
(A) Negative control showing no farnesene. (B) α-farnesene synthase strain with increased biomass showing lack of farnesene in the culture analysed (C)  A standard 
of farnesene in methanol showing farnesene at RT=13.95 (positive control). 
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5.3.6.2 GC-MS analysis of sample extracts form two-phase extraction 
system using decane and n-dodecane  
In this section, GC-MS results for samples and controls prepared using the two-
phase extraction method described in section 2.8.3 are presented. Standards of 
farnesene in decane or n-dodecane were also analysed.   
Two-phase extraction system using decane 
Decane was used as a solvent for product extraction and results in Figure 5.34 
shows the successful detection of farnesene in standards prepared in decane at 
concentrations of 1 ppm, 50 ppm and 100 ppm respectively where all three 
standards showed a clear peak at a retention time of ~13.95, which is similar to 
that obtained for farnesene in hexane (Figure 5.30). The supernatant and cell 
extracts from the negative controls showed no peak at RT~13.95 (Figure 5.35) 
while GC-MS results for samples spiked with 0.02% and 0.2% (v/v) farnesene 
showed a peak at the expected retention time in both the supernatant and cell 
extracts. The sample spiked with 0.02% v/v farnesene shown in Figure 5.36 was 
used as a representative for the results. The detection of farnesene in 
supernatant extracts of spiked samples confirms the reliability of the extraction 
method. The fact that farnesene was also detected in the pellet extract of cells 
gives us an insight on the nature of the interaction between farnesene and 
Synechocystis cells. The exogenously added farnesene in the culture medium 
probably adheres to the surface of the cells thus resulting in a signal for 
farnesene on the GC-MS. However, GC-MS results of endogenous α-farnesene 
synthase from the transgenic strains showed no farnesene in either the 
supernatant or cell extracts. This can be seen in Figure 5.37. 
Similar results for standards, controls and samples prepared with n-dodecane 
were obtained and GC-MS results can be referred to in Appendix 12 (A, B & C 
respectively). 
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Figure 5.34: GC-MS results of standards of farnesene in decane. 
Peaks corresponding to farnesene (RT=13.93) appear in standards of farnesene prepared in decane at concentrations of 1 ppm, 50 ppm, and 100 ppm respectively.  
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Figure 5.35: GC-MS results of negative controls prepared in decane. 
No farnesene (RT~ 13.95) in the negative control samples extracted in decane in both supernatant and pellet fractions. Negative controls are WT 6803 transformed 
with an empty pLAH.A2 vector. 
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Figure 5.36: GC-MS results of samples spiked with farnesene and extracted in decane.  
Farnesene detected by GC-MS from samples spiked with 0.02% farnesene using decane extraction of both supernatant and pellet extracts. The retention time was ~ 
13.91 min.  
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Figure 5.37: GC-MS results of decane supernatant and cell extracts of Synechocystis strains. 
GC-MS results are of the decane supernatant and cell extracts of Synechocystis strains 1 and 2. These represent Synechocystis strains expressing the α-farnesene 
synthase gene under the psbA2 and nrsB promoter, respectively. No peak corresponding to α-farnesene is observed at RT~ 13.95 min for any of the samples. The 
positive control is a 1 ppm standard of farnesene in decane showing a clear peak at the expected retention time.
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5.3.7 Growth analysis & phenotype observation  
Despite the inability to detect α-farnesene by GC-MS in strains that were shown 
to express the α-farnesene synthase gene under the psbA2 and nrsB promoters, 
further analysis was conducted. In this section, results from growth analysis and 
phenotype observation are reported for the strain expressing the gene under the 
inducible promoter. A twin compartment photobioreactor (the Algem 1.0 
(Algenuity, UK)) was used for cultivation and growth curve construction as 
described in section 2.9.  
The Algem monitors cell growth based on absorption at a wavelength of 525 nm. 
Initially, the absorbance of the log phase of the strain was determined under un-
induced conditions until it reached stationary phase (OD525 ~2.1). The log phase 
of the strain at an OD525 was determined to be between ~0.6–1.6 (Figure 5.38). 
 
Figure 5.38: Determining the log phase of α-farnesene synthase expressing strain 
at OD525.  
After determining the log phase of the strain of interest, the α-farnesene synthase 
strain along with a negative control (wild type Synechocystis transformed with 
pLAH.nrsB) were grown from similar OD525 starter cultures. The two strains were 
grown to the early log phase (OD525 ~ 0.55) before being induced with 6.4 µM of 
NiCl2.6H2O. The strains were allowed to grow to the stationary phase under 
conditions described in section 2.9.  
The growth of the two strains were analysed both before and after Ni2+ induction 
to determine whether there was a significant difference in the growth pattern 
between the two strains post induction (i.e. after expressing the FS gene). Figure 
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5.39.A shows similar growth patterns of the two strains before nickel induction 
indicated by the steady increase in growth over 48 hours. Figure 5.39.B on the 
other hand, which shows the growth pattern of the same strains over 11 days 
post nickel induction, shows a retarded growth of the FS strain as compared to 
the negative control. Furthermore, the liquid culture of the FS strain appeared 
less healthy as compared to the negative control with the pigmentation less green 
as seen in Figure 5.39.C. The fact that the FS strain showed both a reduced 
growth pattern and an un-healthy appearance post nickel induction suggests that 
the synthesis of the α-farnesene synthase is indeed active and imposes a 
metabolic burden on the cell. To confirm the results obtained and to allow more 
time for growth pre-nickel induction, the experiment was repeated where the 
cultures were grown under un-induced conditions for three days. Figure 5.40.A 
shows the FS strain (green) out growing the negative control (red). Clearly, both 
strains showed marked growth within the three days of culturing prior to 
induction. After establishing a healthy growth for both strains, the inducer was 
added to both cultures when they reached an OD525 of ~ 0.9. An interesting 
phenomenon was observed two days post nickel induction where the FS strain 
showed a disturbed growth pattern and around day six the culture showed a 
sudden drop in the OD while the negative control continued to show a normal and 
healthy growth pattern (Figure 5.40.B).  
In terms of appearance between the two strains, Figure 5.40.C shows the FS 
strain had a yellowish appearance indicating an un-healthy culture post Ni2+ 
induction while the negative control appears healthy (blue-green). The fact that 
the negative control maintains a healthy culture color confirms that the nickel at 
concentration used for induction (6.4 µM) has no detrimental effect on the cells 
and that the yellowish culture color of the FS strain is in fact a consequence of 
the expression of the α-farnesene synthase gene.  
The reproducibility of the results showing the difference in growth and 
appearance between the FS strain and the negative control post Ni2+ induction is 
a clear indication that the expression of the FS gene in the cell is adding a 
metabolic burden to the cell leading to deteriorating growth that ultimately leads 
to death of the culture. It has been reported that introducing transgenes that 
provide exogenous functions often result in the reduction of the overall fitness 
and robustness of the recombinant cell compared to native cells, and this might 
 229 
be a consequence of intracellular depletion of essential precursors (Zhang and 
Lynd, 2005, Den Haan et al., 2007). 
 
Figure 5.39: Growth of FS expressing strain and negative control pre and post 
nickel induction. 
(A) The growth curve shows similar growth rates for both the α-farnesene synthase strain and the 
negative control pre-nickel induction, but (B) The strain grows at a slower rate as compared to the 
negative control post nickel induction. (C) α-Farnesene synthase strain clearly grows less well as 
compared to the negative control post nickel induction. * WT 6803 transformed with pLAH.nrsB. 
 
 230 
 
Figure 5.40: Growth of FS expressing strain versus negative control pre and post 
Ni2+ induction.  
(A) Growth pattern shows the FS strain (green) out growing the negative control (red). (B) The FS 
strain showed a sharp and sudden drop about three days post induction while the negative 
control continues to grow. (C) FS strain looks unhealthy (yellowish) as compared to the negative 
control (green) post nickel induction.* WT 6803 transformed with an empty pLAH.nrsB.   
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5.4 Conclusion and future work  
Two expression vectors have been successfully developed that allow for the 
expression of foreign genes in Synechocystis under the control of a constitutive 
(psbA2), and an inducible promoter (nrsB). Following this success, the pLAH.A2 
and the pLAH.nrsB expression vectors have been used by fellow researchers 
within the group who were able to produce significant quantities of foreign 
proteins such as limonene synthase (an enzyme for limonene production, a 
potential biofuel), bacterial antimicrobial proteins, an operon of selectable 
markers, and human growth hormone (unpublished results). These vectors can 
be further utilised for the expression of a range of genes of interest in 
Synechocystis with a goal of developing Synechocystis as a generic 
photosynthetic platform for the controlled expression of a wide range of foreign 
proteins. 
The idea of creating an inducible expression vector was primarily to allow for the 
synthesis of the highly toxic monoterpene, geraniol. However, due to the highly 
toxic effect of geraniol on Synechocystis, we failed to generate transformant lines 
containing the GES gene, suggesting that even basal expression of GES under 
un-induced conditions is lethal; In order to achieve monoterpene production in 
microorganisms, it is important to solve this core issue (Brennan et al., 2012). 
This is because metabolically engineered organisms are forced to produce 
compounds that may lead to growth autoinhibition (Angermayr et al., 2009). It has 
been reported that concentration of 0.05% (v/v) geraniol was sufficient to inhibit 
cell growth of E. coli (Dunlop et al., 2011). Using the “two-phase culture system” 
to capture geraniol did help improve tolerance of Synechocystis cultures to small 
amounts of geraniol (0.02% v/v) while it failed to show improved tolerance with 
cultures grown in the presence of high concentrations of geraniol (1%). However, 
the toxicity tests conducted are based on the exogenous addition of geraniol into 
the culture medium while tolerance level may be considerably different when 
geraniol is produced within the cells. Furthermore, an alternative method to 
reduce monoterpenes toxicity could be by expressing an efflux pump to export 
the toxic compounds out of the cell upon production while using a two-phase 
culture system for continues harvesting. The potential of expressing a potential 
efflux pump in Synechocystis is the topic of chapter 6.  
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Farnesene is a potential fuel (Lee et al., 2008), that showed good engine 
performance when tested in a diesel engine together with promising results in 
toxicity tests on Synechocystis where it was the least toxic even at high 
concentrations (1%). Farnesene did eventually prove toxic to Synechocystis after 
four days of incubation, however using a two-phase culture system significantly 
reduced the toxic effects of high concentrations of farnesene. In terms of 
metabolic engineering work, the farnesene synthase gene was successfully 
expressed in Synechocystis under both constitutive and inducible conditions. 
Optimization experiments showed that improved levels of α-farnesene synthase 
expression can be achieved under the psbA2 promoter when cultures are initially 
grown under low light followed by a two hour exposure to high light intensities. On 
the other hand, attempts were made to maximize the induced accumulation of α-
farnesene synthase and results showed that an induction duration of ~7 hours 
induced at an D750 ~ 0.5 produced the best results while the inducer 
concentration did not seem to make much difference to the level of the enzyme. 
However, more experiments need to be done where the amount of the protein 
loaded is quantified and the concentration of protein produced is measured by 
estimation with a protein standard in order to make more accurate conclusions.  
Despite that GC-MS analysis was able to detect farnesene at concentrations as 
low as 0.1 ppm in the standards; no signal was detected in samples following any 
of the different extraction methods tested. Furthermore, the detection of 
farnesene in cultures spiked with farnesene was an indication of a successful 
extraction method. Nevertheless, a limitation of testing extraction using spiked 
samples relies in the fact that the compound is only extracted from the culture 
medium with no indication on the efficiency of extraction from within the cell. 
Testing the extraction of a native protein would provide a better control to test 
extraction of compounds from within the cell. 
A possible explanation for the lack of detectable farnesene could be due to the 
limited amount of substrate available for the enzyme. Such scenario has also 
been suggested by several researchers (Oswald et al., 2007, Glick, 1995, Goff 
and Goldberg, 1985) who suggested that terpene synthesis is limited by the 
availability of IPP and DMAPP substrates. Furthermore, Martin et al.  (2003), 
reported low levels of the terpene carvone in engineered E. coli strains was also 
attributed to the limited availability of IPP and DMAPP substrates. In order to test 
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this hypothesis, experiments would need to be undertaken where the IPP and 
DMAPP substrates and/or the direct precursors to farnesene such as FPP 
(Figure 5.1) are added exogenously into the induced culture followed by testing 
for farnesene production over time. Moreover, the fact that only the FS 
expressing strain showed a detrimental growth rate post nickel induction, 
compared to strains lacking the FS gene (Figure 5.40), is an indication of the 
functional expression of the α-farnesene synthase. However, this conclusion 
needs to be further verified by conducting an enzyme activity assay.  
High levels of farnesene exceeding 14 g/L have been achieved in engineered E. 
coli (Rude and Schirmer, 2009) by introducing the mevalonate pathway from 
yeast in the engineered strain, thereby providing a second route to IPP/DMAPP 
synthesis and increasing the pool of these precursors. If the activity of the 
recombinant α-farnesene synthase is confirmed, then introduction of the 
mevalonate pathway would be an attractive next step.  
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Chapter 6: The expression of AlkL in Synechocystis to 
facilitate substrate delivery and product removal of 
hydrocarbons 
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6.0 Introduction  
       Many efforts have recently been invested in finding replacements for fossil fuels 
utilizing photosynthetic organisms that use solar energy to convert carbon dioxide 
into “drop-in” compatible fuels in a single biological system (Atsumi et al., 2009, 
Dexter and Fu, 2009, Lindberg et al., 2010, Liu et al., 2011, Wang et al., 2013). 
As discussed in chapter 5, one of the main challenges in biofuel production is to 
reduce the overall cost of production of these fuels, a challenging task due to the 
high cost associated with fuel extraction from the biomass. It is estimated that up 
to 60% of the cost of algal-based biofuel production is in the extraction of the 
product from the cell (Molina Grima et al., 2003).  Significant research has been 
done in an effort to reduce the cost of biofuel production in modified 
microorganisms. For example, the expression of efflux pumps that enhance 
product recovery by actively exporting the product out of the cell (Dunlop et al., 
2011); using two phase extraction systems (Brennan et al., 2012, Hejazi et al., 
2004) and the creation of auto-lysing cells (Liu and Curtiss, 2009). In this chapter 
the goal was to examine whether the introduction of a bacterial transporter 
protein into the outer membrane of Synechocystis would facilitate diffusion of 
endogenously produced hydrocarbons (e.g. alkanes) out of the engineered strain 
and into the medium. 
The ‘bio-pump’ transporter discussed here (AlkL) builds on research conducted 
by Christopher Grant at UCL (Grant, 2012) and also published by (Julsing et al., 
2012). The AlkL transporter of Pseudomonas putida GPo1 (also known as 
Pseudomonas oleovorans GPo1) appears to be involved in the transport of 
alkanes (van Beilen et al., 2001, Hong et al., 2006, Hearn et al., 2009, van Beilen 
et al., 1992). When expressed in an E. coli strain engineered for alkane 
production AlkL was shown to enable over 120 fold improvement of uptake of 
C12-C16 alkanes (Grant, 2012). Further work by Grant and colleagues also 
showed that AlkL could lead to up to two fold higher yields of C13-C16 alkanes 
produced by an E. coli strain engineered to produce alkanes. Thus, AlkL appears 
to serve as a channel to facilitate both influx and efflux of hydrocarbons, 
depending on the concentration gradient across the membrane. Given that 
cyanobacteria have a similar Gram-negative arrangement of inner and outer 
membranes as E. coli and Pseudomonas (Hoiczyk and Hansel, 2000), then it 
should be possible to similarly introduce AlkL into Synechocystis to facilitate 
transfer of hydrocarbon products across the cell barrier.  
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In the present work attempts were made to express the alkL gene under different 
promoters in Synechocystis, which is known to naturally produce C17 alkanes 
(Schirmer et al., 2010), and examine whether the alkL gene product (i) could be 
functionally expressed and regulated in Synechocystis (ii) would play a similar 
role in the uptake and increase in intracellular levels of alkanes as that 
demonstrated by Christopher Grant in the engineered E. coli strain and (iii) show 
an improved hydrocarbon yield (iiii) examine its possible role in hydrocarbon 
extraction.  
GC analysis and data processing presented in this chapter were undertaken in 
collaboration with Dr Grant (Department of Biochemical Engineering, UCL).  
6.1 Literature review 
6.1.1. Alkanes  
Alkanes are saturated hydrocarbons with the general chemical formula CnH2n+2. 
They are found throughout nature as they are naturally produced by a diverse 
range of microorganisms (Schirmer et al., 2010, Hu et al., 2013). Typically, 
alkanes with carbon chain lengths of C4-C23 have high energy densities, are 
highly hydrophobic and are compatible with the existing liquid fuel infrastructure 
since they represent the major constituents of gasoline, diesel, and jet fuel 
(Schirmer et al., 2010, Peralta-Yahya et al., 2012). Alkanes can therefore be 
considered potential “drop-in” fuel replacements.  
Although the production of alkanes in many cyanobacteria have been reported 
since the 1960’s (Han et al., 1968), the majority of biochemical studies for alkane 
biosynthesis have focused on eukaryotic systems (Cheesbrough and 
Kolattukudy, 1984, Dennis and Kolattukudy, 1992). Recently however, Schirmer 
et al. (2010), identified the alkane biosynthesis pathway in cyanobacteria. The 
authors described the cyanobacterial genes and enzymes involved in the two-
step conversion of intermediates of fatty acid metabolism to the fatty aldehyde by 
a specific reductase, and then into alkanes and alkenes via a decarbonylation 
reaction (Figure 6.1). The authors also show how the heterologous expression of 
the two genes in an E. coli host strain (that does not naturally produce fatty 
aldehydes) led to the successful production of C13 to C17 alkanes and alkenes. 
The recent discovery of the alkanes biosynthesis pathway in cyanobacteria 
opened a new door for exploring fungible hydrocarbon fuel production from these 
photosynthetic organisms.  
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  Figure removed for copyright reasons 
 
 
Figure 6.1: Schematic overview of alkane (alkene), fatty acid and main competing 
metabolic pathways in Synechocystis. 
Key: enzyme genes are indicated in the pathways. 3-PGA, glyceraldehyde 3-phosphate; PYR, 
pyruvate; PHB, poly-β-hydroxybutyrate; acly-ACP, acyl-acyl carrier protein; ddh, 2-hydroxyacid 
dehydrogenase gene; phaA, polyhydroxyalkanoates-specific beta-ketothiolase gene; accBCDA, 
a muli-subunit acetyl-CoA carboxylase gene; lipA, lipolytic enzyme gene; aas, acyl-ACP 
synthetase gene; aar, acyl-ACP reductase gene; ado, aldehyde-deformylating oxygenase. 
Modified from (Wang et al., 2013).  
 
Heptadecane, a C17 hydrocarbon, is the most abundant alkane reported in 
cyanobacteria (Schirmer et al., 2010) and along with heptadecene forms the two 
major constituents of alka(e)nes in Synechocystis  sp. PCC6803 accounting for 
0.1% of the cyanobacterium’s dry cell weight (Tan et al., 2011, Hu et al., 2013). In 
recent years, many researchers have been interested in enhancing alkane 
production in Synechocystis. For example, Hu et al. (2013), showed a five-fold 
increase in the intracellular levels of heptadecane in an engineered strain of 
Synechocystis. This was done by increasing the number of copies of the genes 
FAR (also referred to as aar) and FAD (also referred to as ado) that encode for 
the fatty acyl-ACP reductase and fatty aldehyde decarbonylase enzymes in the 
native alkane biosynthesis pathway, respectively (Figure 6.1). Moreover, Wang et 
al. (2013), showed that the overexpression of the same two genes in two different 
loci of the genome resulted in an 8.3 fold increase of alka(e)nes production. They 
also demonstrated that redirecting the carbon flux to acyl-ACP can improve 
alka(e)ne production in cyanobacteria significantly and that the AAS enzyme 
encoding acyl-ACP synthetase gene is vital for alka(e)ne synthesis (Figure 6.1).  
The ability to increase the yield of naturally produced alkanes in Synechocystis 
(Wang et al., 2013, Hu et al., 2013) along with their export out of the cell would 
be a step towards producing low-cost renewable transportation fuels. To date, the 
mechanisms for the extraction of synthesised alkanes in cyanobacteria are still 
not well established. However, there is a patent on the expression of an internal 
membrane protein that facilitates the export of produced alkanes in 
Synechocystis into the culture medium (Reppas et al., 2010). The next section 
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describes the AlkL transporter and its potential role in alkane transport in 
Synechocystis.   
6.1.2 The AlkL transporter  
The outer membrane of Gram negative bacteria acts as a protective layer that 
prevents both hydrophobic and hydrophilic substances from crossing freely into 
the cell. This can be attributed to the presence of the lipopolysaccharide layer on 
the outer membrane (Nikaido, 2003, Hearn et al., 2009). Several outer 
membrane proteins have been identified in various bacteria that are likely to aid 
in the transport of small hydrophobic molecules, such as the AlkL and OmpW 
family proteins (van Beilen et al., 2001, Hong et al., 2006). However, the only 
protein family currently confirmed to be involved in the uptake of hydrophobic 
substances is the FadL family in E. coli (Hearn et al., 2009). The alkL gene found 
in Pseudomonas putida GPo1 is part of the alkBFGHJKL and alkST operons 
carried on the OCT-plasmid (Chakrabarty et al., 1973). The two operons are 
reported to contain genes for enzymes responsible for alkane metabolism (van 
Beilen et al., 1992). The AlkL protein (230 aa) was found to show a 27% identity 
to the OmpW outer membrane protein of E. coli (Hong et al., 2006) which in turn 
is homologous to the OmpW protein of Vibrio cholera (van Beilen et al., 1992). A 
key distinct similarity between the OmpW and the AlkL membrane proteins, both 
of which are eight stranded beta barrels, is that they contain a hydrophobic 
channel rather than the hydrophilic interior typically found in membrane protein 
transporters (Hong et al., 2006). Another characteristic similarity is the lateral 
opening of the channel, which is hypothesised to facilitate the exit of hydrophobic 
compounds from within the channel into the membrane rather into the hydrophilic 
periplasm (Figure 6.2).  
It has been previously hypothesised (van Beilen et al., 2001, Hong et al., 2006, 
Hearn et al., 2009, van Beilen et al., 1992) that given the  location of the alkL 
gene in the alkane degradation operon and its position in the outer membrane, 
that it is involved in transporting alkanes into the cell and their subsequent 
degradation. Nevertheless, until recently, the precise function has remained 
unknown with no observed effect on the microorganisms growth rates when the 
alkL gene is deleted (van Beilen et al., 1992). The suggested explanation for the 
absence of an observed effect upon deletion of alkL is that the AlkL protein may 
only be functional when the microorganism is growing in conditions where the 
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levels of alkanes are very low and where the AlkL protein would be necessary for 
importing of the alkanes.  It has also been proposed that the redundancy of the 
outer membrane transporters exhibiting the same function may be another 
possible explanation (Hong et al., 2006). 
Work done by Grant (Grant, 2012) provided clear evidence on the role of the AlkL 
protein in transporting long-chain alkanes across the membrane. The 
mechanisms proposed by which the AlkL protein functions in both importing and 
exporting >C12 alkanes are demonstrated in Figures 6.3 and 6.4, respectively. 
The mechanism by which the bio-pump is proposed to import hydrophobic 
compounds is known as lateral diffusion (Figure 6.3) and involves the facilitated 
binding of the hydrophobic molecules to the extracellular region of the AlkL 
protein. The binding happens with high affinity allowing the molecules to cross 
the lipopolysaccharide layer via hydrophobic channels to get into the cell (Hearn 
et al., 2009, Hong et al., 2006). Figure 6.4 illustrates the proposed method for 
product export where the products within the cell diffuse into the cytoplasmic 
membrane, cross the periplasm and into the outer membrane. Here diffusion is 
blocked due to the presence of the polar lipopolysaccharide layer. The AlkL 
protein forms a hydrophobic channel that allows the product to bypass the 
lipopolysaccharide layer and exit the cell. However, the hydrophobic nature of the 
outer membrane of the AlkL protein brings these products back into the cell until 
a dynamic equilibrium is reached. According to Hearn and colleagues. (2009), all 
transport proteins in which lateral diffusion is proposed, function as efflux pumps. 
Since lateral diffusion is proposed for the AlkL protein, we can therefore consider 
it a potential efflux pump that may allow for the export of alkanes from within the 
cell. 
As mentioned above the expression of the bacterial origin AlkL in Synechocystis 
seems promising given its classification as a Gram-negative bacterium. However, 
it should be noted that the cyanobacterial cell wall shows many differences to 
other Gram-negative bacteria. As an example, the peptidoglycan layer found in 
cyanobacteria is considerably thicker than that found in most Gram-negative 
bacteria and the degree of cross-linking between the peptidoglycan chains also 
varies compared to those of other bacteria (Hoiczyk and Hansel, 2000). Details of 
the cyanobacterial cell structure can be found in chapter 1. These facts need to 
be kept in mind when conducting comparative studies between E. coli and 
Synechocystis. 
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Figure 6.2: Structural comparison between the homology model of AlkL and the X-
ray crystal structure for E.coli OmpW.  
 (A) Surface model indicating hydrophobic side chains for AlkL (blue) and OmpW (green). (B) Cartoon 
structure of AlkL model with cavities shown as a mesh. (C) Close up of the proline residues forming the 
lateral opening into the outer membrane and the side chain interactions closing the channel beneath the 
lateral opening. LPS; lipopolysaccharide layer (unpublished figure provided by C. Grant). 
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Figure 6.3: A schemetic representation of the proposed mechanism for alkane 
import. 
The figure demonstrates the proposed mechanism by which the AlkL protein aids in the uptake of 
long chain alkanes across the lipopolysaccharide layer (LPS) of gram-negative bacteria 
(unpublished figure provided by C. Grant). 
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Figure 6.4:  A schemetic representation of the proposed mechanism for alkane 
export. 
The figure demonstrates the proposed mechanism by which the AlkL protein aids in the export of 
long chain alkanes across the lipopolysaccharide layer (LPS) of gram-negative bacteria 
(unpublished figure provided by C. Grant). 
 
6.2 Aims  
• The development of a bio-pump expression construct that would allow for 
the expression of the alkL gene in Synechocystis under the light regulated 
psbA2 promoter and the nickel inducible nrsB promoter. 
• Investigate the role of the expressed bio-pump in transporting hydrophobic 
compounds across the membrane of Synechocystis and test for increased 
alkane synthesis.  
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6.3 Results and discussion  
6.3.1 Expression of alkL gene in Synechocystis under different promoters 
6.3.1.1 Creating the pLAH.A2.alkL and the pLAH.nrsB.alkL plasmids 
PCR was utilised for the amplification of the alkL gene from plasmid pJ811 
(provided by Dr Grant) using primers that would add an HA tag sequence onto 
the 3’ end of the alkL coding sequence, and NdeI and BamHI restriction sites (on 
the 5’ and 3’ ends respectively) for downstream cloning purposes. PCR 
conditions used were as described in section 2.3.5. Primers used to amplify the 
alkL gene and the full sequence of the pJ811 plasmid including the alkL gene can 
be found in Appendix 3 and Appendix 14 respectively. PCR results shown in 
Figure 6.5 confirm the amplification of the alkL gene (751bp).  
 
Figure 6.5: The amplification of alkL gene with an HA tag.  
PCR amplification of the alkL gene from pJ811:71557–ALC plasmid template.  
 
The purified PCR product was digested with NdeI and BamHI before being 
ligated into pLAH.A2 and pLAH.nrsB expression vectors digested with the same 
enzymes (section 5.3.1 chapter 5). Details for enzyme digestions and ligation can 
be found in sections 2.3.11.2 and 2.3.11.3 respectively. The ligation mix was then 
transformed into competent E. coli cells (section 2.4.1) and selected on LB plates 
supplemented with kanamycin added to a final concentration of 50 μg/ml. No 
transformants were obtained when the alkL gene was ligated to the pLAH.A2 
expression vector while many transformants were recovered from the ligation of 
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the alkL gene in pLAH.nrsB. One possible explanation for the absence of E. coli 
transformants for the pLAH.A2.alkL construct, despite several attempts, might be 
that expression of the alkL gene in the E. coli is toxic and leads to cell death. 
Membrane proteins are typically known to be toxic to the cell when over 
expressed (Narayanan et al., 2011, Akiyama, 2009) and the AlkL protein 
specifically has been shown to have a highly detrimental effect on cell viability 
when expressed in E. coli (Grant, 2012).  Furthermore, we would expect the alkL 
to be expressed in E. coli under the psbA2 promoter (strong light regulated 
promoter) as this promoter has previously shown to successfully express genes 
in E. coli (as seen with the expression of the toxic GES gene in E. coli in chapter 
5). 
Test digests performed on isolated plasmid obtained following the ligation of the 
alkL gene into pLAH.nrsB showed the successful insertion of the alkL gene. In 
order to confirm that the HA tag sequence was successfully attached to alkL, 
aliquots of the purified plasmids were sent for sequencing (section 2.3.6) along 
with primers used to check for the correct insertion of alkL in the psbA2 locus 
(Appendix 3). DNA sequence results confirmed the presence of the HA tag 
sequence at the end of the alkL coding region (Appendix 15).   
6.3.1.2 Synechocystis transformation with pLAH.nrsB.alkL 
The pLAH.nrsB.alkL plasmid obtained in section 6.3.1.1 was used to transform 
WT Synechocystis as described in section 2.4.2. Colonies appeared within one 
week of selection on medium supplemented with 200 µg/ml kanamycin (Figure 
6.6.A). Genomic DNA was isolated from four colonies after they had been re-
streaked three times on fresh selective medium. The isolated DNA was analysed 
by PCR using primers (located upstream of the psbA2 gene and other within the 
pLAH.nrsB vector) designed to check for correct integration of alkL gene in the 
psbA2 locus (Appendix 3). PCR results shown in Figure 6.6.B confirm the 
successful integration of the alkL gene in the psbA2 locus under the control of the 
nrsB promoter.  
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Figure 6.6: Transformation of Synechocystis with pLAH.nrsB.alkL construct and 
PCR confirmation.  
(A) Many transformants were obtained from transformation of WT Synechocystis with pLAH.nrsB 
construct expressing the alkL gene. (B) The successful isolation of Synechocystis transformants 
containing the alkL gene (~1.7 kb product). Negative control: pLAH.nrsB plasmid template (~1 kb 
product). A non-specific band appears at ~3.1 kb.  
6.3.1.3 Western blot analysis to test for the synthesis of the HA-tagged AlkL  
In order to test for the expression of AlkL protein under the nrsB promoter in 
Synechocystis, western blot analysis was carried out using anti-HA antibodies. The 
western blot was set up as described in chapter 2 (section 2.6). The synthesis of the 
AlkL protein (~25 kDa) was observed in cultures that were pre-induced for four hours 
with NiCl2.6H2O added to a final concentration of 6.4 µM (Figure 6.7.A, lane 2).  Un-
induced cultures showed no leaky expression of alkL confirming the successful and 
tightly controlled expression of the gene under the nrsB promoter in Synechocystis 
(Figure 6.7.A, lane 1). A positive control represented by an engineered strain of E. coli 
expressing the AlkL protein with a C-terminal 6xHis tag was used to confirm protein 
detection and can be seen in Figure 6.7 (B). The positive control was provided by C. 
Grant.  
Interestingly, the AlkL protein expressed in Synechocystis appears larger (~25 kDa) 
than that expressed in E. coli as reported by both Grant et al., (unpublished data) and 
(Kok et al., 1989, Eggink et al., 1987) who obtained protein sizes of ~22 kDa and 20 
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kDa, respectively. Nevertheless, our finding is in agreement with van Beilen. (1992), 
who also reported an AlkL protein size of 25 kDa. It can be suggested that since the 
AlkL protein has three closely spaced potential peptidase cleavage sites (van Beilen 
et al., 1992) and if the protein was cleaved at the site with the highest score according 
to (von Heijne, 1986), the calculated molecular mass of the mature AlkL would be 22 
kDa. Once the additional size of the HA tag (~1.1 kDa) is included, then the mature 
size is reasonably close to the observed molecular mass of 25 kDa.  
 
 
Figure 6.7: The induced expression of alkL gene product in Synechocystis. 
(A) The alkL gene product was successfully expressed in Synechocystis (~25 kDa) after the 
induction of the nrsB promoter. (B) E. coli was used as a positive control to demonstrate the 
expression of alkL gene (~22 kDa). Anti-HA antibodies were used in (A) while anti-His used in (B). 
 
The ability to regulate the expression of the alkL gene was previously identified to 
be critical for stable accumulation of AlkL in E. coli, probably as a consequence of 
its toxicity on the cell when over expressed. It was therefore necessary to have a 
way to regulate the expression of alkL in Synechocystis. This was done by 
expressing the alkL gene under the tightly controlled nrsB promoter and using 
different inducer concentrations to achieve titratable expression levels. For this, 
another western blot was set up, as detailed in section 2.6, where the alkL 
expressing strain was grown and induced for four hours at low and high 
concentration of the inducer (0.64 μM and 6.4 μM NiCl2.6H2O, respectively) and 
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the detection was done using the Odyssey system that allowed for band intensity 
measurements to be made for relative comparisons. It is clear from the western 
blot results presented in Figure 6.8 that the level of protein correlated with the 
inducer concentration with higher protein expression levels achieved through 
higher induction while no protein was expressed in the un-induced culture. 
In Synechocystis, the level of alkL gene product was approximately 2.5 times 
higher when induced with the higher concentration of nickel (6.4μM) (Figure 6.8 
lane 3). To check for the reproducibility of the results, an experiment was set up 
where three biological samples were tested for controlled expression of the alkL 
gene. Results presented in Figure 6.9 show that induced cultures of the three 
biological samples (represented by a + sign) showed a protein product at the 
expected size (~25 kDa). However, faint bands also appear in the same location 
in the un-induced cultures. This could either indicate a leaky expression of the 
alkL gene or may just be due to the presence of non-specific bands (several faint 
non-specific bands appear in the blot). In order to quantify the amount of the AlkL 
protein expressed in the cells, 50 ng and 100 ng of the standard HA-tagged 
Human CARHSP1 protein were loaded with the samples in Figure 6.9. The 
quantification was not successful since the standard protein was degraded 
probably due to thaw-freeze effects and therefore the quantification needs to be 
repeated. 
 
 
Figure 6.8: The titrated expression of the alkL gene in Synechocystis. 
Controlled expression of the alkL gene was achieved by inducing Synechocystis cultures with low 
(0.64 μM) represented by (+) and high (6.4 μM) (represented by ++) concentrations of 
NiCl2.6H2O. An un-induced culture was used as a negative control (-).  
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Figure 6.9: Quantification of the alkL gene product.  
An attempt to quantify the alkL gene product using the Odyssey system and CARHSP1 protein. 
The CARHSP1 protein (50 ng and 100 ng) was degraded and quantification was not achievable. 
(-) un-induced cultures, (+) cultures induced with 6.4 μM of NiCl2.6H2O, alkL (1-3) show three 
independent strains expressing the alkL protein.  
6.3.2 Phenotype analysis of the AlkL expressing strain  
Based on the proposed mechanism of alkane transport of the AlkL protein 
suggested in Figures 6.3 and 6.4 (lateral diffusion and equilibrium based), the 
effect of expressing the AlkL on intracellular heptadecane production and 
recovery in Synechocystis was investigated. Furthermore, the effect of using an 
auxiliary phase (n-dodecane) along with a detergent (Triton X100) was examined. 
N-dodecane was added to the culture as an exogenous alkane to test whether; (i) 
AlkL is functional in translocating it inside the cell, (ii) It will improve the yield and 
recovery of endogenous alkanes by milking it outside the cell. On the other hand, 
Triton X100 was used to aid recovery of alkanes that may adhere to the cell 
membrane. Moreover, in E. coli, the combination of the detergent and auxiliary 
phase has shown to improve recovery of C17 alkanes (Grant et al. unpublished).   
To test these parameters on Synechocystis, an experiment was set up as 
illustrated in Table 6.1. In this experiment, both the AlkL expressing strain and the 
negative control (Synechocystis transformed with the pLAH.nrsB expression 
vector) were grown to an OD750=0.6 before being added into the wells of the 
polypropylene plates in the presence or absence of the inducer (NiCl2.6H2O), n-
dodecane and Triton X-100. Cultures were allowed to grow for 21 hours (to reach 
mid log phase) before being analysed phenotypically and later harvested for GC 
analysis (section 6.3.3).  
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Table 6.1: The set up used for phenotype analysis of AlkL expressing strain  
 
6.3.2.1 Phenotype analysis:  
The cultures grown according to the set up presented in Table 6.1 displayed a 
distinct phenotype that can be clearly seen in Figure 6.10.B. The effect of 
expressing the alkL gene at high concentrations of the inducer (6.4 μM) can be 
seen in column three where the cultures displayed a pale green color indicating 
reduced pigmentation. C3, which contained both n-dodecane and Triton X100, 
was an exception as it maintained a green colour with very little loss of 
pigmentation when compared to the negative control (C1). The loss of 
pigmentation is unlikely due to the inducer as the negative controls of the 
equivalent set up, shown in column 6, showed no detrimental effect on the cells. 
This observation clearly indicates that the lower level of pigmentation was a result 
of the expression of the alkL gene in Synechocystis. However in order to confirm 
that the phenotype change in the alkL expressing strain was due to the function 
of the AlkL protein in accumulating intracellular alkanes and not due to 
weakening of the cell membrane as a result of over expression of the protein, 
measurements of intracellular levels of alkanes  were done in section 6.3.3.  
The effect of adding n-dodecane in the presence of Triton X-100 can be seen in 
row C (C1 to C6) where cultures exhibited a darker green culture indicating 
healthier cells. It is speculated that this may be a result of (i) an increased gas 
exchange in the culture since gases are known to be 10 fold more soluble in n-
dodecane compared to water (Ngo and Schumpe, 2012) (ii) n-dodecane might be 
extracting a toxic metabolic byproduct away from the cell resulting in healthier 
cells and increase in the chlorophyll content or (iii) n-dodecane is being used as a 
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carbon source for growth. It is interesting to note that the healthier appearance of 
the cells was only observed when Triton was added to n-dodecane (compare 
rows C and D) suggesting that the detergent is necessary for the role of n-
dodecane on the cell. It was observed that higher cell densities in E. coli were 
achived when cells where grown in the presence of n-dodecane irrespective to 
the presence of the AlkL protein (Grant et al., 2012). Cell density measurements 
of Synechocystis were carried out to compare the results to those obtained for E. 
coli and is discussed in the following section.  
      
Figure 6.10: Phenotype analysis of the AlkL expressing strain.  
(A) The cell dry cell weight is inversely proportional to the inducer concentration. The AlkL expressing strain 
generally had a lower dry cell weight as compared to its equivalent WT strain. (B) The AlkL expressing strain 
of Synechocystis showed a clear phenotype change when induced with 6.4 μM of NiCl2.6H2O under all four 
conditions tested. + and – represent presence or absence of n-dodecane or tritonX100.  
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6.3.2.2 Cell density determination:   
The cell density was measured as described in section 2.10 and results obtained 
are presented in Figure 6.10.A. The results show that expression of the AlkL 
protein in Synechocystis was inversely correlated with cell density, which 
provides some evidence that the AlkL protein was being expressed in a functional 
form and this behavior matches what has been demonstrated in E. coli. On the 
other hand, WT strains also showed a reduction in the dry cell weight with 
increased inducer concentration under all conditions tested. Nevertheless the 
reduction was on a much smaller scale and was most likely a result of prolonged 
induction. Interestingly, under all conditions tested in Figure 6.10.A, the dry cell 
weight of the un-induced alkL expressing strain was found to be less than that of 
the corresponding WT strain indicating that the presence of the alkL gene adds a 
metabolic burden on the cell.  
Next we wanted to focus on the effect of the AlkL protein on dry cell weight 
measurements independent of the presence of a second-phase, for this, rows A 
and B from Figure 6.10.B (absence of n-dodecane) were examined carefully and 
re-presented in Figure 6.11. Figure 6.11.A shows that only the AlkL expressing 
strains of Synechocystis (6803 AL) induced with 6.4 μM of NiCl2.6H2O showed a 
clear phenotype change represented by the pale green culture as opposed to 
dark green color of the rest. This was the case in both cultures grown in the 
presence or absence of triton indicating that the presence of triton alone has no 
apparent effect on the cells. It is important to note that although the phenotype 
appearance of the cultures corresponds fairly well with the dry cell weight 
measurements in a single phase system (a paler color indicated reduced dry cell 
weight) (Figure 6.11). The culture colour cannot be used to predict the effect on 
the dry cell weight when using a two-phase culture system. This is evident in 
Figure 6.10.B where the dark green colour of cultures grown in the presence of n-
dodecane (row C) did not translate to higher dry cell weight measurements 
(6.10.A). This result can be used to rule out the possibility of n-dodecane used as 
a carbon source for growth. The following section describes GC analysis 
conducted  to examine the intracellular levels of alkanes in AlkL expressing 
strains.  
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Figure 6.11: Effect on the dry cell weight of expressing alkL in a single phase.  
(A) Only AlkL expressing strains of Synechocystis (6803 AL) induced with 6.4 μM of NiCl2.6H2O 
showed a clear phenotype change in both cultures grown in the presence or absence of Triton. 
(B) AlkL expressing strains had less dry cell weight than the WT strains while the inducer 
concentration showed an inversely proportional relationship with the dry cell weight of the AlkL 
expressing strain. 
6.3.3 GC analysis of alkL expressing strains  
For the GC analysis, three biological replicates of the AlkL expressing strains 
were cultured in the same set up shown in Table 6.1 and displayed similar 
phenotypes to that seen in Figure 6.10. The pellet and supernatant extracts of the 
cultures (section 2.8.2) were analysed by GC (section 2.8.4) for the detection and 
quantification of the naturally produced C17 heptadecane and the exogenously 
added C12 alkane, n-dodecane.    
This was done to compare (i) the proportion of heptadecane in the pellet and 
supernatant fractions under different conditions (in particular the effect of alkL 
expression), (ii) compare the uptake of n-dodecane into the pellet for rows C and 
D. 
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Overall production of heptadecane: GC measurements of the average amount 
of heptadecane in Synechocystis expressing the AlkL protein presented in Figure 
6.12 showed that the induced expression of the AlkL protein decreased the 
overall yield of heptadecane under all conditions tested (including the presence of 
a two-phase culture system). However, strains lacking the AlkL protein (negative 
controls) also showed the same result indicating that the reduced intracellular 
levels of the heptadecane was not due to the expression of the AlkL protein but 
more likely a side effect of prolonged nickel induction. This is contrary to what 
was observed in E. coli where the expression of the AlkL protein resulted in an 
increased yield of alkanes. Furthermore it was reported that the alkane yields 
were enhanced in E. coli by the addition of n-dodecane and detergent (Triton 
X100) even in the absence of the AlkL transporter. Grant. (2013), hypothesised 
that this might be due to the produced alkane being milked out of the cell, via 
naturally occurring transporters, into the n-dodecane layer reducing its 
concentration within the cell and driving the reaction forward. This is not probable 
in Synechocystis since, to the best of my knowledge, there is no natural exporter 
of alkanes. 
Export of alkanes: Looking at the average C17 content of supernatant and pellet 
fractions of three biological replicates shown in Figure 6.12, we can see that 
there is no observed increase in the export of the produced heptadecane in 
induced AlkL strains grown in single phase. We can therefore conclude that the 
AlkL transporter did not enhance product recovery in this case.  
Auxiliary phase system and C17 export: GC results for influx of n-dodecane 
(C12) into the cell were inconclusive due to experimental errors that resulted in a 
high signal to noise ratio and were therefore not presented in this work. However, 
GC measurements of the proportions of heptadecane in the supernatant and 
pellet presented in Figure 6.12 shows that the addition of the n-dodecane 
auxiliary phase resulted in the increase of heptadecane secretion. This is similar 
to the results observed in E. coli cells where the presence of n-dodecane second-
phase resulted in the extraction of intracellular alkanes irrespective of the 
presence or absence of the transporter. However, contrary to what was observed 
in E. coli, the detergent did not seem to enhance alkane recovery in the second-
phase.   
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Figure 6.12: GC-FID analysis of Heptadecane in alkL expressing strains.  
Heptadecane production was decreased in both WT and AlkL expressing strains upon induction 
under all conditions tested. The figure represents the average of three replicates. 
6.4 Conclusion and future work 
The precise function of the AlkL outer membrane protein remains unknown 
despite a general agreement that the Alk operon (including the alkL gene) is 
responsible for alkane uptake and metabolism (van Beilen et al., 2001, Hong et 
al., 2006, Hearn et al., 2009, van Beilen et al., 1992). The function was proposed 
according to the general structure of the AlkL transporter (distinct hydrophobic 
core) and its location in the outer membrane, and both features support the 
transport of hydrophobic molecules across the outer cell membrane. Analysis of 
an E. coli strain engineered for alkane production demonstrated an increase in 
both the uptake and accumulation of alkanes (Grant, 2012). Work presented in 
the first part of this chapter confirmed the controlled and tightly regulated 
expression of the alkL gene, for the first time, in Synechocystis under the control 
of the nrsB inducible promoter system (Figures 6.7 and 6.8). However, attempts 
to express the alkL gene under the strong light regulated promoter (psbA2) failed, 
probably due to the expression of the gene in E. coli cells that resulted in cell 
death and made subsequent cloning steps unachievable.  
Cyanobacterial strains expressing the alkL gene were analysed phenotypically 
under various conditions and results, presented in Figure 6.10.B, clearly showed 
that the expression of the alkL gene led to an observed phenotypic difference 
represented by reduced pigmentation indicative of the probable functionality of 
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the AlkL protein. Furthermore, it was evident that the presence of n-dodecane 
resulted in healthier cells represented by the darker green culture, probably as a 
result of an increased gas mass transfer in the presence of n-dodecane and an 
increase in the chlorophyll content of the cells (not tested). 
The next steps included examining the effect of expressing the AlkL protein on (i) 
the dry cell weight of the strain (ii) the accumulation of total alkane (iii) the export 
of the intracellular heptadecane (iiii) the effect of growing the culture in an 
auxiliary phase in the presence or absence of a detergent.  
Results from GC analysis suggested that the dry cell weight of AlkL expressing 
strains was inversely correlated with the inducer concentration suggesting that 
the AlkL protein was probably functional (Figure 6.11). On the other hand, GC 
analysis conducted on three biological samples of AlkL strains showed a 
reduction of the total yield of heptadecane (Figure 6.12) however since the 
negative controls (strains lacking the alkL gene) also showed reduced yield of 
heptadecane, probably due to the effect of nickel induction, the role of the AlkL 
transporter in Synechocystis is still not identified. Furthermore, the same figure 
showed that the expression of the AlkL protein did not result in the export of the 
heptadecane as the proportion of C17 in the supernatant was not improved post 
alkL induction. Unfortunately the GC results of the C12 n-dodecane analysis were 
not conclusive and should be repeated in order to confirm this hypothesis. There 
was variability in the total alkane yield between the three biological samples 
presented in Figure 6.12 and trying to find a possible explanation may be 
challenging. Hu et al.(2013), also reported variable amounts of accumulated 
heptadecane (C17) between different samples of wild type Synechocystis. One 
possible explanation is that microbial hydrocarbon synthesis largely depends on 
the growth conditions (Ladygina et al., 2006). Despite growing the cultures under 
the same conditions, small variations within the microplates and slight differences 
in the light intensities might have led to such variations. Recommended future 
work would include the expression of small amounts of the AlkL protein and its 
quantification in order to achieve the desirable induction level that would allow for 
the expression of the protein without resulting in cell toxicity. This will help identify 
the role of the protein avoiding concerns related to possible cell damage due to 
over-expression of the protein. Furthermore the GC set up needs to be repeated 
to examine the transport of n-dodecane across the cell in order to identify its role 
in enhancing growth conditions of Synechocystis and possible export of alkanes.  
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Chapter 7: GENERAL DISCUSSION 
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7.1 Main Findings  
7.1.1 Attempts for the development of a simple system for random insertion 
mutagenesis in Synechocystis 6803 
The creation of random mutants in Synechocystis is currently based on classical 
mutagenesis methods such as chemical and UV mutagenesis, both of which 
result in difficulties in the identification of the mutation in the genome (Labarre et 
al., 1989). The use of transposons for mutagenesis is another classical 
mutagenesis method but is of limited use in cyanobacteria due to its low 
efficiency (Golden, 1988). To overcome the limitations of these classical forward 
genetics methods, an insertional mutagenesis method was developed by 
(Labarre et al., 1989) where the disruption of the host genome is done by the 
insertion of an antibiotic cassette isolated from a bacterial plasmid that is 
randomly ligated to a pool of restriction fragments of the host genome, and used 
directly for transformation into Synechocystis. Nevertheless, this method still 
relies on multiple digestion and ligation steps prior to transformation, making it a 
long process. Therefore, in chapter 3, I conducted experiments that aimed to 
develop a simple and rapid method for random foreign gene insertion into the 
genome of Synechocystis that would not require the construction of cloning 
vectors, digestions or ligation steps and which does not rely on homologous 
recombination to achieve transformation. The idea was to ultimately use the 
proposed method for identification of novel mutants using forward-genetic 
screens. To achieve this goal, it was decided to utilised a recJ– strain of 
Synechocystis as a recipient strain for the transformation of a ‘naked’ kmR 
cassette (not flanked by any DNA homologous to the cyanobacterial genome). 
The reason being that it appears that the loss of the RecJ exonuclease in the 
recJ– strain extends the half-life of the transforming DNA allowing inefficient 
illegitimate (i.e. non-homologous) recombination events to occur. 
Results presented in chapter 3 confirm the successful transformation using naked 
kmR cassettes (isolated as both blunt and sticky end cassettes) in the ∆recJ.ble 
Synechocystis mutant. On the other hand, Southern blot analysis conducted on 
16 isolated transformant lines revealed that the integration of the kmR cassettes 
were at a specific location in the host’s genome and not random, as predicted. 
Detailed investigation as to where the kmR cassettes were being integrated was 
done, and it demonstrated the integration of the cassettes at the speA/psbA2 
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locus. Furthermore, results confirmed that the integration was accompanied by a 
gene deletion where the kmR cassette was replacing the majority of the psbA2 
locus. The observation that genomic DNA had been deleted upon transformation 
with a kmR cassette in Synechocystis is similar to earlier findings by two groups 
(Chauvat et al., 1989, Labarre et al., 1989) who showed that transformants 
obtained using kmR and cmR cassettes that had been ligated randomly to 
fragmented Synechocystis DNA, were usually accompanied by a gene deletion.  
This led to two hypotheses to explain the unexpected result; the first was that the 
preferential integration of the kmR cassettes at the speA/psbA2 locus was a result 
of something related to the sequence of the cassette. This hypothesis is 
supported by two facts: (1) the promoter and termination sequences of 
kanamycin are recognised by Synechocystis (Vermaas, 2007). Therefore, it is 
possible that this may have influenced its integration especially since the 
integration of the cassette happened between the promoter and terminator 
sequences of the deleted psbA2 gene suggesting possible recognition of these 
sequences. Secondly, parallel work conducted in chapter 4 showed that the kmR 
cassette flanked on either end with short regions of homology to the genome (30 
bp) also resulted, on some occasions, in integration at the speA/psbA2 locus 
suggesting that when the short flanks linked to the kmR cassette are not identified 
by the host, the integration of the cassette is effected by the sequence itself. 
Conversely, blast results of the kmR cassette against the genome of 
Synechocystis showed no evidence of sequence homology between the cassette 
and the recipient strain.   
The second hypothesis suggests that the integration of the kmR cassette at the 
speA/psbA2 locus was due to specific sequences at this location making them 
act as “hot spots” for integration. This idea is supported by (Zang et al., 2007) 
who explained that the presence of “hot spots” in the genome of Synechocystis 
was attributed to the presence of a palindromic element in the genome at these 
sites which results in site specific recombination. These elements are identified 
as HIPI palindromic sequences and IS-like elements (Ikeuchi and Tabata, 2001). 
Examining the speA/psbA2 locus for HIPI palindromic sequences revealed the 
presence of two of these sequences both upstream and downstream of locus 
suggesting that these sequences might have indeed resulted in the 
recombination event that took place in the transformants.  
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Experiments were performed to further examine the first hypothesis (integration 
influenced by the sequence of the kmR cassette) where the kmR cassette was 
replaced with a ble cassette and used in transformation of a ∆recJ.km mutant. 
Again, many successful transformants were obtained and Southern blot analysis 
again confirmed targeted integration of the cassette, emphasizing the inability to 
generate random integration using the proposed method. More importantly, 
targeted integration was at two distinct locations of the genome and since we 
previously predicted the speA/psbA2 locus to be a possible “hot spot”, we 
expected one of the two integration sites of the ble marker to be the speA/psbA2 
locus (as with the kmR cassette). Interestingly however, the ble marker was in 
fact being inserted in two different unidentified locations of the genome. These 
findings are very intriguing and suggest that the site-specific integration of the 
selectable markers is most likely affected by their sequence. However, in order to 
make a solid conclusion on the reason behind the site-specific integration of the 
selectable markers, further analysis needs to be done in order to identify the two 
locations at which the ble marker was being integrated and examine the 
presence of palindromic elements at the site of integration. It is possible that both 
the sequence of the selectable marker used and the presence of palindromic 
elements played a role in these site specific integration patterns.  
It important to note that the experimental findings consistently showed that the 
recJ- strains (both the ∆recJ.ble and ∆recJ.kmR mutants) were more efficient than 
wild type strains in generating transformants, where wild type strains constantly 
failed to generate true transformants with any of the two selectable markers 
tested. This result is in agreement with findings reported by Kufryk et al. (2002), 
who demonstrated a two-fold increase in the transformation efficiency of recJ- 
strains as opposed to wild type strains.  
In conclusion, the recJ- strains used in this study allowed for the integration of 
“naked” DNA into the host genome. However, results confirm that the site-specific 
integration of the selectable markers that took place is probably influenced by 
special genomic sequences (e.g. HIPI palindromic element) distributed 
throughout the genome or by the sequence of the selectable marker used for 
transformation or possibly by a combination of both. Therefore, it can be 
concluded that using recJ- strains to achieve the integration of heterologous DNA 
randomly across the Synechocystis genome does not look feasible. 
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Recommended future work would be, (i) the identification of the two integration 
sites of the ble selectable marker, (ii) examining the site of integration for the 
presence of genome repeats that may have led to targeted integration and (iii) 
test the integration pattern of a range of selectable markers. Results obtained 
from these experiments will help concluding whether the integration is based on 
the sequence repeats in the genome or rather related to the choice of the 
selectable marker used. If a selectable marker that does not lead to targeted 
integration can be identified the method might still be achievable. 
7.1.2 Development of a ‘one-step’ PCR-based technique for insertion of 
foreign DNA into Synechocystis 6803 
The most common method for targeted insertion of foreign DNA into 
Synechocystis is the construction of a transformation plasmid using traditional 
cloning methods such that a marker flanked on either side by a large (> ~500 bp) 
tract of homologous sequence (Golden et al., 1987, Vermaas, 2007). This 
method is time-consuming as it involves multiple cloning steps. Despite the 
recent development of next generation cloning methods that allow for the faster 
assembly of plasmids (Hillson et al., 2011), these new methods often require the 
creation of multiple PCR products and the use of reagents for their assembly into 
either an expression vector or the final PCR product used for transformation. 
Therefore, the aim of chapter 4 was to develop a rapid and convenient single-
step method for creating gene knockouts or knock-ins in Synechocystis that 
avoids creating a transforming plasmid or the creation and ligation of multiple 
PCR products. This was to be achieved by firstly identifying the shortest 
homologous recombination flank size necessary for an efficient double 
homologous recombination transformation to occur in Synechocystis and 
subsequently use this information to generate gene knockouts in Synechocystis 
using a quick one-step PCR-based method for gene deletion.  
The minimum flank necessary for transformation was identified after the 
successful isolation of positive psbN gene knockouts using a PCR product with 
30 bp flanking sequences on either side of the kmR cassette. This result shows, 
for the first time, that a successful double homologous recombination event can 
take place in wild type Synechocystis using flanks less than 100 bp (albeit with 
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low efficiency) since the minimum flank size reported was 100-400 bp (Vermaas, 
1998).  
This information was used to design “long tail” primers that were successfully 
employed to create a psbN::kmR knockout PCR product in a single step, and the 
subsequent transformation resulted in the isolation of many kanamycin resistance 
colonies. Unfortunately, most transformants were not targeted psbN knockouts 
and further investigations showed that the PCR products were being inserted 
randomly into the genome via non-homologous recombination. After analyzing 
colonies obtained from transformations using PCR products from the traditional 
method and the one-step PCR method, it was apparent that the former generated 
from the traditional method resulted in targeted gene knockouts (homologous 
recombination, HR) most of the time, while PCR products for the same gene 
knockout from the one-step PCR method resulted in random or non-homologous 
recombination (NHR).  
Therefore, to improve the HR:NHR ratio many parameters were tested. Results 
showed that using ssDNA for transformation and varying both DNA or cell 
concentrations did not lead to an improved HR:NHR ratio. However, replacing 
wild type Synechocystis with the ΔrecJ.ble strain, as recipient strain for 
transformation of PCR products from the one-step PCR method, resulted in the 
isolation of 60 positive psbN::kmR knockouts indicating that the HR:NHR ratio can 
be significantly improved by simply using the more efficient ΔrecJ.ble strain for 
transformation. However, these results were not reproducible suggesting that the 
strain used may have not been the reason behind the improved HR:NHR ratio 
(although it significantly improved the transformation efficiency).  
I then tested deleting two other genes (psbA2 and psb28.2) using the one-step 
PCR-based method to check if the sequence of the psbN gene itself played a role 
in preventing consistent HR. However, no targeted gene knockouts were 
obtained for either of the two genes tested suggesting the integration is not 
influenced by the sequence of the gene targeted (Figure 4.18). Several 
examinations suggested that the sequence of kmR cassette used for selection is 
influencing the NHR events taking place since (i) PCR analysis showed that 
some of the PCR products of LT50.psbN::kmR and LT50.psb28.2::kmR were 
integrating in the same location as the naked kmR cassette seen in chapter 3, (ii) 
sequence analysis of a representative of each of the PCR products of 
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LT50.psbN::kmR and LT50.psbA2::kmR PCR products revealed the presence of 
nucleotide deletions, mutations and insertions near the junction of the kmR 
priming site and the homology extension when long tail primers were used, (iii) 
sequence analysis of the PCR product of the LT50.psbN::kmR exposed the 
presence of a stretch of 30 bp of the kmR cassette in the junction between the 
priming site and homology extension. All these findings suggest that using the 
kmR cassette in the one-step PCR-based method leads to nucleotide mutations, 
deletions and DNA shuffling that ultimately results in the creation of flanks that 
are not identified as flanks by the recipient strain and therefore lead to NHR 
events that target the PCR products to random locations or, in some cases, to the 
speA/psbA2 locus.  
In order to confirm these results, the kmR cassette was replaced with a ble 
selectable marker in creating the three gene (psbN, psbA2 and psb.28.2) 
knockout products using the one-step PCR method, which were then transformed 
into ΔrecJ.ble strain. Analysis of the putative transformants confirmed, for the first 
time, that the one-step PCR method was successful in creating targeted gene 
knockouts of the three genes in a good HR:NHR ratio. These results were very 
encouraging and further investigation into the possibility of generating the same 
gene knockouts using 30 bp homology showed that 50 bp was probably close to 
the minimal length of homology needed for this method using ble as the 
selectable marker. On the other hand, attempts to use the one-step PCR method 
to delete the phycobilisome operon (consisting of four genes) failed, suggesting 
that the one-step PCR method may not be feasible for large chromosomal 
deletions.  
In conclusion, despite several reports on the failure to produce successful gene 
knockouts by means of double homologous recombination in Synechocystis with 
flanks less than 100 bp, this study established the possibility of creating 
knockouts using PCR products containing as little as 30 bp flanking regions. 
Nevertheless, the efficiency of the transformation did drop markedly with 
decreased flank sizes. Additionally, a method was developed that allowed for the 
creation of targeted gene knockouts in a single PCR step utilising the ΔrecJ.ble 
strain as the recipient strain and ble as the selectable marker of choice.  
Recommended next steps would be trying to create targeted gene knockouts 
using the developed one-step PCR method that would result in a phenotype 
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difference to be used as a quick screening method for gene knockouts. An 
example would be converting a sucrose sensitive strain of Synechocystis into a 
sucrose resistance strain. This work has already been initiated on a mutant strain 
of Synechocystis provided by David Lea Smith (Cambridge University, UK). In 
this strain, the COX gene, that encodes for a subunit of the thylakoid membrane-
localised cytochrome c oxidase, was deleted by the insertion of a nptI.sacB 
cassette resulting in the creation of a strain that is sucrose sensitive (Lea-Smith 
et al., 2013) (Figure 7.1.A). The strain provided was then converted into a recJ- 
strain by deleting the recJ gene via the insertion of the ble cassette producing the 
Δcox::sacBnptI::ΔrecJ::ble strain (Figure 7.1.B). The new strain created was both 
kanamycin and zeocin resistant but not sucrose resistant (Table 7.1). The next 
steps (currently on-going by Janet Waterhouse from Saul Purton’s group) would 
be to generate PCR products with 50 bp homology to the COX gene and ~ 22 bp 
homologous to an aadA cassette (confers resistance to spectinomycin) and use 
the PCR product in a transformation to generate the Δcox::aadAΔrecJ::ble strain 
that would be sucrose and spectinomycin resistant (Figure 7.1.C).  
 
Table 7.1: Expected antibiotic resistance patterns of the three strains. 
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Figure 7.1: Schemetic representation of the Δcox::sacBnptI, the Δcox::sacBnptIΔrecJ::ble and the Δcox::aadAΔrecJ::ble strains. 
(A)The Δcox::sacB.nptI strain provided by David Lea Smith (B)The Δcox::sacB.nptIΔrecJ::ble created in this work (C) On going work by Janet 
Waterhouse is being done to create the Δcox::aadAΔrecJ::ble strain.  
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7.1.3 The potential of engineering Synechocystis 6803 for photosynthetic 
terpene production 
The production of terpenes in microbial hosts has gained a lot of attention in 
recent years due to the various industrial applications of this group of compounds 
(Sikkema et al., 1995, Dunlop et al., 2011, Ro et al., 2006). The commercial value 
of geraniol for example, lies in its application as an essential oil used in perfumes 
and cosmetics, and as a natural insect repellent. Furthermore, it holds potential 
as a fungible fuel or fuel precursor, while farnesene on the other hand, serves as 
a potential diesel replacement. One challenge facing the production of terpenes 
in a microbial host is the toxicity of the terpene on the host. Nevertheless, the 
production of geraniol has been achieved in both modified yeast (Oswald et al., 
2007) and tomato (Davidovich-Rikanati et al., 2007) while farnesene has been 
produced in both genetically engineered E. coli  (Wang et al., 2011) and S. 
cerevisiae (Peralta-Yahya et al., 2012, Brennan et al., 2012). However, to the 
best of my knowledge, the production of geraniol and farnesene has not been 
achieved in a photosynthetic microbial host.  
Therefore, the aim of the work presented in chapter 5 was to explore the prospect 
of genetically engineering the isoprenoid biosynthetic pathway of Synechocystis 
for the photosynthetic production of geraniol and farnesene, to test the tolerance 
of Synechocystis to these terpenes, and to find ways to mitigate their toxic 
effects. This was done by expression of the synthase genes in Synechocystis 
under the control of two different promoters: a constitutive light-regulated 
promoter (psbA2) to be utilised in the expression of genes with products that are 
shown to be non-toxic to the cell, and a nickel inducible promoter (nrsB) that 
allows for the expression of toxic foreign genes. After confirming the functionality 
of the two developed expression vectors (pLAH.A2 and pLAH.nrsB), they were 
used in the attempted expression of both the geraniol synthase (GES) and α-
farnesene synthase (FS) genes in Synechocystis.  
The creation of a Synechocystis transformant line expressing the GES gene 
under the psbA2 promoter was not possible as work had to be terminated since 
no E. coli transformants containing the pLAH.A2.GES plasmid were obtained 
possibly due to the active expression of the toxic GES gene in E. coli under the 
psbA2 promoter (which is recognised in E. coli) resulting in cell death. This 
conclusion is perfectly viable since (i) the antimicrobial effects of geraniol have 
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been previously reported by several researchers (Andoğan et al., 2002, Sato et 
al., 2007) and (ii) its highly toxic effect on Synechocystis was demonstrated in 
work presented in chapter 5. On the other hand, despite obtaining E. coli 
transformants for the pLAH.nrsB.GES plasmid, transformation of Synechocystis 
failed to generate true transformants. It is possible that the nrsB promoter 
showed a “leaky” expression of the gene that caused cell death. E. coli cells were 
not affected since there are no reports of the nrsB promoter being active in E. 
coli. Unfortunately, since no Synechocystis transformants were obtained, no 
further work related to expressing GES in Synechocystis was feasible.  
At the same time as the molecular work was taking place in our lab, engine test 
were carried out by Paul Hellier at the Department of Mechanical Engineering at 
UCL and results confirmed that geraniol is not suitable as either a diesel or 
gasoline replacement fuel as its combustion characteristics are not close to fossil 
fuel and therefore cannot be considered a “drop in fuel”. However, engine tests of 
other terpenes showed that farnesene and geranial (citral-a) were better diesel 
replacement fuels, while linalool and citronellene were good gasoline 
replacements. The engine results prompted interest in testing the feasibility of 
expressing the five terpenes in Synechocystis. By examining the isoprenoid 
pathway, together with results from toxicity tests conducted on Synechocystis 
using these five selected terpenes indicated that farnesene was the most 
promising terpene that could potentially and conveniently be produced in a 
controlled manner in Synechocystis due to (i) its reasonably low toxicity (ii) the 
fact that it only requires the introduction of a single gene and (iii) the co-
inoculation of high amounts of farnesene (1%) in the presence of a media 
additive or a “two-phase” culture system shows potential for the production of 
reasonably high amounts of this terpene in Synechocystis. 
Transformants were readily obtained from both the pLAH.A2 and the pLAH.nrsB 
plasmids carrying the codon optimised α-farnesene synthase gene and western 
blot analysis confirmed the successful expression of the synthase under both 
promoters. In order to achieve higher levels of the α-farnesene synthase under 
the psbA2 promoter, cultures need to be incubated under low light levels (20 
µmol/m2/s)  until they reach to an OD750 of ~0.7 followed by a shift to high light 
(200 µmol/m2/s). While, for optimum expression of the synthase under the nrsB 
promoter, cultures need to be induced at an OD750 (0.5 - 0.7) for 7.5 hours. 
Contrary to expectations, the actual concentration of the nickel inducer (in the 
 267 
range tested) didn’t seem to have an effect on the level of expression. This is 
contrary to what was observed with the expression of the alkL gene under the 
same promoter in chapter 6 where more of the protein was observed with 
increased nickel concentration. It might be possible that the steady-state level of 
the FS protein is primarily dictated by rates of degradation rather than rates of 
synthesis. 
After successfully demonstrating the expression of α-farnesene synthase under 
both promoters, the next step was to try to detect farnesene production in the 
strains. Unfortunately, all attempts to detect the product using GC-MS were 
unsuccessful even after testing various extractions methods. Despite the inability 
to detect farnesene, comparative growth studies conducted on the strain 
expressing the synthase under the nrsB promoter and that of a negative control 
showed that the synthase-expressing strain appeared phenotypically different 
from the control post nickel induction. The fact that the Synechocystis culture 
expressing the synthase only showed deteriorated growth “post” nickel induction 
is a clear indication that the expressed synthase is adding a metabolic burden in 
the cell, possibly as a consequence of substrate depletion (IPP and DMAPP 
depletion), a common observation with research aimed at expressing terpenes in 
microbes (Oswald et al., 2007, Glick, 1995, Goff and Goldberg, 1985, Martin et 
al., 2003).  
To summarize, the expression of the GES gene in Synechocystis proved very 
challenging due to the highly toxic effect of geraniol on the cell whereas the α-
farnesene synthase gene was successfully expressed in Synechocystis under 
both the psbA2 and nrsB promoters. However, no farnesene was detected from 
the synthase expressing strains possibly as a consequence of substrate 
deficiency. When working with biological systems, one may expect to encounter 
serious difficulties when it comes to designing optimization strategies for robust 
cellular performance (Angermayr et al., 2009). I believe that the recommended 
next steps that need to be taken in order to ultimately produce detectable 
amounts of farnesene in the farnesene synthase strains created in this work are 
to: (1) test the activity of the α-farnesene synthase by performing standard 
enzyme activity assays; (2) exogenously adding the rate limiting substrates (IDD 
and DMAPP) and check for the accumulation and detection of farnesene (3) 
heterologously express the yeast mevalonate pathway to increase the availability 
of the substrates that will ultimately lead to an increased titer of farnesene (similar 
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to work done by Wang et al. (2011), in engineered E. coli strains). Furthermore, 
since two reliable expression vectors have been developed in this work, it is 
worth testing the expression of a range of foreign genes in Synechocystis, 
particularly gene products with pharmaceutical applications especially after the 
successful expression (by several members of our group) of a range of proteins 
in Synechocystis using the pLAH.A2 and pLAH.nrsB expression vectors (Figure 
7.2). Furthermore, the application of the two expression vectors can be extended 
to express an operon of genes under the control of the nrsB promoter. Ben 
Mackrow (a previous MSc student in the group) used Gibson assembly to build a 
pLAH.A2 based plasmid expressing an operon of four genes encoding three 
antibiotics and a green florescent protein (GFP) (Figure 7.2.A). The ability to 
express an operon under the control of the nrsB promoter would allow for wider 
studies aimed at the controlled expression of multigenic metabolic pathways in 
this model organism.  
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Figure 7.2 : The expression of various proteins in the pLAH.A2 and pLAH.nrsB expression vectors 
(A) Proteins and operons expressed under the constitutive (B) Proteins expressed under the constitutive nrsB promoter. Note: The Ble, farnesene 
synthase and efflux pump proteins were expressed by myself, Endolysin by Laura Stoffels, Human Growth Hormone by Janet Waterhouse, Limonene 
synthase by Alice Liu and the operons by Ben Mackrow. Key: GfP: green fluorescent protein, SpecR; spectinomycin resistance cassette, kmR; kanamycin 
resistance cassette, ZmR; zeomycin resistance cassette.  
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7.1.4 The expression of AlkL in Synechocystis to facilitate substrate 
delivery and product removal of hydrocarbons 
Until recently, the function of the AlkL protein present in Pseudomonas putida 
GPo1 was not clearly identified with most researchers hypothesizing its role to be 
involved in the transport and degradation of alkanes (van Beilen et al., 2001, 
Hong et al., 2006, Hearn et al., 2009, van Beilen et al., 1992). Recently, this 
hypothesis was confirmed after the functional expression of the AlkL protein was 
shown to enable over 120 fold improvement of uptake and conversion of C12-C16 
alkanes by an intracellular enzyme expressed in E. coli strain (Grant, 2012). 
Further work by Grant and colleagues also showed that alkL could lead to up to 
two fold higher yields of C13-C16 alkanes produced by an E. coli strain engineered 
to produce alkanes. My aim in work carried out in chapter 6 was to (i) express the 
AlkL transporter in the natural alkane producing Synechocystis under different 
promoters as a demonstration of the expression of a heterologous outer 
membrane protein, (ii) test if the increase in alkane yields observed in E. coli 
would also be seen in Synechocystis, (iii) test for any changes to the ratio of 
secreted and intracellular accumulation of naturally produced alkanes in 
Synechocystis, and finally (iv) test the effect of a two-phase culture system and 
detergent on the extraction of intracellular alkanes, which had been shown to 
enhance alkane yields in E. coli. Eventually, all these parameters were to be 
compared to results obtained in similar studies on E. coli conducted by 
Christopher Grant.  
My studies on Synechocystis showed that the expression of alkL under the nrsB 
promoter was successful and the protein accumulation was regulated, in a dose-
dependent manner, using different concentrations of the inducer. This titratable 
expression of the AlkL protein is essential in order to avoid over expression of the 
protein that may lead to cell toxicity (Grant, 2012). On the other hand, the 
transformation of E. coli with the pLAH.A2.alkL expression vector did not result in 
any transformants; suggesting that the functional expression of the toxic gene 
under the psbA2 promoter in E. coli resulted in cell death. This is similar to results 
obtained in chapter 5 where attempts to express the toxic GES gene in E. coli 
under the same promoter failed. We therefore concluded that achieving functional 
expression of genes for toxic products under the psbA2 promoter in both E. coli 
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and Synechocystis is not feasible and therefore no further work expressing the 
protein transporter under the psbA2 promoter was carried out.  
However, further analysis using the nrsB promoter showed that the AlkL protein 
is most likely being expressed in a functional form indicated by a clear phenotypic 
change to the strain indicated by the loss of pigmentation compared to the 
negative control. Additionally, the dry cell weight of the alkL expressing strain was 
found to be inversely proportional to the inducer concentration. Both these 
findings are in accordance to what was observed with E. coli and can be used as 
an indication of the functional expression of the protein in Synechocystis. 
However, GC results conducted to examine the role of the AlkL protein in 
accumulating intracellular levels of alkanes in Synechocystis showed a general 
reduction in the intracellular levels of alkanes upon AlkL expression. However, 
this result is not conclusive since the same result was observed with negative 
controls (lacking the AlkL transporter) indicating that the reduction in intracellular 
levels of the naturally produced alkanes is most probably attributed to prolonged 
nickel induction rather than the expression of the AlkL protein. Nonetheless, the 
results on Synechocystis were contrary to what was shown in E. coli cells in 
which case the expression of the AlkL protein resulted in the increase in the 
intracellular yields of alkanes by two fold (1.5 for heptadecane). Moreover, the 
GC analysis of the supernatant and pellet fractions showed no evidence of export 
of the C17 leading to the conclusion that the AlkL protein did not result in the 
transport of heptadecane in Synechocystis. This is an intriguing result in itself as 
it may be that the heptadecane is being retained by the cell and therefore the 
natural function of heptadecane in Synechocystis, which is currently not 
identified, is likely to be within the cell (such as carbon storage) rather than for an 
export related function (such as signaling).  
On the other hand, a larger fraction of the C17 alkane was found in the 
supernatant of cultures grown in a two-phase culture system compared to those 
grown in a single phase indicating the possible role of the added n-dodecane in 
“milking out” the naturally produced C17 alkane. In E. coli, the addition of the 
detergent and n-dodecane led to a much higher extraction with a shift from 20% 
alkane recovery from the medium (with no Triton X-100 or n-dodecane) to up to 
90% recovery of the alkane (Christopher Grant, personal communication). It also 
appears that the addition of n-dodecane second phase has a positive effect on 
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the cell since cultures grown in the presence of n-dodecane displayed a darker 
green appearance possibility as a result of increased chlorophyll content of the 
cells. Nevertheless, the role of n-dodecane in promoting growth is still not clear 
although the cell density measurements did not show a positive correlation with 
the presence of n-dodecane indicating that the solvent was not necessary 
improving growth.  
In conclusion, the AlkL protein was successfully expressed in Synechocystis in a 
dose-dependent manner under the control of the nrsB inducible promoter. The 
reduction of dry cell weight and the clear phenotype change of the AlkL 
expressing strains are strong indications on the functionality or partial activity of 
the transporter. However, the role of the AlkL protein in the transport and 
accumulation of intracellular levels of alkanes is still not conclusive. Nevertheless, 
results presented in this chapter provide a foundation for a deeper understanding 
and further development of the AlkL bio-pump in Synechocystis and also has 
implications for understanding the natural function of heptadecane in 
Synechocystis. Hypothesis such as the following can be investigated: (i) the inner 
membrane of Synechocystis may be the barrier to alkane transport, (ii) there are 
natural alkane importer proteins already expressed in Synechocystis which 
prevent loss of heptadecane through diffusion across the membrane, (iii) or the 
possibility of the heptadecane being compartmentalised in the cell to serve a 
specific function. For this, the following sets of experiments are recommended: 
 
 Functional expression: For clear evidence on the functionality of the AlkL 
protein, alkL expressing strains can be incubated with certain dyes such 
aspropidium iodide, fluorescein or Nile red, and monitored for uptake using 
flow cytometry.  
  
 Translocation of the protein to the outer membrane: In order to confirm 
that the AlkL protein was indeed expressed in the outer membrane 
fraction, the cell can be fractionated and a western blot performed on the 
outer membrane fraction.  
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 C12 Alkane analysis: the GC analysis of the C12 dodecane in the pellet 
and supernatant fractions both pre and post alkL induction in the presence 
and absence of the detergent should be conducted alongside negative 
controls for a better understanding of the behavior of this auxiliary phase 
on Synechocystis cells. This would help answer questions such as: is it 
possible that n-dodecane is naturally taken up by Synechocystis cells? 
How much does the detergent enhance n-dodecane uptake? And finally, 
would the expression of alkL affect the transport of the alkane into the 
cell? 
 
  C17 Alkane analysis: The GC analysis of the C17 should be repeated 
including more controls to obtain a clear answer on the role the AlkL 
protein has on the intracellular levels of heptadecane.  
7.2 Conclusions, challenges and perspectives  
There has been recent interest in exploring cyanobacteria as a platform for the 
production of chemicals and biofuels from CO2 and sunlight (Zhou and Li, 2010, 
Yu et al., 2013, Hu et al., 2013). Although a lot of metabolic engineering tools 
have been developed for the genetically amendable model organism 
Synechocystis 6803 and a range of chemicals, health products, and potential 
biofuels have already been reported (chapter 1), the production rates and titers of 
the products in engineered Synechocystis are currently very low and cannot 
compete with heterotrophic fermentation. One example is the production rate of 
fatty acids in engineered E. coli which is reported to be 5.2 g/L in three days 
(Zhang et al., 2012) while engineering the same pathway in Synechocystis 
yielded less than 0.2 g/L after two weeks of cultivation (Liu et al., 2011).  
Furthermore, most of the products synthesised in Synechocystis and other 
cyanobacteria involved the expression of short pathways (containing 2–5 
heterologous enzymes). It is apparent that as the heterologous pathway gets 
larger, product synthesis becomes more complicated and difficult to achieve (Yu 
et al., 2013). Therefore, the synthesis of products in Synechocystis needs to be 
currently focused on the expression of less complicated pathways until a more 
advanced synthetic biology toolbox is developed for this cyanobacterium. The 
quick one-step PCR-based method for creating targeted gene knockouts/knock-
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ins in Synechocystis developed here and presented in chapter 4 will aid in 
speeding up molecular work. On the other hand, it is common that even the 
expression of a single gene (e.g. α-farnesene synthase seen in chapter 5) in 
Synechocystis may lead to the deterioration of the engineered strain. 
Nonetheless, a range of heterologous genes and proteins were successfully 
expressed in our lab using the psbA2 and nrsB native promoters as shown in 
chapter 5, 6 and 7.  
In order to take photosynthetic bio-production in Synechocystis to an industrial 
scale, an interdisciplinary approach needs to be taken, similar to what was done 
with work presented in chapters 5 and 6 of this thesis, that involves 
microbiologists, synthetic biologists and chemical engineers to create a synthetic 
toolbox for Synechocystis similar to that developed for model heterotrophic 
microbes (E. coli and S. cerviseae) in order to solve issues such as the low 
efficiency of cell metabolism, optimizing growth conditions, limitations in 
bioprocesses, effect of product toxicity and cost associated with product 
recovery.   
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Appendix 1: Plasmids utilised in this work. 
 
(1) pUK.4K: Used as a so.urce of the kmR cassette. 
 
 
 
 
 
Taken from:  
http://bric.postech.ac.kr/myboard/read.php?Board=exp_qna&id=26239 
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(2) pUC18: used as a base for the creation of the pLAH.A2 and pLAH.nrsB 
expression vectors.  
 
 
 
 
Taken from: http://www.genscript.com/vector/SD1162-pUC18_plasmid_DNA.html 
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(3) pUC.psbN.kmR (A): used for the generation of psbN knockouts. 
 
 
 
 
 
 
From: Saul Purton’s personal collection.  
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(4) pZΔES: used as a source of the ble marker gene.  
 
 
 
 
Note: A fragment of 541 bp (region between EcoRV and StuI sites) was deleted from the 
pZErO-1 to remove toxic ccdB gene and create plasmid pZΔES. The Ble fragment (SspI-
DraI fragment) = 607 bop. (Saul Purton’s personal collection).  
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(5) pRecJ.ble: Used to create RecJ knockouts in Synechocystis.  
 
 
 
 
From: Saul Purton’s personal collection. 
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Appendix 2: Recipe for stock solutions preparation of BG11 medium  
 
A) 100XBG11:                                   g/L 
NaNO3                                               149.6 
MgSO4.7H2O                                     7.49 
CaCl2                                                  3.60 
Citric acid                                           0.60 
Na2EDTA                                          1.12 ml 
0.25M solution, pH 8.0 
   B) Trace elements:                         g/100ml 
H3BO3                                                 0.286 
MnCl2.4H2O                                        0.181 
ZnSO4.7H2O                                       0.022 
Na2MoO4.2H2O                                   0.039 
CuSO4.5H2O                                       0.008 
Co(NO3)2.6H2O                                   0.005 
  
 
(c) Iron stock:                               g/100ml 
Ferric citrate                                        0.6 
Or Ferric ammonium citrate               1.11 
   Stock solution g/100ml 
 1) K2HPO4 3.05 
 2) Na2CO3 2.0 
 3) NaHCO3   8.401 
 4) TES buffer (NaOH to pH 8.2                    22.9 
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Appendix 3: List of primers  
 
Primer name Primer sequence 5' to 3' Function Section  
RecJ.F 5'-TACGCCATACCCTCATTTCC-3'  Testing for the isoaltion of + RecJ.Ble Synechoystis mutants  3.3.1 
Recj.R 5'-CTAATTCCACCACCAGATCC-3'  
within km.F 5’-GGAAAGCCACGTTGTGTCTCAAAATCTC-3’  Amplify km cassette  3.3.3 
within km.R 5’-GAAGAAGGTGTTGCTGACTCATACC-3’ 
psbA2.speA.F 5'- CCTCTACACAGCCCAGAACTATGG-3' Amplify area of interest for sequencing 3.3.3.4 
psbA2.speA.R 5'-TAATGCTTTATCCGCCGGCACAGG-3' 
GDP-Mannose.F(1) 5'- GCACTTTGCCGAACATTTCC-3' check integration in psbA2.speA area of genome  3.3.3.4 
km.faceout.F 5'-ccttttaacagcgatcgcg-3' 
GDP-Mannose.F(2) 5'-GGTCAGTGTTAAAGGTAGAAG-3' for sequanciny psbA2.speA area 3.3.3.4 
km.faceout.new.F 5'-acaacgcagaccgttccgtgg-3'  
Ble from pZΔEs.F 5'- AATATTAACGTTTACAATTTCGCCTGATGC-3' amplification ble cassette from the pZΔES plasmid  3.3.4 
Ble from pZΔEs.R 5'-CACCTAGATCCTTTTAAATTAAAAATG-3' 
GDP-Mannose.F(1) 5'- GCACTTTGCCGAACATTTCC-3' for amplification of the psbA2.speA area 3.3.6.2 
5' Ble screen 5'-GATGGCCAAGCTGACCAGCGC-3' 
Primer name Primer sequence 5'to 3' Function Section  
PsbN.km.1000F 5'-GAAGCCAAAAATTCCGTCACC-3' Amplify psbN.km knockout with 1000 flank homology on either side 4.3.1.1 
PsbN.km.1000R 5'- TTTTACCCACACCTCCAATCC -3' 
PsbN.km.600F 5' - GGCCGGCTAAGTTACCGCTACC - 3' Amplify psbN.km knockout with 600 flank homology on either side 4.3.1.1 
PsbN.km.600R 5' - CCGGCTCCAATTAGGTAAGGCAACTGCC-3' 
PsbN.km.400F 5' - CCATTAACCAGCCCAGTCCACGC- 3' Amplify psbN.km knockout with 400 flank homology on either side 4.3.1.1 
PsbN.km.400R 5'- GTGTAACCAGTGGCTAAGTATGTGC- 3' 
PsbN.km.200F 5'- GAGTGCGCTGTGCCATAGACTTCC -3' Amplify psbN.km knockout with 200 flank homology on either side 4.3.1.1 
PsbN.km.200R 5'- GTTGGTGCAAGGAGATCCTTACTGGC - 3' 
PsbN.km.100F 5' - GACAACAGAAACAACTATCAATCTTACC-3' Amplify psbN.km knockout with 100 flank homology on either side 4.3.1.1 
PsbN.km.100R 5'-GTGTTTAAATTAAAGACCCTGACGG -3' 
PsbN.km.50F 5'-CGCAACAGTTCTTAGCATTACTTTTGC -3' Amplify psbN.km knockout with 50 flank homology on either side 4.3.1.1 
PsbN.km.50R 5'- CGTGGTCATCGAAGGGATCACCC - 3' 
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PsbN.km.30F 
 
 
5'-GCTGTCATTCTCATCGCCATCACTGG- 3' Amplify psbN.km knockout with 30 flank homology on either side 4.3.1.1 
PsbN.km.30R 5'-CTCAGCGGACGGAGGGCCAAAGG- 3' 
long tail.37.km 5'-gctgtcattctcatcgccatcactggtctggctgtgtGAAGAAGGTGTTGCTGACTCATACC-3' Amplify psbN.km knockout with 30 flank homology using 1-step PCR 4.3.2.1 
long tail.29.km 5'-ctcagcggacggagggccaaaggaagtgtGGAAAGCCACGTTGTGTCTCAAAATCTC-3' 
long tail.62.km 
5'-cgcaacagttcttagcattacttttgctgtcattctcatcgccatcac 
tggtctggctgtgt GAAGAAGGTGTTGCTGACTCATACC-3' Amplify psbN.km knockout with 50 flank homology using 1-step PCR 4.3.3.3 
long tail.54.km 
5'-cgtggtcatcgaagggatcacccaactcagcggacggagggccaaa 
ggaagtgtGGAAAGCCACGTTGTGTCTCAAAATCTC-3' 
psb28.2.check.F 5'-ggttggcaatgaactatttgtcc-3' Check for correct integration in psb28.2 locus 4.3.3.3 
psb28.2.check.R 5'-gcaaacaataataagggcaacagc-3' 
psbA2.check.F 5'-accacttgcttcatcattgcc-3' Check for correct integration in psbA2 locus 4.3.3.3 
psbA2.check.R 5'-aaccagatgccgattacagg-3' 
psbA2.spea.F 5'-cctctacacagcccagaactatgg-3' check integration in psbA2.spea area of genome "hot spot"  4.3.3.3 
km.faceout.R 5'-ccttttaacagcgatcgcg-3' 
LT62.ble.psbN.F 
5'-cgcaacagttcttagcattacttttgctgtcattctcatcgccatcactggt 
ctggctgtgtGCATCTGTGCGGTATTTCACACCG-3' Amplify psbN.ble knockout with ~50 flank homology using 1-step PCR 4.3.4.2 
LT54.ble.psbN.R 
5'-cgtggtcatcgaagggatcacccaactcagcggacggagggccaaa 
ggaagtgtTGAAGTTTTAGCACGTGTCAGTCC-3' 
LT52.ble.psbA2.F 
5'-ttgctttacggtaacaacatcatctctggtgctgttgtaccttcttccaacg 
GCATCTGTGCGGTATTTCACACCG-3' Amplify psbA2.ble knockout with ~50 flank homology using 1-step PCR 4.3.4.2 
LT52.ble.psbA2.R 
5'-ggaacggctgttgttgaaagaagcatattggaagatcaaccgaccaaa 
gtagTGAAGTTTTAGCACGTGTCAGTCC-3' 
LT53.ble.psb28.2F 
5'- gttaaactgtcctgaccggctctagtaaaagttgttaggatcaaagaaatc 
ccGCATCTGTGCGGTATTTCACACCG-3' Amplify psb28.2.ble knockout with ~50 flank homology using 1-step PCR 4.3.4.2 
LT51.ble.psb28.2R 
5'-ataatcaaggcttaatttcgctagattgtcccctgattagagtctgtttg 
cTGAAGTTTTAGCACGTGTCAGTCC-3' 
PsbN.km.1000F 5'- GAAGCCAAAAATTCCGTCACC -3' Check for correct integration in psbN locus 4.3.4.4 
3' Ble screen 5'-gtcctgctcctcggccacgaa-3' (internal Ble priner) 
psb28.2.check.F 5'-ggttggcaatgaactatttgtcc-3' Check for correct integration in psb28.2 locus 4.3.4.4 
3' Ble screen 5'-gtcctgctcctcggccacgaa-3' (internal Ble priner) 
psbA2.check.F 5'-accacttgcttcatcattgcc-3' Check for correct integration in psbA2 locus 4.3.4.4 
3' Ble screen 5'-gtcctgctcctcggccacgaa-3' (internal Ble priner) 
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LT62.ble.psbN.F 
 
5'-gctgtcattctcatcgccatcactggtctggctgtgtGCATCTGTGCGGTATTTCACACCG-3' Amplify psbN.ble knockout with ~30 flank homology using 1-step PCR 4.3.4.4 
LT54.ble.psbN.R 5'-ccaactcagcggacggaggccaaaggaagtgtTGAAGTTTTAGCACGTGTCAGTCC-3' 
LT52.ble.psbA2.F 5'-ctctggtgctgttgtaccttcttccaacgGCATCTGTGCGGTATTTCACACCG-3' Amplify psbA2.ble knockout with ~30 flank homology using 1-step PCR 4.3.4.4 
LT52.ble.psbA2.R 5'-gcatattggaagatcaaccgaccaaagtagTGAAGTTTTAGCACGTGTCAGTCC-3' 
LT53.ble.psb28.2F 5'-gctctagtaaaagttgttaggatcaaagaaatcccGCATCTGTGCGGTATTTCACACCG-3' Amplify psb28.2.ble knockout with ~30 flank homology using 1-step PCR 4.3.4.4 
LT51.ble.psb28.2R 5'-gctagattgtcccctgattagagtctgtttgcTGAAGTTTTAGCACGTGTCAGTCC-3' 
LT52.Phycobili.ble.F 
5'ggtcaaaagagactcggcacccttgaggcgctcagaatccataatgtaatcg 
GCATCTGTGCGGTATTTCACACCG-3' 
Amplify operon.ble knockout with ~50 flank homology using 1-step PCR 4.3.4.5 
LT50.Phycobili.ble.R 
5'cgtgacatggaaatcatcctccgctatgttacctacgcaaccttcaccggT 
GAAGTTTTAGCACGTGTCAGTCC -3' 
Phycobsome.check.F 5'-ttgccagacgactagaactgc-3' Check for correct integration in the phycobilisome operon 4.3.4.5 
Phycobsome.check.R 5'- ccgttgctgaaggcaacaaacgg-3' 
Primer name Primer sequence 5'to 3' Function Section  
psbA2-SphI-1F 5´-ATGCATGCCCCTAAAAATATCAGAATCC-3´ Amplify upstream element in  pLAH.A2 expression vector  5.3.1.1 
psbA2-NdeI,SalI-1R  5´-GAGAGTCGACGTCATATGGTTATAATTCC-3´ 
psbA2-KpnI-2F  5´-CGGTACCTTCCTTGGTGTAATGCC-3´ Amplify downstream element in pLAH.2 expression vector  5.3.1.1 
psbA2-EcoRI-2R  5´-TCTAGAGAATTCTGGTCTTTGTAGCC-3´ 
A2new-HindIII-F 5´-CAGTGTTAAAGCTTGAAGTTCGG-3´ Amplify upstream element in pLAH.nrsBR expression vector  5.3.1.2 
A2new-HindIII-R 5´-CAGGAAGTTAATATACACGAAGC-3´ 
nrsRegu.SphI.F 5’-CCAGAAAGCCAATTGCATGCGACTACG-3’  Amplify nrsB promoter + regulatory element in pLAH.nrsB expression vector 5.3.1.2 
nrsB.NdeI.XhoI.R 5’-CTACTCGAGTTGTTTTCATCATATGACCTCAAATTGGG-3’ 
6803.nrsB.BleF 5'-GCCCATATGGCCAAGTTGACC-'3   Amplify 381 bp ble selectable marker with engineered NdeI and BamHI sites 5.3.1.3 
6803.nrBb.Ble.R 5'-TGAGGATCCTCAGTCCTGCTCCTCGGCC-'3 
Ben.F.seq.ups 5'-CCCAGAACTATGGTAAAGGCG-3'  used to check correct integration of G.O.I in psbA2 site 5.3.1.3 + 5.3.4.3 
out.GFP.AII.R 5'-GGTCTGCCTCGTGAAGAAGGTGTT-3'  
Farnesene.NdeI.F  5’-GCCCATATGGAATTTCGGGTGCATTTGC-3’ 
Amplify an HA tagged α–farnesene synthase gene  5.3.4.2 
farnesene.HA.BamHI.R 
5’-GTAGGATCCTTAGGCATAATCGGGCACATCAT 
AGGGATAGTTCACCAGGGGTTGAAAC-3’ 
GES-NdeI-F 5'-GCCCATATGCGCCCACGCTTCTCTG-3' 
Amplify GES gene from the pCRT7/CT-TOPO plasmid  5.3.2.3.i  
GES-HA.tag-BamHI-R 
5'-GTAGGATCCTTAGGCATAATCGGGCACA 
TCATAGGGATATTGAGTGAAGAAGAGGGCATC-3' 
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internal.GES.R 
 
 
5'-CCTGCAACCCCCAAATTTGACG-3' 
 check correct integration of GES in psbA2 site along with Ben.F.seq.usps 
primer 5.3.2.3.iii  
Primer name Primer sequence 5'to 3' Function Section  
ALK.NdeI-F 5'-CTAGTCATAGGAGGTAAAACATATGAG-3' 
Amplify alkL gene with its HA tag 6.3.1.1 
ALK-Hatag-BamHI.R 
5'- GTAGGATCCTTAGGCATAATCGGGCACATC 
ATAGGGATAGAAAACATACGACGCACCAAGAC-3' 
Ben.F.seq.ups 5'-CCCAGAACTATGGTAAAGGCG-3'  used to check correct integration of G.O.I in psbA2 site 6.3.1.2 
out.GFP.AII.R 5'-GGTCTGCCTCGTGAAGAAGGTGTT-3'  
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Appendix 4: CDS of GES 
 
ACCESSION   AY362553, Ocimum basilicum: geraniol synthase (GES) 1704 bp  
    
ATGTCTTGTG CACGGATCAC CGTAACATTG CCGTATCGCT CCGCAAAAAC ATCAATTCAA CGGGGAATTA 
CGCATTACCC CGCCCTTATA CGCCCACGCT TCTCTGCTTG CACGCCTTTG GCATCGGCGA TGCCTCTAAG 
TTCAACTCCT CTCATCAACG GGGATAACTC TCAGCGTAAA AACACACGTC AACACATGGA GGAGAGCAGC 
AGCAAGAGGA GAGAATATCT GCTGGAGGAA ACGACGCGAA AACTGCAGAG AAACGACACC GAATCGGTGG 
AGAAACTCAA GCTTATCGAC AACATCCAAC AGTTGGGAAT CGGCTACTAT TTTGAGGACG CCATCAACGC 
CGTACTCCGC TCGCCTTTCT CCACCGGAGA AGAAGACCTC TTCACCGCTG CTCTGCGCTT CCGCTTGCTC 
CGCCACAACG GCATCGAAAT CAGCCCTGAA ATATTCCTAA AATTCAAGGA CGAGAGGGGA AAATTCGACG 
AATCGGACAC GCTAGGGTTA CTGAGCTTGT ACGAAGCGTC AAATTTGGGG GTTGCAGGAG AAGAAATATT 
GGAGGAGGCT ATGGAGTTTG CGGAGGCTCG CCTGAGACGG TCGCTGTCAG AGCCGGCGGC GCCGCTTCAT 
GGTGAGGTGG CGCAAGCGCT AGATGTGCCG AGGCATCTGA GAATGGCGAG GTTGGAAGCG AGACGATTCA 
TCGAGCAGTA TGGTAAACAG AGCGATCATG ATGGAGATCT TTTGGAGCTG GCAATTTTGG ATTATAATCA 
AGTTCAGGCT CAACACCAAT CCGAACTCAC TGAAATAATC AGGTGGTGGA AGGAGCTCGG TTTGGTGGAT 
AAGTTGAGTT TTGGGCGAGA CAGACCATTG GAGTGCTTTT TGTGGACCGT GGGGCTCCTC CCAGAGCCCA 
AGTATTCGAG CGTTAGAATA GAGTTGGCGA AAGCCATCTC TATTCTCTTA GTGATCGATG ATATTTTCGA 
TACCTATGGA GAGATGGATG ACCTCATCCT CTTCACCGAT GCAATTCGAA GATGGGATCT TGAAGCAATG 
GAGGGGCTCC CTGAGTACAT GAAAATATGC TACATGGCGT TGTACAATAC CACCAATGAA GTATGCTACA 
AAGTGCTCAG GGATACTGGA CGGATTGTCC TCCTTAACCT CAAATCTACG TGGATAGACA TGATTGAAGG 
TTTCATGGAG GAAGCAAAAT GGTTCAATGG TGGAAGTGCA CCAAAATTGG AAGAGTATAT AGAGAATGGA 
GTGTCCACGG CAGGAGCATA CATGGCTTTT GCACACATCT TCTTTCTCAT AGGAGAAGGT GTTACACACC 
AAAATTCCCA ACTCTTCACC CAAAAACCCT ACCCCAAGGT CTTCTCCGCC GCCGGCCGCA TTCTTCGCCT 
CTGGGATGAT CTCGGAACCG CCAAGGAAGA GCAAGAGCGA GGAGATCTGG CTTCGTGCGT GCAGTTATTT 
ATGAAAGAGA AGTCGTTGAC GGAAGAGGAG GCAAGAAGTC GCATTTTGGA AGAGATAAAA GGATTATGGA 
GGGATCTGAA TGGGGAACTG GTCTACAACA AGAATTTGCC GTTATCCATA ATCAAAGTCG CACTTAACAT 
GGCGAGAGCT TCTCAAGTTG TGTACAAGCA CGATCAAGAC ACTTATTTTT CAAGCGTAGA CAATTATGTG 
GATGCCCTCT TCTTCACTCA ATAA 
 
Blue = predicted transit sequence 
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Appendix 5: Full sequence of RT17 (CT-TOPO) plasmid 
 
>pCRT7/CT-TOPO, 2702 bp 
GGATCTCGATCCCGCGAAATTAATACGACTCACTATAGGGAGACCACAACGGTTTCCCTCTAGAAATAATTTTGTTTAAC 
TTTAAGAAGGAATTGCCCTTAAGGGCAATTCGAAGCTTGAAGGTAAGCCTATCCCTAACCCTCTCCTCGGTCTCGATTCT 
ACGCGTACCGGTCATCATCACCATCACCATTGAGTTTAAACTATATAGAATAAAAGAAGAAACCTTAGCTGAGCAATAAC 
TAGCATAACCCCTTGGGGCCTCTAAACGGGTCTTGAGGGGTTTTTTGCTGAAAGGAGGAACTATATCCGGATTAACGCTT 
ACAATTTAGGTGGCACTTTTCGGGGAAATGTGCGCGGAACCCCTATTTGTTTATTTTTCTAAATACATTCAAATATGTAT 
CCGCTCATGAGACAATAACCCTGATAAATGCTTCAATAATGTGAGGAGGGCCACCATGGCCAAGTTGACCAGTGCCGTTC 
CGGTGCTCACCGCGCGCGACGTCGCCGGAGCGGTCGAGTTCTGGACCGACCGGCTCGGGTTCTCCCGGGACTTCGTGGAG 
GACGACTTCGCCGGTGTGGTCCGGGACGACGTGACCCTGTTCATCAGCGCGGTCCAGGACCAGGTGGTGCCGGACAACAC 
CCTGGCCTGGGTGTGGGTGCGCGGCCTGGACGAGCTGTACGCCGAGTGGTCGGAGGTCGTGTCCACGAACTTCCGGGACG 
CCTCCGGGCCGGCCATGACCGAGATCGGCGAGCAGCCGTGGGGGCGGGAGTTCGCCCTGCGCGACCCGGCCGGCAACTGC 
GTGCACTTCGTGGCCGAGGAGCAGGACTGACACATTGAAAAAGGAAGAGTATGAGTATTCAACATTTCCGTGTCGCCCTT 
ATTCCCTTTTTTGCGGCATTTTGCCTTCCTGTTTTTGCTCACCCAGAAACGCTGGTGAAAGTAAAAGATGCTGAAGATCA 
GTTGGGTGCACGAGTGGGTTACATCGAACTGGATCTCAACAGCGGTAAGATCCTTGAGAGTTTTCGCCCCGAAGAACGTT 
TTCCAATGATGAGCACTTTTAAAGTTCTGCTATGTGGCGCGGTATTATCCCGTATTGACGCCGGGCAAGAGCAACTCGGT 
CGCCGCATACACTATTCTCAGAATGACTTGGTTGAGTACTCACCAGTCACAGAAAAGCATCTTACGGATGGCATGACAGT 
AAGAGAATTATGCAGTGCTGCCATAACCATGAGTGATAACACTGCGGCCAACTTACTTCTGACAACGATCGGAGGACCGA 
AGGAGCTAACCGCTTTTTTGCACAACATGGGGGATCATGTAACTCGCCTTGATCGTTGGGAACCGGAGCTGAATGAAGCC 
ATACCAAACGACGAGAGTGACACCACGATGCCTGTAGCAATGCCAACAACGTTGCGCAAACTATTAACTGGCGAACTACT 
TACTCTAGCTTCCCGGCAACAATTAATAGACTGGATGGAGGCGGATAAAGTTGCAGGACCACTTCTGCGCTCGGCCCTTC 
CGGCTGGCTGGTTTATTGCTGATAAATCTGGAGCCGGTGAGCGTGGGTCTCGCGGTATCATTGCAGCACTGGGGCCAGAT 
GGTAAGCCCTCCCGTATCGTAGTTATCTACACGACGGGGAGTCAGGCAACTATGGATGAACGAAATAGACAGATCGCTGA 
GATAGGTGCCTCACTGATTAAGCATTGGTAACTGTCAGACCAAGTTTACTCATATATACTTTAGATTGATTTAAAACTTC 
ATTTTTAATTTAAAAGGATCTAGGTGAAGATCCTTTTTGATAATCTCATGACCAAAATCCCTTAACGTGAGTTTTCGTTC 
CACTGAGCGTCAGACCCCGTAGAAAAGATCAAAGGATCTTCTTGAGATCCTTTTTTTCTGCGCGTAATCTGCTGCTTGCA 
AACAAAAAAACGCGCTACCAGCGGTGGTTTGTTTGCCGGATCAAGAGCTACCAACTCTTTTTCCGAAGGTAACTGGCTTC 
AGCAGAGCGCAGATACCAAATACTGTTCTTCTAGTGTAGCCGTAGTTAGGCCACCACTTCAAGAACTCTGTAGCACCGCC 
TACATACCTCGCTCTGCTAATCCTGTTACCAGTGGCTGCTGCCAGTGGCGATAAGTCGTGTCTTACCGGGTTGGACTCAA 
GACGATAGTTACCGGATAAGGCGCAGCGGTCGGGCTGAACGGGGGGTTCGTGCACACAGCCCAGCTTGGAGCGAACGACC 
TACACCGAACTGAGATACCTACAGCGTGAGCTATGAGAAAGCGCCACGCTTCCCGAAGGGAGAAAGGCGGACAGGTATCC 
GGTAAGCGGCAGGGTCGGAACAGGAGACGCACGAGGGAGCTTCCAGGGGGAAACGCCTGGTATCTTTATAGTCCTGTCGG 
GTTTCGCCACCTCTGACTTGAGCGTCGATTTTTGTGATGCTCGTCAGGGGGGCGGAGCCTATGGAAAAACGCCAGCAACG 
CGGCCTTTTTACGGTTCCTGGCCTTTTGCTGGCCTTTTGCTCACATGTTCTTTCCTGCGTTATCCCCTGATTCTGTGGAT 
AACCGTATTACCGCCTTTGAGTGAGCTGATACCGCTCGCCGCAGCCGAACGACCGAGCGCAGCGAGTCAGTGAGCGAGGA 
AGCGGAAGAGCGCCCAATACGCAAACCGCCTCTCCCCGCGCGTTGGCCGATTCATTAATGCA 
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Appendix 6: Annotated sequence of the RecJ.km.HincII transformant vrs 
WT6803 sequence. 
 
RecJ.km.HincII transformant 
 
Key: CDS of Sll1212 (GDP-mannose 4, 6 dehydratease) (green) - kmr cassette (grey) - KpnI site 
(orange) – speA (blue), Blue highlighted sequences are the HIPI palindromic sequences. 
 
gaatggtaatttttgggcgatcgccaccggctgcaattaattgggcaacaacttgtttaccgaggaaaccggccccgcca
gtgaccaaaatacgttgattttctagggaaagcatggttggttaagaaaatattgagttaagggagggatttgcctaggt
ttactgtgcccataaaattctccaccatttgaaggccagggaaaattgctagttgttaaacactttgatcgaggcaacag
ttaagacgctcaaccaagcttaatcgacggcatggccattttggctccgaatgaaggccatatcctgggccatgagctcc
ttgattcgtccactctggttgggagaagttaaaccaaggactgctaagtctgcctccaccattaaatgaactaattccgt
aaaggtaaccgagggttcccagcccaattgggctttggttttcgccggatcgccgattaataaatctacttcagcggggc
gtaaatagcgctcatcaaaggccacatagttctgccagttgaggttgacgtaaccaaaggcaatttctaaaaattccttc
acttcgtgggtttcccccgtggccaccacatagtcatcgggctgttcctgttgcaacatggcccacatggcccgtacata
gtccttggcatagccccaatcccgcttggaatcgatattgcctaaatacaatttcttttgggtgccggccacaattctgg
cgatcgccctagtaattttcctggttacaaaggtttctccccggcggggggattcgtggttgaacaaaatgccgttacag
gcgaataagtcataggattcccgatagttcaccgtttgccaatggccataaaccttggcacaggcgtagggactgcgggg
ataaaagggggtggtttccttttggggaatctcctgcactttgccgaacatttccgaagaaccggcttgatagaacctta
cttggatgccggtgcgatgttgataatcccgaatcgcttccaatagtcgtagcgtccccatggccactgaatctacagtg
tattccggagaatcaaagctcacccgcacgtgggattgggcccccagattgtaaatctccgtcggtttgacatcttctaa
aatgcggcgcagggtggtgccgtcggtcagatcaccataatgaagtcggagtttcgcctcaagatcatggggatcaacat
aaagatgatcaatgcggtcagtgttaaaggtagaagttcggcgaatgatgccatggacttggtagcccttttccaacaac
aattcactcagataggagccatcttgccccgtgatgcctgtcagcaaaacaactttagactttgacattagttaattttt
ccccattgccccaaaatacatccccctaaaaatatcagaatccttgcccagatgcaggccttctggcgatcgccatggtg
agcaacgattgcggctttagcgttccagtggatatttgctgggggttaatgaaacattgtggcggaacccagggacaatg
tgaccaaaaaattcagggatatcaataagtattaggtatatggatcataattgtatgcccgactattgcttaaactgact
gaccactgaccttaagagtaatggcgtgcaaggcccagtgatcaatttcattatttttcattatttcatctccattgtcc
ctgaaaatcagttgtgtcgcccctctacacagcccagaactatggtaaaggcgcacgaaaaaccgccaggtaaactcttc
tcaacccccaaaacgccctctgtttacccatggaaaaaacgacaattacaagaaagtaaaacttatgtcatctataagct
tGCATGCCTGCAGGTCGACTCTAGAGGATCCCCGACctgcaggggggggggggcgctgaggtctgcctcgtgaagaaggt
gttgctgactcataccaggcctgaatcgccccatcatccagccagaaagtgagggagccacggttgatgagagctttgtt
gtaggtggaccagttggtgattttgaacttttgctttgccacggaacggtctgcgttgtcgggaagatgcgtgatctgat
ccttcaactcagcaaaagttcgatttattcaacaaagccgccgtcccgtcaagtcagcgtaatgctCtgccagtgttaca
accaattaaccaattctgaTTAGAAAAACTCATCGAGCATCAAATGAAACTGCAATTTATTCATATCAGGATTATCAATA
CCATATTTTTGAAAAAGCCGTTTCTGTAATGAAGGAGAAAACTCACCGAGGCAGTTCCATAGGATGGCAAGATCCTGGTA
TCGGTCTGCGATTCCGACTCGTCCAACATCAATACAACCTATTAATTTCCCCTCGTCAAAAATAAGGTTATCAAGTGAGA
AATCACCATGAGTGACGACTGAATCCGGTGAGAATGGCAAAAGCTTATGCATTTCTTTCCAGACTTGTTCAACAGGCCAG
CCATTACGCTCGTCATCAAAATCACTCGCATCAACCAAACCGTTATTCATTCGTGATTGCGCCTGAGCGAGACGAAATAC
GCGATCGCTGTTAAAAGGACAATTACAAACAGGAATCGAATGCAACCGGCGCAGGAACACTGCCAGCGCATCAACAATAT
TTTCACCTGAATCAGGATATTCTTCTAATACCTGGAATGCTGTTTTCCCGGGGATCGCAGTGGTGAGTAACCATGCATCA
TCAGGAGTACGGATAAAATGCTTGATGGTCGGAAGAGGCATAAATTCCGTCAGCCAGTTTAGTCTGACCATCTCATCTGT
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AACATCATTGGCAACGCTACCTTTGCCATGTTTCAGAAACAACTCTGGCGCATCGGGCTTCCCATACAATCGATAGATTG
TCGCACCTGATTGCCCGACATTATCGCGAGCCCATTTATACCCATATAAATCAGCATCCATGTTGGAATTTAATCGCGGC
CTCGAGCAAGACGTTTCCCGTTGAATATGGCTCATaacaccccttgtattactgtttatgtaagcagacagttttattgt
tcatgatgatatatttttatcttgtgCAATGTAacatcagagattttgagACACAAcgtggctttcccccccccccctgc
agGTCgggtaccttccttggtgtaatgccaactgaataatctgcaaattgcactctccttcaatggggggtgctttttgc
ttgactgagtaatcttctgattgctgatcttgattgccatcgatcgccggggagtccggggcagttaccattagagagtc
tagagaattaatccatcttcgatagaggaattatgggggaagaacctgtgccggcggataaagcattaggcaagaaattc
aagaaaaaaaatgcctcctggagcattgaagaaagcgaagctctgtaccgggttgaggcctggggggcaccttattttgc
cattaatgccgctggtaacataaccgtctctcccaacggcgatcggggcggttcgttagatttgttggaactggtggaag
ccctgcggcaaagaaagctcggcttacccctattaattcgtttttccgatattttggccgatcgcctagagcgattgaat
agttgttttgccaaggcgatcgcccgttacaattaccccaacacctatcaggcggtttatccggtcaaatgtaaccagca
acgacatctggtggaagccctggttcgctttgggcaaacttcccagtgtggattggaggcaggttccaaaccggaattga
tgattgccctcgcaactctaccacctcccttagaccgtcaggacaagcataccaagcccctaatcatttgtaatggctac
aaagaccaggattatctagaaacagctctgttagccaaacgcttaggccatcgtcccatcatcatcattgaacaactacg 
 
WT sequence 
 
Key: CDS of Sll1212 (GDP-mannose 4, 6 dehydratease) (green) - CDS of psbAII (purple) with 
promoter (maroon and underlined) – speA (blue), Blue highlighted sequences are the HIPI 
palindromic sequences. 
 
gaatggtaatttttgggcgatcgccaccggctgcaattaattgggcaacaacttgtttaccgaggaaaccggccccgcca
gtgaccaaaatacgttgattttctagggaaagcatggttggttaagaaaatattgagttaagggagggatttgcctaggt
ttactgtgcccataaaattctccaccatttgaaggccagggaaaattgctagttgttaaacactttgatcgaggcaacag
ttaagacgctcaaccaagcttaatcgacggcatggccattttggctccgaatgaaggccatatcctgggccatgagctcc
ttgattcgtccactctggttgggagaagttaaaccaaggactgctaagtctgcctccaccattaaatgaactaattccgt
aaaggtaaccgagggttcccagcccaattgggctttggttttcgccggatcgccgattaataaatctacttcagcggggc
gtaaatagcgctcatcaaaggccacatagttctgccagttgaggttgacgtaaccaaaggcaatttctaaaaattccttc
acttcgtgggtttcccccgtggccaccacatagtcatcgggctgttcctgttgcaacatggcccacatggcccgtacata
gtccttggcatagccccaatcccgcttggaatcgatattgcctaaatacaatttcttttgggtgccggccacaattctgg
cgatcgccctagtaattttcctggttacaaaggtttctccccggcggggggattcgtggttgaacaaaatgccgttacag
gcgaataagtcataggattcccgatagttcaccgtttgccaatggccataaaccttggcacaggcgtagggactgcgggg
ataaaagggggtggtttccttttggggaatctcctgcactttgccgaacatttccgaagaaccggcttgatagaacctta
cttggatgccggtgcgatgttgataatcccgaatcgcttccaatagtcgtagcgtccccatggccactgaatctacagtg
tattccggagaatcaaagctcacccgcacgtgggattgggcccccagattgtaaatctccgtcggtttgacatcttctaa
aatgcggcgcagggtggtgccgtcggtcagatcaccataatgaagtcggagtttcgcctcaagatcatggggatcaacat
aaagatgatcaatgcggtcagtgttaaaggtagaagttcggcgaatgatgccatggacttggtagcccttttccaacaac
aattcactcagataggagccatcttgccccgtgatgcctgtcagcaaaacaactttagactttgacattagttaattttt
ccccattgccccaaaatacatccccctaaaaatatcagaatccttgcccagatgcaggccttctggcgatcgccatggtg
agcaacgattgcggctttagcgttccagtggatatttgctgggggttaatgaaacattgtggcggaacccagggacaatg
tgaccaaaaaattcagggatatcaataagtattaggtatatggatcataattgtatgcccgactattgcttaaactgact
gaccactgaccttaagagtaatggcgtgcaaggcccagtgatcaatttcattatttttcattatttcatctccattgtcc
ctgaaaatcagttgtgtcgcccctctacacagcccagaactatggtaaaggcgcacgaaaaaccgccaggtaaactcttc
tcaacccccaaaacgccctctgtttacccatggaaaaaacgacaattacaagaaagtaaaacttatgtcatctataagct
tcgtgtatattaacttcctgttacaaagctttacaaaactctcattaatcctttagactaagtttagtcagttccaatct
gaacatcgacaaatacataaggaattataaccaaatgacaacgactctccaacagcgcgaaagcgcttccttgtgggaac
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agttttgtcagtgggtgacctctaccaacaaccggatttatgtcggttggttcggtaccttgatgatccccaccctctta
actgccaccacttgcttcatcattgccttcatcgccgctccccccgttgacatcgacggtatccgtgagcccgttgctgg
ttctttgctttacggtaacaacatcatctctggtgctgttgtaccttcttccaacgctatcggtttgcacttctacccca
tctgggaagccgcttccttagatgagtggttgtacaacggtggtccttaccagttggtagtattccacttcctcatcggc
attttctgctacatgggtcgtcagtgggaactttcctaccgcttaggtatgcgtccttggatttgtgtggcttactctgc
ccccgtatccgctgccaccgccgtattcttgatctaccccattggtcaaggctccttctctgatggtatgcccttgggta
tttctggtaccttcaacttcatgatcgtgttccaagctgagcacaacatcctgatgcaccccttccacatgttaggtgtg
gctggtgtattcggtggtagcttgttctccgccatgcacggttccttggtaacctcctccttggtgcgtgaaaccaccga
agttgaatcccagaactacggttacaaattcggtcaagaagaagaaacctacaacatcgttgccgcccacggctactttg
gtcggttgatcttccaatatgcttctttcaacaacagccgttccttgcacttcttcttgggtgcttggcctgtaatcggc
atctggttcactgctatgggtgtaagcaccatggcgttcaacctgaacggtttcaacttcaaccagtccatcttggatag
ccaaggccgggtaatcggcacctgggctgatgtattgaaccgagccaacatcggttttgaagtaatgcacgaacgcaatg
cccacaacttccccctcgacttagcgtctggggagcaagctcctgtggctttgaccgctcctgctgtcaacggttaattc
cttggtgtaatgccaactgaataatctgcaaattgcactctccttcaatggggggtgctttttgcttgactgagtaatct
tctgattgctgatcttgattgccatcgatcgccggggagtccggggcagttaccattagagagtctagagaattaatcca
tcttcgatagaggaattatgggggaagaacctgtgccggcggataaagcattaggcaagaaattcaagaaaaaaaatgcc
tcctggagcattgaagaaagcgaagctctgtaccgggttgaggcctggggggcaccttattttgccattaatgccgctgg
taacataaccgtctctcccaacggcgatcggggcggttcgttagatttgttggaactggtggaagccctgcggcaaagaa
agctcggcttacccctattaattcgtttttccgatattttggccgatcgcctagagcgattgaatagttgttttgccaag
gcgatcgcccgttacaattaccccaacacctatcaggcggtttatccggtcaaatgtaaccagcaacgacatctggtgga
agccctggttcgctttgggcaaacttcccagtgtggattggaggcaggttccaaaccggaattgatgattgccctcgcaa
ctctaccacctcccttagaccgtcaggacaagcataccaagcccctaatcatttgtaatggctacaaagaccaggattat
ctagaaacagctctgttagccaaacgcttaggccatcgtcccatcatcatcattgaacaactacg 
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Appendix 7: Sequence results of LT50.psbA2.kmR PCR product  
 
Alignment results between LT50.psbA2.km (Forward reaction sequence analysis) showing 
nucleotide deletions and mutations at the flanks homologous to the psbA2 gene.   
 
LA_LT50_psbAI    190 GGTTGTATTGATGTTGGACGAGTCGGAATCGCAGACCGATACCAGGATCT     
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
Visual           801 GGTTGTATTGATGTTGGACGAGTCGGAATCGCAGACCGATACCAGGATCT     
 
LA_LT50_psbAI    240 TGCCATCCTATGGAACTGCCTCGGTGAGTTTTCTCCTTCATTACAGAAAC     
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
Visual           851 TGCCATCCTATGGAACTGCCTCGGTGAGTTTTCTCCTTCATTACAGAAAC     
 
LA_LT50_psbAI    290 GGCTTTTTCAAAAATATGGTATTGATAATCCTGATATGAATAAATTGCAG     
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
Visual           901 GGCTTTTTCAAAAATATGGTATTGATAATCCTGATATGAATAAATTGCAG     
 
LA_LT50_psbAI    340 TTTCATTTGATGCTCGATGAGTTTTTCTAATCAGAATTGGTTAATTGGTT     
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
Visual           951 TTTCATTTGATGCTCGATGAGTTTTTCTAAtcagaattggttaattggtt    
 
LA_LT50_psbAI    390 GTAACACTGGCAGAGCATTACGCTGACTTGACGGGACGGCGGCTTTGTTG     
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
Visual          1001 gtaacactggcaGagcattacgctgacttgacgggacggcggctttgttg    
 
LA_LT50_psbAI    440 AATAAATCGAACTTTTGCTGAGTTGAAGGATCAGATCACGCATCTTCCCG     
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
Visual          1051 aataaatcgaacttttgctgagttgaaggatcagatcacgcatcttcccg    
 
LA_LT50_psbAI    490 ACAACGCAGACCGTTCCGTGGCAAAGCAAAAGTTCAAAATCACCAACTGG     
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
Visual          1101 acaacgcagaccgttccgtggcaaagcaaaagttcaaaatcaccaactgg    
 
LA_LT50_psbAI    540 TCCACCTACAACAAAGCTCTCATCAACCGTGGCTCCCTCACTTTCTGGCT     
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
Visual          1151 tccacctacaacaaagctctcatcaaccgtggctccctcactttctggct    
 
LA_LT50_psbAI    590 GGATGATGGGGCGATTCAGGCCTGGTATGAGTCAGCAACACCTTCTTCCT     
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
Visual          1201 ggatgatggggcgattcaggcctggtatgagtcagcaacaccttcttcct    
 
LA_LT50_psbAI    640 ACTTTGGTCGGTTGATCTTCCAATATGCTTCTTTC----ACATGGCCCTT     
                     |||||||||||||||||||||||||||||||||||    |||  |||.|| 
Visual          1251 actttggtcggttgatcttccaatatgcttctttcaacaaca--gccgtt    
 
LA_LT50_psbAI    686 TCCAAACCAACACGGGAGTCGAATGCAACCGGCGCAGGAACACTGCCAGC     
                     .|                                                 
Visual          1299 cc------------------------------------------------    
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Appendix 8: Operon responsible for phycobilisome expression  
Key: sll1580 (orange) - sll1579 (green) - sll1578 (blue) - sll1577 (red), primers used for PCR 
check (purple). Primers used for one-step PCR amplification (underlined). 
 
>Chr:724093..729092 
cctagttttgttcgttgctgtcagcttgatagggacgaatgttaacaatagttccccccagacgggaaatgc
ggcgcatctcatcattcatacgggcatagggaactttgataaacacactaccgctgcgacgaatatcgtggg
cactgttttcattggcatcggtctggcggagtccactgacttcatagacaaagacacggttagccgcctggg
tattggaatagcccaccaaagaagattgacctaacatggcgattctaaaaactcctgaacactaaagtttta
atttgctaattagcaaaatcatctacaaagacaaaaagagaagcgaccccaagttattccccaaagggaaaa
taaagtcaagccacttctcctcctgaactaaacagaaatctagctcaagctagccggggtaatactagcaac
cttaccccccaaacgattgatttgttgtaaggtctggttgagttgttcaaagggaacaattaccgccttatt
gctccgacgcactttgggataaccgggcgcagaaatggctgtaatttccacccggaacagcttacttgcttg
accaaagggaaccgtaccacccaacgcttttgctggggtattgccggcccgagaaggacgataggcccaacc
agcattactgccactggggcccacgatcgccgaaacagtattttgtcccaactccgttgccagacgactaga
actgcgctctaactgggaacggtcactgttagcataaccacggtaaagacggaacatgcgggtaaatcccac
agtgcgatcgcctacctgattattaaaacgataatagggaacaatattttccccaaagttctcttggtattc
gaccgaatcaatgtaagaatcgatatccgcatcaaaaccctgattttcatagagatcgagatggaaaatcac
ctcatcttcactgaaaggagcacgacccaacagatgtttgtagttgagttcaatgacccgggtttggaagtt
gttataaaggaatttcttcttataaagttccgacttggccacggtacggacaaattcccgcacactaataga
accattggtcaaaagagactcggcacccttgaggcgctcagaatccataatgtaatcgttgcctaaaacctg
acgatatacagcccgaatcaccattttggcatcatcaaggctaaagtcagggcgtaactccacaggacggga
ctcattatagggagccacccccaatctggaggctgcggttgtaattgccactaaataatctccttttactaa
ctaggttgacaaaaaatcctgattctaggcaagggaaatcattgtgaccgtatctccttggcgattgatttg
ttgcaacttggcagacaaattatcgtaggaaactagatactccgctttaccacggcgcactcgggtgccacg
accgggggccgccccttgaatcacttgcaaacgatacatttggttacgactacccgccgaagttccccgcaa
actctcggccgtagaaccggcatacaccggagaagctgtattgcgagccaactcccgcgtcaatcgagaacg
ggaaccatttccctgggaacgatcactggtagcgtagccccgatacacctggaaagaacggctgaaaccaac
ggttttttgattccgctgggtagcaaagccgcggaaataaggtacaacccaatctccaaagttttccgtgta
ttctacggagtcaatataggaattgatctccgcttcatagcccccctggtgataaagatcggtgtggaaagc
aatttccgactgatcgtagggagcccgtcccagtaaatgcttataattaagctcgataaaacgattttgtgg
gttggaatggaaaaacttctgccggtacacttccgacagagccacagcccgaacaaaatcccttaccgaaat
ctccctgccccggagcaaagattctgcactggtcagtcgttcctgggacatgagatgatcgttgcccaaaac
ttgacggtaaaccgccaggataacggcatccacctcttcctctgtactccgggaacgaagctcgaggggaat
agcctcatccacggccacaatgcccagacgctgggccgaaactaaactagtcattttgttctcctagataag
tgtcaataaatacgacaagacctggaaaagcggaatattgtcaaccagttgttaacactttcccacccttcc
aggccagctagaattaaaaactgactagctcagagcattgatggcgtaatcgaggtaggaattagcttcgtc
acgggcatcgccactcaagccgtggttagctttgatgtatttcagagcttcaacataccagctgggggagag
gtcaaaggtgcggttgatttcatcaataccggcgatcaagtactcatccaaaggaccggtaccaccagcaac
taagcagtaggtaacgatgcggaggtagtagccgatgtcccgggcacacttgtctttaccccgttgatccgc
agcaaagttgttgccttgggtttgggtggtgtaggggaatttgttataaacggcttgggcagcaccatttac
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caagctctgggcattgtcggtcagagctttagcggcttgcaaaccagcattagcttgacgtagacgaccgaa
agcagcgaccttgagagtcagcggtggaaacggcttcagttaaaggggttttcatatttgcaattcggtgct
gctcagaaatgttctggtatctcccgttagaatgtgaaaattttcctagatatgtcagctttaagctggatt
ttctcgggtatggaacctgagtaaagttggtttttaaaataaccagactaggctacggcagcagcggcgcgg
tcgaagtaaccagcgatttcagcaacgatagcactgcaatcaccacgggtgatgccattgggatcgttaacg
atgtccagggcagcttctttcattttttgaacgccagcagctacggaagcaccgggaacacccagggcaacg
taggtttcacggagaccgttcaagcaacgatcttctagaacggaagcgtcgccggtgaaggttgcgtaggta
acatagcggaggatgatttccatgtcacgcaaacaagcagccatacgacggctggtgtaggcgtttccaccg
ggttggattaattggggctgttcggcgaacaaagcacgagcagcgttggaaacgatagcggaagcattaccg
gtgatgcggttaacagaatcaatccgtttgttgccttcagcaacggtagcgctcaaagcatctaactgagaa
ccagagaggtactcgccgcgagcatcagcttgggaaacaacccgagtgaatacgtcgaacattgaattaatc
tcctacttgactttatgagttgggattttcttaaacacaattcccccggataaactgagggagtccaaagta
atgaccctagagttattgttactgatctccattaactttcgttaactacccggggatttatgagagatatta
cctaaataaatccagggagaaacacggaggcagcgacaagggccaccgggatgctcaaacagctcagcgcct
aggcttgaatgcttttgcaatcccacagttaactttatacaacggtgatgggacttatgtctgttacatctt
gttaattttattcctgcttttttgttaagtaatgttgcaggggattctcagattgtcctggattgggaaggg
aagacaaccagtttcgttcagcttatgttttagggctaaaattatgcaatt 
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Appendix 9: Sequence analysis of the pLAH.nrsB.ble expression vector. 
 Key: nrsB promoter + regulatory elements (red), ble selectable marker (blue). 
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Appendix 10: Sequenced analysis of pLAH.A2.GES.F expression vector 
 
• Key: Primers used for sequencing (red), Match with psbA2 gene (blue) 
• Sequence results show 99% match with the psbA2 gene but no match with GES gene.  
• Identities = 203/204 (99%), Gaps = 1/204 (0%), Strand=Plus/Plus 
 
Query  12   ACTCTTCTC-ACCCCCAAAACGCCCTCTGTTTACCCATGGAAAAAACGACAATTACAAGA  70 
            ||||||||| |||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  42   ACTCTTCTCAACCCCCAAAACGCCCTCTGTTTACCCATGGAAAAAACGACAATTACAAGA  101 
 
Query  71   AAGTAAAACTTATGTCATCTATAAGCTTCGTGTATATTAACTTCCTGTTACAAAGCTTTA  130 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  102  AAGTAAAACTTATGTCATCTATAAGCTTCGTGTATATTAACTTCCTGTTACAAAGCTTTA  161 
 
Query  131  CAAAACTCTCATTAATCCTTTAGACTAAGTTTAGTCAGTTCCAATCTGAACATCGACAAA  190 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  162  CAAAACTCTCATTAATCCTTTAGACTAAGTTTAGTCAGTTCCAATCTGAACATCGACAAA  221 
 
Query  191  TACATAAGGAATTATAACCATATG  214 
            |||||||||||||||||||||||| 
Sbjct  222  TACATAAGGAATTATAACCATATG  245 
 
 
• Visual of GES under the psbA2 promoter  
 
Sequence alignment results presented above show a match only to the 
psbA2 promoter (BLUE).  
 
cccagaactatggtaaaggcgcacgaaaaaccgccaggtaaactcttctcaacccccaaaacgccctctgtttacccatggaaaaaacga
caattacaagaaagtaaaacttatgtcatctataagcttcgtgtatattaacttcctgttacaaagctttacaaaactctcattaatcct
ttagactaagtttagtcagttccaatctgaacatcgacaaatacataaggaattataaccaTATgCGCCCACGCTTCTCTG CTTG 
CACGCCTTTGGCATCGGCGA TGCCTCTAAG TTCAACTCCT CTCATCAACG GGGATAACTC TCAGCGTAAAAACACACGTC 
AACACATGGA GGAGAGCAGC AGCAAGAGGA GAGAATATCT GCTGGAGGAAACGACGCGAA AACTGCAGAG AAACGACACC 
GAATCGGTGG AGAAACTCAA GCTTATCGACAACATCCAAC AGTTGGGAAT CGGCTACTAT TTTGAGGACG CCATCAACGC 
CGTACTCCGCTCGCCTTTCT CCACCGGAGA AGAAGACCTC TTCACCGCTG CTCTGCGCTT CCGCTTGCTCCGCCACAACG 
GCATCGAAAT CAGCCCTGAA ATATTCCTAA AATTCAAGGA CGAGAGGGGAAAATTCGACG AATCGGACAC GCTAGGGTTA 
CTGAGCTTGT ACGAAGCGTC AAATTTGGGGGTTGCAGGAG AAGAAATATT GGAGGAGGCT ATGGAGTTTG CGGAGGCTCG 
CCTGAGACGGTCGCTGTCAG AGCCGGCGGC GCCGCTTCAT GGTGAGGTGG CGCAAGCGCT AGATGTGCCGAGGCATCTGA 
GAATGGCGAG GTTGGAAGCG AGACGATTCA TCGAGCAGTA TGGTAAACAGAGCGATCATG ATGGAGATCT TTTGGAGCTG 
GCAATTTTGG ATTATAATCA AGTTCAGGCTCAACACCAAT CCGAACTCAC TGAAATAATC AGGTGGTGGA AGGAGCTCGG 
TTTGGTGGATAAGTTGAGTT TTGGGCGAGA CAGACCATTG GAGTGCTTTT TGTGGACCGT GGGGCTCCTCCCAGAGCCCA 
AGTATTCGAG CGTTAGAATA GAGTTGGCGA AAGCCATCTC TATTCTCTTAGTGATCGATG ATATTTTCGA TACCTATGGA 
GAGATGGATG ACCTCATCCT CTTCACCGATGCAATTCGAA GATGGGATCT TGAAGCAATG GAGGGGCTCC CTGAGTACAT 
GAAAATATGCTACATGGCGT TGTACAATAC CACCAATGAA GTATGCTACA AAGTGCTCAG GGATACTGGACGGATTGTCC 
TCCTTAACCT CAAATCTACG TGGATAGACA TGATTGAAGG TTTCATGGAGGAAGCAAAAT GGTTCAATGG TGGAAGTGCA 
CCAAAATTGG AAGAGTATAT AGAGAATGGAGTGTCCACGG CAGGAGCATA CATGGCTTTT GCACACATCT TCTTTCTCAT 
AGGAGAAGGTGTTACACACC AAAATTCCCA ACTCTTCACC CAAAAACCCT ACCCCAAGGT CTTCTCCGCCGCCGGCCGCA 
TTCTTCGCCT CTGGGATGAT CTCGGAACCG CCAAGGAAGA GCAAGAGCGAGGAGATCTGG CTTCGTGCGT GCAGTTATTT 
ATGAAAGAGA AGTCGTTGAC GGAAGAGGAGGCAAGAAGTC GCATTTTGGA AGAGATAAAA GGATTATGGA GGGATCTGAA 
TGGGGAACTGGTCTACAACA AGAATTTGCC GTTATCCATA ATCAAAGTCG CACTTAACAT GGCGAGAGCTTCTCAAGTTG 
TGTACAAGCA CGATCAAGAC ACTTATTTTT CAAGCGTAGA 
CAATTATGTGGATGGTAGgatccccgacctgcaggggggggggggcgctgaggtctgcctcgtgaagaaggtgtt 
 
 No match for GES gene  
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Appendix 11: Condon optimised α-farnesene synthase gene and its 
corresponding protein sequence. 
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 318 
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Appendix 12: GC-MS results of Farnesene in n-dodecane. 
(A) GC-MS results of farnesene in n-dodecane standards  
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(B) GC-MS results of farnesene in n-dodecane controls  
• Negative controls 
 
 
• Positive controls: cultures spiked with 0.02% farnesene 
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(C) GC-MS results of samples extracted in n-dodecane  
GC-MS results of n-dodecane supernatant and cell extracts of Synechocystis strain one 
and strain two expressing farnesene synthase under the psbA2 and nrsBR promoter 
respectively. No peak corresponding to α-farnesene observed at RT~ 13.95 min. Positive 
control is a 50 ppm standard of farnesene in n-dodecane. 
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Appendix 13: pLAH.nrsB.GES.HA sequence results 
Key: Primer used for seq (blue), deleted area from con2.GES plasmid upstream nrsB promoter 
(red), full nrsB promoter & regulator element (purple), GES gene (orange) showing start codon 
(green), A-tag (underlined) and stop codon (bold and stared*).  
 Forward reaction: shows perfect match with all of the nrsBR + front part of 
GES. 
 
 
Seq.result.GE      1 --------------------------------------------------      0 
                                                                        
visual             1 tgtgtcgcccctctacacagcccagaactatggtaaaggcgcacgaaaaa     50 
 
Seq.result.GE      1 CGGCCCGCAGT--ACTCTTCTC-ACCCCCAAAACGCCCTCTGTTTACCCA     47 
                     |.|||.|  ||  ||||||||| ||||||||||||||||||||||||||| 
visual            51 ccgccag--gtaaactcttctcaacccccaaaacgccctctgtttaccca     98 
 
Seq.result.GE     48 TGGAAAAAACGACAATTACAAGAAAGTAAAACTTATGTCATCTAT-----     92 
                     |||||||||||||||||||||||||||||||||||||||||||||      
visual            99 tggaaaaaacgacaattacaagaaagtaaaacttatgtcatctatcagga    148 
 
Seq.result.GE     93 --------------AAGCTTGCATGCGACTACGGGCAAAGAGGCGACGGG    128 
                                   |||||||||||||||||||||||||||||||||||| 
visual           149 agttaatatacacgaagcttgcatgcgactacgggcaaagaggcgacggg    198 
 
Seq.result.GE    129 TATTCATGGCGATAGGGTGAACCGATAGCCTTGACCGGGAACTGTTTTAA    178 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
visual           199 tattcatggcgatagggtgaaccgatagccttgaccgggaactgttttaa    248 
 
Seq.result.GE    179 TTGGGCAAGGACAATTTTGTTGAGCTAGCTTGCGTCGTATCAAACGCATT    228 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
visual           249 ttgggcaaggacaattttgttgagctagcttgcgtcgtatcaaacgcatt    298 
 
Seq.result.GE    229 TGGGCCGCCACCACATTACTCATGGGCTCCTCATCAAGATCCCACAGTTG    278 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
visual           299 tgggccgccaccacattactcatgggctcctcatcaagatcccacagttg    348 
 
Seq.result.GE    279 TTGCCGGATCTTGCTACCGGAAATGATCCGCTCTGGGTTTTGCATCAGAT    328 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
visual           349 ttgccggatcttgctaccggaaatgatccgctctgggttttgcatcagat    398 
 
Seq.result.GE    329 ATTGAAAAATTTGAAATTCTCTTACGGTTAAAGCAATTTCCTGTCTTTCT    378 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
visual           399 attgaaaaatttgaaattctcttacggttaaagcaatttcctgtctttct    448 
 
Seq.result.GE    379 AGGTTTAGTGGCTCCGAGATAGTTACCGATAACAGATTATTACTGGGATC    428 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
visual           449 aggtttagtggctccgagatagttaccgataacagattattactgggatc    498 
 
Seq.result.GE    429 AAGGCTGAAGTTGCCCAAAGTTAAAATTTGCGGTTGGAATTGTGGCGATC    478 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
visual           499 aaggctgaagttgcccaaagttaaaatttgcggttggaattgtggcgatc    548 
 
Seq.result.GE    479 GCCGTTGTAGTGCCCGCAGTCTTGCTAATAGCTCTGCCATCACAAACGGT    528 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
visual           549 gccgttgtagtgcccgcagtcttgctaatagctctgccatcacaaacggt    598 
 
Seq.result.GE    529 TTTGTTAGATAGTCATCTGCCCCGGCATCTAGTCCTTCGACACGGTTTTC    578 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
visual           599 tttgttagatagtcatctgccccggcatctagtccttcgacacggttttc    648 
 
Seq.result.GE    579 CGGTTCTCCTAACGCTGTTAACATCAACACCGGCAAGGAATTACCCTGGG    628 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
visual           649 cggttctcctaacgctgttaacatcaacaccggcaaggaattaccctggg    698 
 
Seq.result.GE    629 TTCTCAGTTTTTGACAGAGTTCCAAACCCGATAATCCCGGCAGTAACCAA    678 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
visual           699 ttctcagtttttgacagagttccaaacccgataatcccggcagtaaccaa    748 
 
Seq.result.GE    679 TCCACAATGGCAAGGGTGTATTCCGTCCATTGATTTTCCAAATAATCCCA    728 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
visual           749 tccacaatggcaagggtgtattccgtccattgattttccaaataatccca    798 
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Seq.result.GE    729 AGCTTGGGAGCCATCCGTCACCCAATCCACCACATACTTTTCACTAACTA    778 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
visual           799 agcttgggagccatccgtcacccaatccaccacatacttttcactaacta    848 
 
Seq.result.GE    779 GCACTTTCTTAATAGCCATTCCCAAATCCGTCTCATCTTCCACCAGCAAA    828 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
visual           849 gcactttcttaatagccattcccaaatccgtctcatcttccaccagcaaa    898 
 
Seq.result.GE    829 ATTCGCATCGCCTCTGCCTTTTTTATAACGGTCTGATCTTAGCGGGGGAA    878 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
visual           899 attcgcatcgcctctgccttttttataacggtctgatcttagcgggggaa    948 
 
Seq.result.GE    879 GGAGATTTTCACCTGAATTTCATACCCCCTTTGGCAGACTGGGAAAATCT    928 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
visual           949 ggagattttcacctgaatttcataccccctttggcagactgggaaaatct    998 
 
Seq.result.GE    929 TGGACAAATTCCCAATTTGAGGTCATATGCGCCCACGCTTCTCTGCTTGC    978 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
visual           999 tggacaaattcccaatttgaggtCATATgCGCCCACGCTTCTCTGCTTGC   1048 
 
Seq.result.GE    979 ACGCCTTTGGCATCGGCGATGCCTCTAAGTTCAACTCCTCTCATCAACGG   1028 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
visual          1049 ACGCCTTTGGCATCGGCGATGCCTCTAAGTTCAACTCCTCTCATCAACGG   1098 
 
Seq.result.GE   1029 GGATAACTCTCAGCGTAAAAACACACGTCAACACATGGAGGAGAGCAGCA   1078 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
visual          1099 GGATAACTCTCAGCGTAAAAACACACGTCAACACATGGAGGAGAGCAGCA   1148 
 
Seq.result.GE   1079 GCA----GAGAGAGATATCTGCTG--AGAAACGACGCG-AAACTGCAGAG   1121 
                     |||    |||||| ||||||||||  .||||||||||| ||||||||||| 
visual          1149 GCAAGAGGAGAGA-ATATCTGCTGGAGGAAACGACGCGAAAACTGCAGAG   1197 
 
 Reverse reaction: shows a very good match (for about 1000 bp) with GES.  
 
 
LA_pLAH_nrsB_    201                    CAAGTTCAGGCTACTGAAATAATCAGGT       250 
                                        |||||||||||||||||||||||||||| 
visual             1                    CAATCCGAACTCACTGAAATAATCAGGT       34 
 
LA_pLAH_nrsB_    251 GGTGGAAAGGAGCTCGGTTTGGTGGATAAGTTGAGTTTTGGGCGAGACAG    300 
                     ||||| |||||||||||||||||||||||||||||||||||||||||||| 
visual            35 GGTGG-AAGGAGCTCGGTTTGGTGGATAAGTTGAGTTTTGGGCGAGACAG     83 
 
LA_pLAH_nrsB_    301 ACCATTGGAGTGCTTTTTGTGGACCGTGGGGCTCCTCCCAGAGCCCAAGT    350 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
visual            84 ACCATTGGAGTGCTTTTTGTGGACCGTGGGGCTCCTCCCAGAGCCCAAGT    133 
 
LA_pLAH_nrsB_    351 ATTCGAGCGTTAGAATAGAGTTGGCGAAAGCCATCTCTATTCTCTTAGTG    400 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
visual           134 ATTCGAGCGTTAGAATAGAGTTGGCGAAAGCCATCTCTATTCTCTTAGTG    183 
 
LA_pLAH_nrsB_    401 ATCGATGATATTTTCGATACCTATGGAGAGATGGATGACCTCATCCTCTT    450 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
visual           184 ATCGATGATATTTTCGATACCTATGGAGAGATGGATGACCTCATCCTCTT    233 
 
 
LA_pLAH_nrsB_    451 CACCGATGCAATTCGAAGATGGGATCTTGAAGCAATGGAGGGGCTCCCTG    500 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
visual           234 CACCGATGCAATTCGAAGATGGGATCTTGAAGCAATGGAGGGGCTCCCTG    283 
 
LA_pLAH_nrsB_    501 AGTACATGAAAATATGCTACATGGCGTTGTACAATACCACCAATGAAGTA    550 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
visual           284 AGTACATGAAAATATGCTACATGGCGTTGTACAATACCACCAATGAAGTA    333 
 
LA_pLAH_nrsB_    551 TGCTACAAAGTGCTCAGGGATACTGGACGGATTGTCCTCCTTAACCTCAA    600 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
visual           334 TGCTACAAAGTGCTCAGGGATACTGGACGGATTGTCCTCCTTAACCTCAA    383 
 
LA_pLAH_nrsB_    601 ATCTACGTGGATAGACATGATTGAAGGTTTCATGGAGGAAGCAAAATGGT    650 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
visual           384 ATCTACGTGGATAGACATGATTGAAGGTTTCATGGAGGAAGCAAAATGGT    433 
 
LA_pLAH_nrsB_    651 TCAATGGTGGAAGTGCACCAAAATTGGAAGAGTATATAGAGAATGGAGTG    700 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
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visual           434 TCAATGGTGGAAGTGCACCAAAATTGGAAGAGTATATAGAGAATGGAGTG    483 
 
LA_pLAH_nrsB_    701 TCCACGGCAGGAGCATACATGGCTTTTGCACACATCTTCTTTCTCATAGG    750 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
visual           484 TCCACGGCAGGAGCATACATGGCTTTTGCACACATCTTCTTTCTCATAGG    533 
 
LA_pLAH_nrsB_    751 AGAAGGTGTTACACACCAAAATTCCCAACTCTTCACCCAAAAACCCTACC    800 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
visual           534 AGAAGGTGTTACACACCAAAATTCCCAACTCTTCACCCAAAAACCCTACC    583 
 
LA_pLAH_nrsB_    801 CCAAGGTCTTCTCCGCCGCCGGCCGCATTCTTCGCCTCTGGGATGATCTC    850 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
visual           584 CCAAGGTCTTCTCCGCCGCCGGCCGCATTCTTCGCCTCTGGGATGATCTC    633 
 
LA_pLAH_nrsB_    851 GGAACCGCCAAGGAAGAGCAAGAGCGAGGAGATCTGGCTTCGTGCGTGCA    900 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
visual           634 GGAACCGCCAAGGAAGAGCAAGAGCGAGGAGATCTGGCTTCGTGCGTGCA    683 
 
LA_pLAH_nrsB_    901 GTTATTTATGAAAGAGAAGTCGTTGACGGAAGAGGAGGCAAGAAGTCGCA    950 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
visual           684 GTTATTTATGAAAGAGAAGTCGTTGACGGAAGAGGAGGCAAGAAGTCGCA    733 
 
LA_pLAH_nrsB_    951 TTTTGGAAGAGATAAAAGGATTATGGAGGGATCTGAATGGGGAACTGGTC   1000 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
visual           734 TTTTGGAAGAGATAAAAGGATTATGGAGGGATCTGAATGGGGAACTGGTC    783 
 
LA_pLAH_nrsB_   1001 TACAACAAGAATTTGCCGTTATCCATAATCAAAGTCGCACTTAACATGGC   1050 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
visual           784 TACAACAAGAATTTGCCGTTATCCATAATCAAAGTCGCACTTAACATGGC    833 
 
LA_pLAH_nrsB_   1051 GAGAGCTTCTCAAGTTGTGTACAAGCACGATCAAGACACTTATTTTTCAA   1100 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
visual           834 GAGAGCTTCTCAAGTTGTGTACAAGCACGATCAAGACACTTATTTTTCAA    883 
 
LA_pLAH_nrsB_   1101 GCGTAGACAATTATGTGGATGCCCTCTTCTTCACTCAATATCCCTATGAT   1150 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
visual           884 GCGTAGACAATTATGTGGATGCCCTCTTCTTCACTCAATATCCCTATGAT    933 
 
LA_pLAH_nrsB_   1151 GTGCCCGATTATGCCTAA*GG-TCCCCGACCTGCAGGGGGGACGTT   1194 
                     |||||||||||||||||||| |  ||.||                 
visual           934 GTGCCCGATTATGCCTAAGGAT--CCTAC----------------    960 
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Appendix 14:  Full sequence and map of the pJ811 plasmid including the 
alkL gene (red)  
 
Sequence 
1 TTAATCTTTC TGCGAATTGA GATGACGCCA CTGGCTGGGC GTCATCCCGG TTTCCCGGGT AAACACCACC 
71 GAAAAATAGT TACTATCTTC AAAGCCACAT TCGGTCGAAA TATCACTGAT TAACAGGCGG CTATGCTGGA 
141 GAAGATATTG CGCATGACAC ACTCTGACCT GTCGCAGATA TTGATTGATG GTCATTCCAG TCTGCTGGCG 
211 AAATTGCTGA CGCAAAACGC GCTCACTGCA CGATGCCTCA TCACAAAATT TATCCAGCGC AAAGGGACTT 
281 TTCAGGCTAG CCGCCAGCCG GGTAATCAGC TTATCCAGCA ACGTTTCGCT GGATGTTGGC GGCAACGAAT 
351 CACTGGTGTA ACGATGGCGA TTCAGCAACA TCACCAACTG CCCGAACAGC AACTCAGCCA TTTCGTTAGC 
421 AAACGGCACA TGCTGACTAC TTTCATGCTC AAGCTGACCA ATAACCTGCC GCGCCTGCGC CATCCCCATG 
491 CTACCTAAGC GCCAGTGTGG TTGCCCTGCG CTGGCGTTAA ATCCCGGAAT CGCCCCCTGC CAGTCAAGAT 
561 TCAGCTTCAG ACGCTCCGGG CAATAAATAA TATTCTGCAA AACCAGATCG TTAACGGAAG CGTAGGAGTG 
631 TTTATCATCA GCATGAATGT AAAAGAGATC GCCACGGGTA ATGCGATAAG GGCGATCGTT GAGTACATGC 
701 AGGCCATTAC CGCGCCAGAC AATCACCAGC TCACAAAAAT CATGTGTATG TTCAGCAAAG ACATCTTGCG 
771 GATAACGGTC AGCCACAGCG ACTGCCTGCT GGTCGCTGGC AAAAAAATCA TCTTTGAGAA GTTTTAACTG 
841 ATGCGCCACC GTGGCTACCT CGGCCAGAGA ACGAAGTTGA TTATTCGCAA TATGGCGTAC AAATACGTTG 
911 AGAAGATTCG CGTTATTGCA GAAAGCCATC CCGTCCCTGG CGAATATCAC GCGGTGACCA GTTAAACTCT 
981 CGGCGAAAAA GCGTCGAAAA GTGGTTACTG TCGCTGAATC CACAGCGATA GGCGATGTCA GTAACGCTGG 
1051 CCTCGCTGTG GCGTAGCAGA TGTCGGGCTT TCATCAGTCG CAGGCGGTTC AGGTATCGCT GAGGCGTCAG 
1121 TCCCGTTTGC TGCTTAAGCT GCCGATGTAG CGTACGCAGT GAAAGAGAAA ATTGATCCGC CACGGCATCC 
1191 CAATTCACCT CATCGGCAAA ATGGTCCTCC AGCCAGGCCA GAAGCAAGTT GAGACGTGAT GCGCTGTTTT 
1261 CCAGGTTCTC CTGCAAACTG CTTTTACGCA GCAAGAGCAG TAATTGCATA AACAAGATCT CGCGACTGGC 
1331 GGTCGAGGGT AAATCATTTT CCCCTTCCTG CTGTTCCATC TGTGCAACCA GCTGTCGCAC CTGCTGCAAT 
1401 ACGCTGTGGT TAACGCGCCA GTGAGACGGA TACTGCCCAT CCAGCTCTTG TGGCAGCAAC TGATTCAGCC 
1471 CGGCGAGAAA CTGAAATCGA TCCGGCGAGC GATACAGCAC ATTGGTCAGA CACAGATTAT CGGTATGTTC 
1541 ATACAGATGC CGATCATGAT CGCGTACGAA ACAGACCGTG CCACCGGTGA TGGTATAGGG CTGCCCATTA 
1611 AACACATGAA TACCCGTGCC ATGTTCGACA ATCACAATTT CATGAAAATC ATGATGATGT TCAGGAAAAT 
1681 CCGCCTGCGG GAGCCGGGGT TCTATCGCCA CGGACGCGTT ACCAGACGGA AAAAAATCCA CACTATGTAA 
1751 TACGGTCATA CTGGCCTCCT GATGTCGTCA ACACGGCGAA ATAGTAATCA CGAGGTCAGG TTCTTACCTT 
1821 AAATTTTCGA CGGAAAACCA CGTAAAAAAC GTCGATTTTT CAAGATACAG CGTGAATTTT CAGGAAATGC 
1891 GGTGAGCATC ACATCACCAC AATTCAGCAA ATTGTGAACA TCATCACGTT CATCTTTCCC TGGTTGCCAA 
1961 TGGCCCATTT TCCTGTCAGT AACGAGAAGG TCGCGAATTC AGGCGCTTTT TAGACTGGTC GTAATGAAAT 
2031 TCTTTTGTCG ACACTAGTCA TAGGAGGTAA AACATATGAG TTTTTCTAAT TATAAAGTAA TCGCGATGCC 
2101 GGTGTTGGTT GCTAATTTTG TTTTGGGGGC GGCCACTGCA TGGGCGAATG AAAATTATCC GGCGAAATCT 
2171 GCTGGCTATA ATCAGGGTGA CTGGGTCGCC AGCTTCAATT TTTCTAAGGT CTATGTGGGT GAGGAGCTTG 
2241 GCGATCTAAA TGTTGGAGGG GGGGCTTTGC CAAATGCTGA TGTAAGTATT GGTAATGATA CAACACTTAC 
2311 GTTTGATATC GCCTATTTTG TTAGCTCAAA TATAGCGGTG GATTTTTTTG TTGGGGTGCC AGCTAGGGCT 
2381 AAATTTCAAG GTGAGAAATC AATCTCCTCG CTGGGAAGAG TCAGTGAAGT TGATTACGGC CCTGCAATTC 
2451 TTTCGCTTCA ATATCATTAC GATAGCTTTG AGCGACTTTA TCCTTATGTT GGGGTTGGTG TTGGTCGGGT 
2521 GCTATTTTTT GATAAAACCG ACGGTGCTTT GAGTTCGTTT GATATTAAGG ATAAATGGGC GCCTGCTTTT 
2591 CAGGTTGGCC TTAGATATGA CCTTGGTAAC TCATGGATGC TAAATTCAGA TGTGCGTTAT ATTCCTTTCA 
2661 AAACGGACGT CACAGGTACT CTTGGCCCGG TTCCTGTTTC TACTAAAATT GAGGTTGATC CTTTCATTCT 
2731 CAGTCTTGGT GCGTCGTATG TTTTCCATCA TCATCATCAT CATTAATAAG CTAGCGAATT CAAGCTTGAT 
2801 ATCATTCAGG ACGAGCCTCA GACTCCAGCG TAACTGGACT GAAAACAAAC TAAAGCGCCC TTGTGGCGCT 
2871 TTAGTTTTTC TAGAGGATCC GTCGACCCCC TCATCCGAAA GGGCGTATTG GTACCGAGCT CGAATTCGTA 
2941 ATCATGTCAT AGCTGTTTCC TGTGTGAAAT TGTTATCCGC TCACAATTCC ACACAACATA CGAGCCGGAA 
3011 GCATAAAGTG TAAAGCCTGG GGTGCCTAAT GAGTGAGCTA ACTCACATTA ATTGCGTTGC GCTCACTGCC 
3081 CGCTTTCCAG TCGGGAAACC TGTCGTGCCA GCTGCATTAA TGAATCGGCC AACGCGCGGG GAGAGGCGGT 
3151 TTGCGTATTG GGCGCTCTTC CGCTTCCTCG CTCACTGACT CGCTGCGCTC GGTCGTTCGG CTGCGGCGAG 
3221 CGGTATCAGC TCACTCAAAG GCGGTAATAC GGTTATCCAC AGAATCAGGG GATAACGCAG GAAAGAACAT 
3291 GTGAGCAAAA GGCCAGCAAA AGGCCAGGAA CCGTAAAAAG GCCGCGTTGC TGGCGTTTTT CCATAGGCTC 
3361 CGCCCCCCTG ACGAGCATCA CAAAAATCGA CGCTCAAGTC AGAGGTGGCG AAACCCGACA GGACTATAAA 
3431 GATACCAGGC GTTTCCCCCT GGAAGCTCCC TCGTGCGCTC TCCTGTTCCG ACCCTGCCGC TTACCGGATA 
3501 CCTGTCCGCC TTTCTCCCTT CGGGAAGCGT GGCGCTTTCT CATAGCTCAC GCTGTAGGTA TCTCAGTTCG 
3571 GTGTAGGTCG TTCGCTCCAA GCTGGGCTGT GTGCACGAAC CCCCCGTTCA GCCCGACCGC TGCGCCTTAT 
3641 CCGGTAACTA TCGTCTTGAG TCCAACCCGG TAAGACACGA CTTATCGCCA CTGGCAGCAG CCACTGGTAA 
3711 CAGGATTAGC AGAGCGAGGT ATGTAGGCGG TGCTACAGAG TTCTTGAAGT GGTGGCCTAA CTACGGCTAC 
3781 ACTAGAAGGA CAGTATTTGG TATCTGCGCT CTGCTGAAGC CAGTTACCTT CGGAAAAAGA GTTGGTAGCT 
3851 CTTGATCCGG CAAACAAACC ACCGCTGGTA GCGGTGGTTT TTTTGTTTGC AAGCAGCAGA TTACGCGCAG 
3921 AAAAAAAGGA TCTCAAGAAG ATCCTTTGAT CTTTTCTACG GGGTCTGACG CTCAGTGGAA CGAAAACTCA 
3991 CGTTAAGGGA TTTTGGTCAT GAGATTATCA AAAAGGATCT TCACCTAGAT CCTTTTAAAT TAAAAATGAA 
4061 GTTTTAAATC AATCTAAAGT ATATATGAGT AAACTTGGTC TGACAGTTAG AAAAACTCAT CGAGCATCAA 
4131 ATGAAACTGC AATTTATTCA TATCAGGATT ATCAATACCA TATTTTTGAA AAAGCCGTTT CTGTAATGAA 
4201 GGAGAAAACT CACCGAGGCA GTTCCATAGG ATGGCAAGAT CCTGGTATCG GTCTGCGATT CCGACTCGTC 
4271 CAACATCAAT ACAACCTATT AATTTCCCCT CGTCAAAAAT AAGGTTATCA AGTGAGAAAT CACCATGAGT 
4341 GACGACTGAA TCCGGTGAGA ATGGCAAAAG TTTATGCATT TCTTTCCAGA CTTGTTCAAC AGGCCAGCCA 
4411 TTACGCTCGT CATCAAAATC ACTCGCATCA ACCAAACCGT TATTCATTCG TGATTGCGCC TGAGCGAGAC 
4481 GAAATACGCG ATCGCTGTTA AAAGGACAAT TACAAACAGG AATCGAATGC AACCGGCGCA GGAACACTGC 
4551 CAGCGCATCA ACAATATTTT CACCTGAATC AGGATATTCT TCTAATACCT GGAATGCTGT TTTCCCGGGG 
4621 ATCGCAGTGG TGAGTAACCA TGCATCATCA GGAGTACGGA TAAAATGCTT GATGGTCGGA AGAGGCATAA 
4691 ATTCCGTCAG CCAGTTTAGT CTGACCATCT CATCTGTAAC ATCATTGGCA ACGCTACCTT TGCCATGTTT 
4761 CAGAAACAAC TCTGGCGCAT CGGGCTTCCC ATACAATCGA TAGATTGTCG CACCTGATTG CCCGACATTA  
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Plasmid sequence and construct were provided from the supplier “gene art”.  
http://www.lifetechnologies.com/om/en/home/life-science/cloning/gene-
synthesis/geneart-gene-synthesis.html  
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Appendix 15: Sequence results of the alkL gene with an HA tag 
Key: alkL gene: (black), HA tag:(blue), Stop codon: (red)  
  
Visual             1 ------Tatgagtttttctaattataaagtaatcgcgatgccggtgttgg     44 
                           |||||||||||||||||||||||||||||||||||||||||||| 
Seq              451 AGGTCATATGAGTTTTTCTAATTATAAAGTAATCGCGATGCCGGTGTTGG    500 
 
Visual            45 ttgctaattttgttttgggggcggccactgcatgggcgaatgaaaattat     94 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
Seq              501 TTGCTAATTTTGTTTTGGGGGCGGCCACTGCATGGGCGAATGAAAATTAT    550 
 
Visual            95 ccggcgaaatctgctggctataatcagggtgactgggtcgccagcttcaa    144 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
Seq              551 CCGGCGAAATCTGCTGGCTATAATCAGGGTGACTGGGTCGCCAGCTTCAA    600 
 
Visual           145 tttttctaaggtctatgtgggtgaggagcttggcgatctaaatgttggag    194 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
Seq              601 TTTTTCTAAGGTCTATGTGGGTGAGGAGCTTGGCGATCTAAATGTTGGAG    650 
 
Visual           195 ggggggctttgccaaatgctgatgtaagtattggtaatgatacaacactt    244 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
Seq              651 GGGGGGCTTTGCCAAATGCTGATGTAAGTATTGGTAATGATACAACACTT    700 
 
Visual           245 acgtttgatatcgcctattttgttagctcaaatatagcggtggatttttt    294 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
Seq              701 ACGTTTGATATCGCCTATTTTGTTAGCTCAAATATAGCGGTGGATTTTTT    750 
 
Visual           295 tgttggggtgccagctagggctaaatttcaaggtgagaaatcaatctcct    344 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
Seq              751 TGTTGGGGTGCCAGCTAGGGCTAAATTTCAAGGTGAGAAATCAATCTCCT    800 
 
Visual           345 cgctgggaagagtcagtgaagttgattacggccctgcaattctttcgctt    394 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
Seq              801 CGCTGGGAAGAGTCAGTGAAGTTGATTACGGCCCTGCAATTCTTTCGCTT    850 
 
Visual           395 caatatcattacgatagctttgagcgactttatccttatgttggggttgg    444 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
Seq              851 CAATATCATTACGATAGCTTTGAGCGACTTTATCCTTATGTTGGGGTTGG    900 
 
Visual           445 tgttggtcgggtgctattttttgataaaaccgacggtgctttgagttcgt    494 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
Seq              901 TGTTGGTCGGGTGCTATTTTTTGATAAAACCGACGGTGCTTTGAGTTCGT    950 
 
Visual           495 ttgatattaaggataaatgggcgcctgcttttcaggttggccttagatat    544 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
Seq              951 TTGATATTAAGGATAAATGGGCGCCTGCTTTTCAGGTTGGCCTTAGATAT   1000 
 
Visual           545 gaccttggtaactcatggatgctaaattcagatgtgcgttatattccttt    594 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
Seq             1001 GACCTTGGTAACTCATGGATGCTAAATTCAGATGTGCGTTATATTCCTTT   1050 
 
Visual           595 caaaacggacgtcacaggtactcttggcccggttcctgtttctactaaaa    644 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
Seq             1051 CAAAACGGACGTCACAGGTACTCTTGGCCCGGTTCCTGTTTCTACTAAAA   1100 
 
Visual           645 ttgaggttgatcctttcattctcagtcttggtgcgtcgtatgttttcTAT    694 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
Seq             1101 TTGAGGTTGATCCTTTCATTCTCAGTCTTGGTGCGTCGTATGTTTTCTAT   1150 
 
Visual           695 CCCTATGATGTGCCCGATTATGCCTAA*GGAT--CCTAC------------    730 
                     ||||||||||||||||||||||||||||| |  ||.||             
Seq             1151 CCCTATGATGTGCCCGATTATGCCTAA*GG-TCCCCGACTGCATGGGGGGG   1199 
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Appendix 16: List of websites used in this work. 
figure # website (URL) access date 
1.1.A http://www.ucmp.berkeley.edu/bacteria/cyanolh.html 02/03/2014 
1.1.B http://ashonko.blogspot.com/2010/11/nostoc.html 02/03/2014 
1.1.C http://eol.org/data_objects/2086619 02/03/2014 
1.1.D https://microbewiki.kenyon.edu/index.php/Merismopedia 02/03/2014 
1.1.E http://schwarz10.de/tribal/urban_gardening/spirulina/index-en.html 02/03/2014 
1.1.F http://protist.i.hosei.ac.jp/pdb/Images/Prokaryotes/Chroococcaceae/Synechocystis/index.html 02/03/2014 
1.2.B http://palaeos.com/eukarya/glossary/glossaryP.htm 02/03/2014 
1.2.C http://www.jochemnet.de/fiu/bot4404/BOT4404_12.html 02/03/2014 
1.3.A http://cmore.soest.hawaii.edu/microscopy/album/symbionts/ 02/03/2014 
1.3.B http://www.soils.umn.edu/academics/classes/soil3612/Symbiotic_Nitrogen_Fixation/Other.htm 02/03/2014 
1.3.C http://schuessler.userweb.mwn.de/geosiphon/geosiphon_home.html 02/03/2014 
1.5 http://parts.igem.org/Help:Plasmid_backbones/Glossary 02/03/2014 
1.7.A http://academic.brooklyn.cuny.edu/biology/bio4fv/page/molecular%20biology/mutation-amestest.html 02/03/2014 
1.8.B http://www.motifolio.com/6111153.html 02/03/2014 
1.10.B http://www.emsl.pnl.gov/news/viewArticle.jsp?articleId=167 02/03/2014 
1.15.A1 http://www.sigmaaldrich.com/catalog/product/sigma/i9516?lang=en&region=OM 03/03/2014 
1.15.A2 http://en.wikipedia.org/wiki/File:1-Butanol_skeletal.svg 03/03/2014 
1.15.A3 http://www.sigmaaldrich.com/catalog/product/aldrich/110949?lang=en&region=OM 03/03/2014 
1.15.A4 http://en.wikipedia.org/wiki/Isobutanol 03/03/2014 
1.15.B1 http://en.wikipedia.org/wiki/File:Limonene-2D-skeletal.svg 03/03/2014 
1.15.B2 http://en.wikipedia.org/wiki/Farnesene  03/03/2014 
1.15.C1 http://www.google.com/patents/US20120137574 03/03/2014 
1.15.C2 http://www.google.com/patents/US20120137574 03/03/2014 
1.17.A http://biofuels.asu.edu/biomaterials.shtml 02/03/2014 
1.17.B 
http://www.me-newswire.net/news/exxonmobil-and-synthetic 
-genomics-inc-advance-algae-biofuels-program-with-new-greenhouse/en 02/03/2014 
1.17.C http://www.indiamart.com/jbnenterprises/algae-reactors.html 02/03/2014 
1.17.D http://www.powerplantccs.com/ccs/cap/fut/alg/algae_cultivation_systems.html 02/03/2014 
1.17.E http://inhabitat.com/new-submission-30/ 02/03/2014 
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Appendix 17: Sequence analysis of α–farnesene synthase in the pLAH.A2 and pLAH.nrsB 
plasmids. 
Sequence analysis of pLAH.A2.FS plasmid 
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Con2F_OutGFP.      1 ATAATTTGAAATTTGCCCGTGATCGGTTGGTGGAATG-TTTGCNTGTGCC     49 
                     ||||||||||||||||||||||||||||||||||||| ||||| |||||| 
Visual             1 ATAATTTGAAATTTGCCCGTGATCGGTTGGTGGAATGTTTTGCCTGTGCC     50 
 
Con2F_OutGFP.     50 GTGGGCGTGGCCTTTGAACCCGAATATTCNTCCTTTCGGATTTGTTTGAC     99 
                     ||||||||||||||||||||||||||||| |||||||||||||||||||| 
Visual            51 GTGGGCGTGGCCTTTGAACCCGAATATTCCTCCTTTCGGATTTGTTTGAC    100 
 
Con2F_OutGFP.    100 CAAAGTGATTAACTTGGTGTTGATTATTGACGATGTGTATGACATTTACG    149 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
Visual           101 CAAAGTGATTAACTTGGTGTTGATTATTGACGATGTGTATGACATTTACG    150 
 
Con2F_OutGFP.    150 GCTCCGAAGAAGAACTGAAACATTTTACCAATGCCGTGGATCGGTGGGAT    199 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
Visual           151 GCTCCGAAGAAGAACTGAAACATTTTACCAATGCCGTGGATCGGTGGGAT    200 
 
Con2F_OutGFP.    200 AGTCGGGAAACCGAACAATTGCCCGAATGTATGAAAATGTGTTTTCAGGT    249 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
Visual           201 AGTCGGGAAACCGAACAATTGCCCGAATGTATGAAAATGTGTTTTCAGGT    250 
 
Con2F_OutGFP.    250 GTTGTATAATACCACCTGTGAAATTGCCCATGAAATTGAAAAAGAAAACG    299 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
Visual           251 GTTGTATAATACCACCTGTGAAATTGCCCATGAAATTGAAAAAGAAAACG    300 
 
Con2F_OutGFP.    300 GCTGGAATCAAGTGTTGCCCCAATTAACCAAAGTGTGGGCTGATTTTTGT    349 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
Visual           301 GCTGGAATCAAGTGTTGCCCCAATTAACCAAAGTGTGGGCTGATTTTTGT    350 
 
Con2F_OutGFP.    350 AAAGCCTTGTTGGTGGAAGCCGAATGGTACAATAAATCCCATATTCCCAC    399 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
Visual           351 AAAGCCTTGTTGGTGGAAGCCGAATGGTACAATAAATCCCATATTCCCAC    400 
 
Con2F_OutGFP.    400 CTTGGAAGAATATTTGCGGAATGGCTGTAATTCCTCATCCGTGTCCATTT    449 
                     ||||||||||||||||||||||||||||||||||||.||||||||||||| 
Visual           401 CTTGGAAGAATATTTGCGGAATGGCTGTAATTCCTCCTCCGTGTCCATTT    450 
 
Con2F_OutGFP.    450 TGTTGGTGCATTCCTTTTTTTCCATTACCCATGAAGGCACCAAAGAAATG    499 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
Visual           451 TGTTGGTGCATTCCTTTTTTTCCATTACCCATGAAGGCACCAAAGAAATG    500 
 
Con2F_OutGFP.    500 GCCGATTTTCTGCACAAAAATGAAGATCTGCTGTACAACTTGTCCTTGAT    549 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
Visual           501 GCCGATTTTCTGCACAAAAATGAAGATCTGCTGTACAACTTGTCCTTGAT    550 
 
Con2F_OutGFP.    550 TGTGCGGTTGAATAATGATTTGGGCACCTCCGCTGCCGAACAAGAACGGG    599 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
Visual           551 TGTGCGGTTGAATAATGATTTGGGCACCTCCGCTGCCGAACAAGAACGGG    600 
 
Con2F_OutGFP.    600 GTGATTCCCCCTCCTCCATTGTGTGTTATATGCGGGAAGTGAATGCCTCC    649 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
Visual           601 GTGATTCCCCCTCCTCCATTGTGTGTTATATGCGGGAAGTGAATGCCTCC    650 
 
Con2F_OutGFP.    650 GAAGAAATTGCCCGTAAAAACATTAAAGGCATGATTGACAACGCCTGGAA    699 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
Visual           651 GAAGAAATTGCCCGTAAAAACATTAAAGGCATGATTGACAACGCCTGGAA    700 
 
Con2F_OutGFP.    700 AAAAGTGAATGGCAAATGTTTTACCACCAACCAAGTGCCCTTTTTGTCCT    749 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
Visual           701 AAAAGTGAATGGCAAATGTTTTACCACCAACCAAGTGCCCTTTTTGTCCT    750 
 
Con2F_OutGFP.    750 CCTTTATGAATAATGCCACCAATATGGCTCGGGTGGCCCATTCCTTGTAT    799 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
Visual           751 CCTTTATGAATAATGCCACCAATATGGCTCGGGTGGCCCATTCCTTGTAT    800 
 
Con2F_OutGFP.    800 AAAGATGGTGATGGCTTTGGCGATCAAGAAAAAGGTCCCCGTACCCATAT    849 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
Visual           801 AAAGATGGTGATGGCTTTGGCGATCAAGAAAAAGGTCCCCGTACCCATAT    850 
 
Con2F_OutGFP.    850 TTTGTCCTTGTTGTTTCAACCCCTGGTGAACTATCCCTATGATGTGCCCG    899 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
Visual           851 TTTGTCCTTGTTGTTTCAACCCCTGGTGAACTATCCCTATGATGTGCCCG    900 
 
Con2F_OutGFP.    900 ATTATGCCTAA---------    910 
                     |||||||||||          
Visual           901 ATTATGCCTAATAAGGATCC    920 
 
  
The two mutations in the pLAH.nrsB.FS plasmid were silent and did not affect the amino acid sequence. 
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Sequence analysis of pLAH.A2.FS plasmid 
Con1.FS.HA       201 GAATTATAACCATATGGAATTTCGGGTGCATTTGCATGCCGATCATGAAC    250 
                               |||||||||||||||||||||||||||||||||||||||| 
Visual             1 ----------CATATGGAATTTCGGGTGCATTTGCATGCCGATCATGAAC     40 
 
Con1.FS.HA       251 AAAAAATTCTGCAAAACCAGATGAAACCCGAACCCGAAGCCTCCTATCTG    300 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
Visual            41 AAAAAATTCTGCAAAACCAGATGAAACCCGAACCCGAAGCCTCCTATCTG     90 
 
Con1.FS.HA       301 ATTAATCAACGGCGTTCCGCCAATTACAAACCCAATATTTGGAAAAACGA    350 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
Visual            91 ATTAATCAACGGCGTTCCGCCAATTACAAACCCAATATTTGGAAAAACGA    140 
 
Con1.FS.HA       351 CTTTCTGGACCAATCCTTGATTTCCAAATACGACGAAGATCAATATCGGA    400 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
Visual           141 CTTTCTGGACCAATCCTTGATTTCCAAATACGACGAAGATCAATATCGGA    190 
 
Con1.FS.HA       401 AACTGTCCGAAAAATTGATTGAAGAAGTGAAAATTTACATTAGTGCCGAA    450 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
Visual           191 AACTGTCCGAAAAATTGATTGAAGAAGTGAAAATTTACATTAGTGCCGAA    240 
 
Con1.FS.HA       451 ACCAAAGATTTGGTGGCCAAATTTGAACTGATTGATTCCGTGCGGAAATT    500 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
Visual           241 ACCAAAGATTTGGTGGCCAAATTTGAACTGATTGATTCCGTGCGGAAATT    290 
 
Con1.FS.HA       501 GGGCTTGGCCAATCATTTTGAAAAAGAAATTAAAGAAGCCTTGGATTCCA    550 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
Visual           291 GGGCTTGGCCAATCATTTTGAAAAAGAAATTAAAGAAGCCTTGGATTCCA    340 
 
Con1.FS.HA       551 TTGCCGCTATTGAATCCGATAATTTGGGCACCCGTGATGATTTGTATGGC    600 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
Visual           341 TTGCCGCTATTGAATCCGATAATTTGGGCACCCGTGATGATTTGTATGGC    390 
 
Con1.FS.HA       601 ACCGCCTTGCATTTTAAAATTTTGCGGCAACATGGCTACAAAGTGTCCCA    650 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
Visual           391 ACCGCCTTGCATTTTAAAATTTTGCGGCAACATGGCTACAAAGTGTCCCA    440 
 
Con1.FS.HA       651 AGATATTTTTGGTCGGTTTATGGATGAAAAAGGCACCCTGGAAAATCATC    700 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
Visual           441 AGATATTTTTGGTCGGTTTATGGATGAAAAAGGCACCCTGGAAAATCATC    490 
 
Con1.FS.HA       701 ATTTTGCCCATTTGAAAGGCATGTTGGAATTGTTTGAAGCCTCCAATTTG    750 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
Visual           491 ATTTTGCCCATTTGAAAGGCATGTTGGAATTGTTTGAAGCCTCCAATTTG    540 
 
Con1.FS.HA       751 GGCTTTGAAGGCGAAGATATTTTGGATGAAGCCAAAGCCTCCTTGACCTT    800 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
Visual           541 GGCTTTGAAGGCGAAGATATTTTGGATGAAGCCAAAGCCTCCTTGACCTT    590 
 
Con1.FS.HA       801 GGCCTTGCGGGATAGTGGCCATATTTGTTATCCCGATTCCAATTTGAGTC    850 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
Visual           591 GGCCTTGCGGGATAGTGGCCATATTTGTTATCCCGATTCCAATTTGAGTC    640 
 
Con1.FS.HA       851 GGGATGTGATTCATTCCTTGGAATTGCCCTCCCATCGGCGTGTGCAATGG    900 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
Visual           641 GGGATGTGATTCATTCCTTGGAATTGCCCTCCCATCGGCGTGTGCAATGG    690 
 
Con1.FS.HA       901 TTTGATGTGAAATGGCAAATTAATGNCTATGAAAAANATATTTGTCGGGT    950 
                     ||||||||||||||||||||||||| |||||||||| ||||||||||||| 
Visual           691 TTTGATGTGAAATGGCAAATTAATGCCTATGAAAAAGATATTTGTCGGGT    740 
 
Con1.FS.HA       951 GAATGCCACCTTGTTGGAATTGGCCAAACTGAATTTTAACATGGTGCAAG   1000 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
Visual           741 GAATGCCACCTTGTTGGAATTGGCCAAACTGAATTTTAACATGGTGCAAG    790 
 
Con1.FS.HA      1001 CCCAACTGNNNNNN------------------------------------   1014 
                     ||||||||                                           
Visual           791 CCCAACTGCAAAAAGATTTGCGGGAAGCCTCCAAATGGTGGGCCAATTTG    840 
 
 
  (The two sequences do not overlap since 42 base pairs have not been sequenced  
             due to bad DNA signal at the end of the chromatogrames) 
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FS.Con1.R         51 GNNNAATTTGGGCATTGCCGAT-ANNTGAAATTTNNCCGTGATCGGTTGG     99 
                               |||||||||||| |  ||||||||  |||||||||||||| 
Visual             1 ----------GGCATTGCCGATAATTTGAAATTTGCCCGTGATCGGTTGG     40 
 
FS.Con1.R        100 TGGAATGTTTTGCNTGTGCCGTGGGCGTGGCCTTTGAACCCGAATATTCN    149 
                     ||||||||||||| |||||||||||||||||||||||||||||||||||  
Visual            41 TGGAATGTTTTGCCTGTGCCGTGGGCGTGGCCTTTGAACCCGAATATTCC     90 
 
FS.Con1.R        150 TCCTTTCGGATTTGTTTGACCAAAGTGATTAACTTGGTGTTGATTATTGA    199 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
Visual            91 TCCTTTCGGATTTGTTTGACCAAAGTGATTAACTTGGTGTTGATTATTGA    140 
 
FS.Con1.R        200 CGATGTGTATGACATTTACGGCTCCGAAGAAGAACTGAAACATTTTACCA    249 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
Visual           141 CGATGTGTATGACATTTACGGCTCCGAAGAAGAACTGAAACATTTTACCA    190 
 
FS.Con1.R        250 ATGCCGTGGATCGGTGGGATAGTCGGGAAACCGAACAATTGCCCGAATGT    299 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
Visual           191 ATGCCGTGGATCGGTGGGATAGTCGGGAAACCGAACAATTGCCCGAATGT    240 
 
FS.Con1.R        300 ATGAAAATGTGTTTTCAGGTGTTGTATAATACCACCTGTGAAATTGCCCA    349 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
Visual           241 ATGAAAATGTGTTTTCAGGTGTTGTATAATACCACCTGTGAAATTGCCCA    290 
 
FS.Con1.R        350 TGAAATTGAAAAAGAAAACGGCTGGAATCAAGTGTTGCCCCAATTAACCA    399 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
Visual           291 TGAAATTGAAAAAGAAAACGGCTGGAATCAAGTGTTGCCCCAATTAACCA    340 
 
FS.Con1.R        400 AAGTGTGGGCTGATTTTTGTAAAGCCTTGTTGGTGGAAGCCGAATGGTAC    449 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
Visual           341 AAGTGTGGGCTGATTTTTGTAAAGCCTTGTTGGTGGAAGCCGAATGGTAC    390 
 
FS.Con1.R        450 AATAAATCCCATATTCCCACCTTGGAAGAATATTTGCGGAATGGCTGTAA    499 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
Visual           391 AATAAATCCCATATTCCCACCTTGGAAGAATATTTGCGGAATGGCTGTAA    440 
 
FS.Con1.R        500 TTCCTCCTCCGTGTCCATTTTGTTGGTGCATTCCTTTTTTTCCATTACCC    549 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
Visual           441 TTCCTCCTCCGTGTCCATTTTGTTGGTGCATTCCTTTTTTTCCATTACCC    490 
 
FS.Con1.R        550 ATGAAGGCACCAAAGAAATGGCCGATTTTCTGCACAAAAATGAAGATCTG    599 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
Visual           491 ATGAAGGCACCAAAGAAATGGCCGATTTTCTGCACAAAAATGAAGATCTG    540 
 
FS.Con1.R        600 CTGTACAACTTGTCCTTGATTGTGCGGTTGAATAATGATTTGGGCACCTC    649 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
Visual           541 CTGTACAACTTGTCCTTGATTGTGCGGTTGAATAATGATTTGGGCACCTC    590 
 
FS.Con1.R        650 CGCTGCCGAACAAGAACGGGGTGATTCCCCCTCCTCCATTGTGTGTTATA    699 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
Visual           591 CGCTGCCGAACAAGAACGGGGTGATTCCCCCTCCTCCATTGTGTGTTATA    640 
 
FS.Con1.R        700 TGCGGGAAGTGAATGCCTCCGAAGAAATTGCCCGTAAAAACATTAAAGGC    749 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
Visual           641 TGCGGGAAGTGAATGCCTCCGAAGAAATTGCCCGTAAAAACATTAAAGGC    690 
 
FS.Con1.R        750 ATGATTGACAACGCCTGGAAAAAAGTGAATGGCAAATGTTTTACCACCAA    799 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
Visual           691 ATGATTGACAACGCCTGGAAAAAAGTGAATGGCAAATGTTTTACCACCAA    740 
 
FS.Con1.R        800 CCAAGTGCCCTTTTTGTCCTCCTTTATGAATAATGCCACCAATATGGCTC    849 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
Visual           741 CCAAGTGCCCTTTTTGTCCTCCTTTATGAATAATGCCACCAATATGGCTC    790 
 
FS.Con1.R        850 GGGTGGCCCATTCCTTGTATAAAGATGGTGATGGCTTTGGCGATCAAGAA    899 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
Visual           791 GGGTGGCCCATTCCTTGTATAAAGATGGTGATGGCTTTGGCGATCAAGAA    840 
 
FS.Con1.R        900 AAAGGTCCCCGTACCCATATTTTGTCCTTGTTGTTTCAACCCCTGGTGAA    949 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
Visual           841 AAAGGTCCCCGTACCCATATTTTGTCCTTGTTGTTTCAACCCCTGGTGAA    890 
 
FS.Con1.R        950 C TAAG--------    981 TATCCCTATGATGTGCCCGATTATGCC
                     |||||||||||||||||||||||||||||||.         
Visual           891 CTATCCCTATGATGTGCCCGATTATGCCTAATAAGGATCC    930  
Key: NdeI site (blue), over-lapping sequences between forward and reverse DNA sequence reactions (purple), HA tag 
(orange), stop codon (green). 
 
 333 
Publications 
 
 
